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Summary 
Herpes simplex virus type 1 (HSV-1) has a large linear double-stranded DNA genome in 
an icosahedral capsid shell, a cell-derived lipid envelope and a proteinaceous tegument 
layer. There are over fifty viral proteins and many host proteins identified in HSV-1 virions. 
The final formation of mature virus particles requires the membrane wrapping of 
tegumented capsids in the cytoplasm, a process termed secondary envelopment. This 
process involves the coordination of numerous viral and cellular proteins and results in 
double-membrane structures with enveloped virions contained within cellular vesicles. 
Mature viruses are then released through the fusion of these virion-containing vesicles and 
plasma membranes. This thesis describes investigation into the functions of viral 
glycoprotein M (gM) and the cellular Endosomal Sorting Complexes Required for 
Transport (ESCRT) in secondary envelopment.  
Firstly, it has been reported that gH/L can be efficiently internalised and targeted to the 
TGN by the co-expression of gM in transfection assays. In order to examine the role of 
gM in guiding the localisation of viral proteins in infected cells, a HSV-1 gM deletion virus 
(∆gM), and its revertant virus were constructed. The major phenotype demonstrated was 
that the absence of gM caused the internalisation of cell surface gH/L to be inhibited and 
higher levels of gH/L to be observed on the cell surface. Further, lower levels of gH/L 
were detected in purified ∆gM virions, which was in agreement with the delayed entry 
kinetics, smaller plaque sizes and greater replication deficits at low multiplicity of infection 
observed in ∆gM infected cells. Over all the results presented in this thesis demonstrate 
that in infected cells the efficient incorporation of gH/L into virions relies on the function 
of gM in HSV-1.  
Secondly, during HSV-1 secondary envelopment the budding and scission of the viral 
envelope from the host membrane share topological similarities with the formation of 
intraluminal vesicle in multivesicular bodies, retrovirus budding, and abscission at the end 
of cytokinesis, processes that require the cellular ESCRT machinery. There are four 
multiprotein ESCRT complexes and many associated proteins involved in their regulation. 
It has been previously shown that the ESCRT-III complex and a functional ATPase VPS4 
are required for HSV-1 secondary envelopment, but different from the strategy utilised by 
HIV-1, the recruitment of ESCRT during HSV-1 infection is independent of TSG101 
and/or ALIX. Data presented in this thesis demonstrate that CHMP4A/B/C proteins of 
the ESCRT-III complex are specifically crucial for HSV-1 secondary envelopment. 
 v 
 
Simultaneous depletion of CHMP4A/B/C proteins significantly inhibited HSV-1 
replication. Ultrastructure analysis revealed that there were virtually no extracellular virions 
in CHMP4A/B/C depleted samples while more free capsids were observed in the 
cytoplasm, although the nuclear capsids and primary envelopment events appeared to be 
normal. In order to identify interactions between HSV-1 and ESCRT proteins, 22 HSV-1 
tegument proteins were cloned and tested against a panel of ESCRT and ESCRT-
associated proteins in yeast two-hydrid assays. Analysis of positive hits from yeast two-
hybrid interaction screens using GST pull-down, co-immunoprecipitation and protein co-
localisation assays have validated interactions of pUL47 with CC2D1A/1B, CIN85, 
CHMP6 and ALIX, pUL46 and pUL49 with CC2D1A/1B and CIN85, and pUL16 with 
CC2D1A/1B. Furthermore, the newly identified ESCRT associated proteins CC2D1A and 
CC2D1B have been detected in purified virions. The role of the identified ESCRT 
proteins in HSV-1 replication has been investigated using siRNA depletion. Unfortunately 
siRNA depletions of the various ESCRT candidates individually or in combinations did 
not show any significant effect on HSV-1 replication. Overall these data suggest that 
unlike HIV and other retroviruses, HSV-1 has evolved multiple parallel pathways to hijack 
the ESCRT machinery to facilitate its replication, particularly, through the interactions that 
lead directly to the recruitment of CHMP4A/B/C proteins. Disruption of some of these 
pathways did not prevent HSV-1 replication in tissue culture, suggesting any one potential 
pathway is sufficient for ESCRT recruitment to sites of HSV-1 assembly. 
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1     Introduction 
1.1 The order Herpesvirales 
1.1.1 Classification 
Our earliest recorded knowledge of herpes simplex virus (HSV) can be traced back to the 
ancient Greeks who used the word ‘herpes’ to describe lesions that appeared to creep or 
crawl along the skin. However, it was not until 1981 that the definition, nomenclature and 
taxonomy of Herpesviridae had been established (Roizman & Whitley, 2001). The members 
of Herpesviridae family were initially classified based on the structures and biological 
properties of the virions by the Herpesvirus Study Group of the International Committee 
on the Taxonomy of Viruses (ICTV). Herpesviruses have a broad host range and up to 
135 species have been identified in animals as varied as shellfish and mammals (Davison et 
al., 2009). Recently, the taxonomy has been updated by ICTV. The former family 
Herpesviridae has been split into three families and incorporated into the new order 
Herpesvirales. In the new classification system, the family Herpesviridae retains the mammal, 
bird and reptile viruses. The two new families are Alloherpesviridae (Allo is from Greek 
meaning other or different), which incorporates the fish and frog viruses, and 
Malacoherpesviridae (Malaco is from Greek meaning soft), which currently contains only one 
bivalve virus (Ostreid herpesvirus 1). The family Herpesviridae consists of three sub-families: 
Alphaherpesvirinae (containing the Simplexvirus, Varicellovirus, Mardivirus and Iltovirus genera), 
Betaherpesvirinae (containing the Cytomegalovirus, Muromegalovirus, Roseolovirus and Proboscivirus 
genera) and Gammaherpesvirinae (containing the Lymphocryptovirus, Rhadinovirus, Macavirus and 
Percavirus genera). Three new genera, Proboscivirus, Macavirus and Percavirus, have been added 
to the new herpesvirus taxonomy. Members in the family Herpesviridae have mature virions 
that vary in size from 120 to 300 nm. The distinct morphologies of herpesviruses virions 
includes at least four structure features: 1) a linear double-stranded DNA genome that 
varies from approximately 125 to 290 kbp; 2) an icosahedral (T=16) capsid with a diameter 
of approximately 100 nm containing the viral genome; 3) a proteinaceous layer between 
the capsid and the envelope termed the tegument; 4) a lipid envelope derived from cell 
membrane structures carrying viral glycoprotein spikes. These four features of virion 
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morphology are the primary criterion for inclusion of an agent into this family (Davison et 
al., 2009; Mettenleiter, 2002; Mettenleiter et al., 2006; 2009; Pellett & Roizman, 2007). 
Despite the common characteristics, members of the Herpesviridae family have a wide range 
of biological properties. The three sub-families under the family Herpesviridae were initially 
classified according to these biological properties of the viruses without the information 
on their genome sequences (Table 1.1) (Pellett & Roizman, 2007; Weir, 1998). 
Subsequently, the sequence information (gene organisation and arrangement according to 
DNA sequencing and protein homology from aa sequences) has become the primary basis 
for classification. This sequence analysis has proved that the previous classification system 
was very accurate in representing the relatedness of different species of herpesviruses. 
However, the classification of a few members has been changed according to the newly 
identified biological properties. For instance, the Marek’s disease virus type 1 was classified 
as a gammaherpesvirus as the virus causes lymphloid tumors in chickens, but sequence 
data indicated that it is more related to alphaherpesviruses (Weir, 1998).  
Table 1.1 Sub-families of Herpesviridae. 
Sub-family Biological properties 
Alphaherpesvirinae 
A variable host range, relatively short reproductive cycle, rapid spread 
in culture, efficient destruction of host cells and capability to establish 
latency primarily in sensory ganglia. 
Betaherpesvirinae 
A more restricted host range, relatively long reproductive cycle, slow 
infection progress in culture, infected cells frequently become enlarged 
and capable to establish latency in secretory glands, lymphoreticular 
cells, kidneys and other tissues. 
Gammaherpesvirinae 
A restricted host range limited to the natural hosts, replicate in 
lymphoblastoid cells in vitro, lytic infections could be caused in some 
epithelioid and fibroblastic cells, latency is usually in lymphoid tissue 
and viruses are specific for either T or B lymphocytes. 
 
The human herpesviruses are among the best characterised viruses from the Herpesviridae 
family. There are eight members infecting humans as the natural host (Table 1.2). These 
viruses frequently infect human beings and are associated with various human diseases, 
including vesicular skin lesion, viral encephalitis, mononucleosis, and cancer (Schleiss, 
2009). The formal names for the eight human herpesviruses are human herpesvirus (HHV) 
1-8, but the common names for some of these viruses are more frequently used. 
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Table 1.2 List of human herpesviruses. 
Virus 
Common 
name 
Genome 
Sub-
family 
Related disease 
HHV-1 HSV-1 152 kbp α 
Encephalitis (an acute inflammation of the brain) 
Aseptic meningitis (viral meningitis) 
Herpetic keratitis (infection of the corneal 
epithelium) 
Gingivostomatitis/pharyngitis (peri- and intraoral 
lesions involving the pharyngeal mucosa) 
Herpetic whitlow (primary lesion involves the 
fingers or hand) 
Herpes gladiatorum (primary cutaneous infection 
associated with the close, skin-to-skin contact 
during athletic competitions) 
Eczema herpeticum (cutaneous infection in 
children with atopic dermatitis) 
Genital herpes, neonatal herpes, herpes labialis 
and erythema multiforme 
HHV-2 HSV-2 152 kbp α 
HHV-3 VZV 125 kbp α 
Varicella (chickenpox) 
Herpes zoster (shingles) 
Encephalitis 
Fetal varicella syndrome 
HHV-4 EBV 172 kbp γ 
Infectious mononucleosis (glandular fever) 
EBV-associated malignancies 
HHV-5 HCMV 248 kbp β 
Mononucleosis 
Congenital CMV infection 
HHV-
6A/B 
NA 
159-170 
kbp 
β 
Encephalitis 
Congenital transmission 
Febrile seizures (a convulsion associated with a 
significant rise in body temperature) 
Roseola infantum (exanthem subitum; rose rash of 
infants) 
HHV-7 NA 145 kbp β 
HHV-8 KSHV 
170-210 
kbp 
γ 
Kaposi sarcoma 
Castleman’s disease 
HSV-1/2: Herpes simplex virus-1/2. VZV: Varicella-zoster virus. EBV: Epstein-Barr virus. 
HCMV: Human cytomegalovirus. HHV-6A/B: Human herpesvirus-6A/B. HHV-7: Human 
herpesvirus-7. KSHV: Kaposi’s sarcoma-associated herpesvirus. 
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Herpes Simplex Virus type 1 (HSV-1) belongs to the sub-family Alphaherpesvirinae. It has a 
high worldwide infection rate of between 40-80% (Diefenbach et al., 2008) and is one of 
the common human pathogens causing most forms of non-genital herpes simplex 
infection (such as cold sores) in human beings. HSV-1 is relatively easy to work with in 
culture and serves as a good model for research into the conserved functions of viral 
proteins. Therefore HSV-1 is the virus model employed in this thesis and the subsequent 
part of the introduction related to virus genome, structure and life cycle will be mainly 
focussed on this virus. 
1.1.2 HSV-1 genome organisation 
The viral genome of HSV-1 (strain 17, Refseq: NC_001806) consists of approximately 152 
kilo base pairs and has a G + C content of 68% (Weir, 1998). The genome is composed of 
two covalently linked segments called Long (L) and Short (S) according to their relative 
length. L and S segments contain unique long (UL) (108 kb) and unique short (US) (13 kb) 
sequence regions respectively, and these regions are flanked by inverted repeat sequences 
including two internal repeats (IR) and two terminal repeats (TR). Therefore the six 
regions in the viral genome are presented as: TRL – UL – IRL – IRS – US – TRS. There is 
only a single copy for each viral gene located in the unique regions. However, genes 
encoded in the repeat regions (e.g., ICP0 and ICP4) have two copies (Weir, 1998). Viral 
genes are usually named based on their positions in the L or S region (e.g., UL1 or US2), 
and the protein products of these genes are often named by adding the prefix ‘p’ to the 
gene (e.g., pUL10). However, many viral proteins are also named according to other 
features including function (e.g., origin binding protein), infected cell protein number (e.g., 
ICP0), and virion polypeptide/protein number (e.g., VP5) (Pellett & Roizman, 2007).  
The HSV-1 genome contains three origins of replication: one copy of oriL, which is 
located in the UL region, and two copies of oriS, which are located in IRS and TRS. These 
origins of replication contain multiple binding sites for the viral origin binding protein 
(pUL9). It has been reported that either oriL or one of the oriS is sufficient for viral 
replication. During viral DNA synthesis, progeny genomes are generated in the form of 
long concatemers and need to be cleaved into monomers. Within the inverted repeat 
regions there are two DNA sequence elements, pac1 and pac2, to ensure proper cleavage 
and packaging of the viral genome (Igarashi et al., 1993; Polvino-Bodnar et al., 1987; Taylor 
et al., 2002). For HSV-1, there are at least 74 open-reading frames (ORFs), which encode 
all the proteins required to form the virus capsid, tegument and envelope as a virus particle, 
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as well as to regulate the viral replication and infectivity (McGeoch et al., 2006; Mettenleiter 
et al., 2006). All of these characteristics of the genome form the foundation of the large, 
complex herpesviruses. 
1.1.3 HSV-1 virion structure 
With the emergence of highly sensitive techniques, such as mass spectrometry and electron 
microscopy, the HSV-1 virion structure has gradually been uncovered. HSV-1 is a large 
complex enveloped virus with a diameter of 170-200 nm. The viral genomic DNA is 
densely packed in an icosahedral (T = 16) shaped viral capsid, which is 115 to 130 nm in 
diameter and about 15 nm in thickness. The capsid has 162 surface capsomeres including 
150 hexons and 12 pentons. The hexons have six-fold symmetry occupying the faces and 
edges of the icosahedral structure while the pentons have five-fold symmetry located at the 
vertices (Newcomb et al., 1993). The three-dimensional structure of HSV virions 
determined using cryo-electron tomography was reported in 2003 by A. Steven’s group. 
The virions are pleomorphic membrane-bound particles and generally have a spherical 
shape although some particles have genuine non-spherical shapes. The viral envelope 
bilayer membrane is about 5 nm thick and the envelope is 170 to 200 nm in diameter 
(mean, 186 nm). The array of glycoprotein spikes on the virions makes the full diameter 
around 225 nm on average. Within the envelope the viral capsid is located at an eccentric 
position occupying about one-third of the volume and the rest of the volume is occupied 
by the tegument. Linkers with about 4 nm length were observed and they connected the 
tegument cap to the envelope. There are 595 to 758 spikes on each virion with length 
ranging from 10 to 25 nm (Grunewald et al., 2003).  
HSV-1 virions are large and have complex structures. A unique structure is the tegument, a 
protein layer located between the capsid and envelope, which often has been described as 
amorphous. The tegument consists of many proteins which are non-essential in tissue 
culture and the exact roles of many individual proteins are unknown. Recently, the 
component profile of extracellular HSV-1 virions has been revealed from a mass 
spectrometry study and the reported work has shown 8 capsid proteins, 13 envelope 
proteins (including pUL20), 23 tegument proteins and up to 49 distinct host cellular 
proteins in purified HSV-1 virions (Loret et al., 2008). In addition, three envelope proteins, 
gJ, gK and pUL49.5, were not detected in the reported mass spectrometry study. The 
virion incorporation of these glycoproteins is still an open question as other studies have 
reported that these membrane proteins are constituents of mature viruses (Adams et al., 
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1998; Ghiasi et al., 1998; Klupp et al., 1998; Loret et al., 2008). All of the HSV-1 tegument 
proteins detected by mass spectrometry are listed in Table 1.3. In addition, the asymmetric 
form of tegument around the capsid, especially the ‘actin-like’ substructure observed by 
cyto-electron tomograms, and functional roles of HSV-1 tegument proteins that have been 
discovered suggest that there is an order among the numerous tegument proteins 
(Grunewald et al., 2003; Kelly et al., 2009).   
 
Table 1.3 HSV-1 tegument proteins. 
Gene 
Common 
protein 
name 
Size 
(kDa) 
Roles* 
in vitro 
Conservation 
in Herpesviridae 
(+/-) 
Functions 
UL36 VP1/2 336 E + 
Important for capsid transport 
(Abaitua & O'Hare, 2008; Coller 
& Lee, 2007), viral DNA 
uncoating (Ojala et al., 2000), 
secondary envelopment 
(Roberts et al., 2009), transport 
of the virus along axons (Shanda 
& Wilson, 2008), addition of 
pUL37 and pUL48 (Ko et al., 
2010), has deubiquitinating 
activity (Schlieker et al., 2005). 
UL37 / 121 E + 
Tightly associated with pUL36, 
important for secondary 
envelopment (Roberts et al., 
2009), capsid transport 
(Krautwald et al., 2009; 
Pasdeloup et al.). 
UL48 VP16 54 E - 
Infectious virus particle 
assembly (Weinheimer et al., 
1992), regulates viral gene 
transcription (Stern et al., 1989). 
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RS1 ICP4 133 E - 
Regulates viral gene 
transcription (Smith et al., 1993). 
UL7 / 33 NE + 
Interacts with mitochondrial 
protein (Tanaka et al., 2008). 
UL11 / 10 NE + 
Involved in secondary 
envelopment (Leege et al., 2009). 
UL13 / 57 NE + 
Has protein kinase activity to 
phosphorylate other viral 
proteins (Kato et al., 2006), 
involved in nuclear lamins 
disruption during nuclear egress 
(Cano-Monreal et al., 2009). 
UL14 / 24 NE + 
Important for transporting of 
VP16 and capsid nuclear 
targeting (Yamauchi et al., 2008). 
UL16 / 40 NE + 
Forms complex with pUL11 
(Loomis et al., 2003) and pUL21 
(Harper et al., 2010), interacts 
with gE (Yeh et al., 2011) and 
transiently with capsid (Meckes 
& Wills, 2007). 
UL21 / 58 NE - 
Important for other viral protein 
incorporation (Michael et al., 
2007), forms a complex with 
UL11 and UL16 (Harper et al., 
2010). 
UL23 TK 41 NE - 
Has thymidine kinase activity to 
phosphorylate deoxythymidine, 
related to viral DNA replication 
(Brown et al., 1995). 
UL41 VHS 55 NE - 
Host shutoff protein, has 
mRNA-specific RNase activity, 
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induces shutoff of host protein 
synthesis, disruption of 
preexisting polysomes, and 
degradation of host mRNAs 
(Saffran et al., 2010). 
UL46 VP11/12 78 NE - 
Interacts with VP16, possibly 
involved in modulation of host 
cell signalling pathways (Wagner 
& Smiley, 2009; 2011). 
UL47 VP13/14 74 NE - 
Contains nuclear localisation 
and exporting signals, shuttles 
between nucleus and cytoplasm, 
has RNA binding activity 
(Donnelly & Elliott, 2001; 
Donnelly et al., 2007; Verhagen 
et al., 2006b; Williams et al., 
2008). 
UL49 VP22 32 NE - 
Recruits ICP0 for virion 
incorporation (Maringer & 
Elliott, 2010), interacts with 
VP16 (Mouzakitis et al., 2005). 
UL50 / 39 NE - 
Encodes a dUTPase (Jons & 
Mettenleiter, 1996). 
UL51 / 26 NE + 
Plays role in nuclear egress 
(Nozawa et al., 2005). 
UL55 / 21 NE - Unknown. 
US2 / 33 NE - 
Interacts with cytokeratin 18 
(Goshima et al., 2001). 
US3 / 53 NE - 
Encodes a protein kinase (Kato 
et al., 2005), inhibits host cell 
apoptosis (Leopardi et al., 1997). 
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US10 / 34 NE - 
Encodes a capsid/tegument-
associated phosphoprotein 
(Yamada et al., 1997). 
US11 / 18 NE - 
Encodes an RNA binding 
protein (Roller & Roizman, 
1990). 
RL1 ICP34.5 26 NE - 
Encodes a viral neurovirulence 
factor (Brown et al., 1994). 
RL2 ICP0 79 NE - 
Has E3 ubiquitin-protein ligase 
activity and involved in cellular 
protein down regulation (Boutell 
et al., 2005; Everett, 2000a; b). 
 * E: essential; NE: nonessential. 
 
The diverse functional roles of HSV-1 tegument proteins have been reviewed in detail by 
Kelly and colleagues. According to the data reported from a combination of research 
approaches, it has been gradually uncovered that the tegument is not a simple protein layer 
without an ordered structure. Yeast two-hybrid screens have identified several interactions 
between HSV-1 tegument proteins and subsequently they have revealed broader 
interactions between the viral structure proteins. Among those interactions, there are 
capsid-tegument interactions (such as pUL35 and pUL37), tegument-tegument interactions 
(such as pUL37-pUL46) and tegument-envelope interactions (such as pUL49-pUS9) 
(Fossum et al., 2009). Together with electron microscopy imaging showing the physical 
position of the tegument as the bridge between the capsid and envelope, these interactions 
linking capsid, tegument and envelope have offered further hints for the functional roles 
of the tegument in forming HSV-1 virions (Kelly et al., 2009; Lee et al., 2008; Vittone et al., 
2005). However, the functional redundancy among these proteins has increased the 
difficulty and complexity of research into tegument assembly. 
1.1.4 HSV-1 life cycle 
HSV-1 is a very successful human pathogen, probably due to such a long history of co-
evolution. Primary infection occurs mainly in infants and young children, after which the 
virus becomes latent in the dorsal root ganglion, and can be periodically reactivated 
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throughout life (Gilden et al., 2007). The ability of HSV-1 to establish latency for the life 
time of the host is a highly successful strategy that this family of virus has evolved in order 
to survive and it is a very interesting area of research. However, this thesis is focussed on 
assembly mechanisms of HSV-1 lytic infection, so the rest of this section will be primarily 
concerned with the HSV-1 life cycle during lytic replication (Figure 1.1). 
 
 
Figure 1.1: Diagram of HSV-1 life cycle. 
1.1.4.1 Entry 
An enveloped virus particle is composed of a lipid bilayer envelope, proteins and a nucleic 
acid genome. Viruses don’t have full replication systems themselves and must rely on the 
machineries in host cells to support their life cycle. At the beginning of infection, the first 
hurdle the virus encounters is entering the host cell. The entry of herpesviruses is a 
complex process requiring the concerted interactions of multiple glycoproteins and 
multiple host receptors (Table 1-4). HSV-1 can enter cells by fusion at the plasma 
membrane at neutral pH or fusion with an endocytic membrane after endocytosis in either 
a pH-dependent or a pH-independent manner (Connolly et al., 2011). For example, HSV-1 
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enters into Vero cells via fusion at the plasma membrane while in most cell types the virus 
appears to enter by endocytosis (Reske et al., 2007). The viral glycoprotein involvement in 
the entry of HSV-1 into host cells can be roughly divided into three stages: 
1) The initial attachment of the virion to the cell surface. Glycoprotein B (gB) and 
glycoprotein C (gC) are able to attach to the heparan sulfate on the surface. gC has the 
greater efficiency for the attachment although gC is not essential for either entry or 
replication. It has been reported that heparan sulfate is the cellular receptor of gC, 
although there are reported data suggesting a heparan sulfate independent receptor 
may mediate interaction with gB because a soluble form of gB interacts with the 
surface of cells independent of heparan sulfate (Reske et al., 2007).  
2) The interaction of glycoprotein D (gD) with its cellular receptors. After the initial 
attachment to the cell surface, the next stage requires the interaction of gD with one of 
the several potential entry receptors. These receptors are herpesvirus entry mediator 
(HVEM) (a member of the tumor necrosis factor (TNF) receptor family) 
(Montgomery et al., 1996), nectin-1 (a member of the immunoglobulin superfamily) 
(Connolly et al., 2005; Krummenacher et al., 1998), and 3-O-sulfated heparan sulfate 
(Rey, 2006; Shukla et al., 1999; Tiwari et al., 2004). This diversity of potential receptors 
of gD may contribute to the ability of HSV-1 to infect a wide range of different cell 
types. Upon receptor binding, gD undergoes conformational changes to be the 
receptor-activated form, which is able to induce alteration in the gH/L complex as 
stated below. 
3) The fusion of viral envelope with the plasma or endosome membrane and 
release of the tegument and capsid into the cytoplasm. gD is a type I membrane 
protein and does not have the characteristics of a fusion protein. It was assumed that 
the central fusion machinery involves gB and the heterodimer gH/L. Recently, the 
structures of gB (Heldwein et al., 2006) and gH/L (Backovic et al., 2010; Chowdary et 
al., 2010a; Matsuura et al., 2010) have been resolved. Multiple cellular receptors of gB 
have been reported and gH/L complex binds to integrins (Table 1.4). The structures 
reveal that gB is a class III viral fusion protein which is capable of inserting into target 
membranes and inducing fusion through conformational changes. However, the 
gH/gL heterodimer does not have viral fusion protein characteristics at the structural 
level. Thus gB is more likely to be the fusion protein and gH/L a regulator for the 
function of gB (Connolly et al., 2011). The current data suggest that alterations in the 
gH/L complex induced by activated gD allows gH/L to interact with gB and up-
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regulate the fusogenic potential of gB, which leads to the completion of membrane 
fusion between the host cell membrane and viral envelope (Atanasiu et al., 2010). 
Table 1.4 HSV-1 entry related glycoproteins. 
Glycoprotein Cell receptor Function 
gB 
HS 
DC-SIGN 
PILRα 
MAG 
NMMHCIIA 
Catalyses membrane fusion. 
gC HS 
Facilitates entry by binding to host cells at 
initial stage, non-essential. 
gD 
HVEM 
Nectin 1/2 
3-O-sulphated HS 
Binds cells and triggers fusion. 
gH/L Integrins Triggers/regulates fusion. 
HS: heparan sulfate. DC-SIGN: dendritic cell-specific ICAM3-grabbing non-integrin (CD209). 
PILRα: paired immunoglobulin-like type 2 receptor-α. MAG: myelin-associated glycoprotein. 
NMMHCIIA: non-muscle myosin heavy chain IIA (myosin 9). HVEM: herpesvirus entry mediator. 
Additional evidence to support this glycoprotein fusion machinery is that the simultaneous 
expression of these four glycoproteins by transfection is able to promote cell-cell fusion 
(Turner et al., 1998). Overall, glycoprotein gB, gD and gH/L compose the membrane 
fusion machinery and they are essential for the entry of HSV-1. 
1.1.4.2 Transport to the nucleus 
HSV-1 is an enveloped virus that replicates and packages its viral DNA inside the cell 
nucleus. After the initial fusion event of the virus envelope and host plasma or endosome 
membrane, the viral capsid-tegument complex is released into the cytoplasm. This 
complex needs to move through the cytoplasm to the nucleus to release the viral genome. 
The cytoplasm is a crowded environment due to the presence of organelles, the 
cytoskeleton and high protein concentrations (up to 300 mg/ml) and it effectively restricts 
free diffusion of molecules larger than 500 kDa. Thus, for the capsid-tegument complex to 
rely on passive diffusion alone is virtually impossible. The cytoplasmic transport procedure 
must be an active process (Sodeik, 2000). Microtubules provide the ‘high-way’ system 
within the cells for long-distance transport of cargos (such as vesicles, organelles and 
chromosomes). Alpha-tubulin and beta-tubulin heterodimers are the building blocks of 
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microtubules, which have a structural polarity, with a highly dynamic “plus” end that can 
grow and shrink rapidly and a relatively stable “minus” end that is anchored at the 
microtubule-organizing centre (MTOC). There is plus-end-directed transport (also called 
anterograde direction), which involves the transport towards the periphery, and minus-end 
directed transport (also called retrograde direction), which involves transport from the 
periphery towards the MTOC respectively. Two types of molecular motors mediate these 
two types of transport: kinesins are plus-end-directed transport motors and dyneins are 
minus-end directed transport motors (Dodding & Way, 2011; Lyman & Enquist, 2009). 
The transport mediated by dynein shares the same direction with the transport of 
incoming viral capsids to the nucleus. Indeed, evidence has shown that upon penetration, 
HSV-1 hijacks the dynein for its movement towards the cell nucleus (Sodeik et al., 1997). 
It was initially observed in neuronal cells that HSV-1 capsids bind to microtubules through 
studies using electron microscopy (Lycke et al., 1984).  In Vero cells, Sodeik and colleagues 
demonstrated that the capsid transport in cytoplasm is mediated by microtubules and the 
presence of microtubule depolymerizing drugs (such as nocodazole) blocks the transport 
of capsids. Antibody labelling of dynein revealed the co-localisation of dynein and the viral 
capsids. Furthermore, the capsids had reached the nucleus and attached themselves to the 
nuclear pore complexes within 1 hpi during the transport procedure (Sodeik et al., 1997). 
This suggests that after viral entry, the capsids bind to microtubules and employ dynein to 
delivery them from the cell periphery to the nucleus in a rapid and efficient manner. 
Subsequently, viral capsid transport was successfully reconstituted in vitro, which 
demonstrated that capsids moved along MT at up to 30 µm/s in the presence of ATP. 
Further, the blocking of the dynein co-factor, dynactin, inhibited capsid transport 
(Wolfstein et al., 2006).  
Viral components derived from the tegument are likely to be involved in capsid transport. 
For example, the large tegument protein VP1/2 (pUL36), a 336 kDa protein, is tightly 
associated with the capsids through the interaction with the capsids protein pUL25 (Coller 
& Lee, 2007). It has been shown that efficient movement of capsids along microtubules in 
vitro requires the HSV inner tegument proteins UL36 (VP1/2) and UL37, and removing 
outer tegument proteins from the capsids increased in vitro mobility. However, capsids 
harvested from cell nuclei without any tegument proteins had virtually no interactions with 
the motor molecules. This suggests the inner tegument is important for transport and 
these proteins may interact with dynein and/or dynactin (Lyman & Enquist, 2009; 
Wolfstein et al., 2006). However, the microtubule mediated transport is not essential for 
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viral infection as it has been shown that the viral infection is only delayed in the absence of 
microtubules (Sodeik et al., 1997), suggesting other pathways for the viral capsid transport 
after entry. 
Unlike certain tegument proteins (such as VP1/2), the majority of the tegument dissociates 
from the capsid after fusion and does not travel together with the capsid to the nuclear 
pore complex. The distribution and/or transport of these tegument proteins are different 
due to their different functions. For instance, the structural component VP16 (pUL48, also 
called αTIF and Vmw65) needs to bind directly to a cellular protein called host cell factor 
(HCF) in the cytoplasm, which acts as a nuclear import factor and carries VP16 into the 
host cell nucleus (La Boissière et al., 1999). Upon transport into the nucleus, the VP16-
HCF complex binds to Oct-1 and forms the activator complex that drives IE gene 
expression (Stern & Herr, 1991). Another example is pUL41 (VHS) which plays an 
important role in preparing the cellular environment for efficient viral replication. pUL41 
is an mRNA-specific RNase and causes non-specific degradation of mRNA, disruption of 
polyribosomes and shutoff of macro-molecular synthesis after infection (Smiley, 2004).  
1.1.4.3 Capsid docking and DNA uncoating 
After transport to the nucleus, the incoming capsids dock to nuclear pore complexes 
(NPCs). NPCs are large protein complexes consisting of key components including 
cytoplasmic filaments, spoke ring complex, transporter and nuclear basket (Allen et al., 
2000). The basic structure of NPCs is conserved from yeast to human. The proteins that 
make up the nuclear pore complex are known as nucleoporins and each NPC is composed 
of about 30 distinct nucleoporins, which were initially identified in yeast (Rout et al., 2000). 
HSV-1 has evolved a strategy to utilise these NPCs as the channels to deliver its viral 
genome into the nucleus.  
It has been observed that within 1 h after penetration the viral capsids associate with the 
NPCs, where they release the viral genomic DNA and empty capsid shells can be observed 
to remain at the cytoplasmic side of the nuclear pore complex (Sodeik et al., 1997). 
Subsequently, the association between the capsid and NPC was reconstituted in vitro by 
Ojala and colleagues. During these assays, the viral capsids were isolated and incubated 
with cytosol and purified nuclei. It was found the capsids bind to NPCs and the binding 
could be inhibited by anti-NPC antibodies (Ojala et al., 2000). 
The ejection of viral DNA from the capsid to the nucleus is called DNA uncoating. It was 
reported that up to 60-70% of capsids docking on NPCs released their DNA genome, 
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implying the interactions between the capsid and NPC plays an important role during this 
stage (Ojala et al., 2000). It has been reported that the capsid protein pUL25 interacts with 
nucleoporins, which is important for DNA release into the nucleus (Pasdeloup et al., 2009). 
In addition, some tegument proteins that travel together with the capsids towards the 
nucleus are involved in the DNA uncoating. For instance, VP1/2 is important in the DNA 
uncoating stage as it has been reported that mutation in the UL36 gene causes the 
accumulation of DNA containing capsids at NPCs (Batterson et al., 1983; Ojala et al., 2000). 
Furthermore it has been demonstrated that the proteolytic cleavage of VP1/2 is important 
for DNA release (Jovasevic et al., 2008). 
1.1.4.4 Viral gene expression and DNA replication 
Following the initial entry, the tegument protein VHS encoded by the UL41 gene is 
released in the cytoplasm to induce the shut-off of host cell protein expression. This 
procedure inhibits host cellular gene expression and reserves the gene expression 
machinery for the virus. After uncoating, the viral DNA genomes circularise by ligating 
head to tail in the cell nucleus and serve as the templates for gene transcription and 
replication (Duyk et al., 1985; Garber et al., 1993; Strang & Stow, 2005). HSV-1 genes can 
be divided into three groups according to the length of time for the viral gene to generate 
its product: immediate early (IE or α), early (E or β) and late (L or γ) genes. Despite the 
classification of HSV-1 genes into three groups, all three classes of genes are expressed in a 
continuous pattern rather than stages that have clear time boundaries. Furthermore, the 
expression of the products of the earlier gene groups affects the expression of the later 
groups. Thus the whole gene expression can be described in a temporal cascade fashion.  
Host RNA polymerase II is responsible for synthesis of all viral mRNA and VP16 is a 
strong transactivator that stimulates immediate early gene transcription (Campbell et al., 
1984). The immediate early gene expression happens before any viral protein synthesis and 
this process activates the transcription of early genes, which leads to the viral DNA 
replication. As a final stage of viral gene expression, the late genes expression is induced by 
the DNA replication process. ICP4 and ICP27 are two IE genes which are important for 
gene regulation. ICP4 is essential for all early and late genes, while ICP27 is required for 
the late genes. However, this is not a completely strict rule. For example, the products of 
IE gene also initiate the transcription of certain late genes (named early/late, leaky late or 
γ1 genes) although the expression levels of these genes are up-regulated by the DNA 
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replication. The rest of the late genes which only express after the viral DNA replication 
are called true late or γ2 genes (Taylor et al., 2002).  
After the expression of IE genes and before the onset of late genes, viral DNA replication 
is initiated. There are seven viral genes coding four protein complexes which have essential 
roles during HSV-1 replication. 1) Origin binding protein is the product of gene UL9. It 
has DNA helicase activity and is able to bind both oriL and oriS origins in the HSV-1 
genome. 2) Single-stranded DNA (ssDNA) binding protein (also called ICP8) encoded by 
UL29, which is able to bind ssDNA and stimulate DNA polymerase and helicase-primase 
activities. 3) The heterotrimer helicase-primase complex encoded by the UL5, UL8 and 
UL52 genes. 4) The heterodimer DNA polymerase (that also has exonuclease activities) 
encoded by the genes UL30 and UL42. Although the other early gene products (including 
thymidine kinase encoded by the gene UL23) are not essential for viral DNA replication in 
tissue culture, they are important in vivo, especially in non-dividing cells such as neurons.  
The structures of DNA molecules and replication complexes observed within the cell 
nuclei were described as replication compartments (Quinlan et al., 1984). At the beginning 
of DNA replication, the origin-binding protein pUL9 binds to either oriL or oriS to 
unwind the DNA by its helicase activity. ICP8 is recruited to bind to ssDNA and together 
with pUL9 the other five DNA replication proteins are recruited to the replication fork to 
initiate the theta type replication. The subsequent process has been described as a ‘rolling-
circle’ mechanism and the newly synthesised DNA molecules accumulating in the cell 
nucleus are ‘head-to-tail’ concatemers containing four isomers (Jacob et al., 1979). These 
concatemers have to be cleaved into monomers for packaging into capsids (see section 
1.1.2). 
1.1.4.5 Capsid assembly and DNA packaging 
HSV-1 capsid assembly starts in the cell nucleus after late gene expression. Some proteins 
required for this assembly stage, including VP26 (pUL35), VP23 (pUL18) and the major 
capsid protein VP5 (pUL19), would remain in the cytoplasm if expressed alone. By 
forming complexes with other viral proteins that contain nuclear localisation signals (NLS), 
these proteins arrive at the nucleus for assembly. For example, VP5 can be transported 
into the nucleus by the capsid triplex protein VP19C (pUL38), or the scaffolding protein 
pre-VP22a (also called ICP35 encoded by gene UL26.5) (Taylor et al., 2002).  
Electron microscopy studies have shown four distinct stages of capsids in herpesvirus 
infected cells. The precursor of the other types of capsids, procapsid, contains a roughly 
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spherical porous outer shell surrounding an inner protein core. A capsids consist of an 
icosahedral protein shell while B capsids have the same protein shell as A capsids plus an 
inner spherical protein core. C capsids also have the indistinguishable outer protein shell 
but with the inner protein core replaced with the viral DNA genome (Baines et al., 2007a; 
Mettenleiter et al., 2006).  
After protein expression and transport to the nucleus, capsid assembly itself is a host cell 
independent process. Newcomb and colleagues purified three capsid components from 
insect cells and described an in vitro cell free system to assemble HSV-1 procapsids 
(Newcomb et al., 1996). These three components are: 1) the building blocks for hexons 
and pentons VP5; 2) the triplexes VP19C and VP23; 3) a scaffolding protein pre-VP22a. 
Interestingly, a hybrid scaffolding protein containing the N-terminal 364 amino acids of 
the HCMV scaffolding protein (UL80.5 gene product) and only the C-terminal 25 amino 
acids of HSV-1 pre-VP22a, is able to perform the role of pre-VP22a highlighting the 
conserved nature of herpesvirus capsid assembly (Newcomb et al., 1999; Oien et al., 1997).  
Newly synthesised HSV-1 genomes are in the form of concatemers (refer to section 
1.1.4.4), which need to be cleaved into unit-length monomers to be packaged into capsid 
in the nucleus. There are a group of conserved proteins involved during this stage. The 
HSV-1 capsid portal complex is a ring-like dodecameric complex of the portal protein 
(pUL6). The portal complex is located at one of the 12 vertices on the icosahedral capsid 
and forms the channel for viral DNA packaging and possibly for genome release through 
nuclear pores during the initial stage of infection (Chang et al., 2007; Mettenleiter et al., 
2006; 2009). pUL15, pUL28 and pUL33 are the sub-units of the terminase, which is able 
to recognise the portal complex. Terminase is able to drive the DNA into the capsid and 
its nuclease activity performs the cleavages in the concatemers at specific sites to generate 
single genomes. Additionally, pUL17 and pUL25 form a complex named the C capsid-
specific complex (CCSC), which is located on the capsid surface. pUL17 has been reported 
to be important for cleavage and packaging of HSV-1 DNA (Salmon et al., 1998) and 
pUL25 is required for encapsidation (McNab et al., 1998). CCSC is also likely to be 
involved in selecting DNA containing C capsid for nuclear egress (Johnson & Baines, 
2011). Other viral proteins (such as pUL32) are also involved but their exact roles are still 
unclear (Mettenleiter et al., 2006; 2009; Taylor et al., 2002). 
Interestingly the portal complex in the HSV-1 capsid, the process of capsid formation 
initiated by the scaffold protein and the viral genome cleavage/encapsidation all share 
similarities with DNA bacteriophage. This suggests that herpesvirus and bacteriophage 
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may have a common ancestor (Chang et al., 2007; Mettenleiter et al., 2006; 2009; Rixon, 
2008). 
1.1.4.6 Assembly and egress 
Capsid assembly and viral genomic DNA packaging result in the formation of mature 
capsids in the cell nucleus. In order to acquire the numerous tegument proteins and the 
envelope required to form mature virus particles and subsequently be released from the 
infected cell, capsids encounter several physical obstacles within the highly structured host 
cell. For instance, translocation through the dense stable nuclear lamina structure lining the 
inner side of INM and the double membrane nuclear envelope, as well as the transport 
across the long distance of the host cytoplasm and being released through the plasma 
membrane as free virions. The virus assembly and egress process involves at least five 
stages: primary envelopment, de-envelopment, tegumentation, secondary envelopment and 
release through exocytosis.  
Primary envelopment 
The primary envelopment is the process where nucleocapsids bud into the INM and form 
primary virions in perinuclear space. The nuclear envelope is the same barrier that capsids 
face when they need to deliver the viral genome to the nucleus during entry (section 
1.1.4.3), although in the opposite direction. Capsids, with a diameter approximately 125 
nm, are too large to transport through the NPC. Herpesviruses have evolved the strategy 
where incoming capsids utilise NPCs to deliver the viral genomes into the nucleus, leaving 
the empty capsid shells in the cytoplasm. However, the progeny capsids assembled in the 
nucleus need to cross the nuclear envelope and enter the cytoplasm in an intact form and 
so different strategies are required to overcome the same barrier.  
There are three lamin proteins (A, B and C) that make up the nuclear lamina structure. 
HSV-1 has evolved several mechanisms to disrupt the nuclear lamina at specific sites and 
this has been recently reviewed by Johnson and Baines: 1) the nuclear envelopment 
complex (NEC) formed by pUL31 and pUL34 is able to recruit cellular protein kinases to 
phosphorylate lamin B and cause disassembly of the lamina. 2) HSV-1 pUS3 and pUL13 
both have kinase activities, and are able to catalyse the phosphorylation of lamin A and 
lamin C leading to solublisation of the lamins. 3) the nuclear lamina is formed by 
interactions between the lamins and lamin receptors, while HSV-1 pUL31 and pUL34 are 
able to bind to lamin A and lamin C. These interactions disrupt the normal lamin-lamin 
interactions to the benefit of the approaching capsids. 4) the viral/cellular kinases recruited 
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to those sites cause phosphorylation in lamin receptors and interfere with the lamin-
receptor interactions (Johnson & Baines, 2011). After disruption of the nuclear lamina, the 
nucleocapsids may engage with certain tegument proteins (such as VP16) and bud through 
the INM resulting in primary enveloped virions in the space between the INM and ONM 
(also called perinuclear space) (Naldinho-Souto et al., 2006). It has been found that gD and 
VP22 also can be detected in primary virions suggesting possible functions of these 
proteins during this stage (Padula et al., 2009). 
De-envelopment 
There are two models for the subsequent pathway from the primary envelopment stage to 
the release of virus particles into the extracellular space: the lumenal pathway (also called 
“single envelopment” pathway) and the primary and secondary envelopment model (also 
called envelopment-deenvelopment-reenvelopment pathway, “two-step envelopment” 
pathway or reenvelopment model). The lumenal pathway model proposes that the primary 
virions travel through the lumen of endoplasmic reticulum (ER), which is continuous with 
the nuclear envelope, followed by vesicular transport through the Golgi apparatus and 
release to extracellular area through the normal secretory pathway (Enquist et al., 1998; 
Taylor et al., 2002). Some early evidence of the lumenal pathway is that enveloped particles 
within vesicles in cytoplasm were observed by electron microscopy (Roizman & Sears, 
2001). However, a series of subsequent electron microscopy studies, data on the lipid 
content of the viral envelope compared to the nuclear membrane, and immunoelectron 
microscopy of ER-retrieved glycoproteins (Skepper et al., 2001; van Genderen et al., 1994) 
support the primary and secondary envelopment model and this has become the most 
widely accepted model of HSV-1 assembly and egress [reviewed in (Johnson & Baines, 
2011; Mettenleiter, 2002; Mettenleiter et al., 2006; 2009)]. The research in this thesis will be 
described and analysed based on this model.  
In the secondary envelopment model, primary enveloped virions undergo a de-
envelopment process. This de-envelopment is the process of membrane fusion involving 
the envelope of primary virions and the ONM. The first description of “de-envelopment” 
events in herpesvirus assembly and egress were made in the 1960s when Stackpole studied 
frog herpesvirus by electron microscopy and autoradiography using 3H-thymidine. Viral 
particles were observed being enveloped by budding through the INM, and subsequently 
being de-enveloped in passing through the ONM and reaching the cytoplasm (Mettenleiter, 
2004; Skepper et al., 2001; Stackpole, 1969).  
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Recently, it has been shown that the tegument protein pUS3 is associated with primary 
enveloped virions in the perinuclear space (Padula et al., 2009; Reynolds et al., 2002). 
Deletion of US3 from the viral genome resulted in accumulation of primary virions in the 
perinuclear space (Farnsworth et al., 2007). These reports imply pUS3 is likely to be 
involved in HSV-1 de-envelopment stage. In addition, gB and gH are also thought to be 
involved in the de-envelopment of HSV-1. Simultaneous mutations in both gB and gH led 
to the accumulation of primary virions in the perinuclear space, a phenotype similar to the 
observations with the US3 deletion virus. However, different from the membrane fusion 
during entry which requires both gB and gH/L, a single mutation in gB or gH/L did not 
significantly affect the de-envelopment stage (Farnsworth et al., 2007). These data imply 
that the membrane fusion of primary virion envelope and ONM during de-envelopment is 
different from viral envelope fusion with host membranes during the initial entry and these 
two fusion processes require different viral proteins. Furthermore, pUS3 kinase activity has 
been shown to regulate gB mediated nuclear egress and down-regulates the cell surface 
expression of gB through phosphorylation in HSV-1 (Kato et al., 2009; Wisner et al., 2009). 
However, it is important to note that different from HSV-1, simultaneous double deletion 
combinations of gB, gD and gH/L did not show any effect on PRV nuclear egress (Klupp 
et al., 2008), suggesting potential different mechanisms between these two 
alphaherpesviruses. The de-envelopment stage is one of the most poorly understood 
aspects of herpesvirus assembly and further research is needed to determine the 
mechanisms.  
Tegumentation 
Following the de-envelopment, the viral capsids are release into the cytoplasm, where they 
are coated with a layer of tegument proteins (a process called tegumentation). The 
tegument proteins which are closely associated with capsids are incorporated first to form 
the inner tegument layer and through interactions between the tegument proteins, the 
outer tegument layer is assembled. However, many tegument proteins have been shown to 
be nonessential in tissue culture (summarised in Table 1.3), and details of how the 
tegumentation occurs around the capsid are unclear. The assembly of outer tegument is 
thought to be closely related to the secondary envelopment stage and therefore is an 
important stage for the final formation of mature virus particles. 
Three tegument proteins, pUL36, pUL37 and pUS3, constitute the inner tegument and 
they initially coat the nucleocapsid during tegumentation (Mettenleiter, 2006; Mettenleiter 
et al., 2006). It has been shown that pUL37 directly interacts with pUL36 (Mijatov et al., 
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2007; Vittone et al., 2005). These two tegument proteins are both closely associated with 
capsids as the inner layer and remain attached to the capsids during the transport to the 
nucleus after entry. The interactions between pUL36 and the capsid protein pUL25 as well 
as the possible interaction of pUL37 and the capsid protein pUL35 are direct evidence for 
the early incorporation of pUL36 and pUL37 during tegumentation (Coller et al., 2007; Lee 
et al., 2008). pUS3 is a component of the primary virions in alphaherpesviruses and there is 
evidence for possible early involvement of pUS3 to regulate the function of pUL31 and 
pUL34 in the nucleus (Kato et al., 2006; Reynolds et al., 2002). Therefore, it is likely that 
pUS3 is incorporated as a tegument protein at an early stage. Furthermore, due to the 
essential role and multiple functions (listed in Table 1-3), pUL36 (and possibly pUL37) 
may function as a scaffold to recruit other tegument proteins to be assembled around 
capsids. The deletion of either UL36 or UL37 genes in the HSV-1 genome blocks 
tegumentation of the capsid in the cytoplasm and an accumulation of unenveloped capsids 
has been observed in infected cells (Roberts et al., 2009). As the formation of C capsids 
was not affected in the absence of UL36 or UL37, it implies that the viral life cycle stages 
(including capsid assembly, DNA packaging and nuclear egress) before the capsids arrival 
in cytoplasm are not affected, but these proteins are important for the further addition of 
tegument. For example, direct interaction between HSV-1 pUL36 and pUL48 has been 
demonstrated and the expression of pUL36 is required for the association of pUL48 with 
capsids in infected cells (Ko et al., 2010; Vittone et al., 2005). However, whether the 
addition of pUL36 occurs in the nucleus or in the cytoplasm is still unclear.  
Compared to the inner tegument layer, the incorporation of the outer tegument layer is 
much more complicated and it potentially involves 20 tegument proteins with significant 
redundancy (Loret et al., 2008). It is conceivable that multiple ways are available for the 
virus to complete the outer tegument assembly. More evidence has been reported from 
recent studies but the details of this process are still not clear. Thus, the tegument proteins 
with high abundance and/or important functions will be focussed on in this introduction.  
Firstly, HSV-1 pUL48 (VP16) is essential for replication in tissue culture, although it is not 
conserved among the three sub-families of Herpesviridae. It has been shown that VP16 is 
present in perinuclear virions in HSV-1 (Naldinho-Souto et al., 2006), which implies an 
early involvement of VP16. However, it is not clear whether this is related to other VP16 
functions in the nucleus or the incorporation of VP16 prior to the nuclear egress 
constitutes the population of VP16 in the tegument. Interestingly, studies on PRV showed 
the deletion of pUL48 did not have any effect on the association of pUL36 and pUL37 
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with the nascent capsids, which suggests that the incorporation of the inner tegument layer 
occurs earlier than pUL48. Furthermore, L particles (virus light particles without capsids) 
generated in cells infected by PRV with UL48 deletion were found to contain pUL46, 
pUL47 and pUL49 but not pUL36 or pUL37 (Fuchs et al., 2002). These findings imply 
pUL48 might be the “linker” for the inner tegument layer to the outer layer of tegument.  
Indeed, pUL48 has been shown to interact with tegument proteins pUL46, pUL47, pUL49 
as well as pUL41 (Elliott et al., 1995; Smibert et al., 1994; Vittone et al., 2005). These 
interactions provide the possibility for pUL48 to recruit the outer tegument proteins.  
Secondly, the complex formed by pUL11, pUL16 and pUL21 may be able to link the 
capsids and envelope during secondary assembly. pUL11 has been reported to be 
membrane associated and bind to the cytoplasmic side of cellular membranes (Baird et al., 
2008), while pUL21 was shown to associated with A, B and C capsids (Takakuwa et al., 
2001). In addition, pUL16 interacts with both pUL11 and pUL21 to form a complex 
(Table 1.3). These data suggest the possibility for this complex to directly link the capsids 
and envelope. However, all of these three tegument proteins are not essential for HSV-1 in 
cell culture. Therefore the link provided by this complex is dispensable, although it may 
offer an alternative route to pUL48 for capsids-outer tegument/envelope association and 
this might be of more importance in vivo. 
Secondary envelopment 
The secondary envelopment is also called re-envelopment, final envelopment or 
cytoplasmic assembly. It is the process where tegumented capsids bud into the lumen of 
membrane compartment in the cytoplasm and form mature virus particles. During the 
process the virus acquires the envelope embedded with various glycoproteins. Many 
different viral envelope proteins (gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL, gM, gN/pUL49.5, 
pUL20, pUL45, pUL56, pUS9) have been identified in mature HSV-1 particles, and they 
need to be correctly localised to the appropriate cytoplasmic assembly sites to be 
incorporated into virions (Adams et al., 1998; Foster et al., 2001b; Ghiasi et al., 1998; Loret 
et al., 2008). Many herpesvirus envelope proteins contain targeting signals such as tyrosine-
based motifs [YXXΦ, where X = any amino acid and Φ = a bulky hydrophobic residue 
such as phenylalanine (F) and tryptophan (W)] that are likely to play important roles in 
their efficient endocytosis and TGN localisation through mediating interactions with the 
clathrin adaptor proteins [reviewed in (Favoreel, 2006)]. Functional YXXΦ endocytosis 
motifs have been demonstrated to be present in the HSV envelope proteins gB and gE 
(Alconada et al., 1999; Beitia Ortiz de Zarate et al., 2007; Fan et al., 2002). YXXΦ motifs 
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have also been identified in the cytoplasmic domains of the HSV-1 envelope proteins gM, 
gK and UL20, all of which are localised to the TGN (Crump et al., 2004; Foster et al., 2004). 
However, other HSV-1 envelope proteins do not contain any recognisable targeting motifs 
and when expressed in the absence of other viral proteins (gD and gH/L for example) 
they are localised to the plasma membrane. gD and gH/L together with gB constitute the 
entry machinery that is essential for fusion of the virus envelope with cellular membranes 
(Heldwein & Krummenacher, 2008). It is therefore critical for the production of infectious 
viruses that both gD and gH/L are correctly localised to the appropriate intracellular 
membrane compartments in order to be incorporated into the virion envelope. This is 
demonstrated by the reported experiment where gD or gH is artificially retained in the 
endoplasmic reticulum. Despite normal levels of enveloped particle release, the virions are 
significantly less infectious because they do not contain detectable gD or gH respectively 
(Browne et al., 1996; Whiteley et al., 1999). 
Membrane protein trafficking in eukaryotic cells involves a series of dynamically 
interconnected membrane structures including the ER, Golgi apparatus, plasma membrane 
and vesicles generated through the membrane deformation and remodelling. Vesicles are 
cellular transporting vehicles for proteins cargos [reviewed in (Bonifacino & Rojas, 2006; 
Seaman, 2008)]. Many electron microscopy studies have shown capsids budding into 
membrane compartments and virion-containing vesicles and it is believed that HSV-1 
hijacks this secretory pathway to obtain envelope and complete egress (Mettenleiter, 2004; 
Mettenleiter et al., 2006; 2009). There are four possible sites for the capsids to acquire 
envelope proteins and form mature virus particles within a cellular vesicle: 1) TGN; 2) 
early endosome; 3) tubular endosomal network; 4) late endosome. 
The exact assembly site in cytoplasm is still under debate [reviewed in (Johnson & Baines, 
2011; Mettenleiter et al., 2006; 2009)]. Multiple glycoproteins have been shown to co-
localise with TGN markers in immunofluorescence microscopy studies and nascent viral 
capsids also appear to be localised at the TGN. This finding supports the hypothesis that 
the viral final assembly occurs at TGN where the glycoproteins are incorporated into the 
virions (the TGN assembly model) (Turcotte et al., 2005). Recently, studies performed by 
Elliott and colleagues using horseradish peroxidise labelling and electron microscopy have 
challenged the TGN assembly model, where they have shown HSV-1 capsids are wrapped 
by tubules derived from the plasma membrane. Furthermore, the tubules have been 
characterised as newly endocytosed envelope protein containing plasma membrane, but 
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not derived from the exocytic pathway (Elliott et al., IHW conference presentation 2010, 
2011). 
Physically located in between the capsid and virus envelope, the interactions between the 
outer tegument layer with envelope proteins are important for the secondary envelopment. 
It has been shown that pUL48 interacts with the cytoplasmic tails of HSV-1 gB, gD and 
gH (Gross et al., 2003; Kamen et al., 2005; Zhu & Courtney, 1994). In addition, pUL49 has 
been shown to interact with gE and gM (Stylianou et al., 2009). These interactions may 
initiate the recognition of tegumented capsids and viral envelope protein embedded host 
membrane. In addition, viral proteins (most likely tegument and envelope proteins) also 
need to interact with host cellular proteins to facilitate secondary envelopment.  
Exocytosis and release 
Secondary assembly results in virion-containing vesicles and the mature virions are 
transported within these vesicles to the plasma membrane and released when the vesicle 
membrane fuses with the plasma membrane. Little information is known about the 
function of viral proteins involved in this stage. Presumably, the virus hijacks the cellular 
secretory pathway (exocytosis) for the release. Questions remain about the transport of the 
vesicles for subsequent release at the cell surface. The possible cytoplasmic assembly sites 
would all allow the virion-containing vesicles to be either transported “retrogradely” from 
endosomal membrane or “anteretrogradely” from the TGN directly to plasma membrane 
for release. In addition to the movement of cellular vesicles along microtubule tracks from 
the TGN to the plasma membrane, a transport network of actin filaments has recently 
been shown as a new dynamic and flexible way for intracellular vesicle movement (Schuh, 
2011; Toomre et al., 1999). Unfortunately for the host cells, these cellular transport 
networks could be hijacked by the virus. 
Of the many viral and cellular factors involved in the viral assembly and egress, this thesis 
is concerned with the roles of glycoprotein M (gM) and the cellular Endosomal Sorting 
Complex Required for Transport (ESCRT).  
1.2 Glycoprotein M and cytoplasmic assembly 
1.2.1 Gene and protein predicted structure 
Glycoprotein M (gM) is the product of gene UL10, which is located at nucleotide position 
23204-24625 according to the online sequence of human herpesvirus 1 complete genome 
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(strain 17, Refseq: NC_001806). UL10 is a 1422 bp intronless gene encoding a protein of 
473 aa and it has been described as a late (γ) gene (Baradaran et al., 1994). However, the 
possible early function of gM at the nuclear membrane that has recently been suggested 
implies it might be an early gene (Zhang et al., 2009a). In early research work, the UL10 
gene product was predicted to be a membrane protein on the basis of the extent and size 
of the hydrophobic domains of the predicted protein (Baines & Roizman, 1991). 
Subsequent research revealed that the product of UL10 gave a sharp band (~50 kDa, 
immature form) and a broad band (~53-63 kDa, mature form) detectable by western 
blotting using a rabbit polyclonal antiserum. This protein was found to be N-glycosylated 
because both of these bands were labelled with [3H] glucosamine and treatment with 
tunicamycin (which blocks the synthesis of all N-linked glycoproteins) resulted in a single 
precursor band (~47 kDa). Thereafter the UL10 protein has been designated glycoprotein 
M (Baines & Roizman, 1993). 
UL10 is conserved throughout the Herpesviridae. Genomic comparison has suggested that 
the three sub-families (α, β and γ) were descended from a common ancestor up to 400 
million years ago (McGeoch et al., 2006), which implies that this gene has existed for a 
similar time. Despite the high conservation suggesting important functions of this gene, 
the exact functions of gM have not yet been clearly revealed. It has been predicted that gM 
is a type III membrane protein with eight transmembrane domains (Crump et al., 2004).  
1.2.2 Potential functions 
As described in section 1.1.4.6, numerous glycoproteins need to be correctly localised to 
the assembly compartment membrane. HSV-1 gM contains four potential YXXΦ motifs 
within its predicted C-terminal cytoplasmic domain: YDEV426, YAKI438, YDTV454 and 
YSTV470. gM localises predominantly to the TGN when expressed in the absence of other 
viral proteins and by analogy to cellular TGN proteins with similar trafficking motifs, gM 
is likely to be actively transported between the TGN and the plasma membrane (Crump et 
al., 2004). Previous work in the laboratory has demonstrated that gM may play a role in 
guiding other viral glycoproteins with no cellular targeting motifs to the assembly 
compartment. For example, both gD and gH/L can be efficiently internalised and targeted 
to the TGN by the co-expression of gM in transfection assays (Crump et al., 2004). These 
data suggest that gM can directly or indirectly interact with gD or gH/L and drive their 
endocytosis and TGN localisation through the activity of targeting motifs present in the 
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cytoplasmic domain of gM. This may be one activity by which the essential envelope 
proteins gD and gH/L are correctly localised to sites of secondary envelopment.  
Despite being one of the few conserved envelope proteins in the Herpesviridae, gM is not 
essential for growth in tissue culture of the alphaherpesviruses HSV-1 (Baines & Roizman, 
1991; MacLean et al., 1993), PRV (Dijkstra et al., 1996), BHV-1 (Konig et al., 2002), 
varicella-zoster virus (VZV) (Yamagishi et al., 2008), infectious laryngotracheitis virus 
(ILTV) (Fuchs & Mettenleiter, 1999), EHV-1 (Osterrieder et al., 1996) and equine 
herpesvirus type 4 (EHV-4) (Ziegler et al., 2005). However, gM is essential for replication 
of the alphaherpesvirus Marek’s disease virus (MDV) (Tischer et al., 2002), the 
betaherpesvirus HCMV (Hobom et al., 2000) and the gammaherpesvirus murine 
gammaherpesvirus 68 (MHV-68) (May et al., 2005).  
Despite the fact that gM is not essential, it has been reported that the mutant of HSV-1 
strain 17 by insertion of lacZ into UL10 resulted in approximately 10-fold lower yields at 
low multiplicity (0.001 PFU/cell) and 2 to 10-fold at high multiplicity (MacLean et al., 
1991). A mutant virus with 972 bp deletion within the gene UL10 was created from wild 
type HSV-1 strain F and according to single-step growth analysis, this virus had 
approximately 10-fold lower yields than wild type strain F in both BHK and Vero cells 
(Baines & Roizman, 1991). However a mutation of UL10 in HSV-1 strain SC16 was 
reported to have normal plaque sizes and no reduction in growth compared to parental 
virus in both Vero and BHK cells at MOI of 10 PFU per cell (Browne et al., 2004). One 
potential issue with this gM deletion mutant is that the lacZ insertion site is relatively close 
to the 3’ end of the UL10 ORF and an altered polypeptide containing the first 380 amino 
acids of gM could potentially be expressed. Such a protein product would include all 8 of 
the predicted transmembrane domains of gM and thus could have some activity. More 
recently, a BAC cloned HSV-1 strain KOS with a deletion corresponding to codons 234-
442 of UL10 has been constructed and this mutant virus had small plaques, an 
approximate 5-fold reduction in infectious virus production in Vero cells but a much 
greater effect of >100-fold decrease in RK13 cells infected at 5 PFU/cell (Leege et al., 
2009). Interestingly the authors also observed fewer extracellular virus particles and 
increased numbers of unenveloped capsids in the cytoplasm in HSV-1∆gM infected cells 
suggesting a role of gM in secondary envelopment. 
An in vivo study using a mouse model reported that HSV-1 with gM deletion was capable 
of establishing latency, although the virus growth at the periphery and spread to and/or 
growth within the nervous system were impaired (MacLean et al., 1993). Therefore, HSV-1 
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gM is required for efficient infection both in vitro and in vivo, although gM is not essential in 
both cases.  
1.3 ESCRT machinery 
During the cytoplasmic assembly stage in the HSV-1 life cycle, the budding/wrapping of 
tegumented capsids to form mature virus particles requires membrane remodelling at the 
assembly sites. Previous data from the laboratory has demonstrated that the Endosomal 
Sorting Complex Required for Transport (ESCRT) machinery plays an important role 
during HSV-1 assembly (Crump et al., 2007; Pawliczek & Crump, 2009).  
 
 
Figure 1.2: Diagram of ESCRT machinery and its associated proteins.  
 
ESCRT is a cellular machinery consists of four multimeric protein complexes: ESCRT-0, -
I, -II and -III (Figure 1.2). This machinery controls the sorting of endosomal cargo 
proteins into intraluminal vesicles (ILVs) of multivesicular bodies (MVBs). The ESCRT 
machinery is conserved from yeast to humans and the individual proteins forming the 
complexes were firstly identified in yeast cells.  
During the studies of the vacuolar protein sorting pathway in yeast, the research groups of 
Stevens and Emr identified numerous genes in the model yeast system Saccharomyces 
cerevisiae [reviewed by (Coonrod & Stevens, 2010; Henne et al., 2011)]. The yeast vacuole is 
regarded as the equivalent organelle of the mammalian lysosome. The loss of genes that 
displayed vacuolar protein sorting defects, termed ‘vps’ genes,  resulted in certain vacuolar 
glycoproteins not being sorted to the vacuolar lumen but mis-localised to the cell surface. 
These genes were classed into three different groups (A, B and C), initially by Emr and 
colleagues. Subsequently, Stevens and colleagues identified in total 41 yeast vps mutants 
that were divided into six classes (A to F). The class E vps was named because disruption 
1 Introduction 
28 
 
of these gene products leads to formation of aberrant endosome-like compartments and it 
is the study of these genes that led to the discovery of the ESCRT complexes.  
Subsequently, many homologous ESCRT proteins have been identified in a wide variety of 
organisms including humans, providing evidence for the extensive conservation of this 
machinery. Furthermore, ESCRT-like proteins have been identified in archaea, which 
function in the scission of the membrane neck between dividing cells suggesting an ancient 
origin for this machinery (Samson & Bell, 2009).  The high conservation of ESCRTs 
implies the important functions of them in a wide range of living organisms. 
In this section, the names and known functions of the four core ESCRT complexes will be 
introduced, followed by the relationship discovered for ESCRT and two cellular biological 
events as well as retrovirus budding (Field & Dacks, 2009). Finally, the crucial stage of 
membrane scission and the role of proteins of the ESCRT III complex will be described 
according to the current evidence in the literature. Research into ESCRT proteins is a 
rapidly growing research field and many review papers contain excellent and detailed 
information about ESCRT function in three major pathways: MVB formation, retrovirus 
budding and cytokinesis (Caballe & Martin-Serrano, 2011; Henne et al., 2011; Martin-
Serrano & Neil, 2011; Morita & Sundquist, 2004; Weiss & Gottlinger, 2011). 
1.3.1 ESCRT complexes and their functions 
Ubiquitin conjugation is one of the well characterised signals for membrane protein sorting 
during endocytosis and early endosomal protein trafficking. The ESCRT machinery can 
interact with ubiquitinated proteins via ubiquitin-binding domains and engage in the 
sorting of these protein cargos to MVBs for lysosome degradation. It has been shown that 
ubiquitination is necessary and sufficient to direct many proteins from the limiting 
membrane of the endosome into MVB vesicles. From the start of cargo recognition to the 
final degradation, it involves various interactions of the four ESCRT complexes, VPS4 
ATPase and potentially many ESCRT associated proteins (Hicke & Dunn, 2003; 
Katzmann et al., 2001; Morita & Sundquist, 2004).  
ESCRT-0 
This complex contains HRS (hepatocyte growth factor-regulated tyrosine kinase substrate) 
and STAM1/2 (signal transducing adaptor molecule 1/2) proteins (Vps27 and Hse1 in 
yeast) (Bilodeau et al., 2002). It was proposed as an extension of the initially identified 
ESCRT-I, -II and –III complexes. ESCRT-0 complex binds to ubiquitin and is involved in 
the initial cargo recognition. It has been shown that this complex is a 1:1 heterodimer and 
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the hybrid structure of endogenous ESCRT-0 core complex in HeLa cells showed high 
similarity to yeast (Ren et al., 2009). HRS contains two important domains: the UIM 
(ubiquitin-interacting motif) domain binds to ubiquitinated transmembrane protein cargo 
and the FYVE (Fab-1, YGL023, VPS27 and EEA1) domain binds to the lipid 
phosphatidylinositol 3-phosphate (PI3P) that is enriched on the late endosomal membrane. 
ESCRT-0 itself does not deform the membrane but it recruits late-acting ESCRT 
complexes and initiates the MVB pathway [reviewed in (Wollert & Hurley, 2010)]. 
ESCRT-I 
The ESCRT-I complex is also involved in the cargo recruitment stage. It was initially 
characterised in yeast as a 350 kDa complex composed of Vps23, Vps28 and Vps37 
proteins ten years ago (Katzmann et al., 2001). Subsequently, Mvb12 (multivesicular body 
sorting factor of 12 kDa) was identified as another subunit of ESCRT-I (Audhya et al., 
2007; Oestreich et al., 2007). Human ESCRT-I is a similar heterotetramer consisting of 
TSG101, VPS28, VPS37A/B/C/D and hMVB12A/B (VPS37 and hMVB12 have two or 
more isoforms) (Bishop & Woodman, 2001; Morita et al., 2007a). The crystal structure of 
the yeast ESCRT-I complex shows an elongated shape with two end domains 
(Kostelansky et al., 2007). ESCRT-I links ESCRT-0 and ESCRT-II complexes through the 
following interactions: the UEV domain of TSG101 binds to PTAP/PTAP-like motifs of 
HRS in ESCRT-0 and VPS28 interacts with the GLUE domain of EAP45 in the ESCRT-
II complex. The structure of the TSG101 UEV domain in complex with the PTAP motif 
in HIV-1 Gag has been determined (Pornillos et al., 2002), which revealed that HIV 
mimics the interaction between ESCRT-0 and TSG101 to recruit this machinery (Henne et 
al., 2011; Hurley & Emr, 2006). 
ESCRT-II 
ESCRT-II is a ~155 kDa heterotetramer formed of EAP45, EAP30 and two EAP20 
molecules (Vps36, Vps22 and two Vps25 in yeast) (Babst et al., 2002). Together with 
ESCRT-I, these complexes are responsible during the cargo recruitment and initial 
membrane deformation. The structure of this complex is of a ‘Y’ shape (Im & Hurley, 
2008; Teo et al., 2004). EAP45 and EAP30 form the base and two copies of EAP20 form 
the arms. The GLUE domain of EAP45 binds PI3P, VPS28 and ubiquitinated membrane 
proteins, demonstrating the link of this complex to ESCRT-I and protein cargo 
recognition. EAP20 interacts with CHMP6 of the ESCRT-III complex, which suggests a 
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role of ESCRT-II in initiating ESCRT-III action (Teo et al., 2004; Wollert & Hurley, 2010; 
Yorikawa et al., 2005). 
ESCRT-III 
The ESCRT-III complex is required for the last steps of MVB sorting, cargo sequestration, 
and MVB vesicle formation. It is still unclear about the detailed mechanisms underlining 
the processes, including the shaping of the membrane into buds and solutions to the 
energy barrier during the scission event that separates the membranes. However, the 
ESCRT-III complex has been shown to be important for the membrane scission stage. 
The results observed from in vitro studies carried out using giant unilamellar vesicles 
(GUVs) by Wollert and colleagues have revealed that the ESCRT-III complex is crucial for 
the scission stage. The researchers observed that the purified yeast ESCRT-III component 
Snf-7 (sucrose non-fermenting, the homologue of CHMP4 proteins in human) plays a key 
role for membrane pinching, as ILVs detached within GUVs after the addition of purified 
Snf-7 protein (Wollert et al., 2009). 
ESCRT-III assembles into a highly ordered filament-like hetero-oligomer and, different 
from the other ESCRT complexes, it is not a stable complex. Therefore there is as yet no 
crystal structure of the entire complex. Studies of the yeast ESCRT-III component has 
revealed that a transient complex of 450 kDa formed on endosomes (Teis et al., 2008). The 
mammalian subunits of ESCRT-III are named as CHarged Multivesicular body Proteins 
(CHMPs), although they were originally indentified as CHromatin-Modifying Proteins 
(Piper & Katzmann, 2007). There are four key subunits: CHMP6, CHMP4A/B/C, 
CHMP3 and CHMP2A/B (Vps20, Snf7, Vps24 and Vps2 in yeast). As ESCRT-III 
proteins have a positively charged N terminus and a negatively charged C-terminus, 
intramolecular interactions between these termini form an autoinhibited status (Bajorek et 
al., 2009; Lata et al., 2009). Studies of the yeast proteins have demonstrated ESCRT-III 
activation is initiated by the binding between EAP20 and CHMP6 (Vps20) (Teo et al., 
2004). CHMP6 nucleates the homo-oligomerisation of CHMP4A/B/C (Snf-7 in yeast) 
proteins into circular filaments which have been observed by electron microscopy and they 
are thought to constitute the neck of the membrane bud and to be sufficient to allow 
scission (Hanson et al., 2008). During this process, it has been shown that the 
oligomerisation of CHMP4A/B/C requires both interactions with the cellular membrane 
and CHMP6. To terminate CHMP4A/B/C oligomerisation the filaments are capped by 
CHMP3 (Vps24 in yeast), which further recruits CHMP2A/B (Vps2 in yeast) and initiates 
VPS4-dependent ESCRT-III disassembly (Saksena et al., 2009; Teis et al., 2008).  
1 Introduction 
31 
 
VPS4 complex 
VPS4 was firstly identified as a 48 kDa protein belonging to the protein family of AAA 
(ATPase associated with various cellular activities) ATPases from the studies in yeast cells. 
It has been shown that the loss of ATPase activity of VPS4 results defects in vacuolar 
protein transport (Babst et al., 1997). It has two isoforms (A and B) in human cells 
(Scheuring et al., 2001). VPS4 is the energy providing complex in the ESCRT machinery 
and disassembles ESCRT-III into monomeric subunits and catalyses the final step of the 
MVB pathway (Lata et al., 2008; Saksena et al., 2009). However, it is still unclear how the 
protein oligomerises into an active ATPase that is associated with the ESCRT-III complex. 
It has been reported that the N-terminal MIT (microtubule-interacting and trafficking) 
domain of VPS4 interacts directly with the C-terminal MIMs (MIT interacting motifs) of 
ESCRT-III subunit Vps2 (CHMP2A/B) (Stuchell-Brereton et al., 2007; Vajjhala et al., 
2007). Furthermore, structural association has been shown between VPS4 and LIP5 (Vta1 
in yeast), which contains two MIT domains, and this interaction may initiate the assembly 
of the active VPS4 and enhance the activity of VPS4 to facilitate the ESCRT-III 
disassembly (Yang & Hurley, 2010). 
ESCRT associated proteins 
In addition to the many proteins that form the core complexes of the ESCRT machinery, 
there are also many ESCRT associated cellular factors that have been identified 
(Agromayor et al., 2009; Doyotte et al., 2008; Tsang et al., 2006). In this section, the 
reported links and functions of four ESCRT associated proteins (ALIX, CIN85, HD-PTP 
and CC2D1A/1B) will be presented, which will be closely related to the studies and 
analysis in Chapter 3 and Chapter 4. 
ALIX (apoptosis-linked gene-2 interacting protein X) is also named as AIP1 and both of 
these names come from its interacting partner ALG-2 (apoptosis-linked gene-2), which 
was initially found to be involved in apoptotic signalling. ALIX has a Bro1 domain at its 
N-terminal region, a “V” shaped central domain composed of two extended helix bundles 
and a C-terminal proline-rich domain (Fisher et al., 2007; Usami et al., 2007).  The yeast 
orthologous protein is Bro1. ALIX was also found to be engaged in the ESCRT mediated 
MVB pathway through direct interactions. ALIX interacts with ESCRT-I component 
TSG101 through its C-terminal prolin-rich domain, while the N-terminal Bro1 domain 
interacts with the C-terminus of ESCRT-III proteins CHMP4A/B/C (McCullough et al., 
2008). Therefore ALIX is able to act as a bridge between ESCRT-I and ESCRT-III 
1 Introduction 
32 
 
complexes. In addition, the interaction between CHMP4s and ALIX is thought to stabilise 
the CHMP4 oligomerisation (Peck et al., 2004). Gag proteins encoded by retroviruses (such 
as HIV-1) contain YPXnL (Xn indicates 1-3 unspecified amino acid) motifs, which can 
directly bind to ALIX and facilitate virus budding (Strack et al., 2003). 
About ten years ago, CIN85 (Cbl-interacting protein of 85 kDa) was initially characterised 
as a novel adaptor protein that interacts with c-Cbl (Take et al., 2000). It has been recently 
reported that CIN85 also binds to the C-terminal proline-rich domain of ALIX (Usami et 
al., 2007). As this interaction may modulate the activity of ALIX, CIN85 has been included 
as an ESCRT-associated protein.  
HD-PTP was identified as a novel protein tyrosine phosphatase (PTP) from human cDNA, 
and is also called type N23 protein tyrosine phosphatase (PTPN23). According to the 
amino acid sequence, it has a similar N-terminal domain to yeast Bro1 and human ALIX. 
Similarly as ALIX, the Bro1 domain of HD-PTP also been shown to interact with the 
ESCRT-III component CHMP4B. Furthermore, depletion of HD-PTP by siRNA was 
reported to impair endosomal cargo sorting and disrupt the morphogenesis of MVBs 
(Doyotte et al., 2008; Toyooka et al., 2000). 
CC2D1A (coiled-coil and C2 domain containing 1A) is also called Freud-1 (5' repressor 
element under dual repression binding protein-1), and has been reported to be involved in 
regulating expression of the 5-hydroxytryptamine (serotonin) receptor 1A (5-HT1A) gene 
in neuronal cells (Ou et al., 2003). CC2D1B (coiled-coil and C2 domain containing 1B, also 
called Freud-2), which shares 50% amino acid identity with CC2D1A, was also identified 
to be involved in 5-HT1A regulation as a repressor (Hadjighassem et al., 2009). It has been 
shown that the regulation in both cases were at the gene expression stage. Furthermore, 
studies performed on Drosophila have shown that C2 domain binds to membrane of 
endosomes and homologues of CC2D1A/1B play roles in the regulation of endosomal 
trafficking (Gallagher & Knoblich, 2006; Jaekel & Klein, 2006). Additionally, CC2D1A has 
been reported to interact with all three CHMP4 isoforms according to a yeast two-hybrid 
study (Tsang et al., 2006). Hence, it is plausible that CC2D1A, and potentially its 
homologous protein CC2D1B, may be involved in regulating cellular receptor(s) through 
the interaction with ESCRT machinery at a protein level. 
Many other ESCRT-associated proteins also have been reported. In addition to ALIX and 
HD-PTP mentioned above, there are other Bro1 domain-containing proteins, Brox and 
Rhophilin (Popov et al., 2009). Human increased sodium tolerance (hIST) has been shown 
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to interact with VPS4, CHMP1A/B, LIP5, SPG20 and the MIT domain-containing 
proteins (MITD1, AMSH, UBPY and Spastin) (Agromayor et al., 2009; Renvoise et al., 
2010). Interactions between ESCRT and centrosome protein 55 (CEP55) have been 
demonstrated during cytokinesis (Carlton & Martin-Serrano, 2007) while various 
interactions have been reported between ESCRT and the arrestin-related trafficking 
proteins [arrestin domain-containing protein (ARRDC1-4) and thioredoxin-interacting 
protein (TXNIP)] (Rauch & Martin-Serrano, 2011). In addition, ESCRT associated 
ubiquitin ligases (WWP1, WWP2, Itch and Nedd4) (Rauch & Martin-Serrano, 2011; Sette 
et al., 2010) also have been shown to have function in the MVB pathway.   
1.3.2 ESCRT in membrane deformation events 
Biological membranes consist of phospholipid bilayers with numerous membrane proteins 
embedded. The plasma membrane is a selectively permeable membrane barrier between 
the inside of the cell and outside environment. The membrane wrapped organelles [such as 
the endoplasmic reticulum (ER) and the Golgi apparatus] are involved in various 
membrane trafficking pathways. They are all highly dynamic and organised biological 
structures involved in many processes to support living organisms from yeast to primates. 
There are a variety of biological events (e.g., forming two separate daughter cells during cell 
division and vesicle biogenesis) involving membrane deformation and reorganisation. 
Although there is some evidence for the ESCRT machinery involvement in other events 
(e.g., autophagy) (Lee et al., 2007), the following sections of this introduction will be 
focused on the reported functional involvement of this machinery during three biological 
events: the MVB pathway, cell division and retrovirus budding at the plasma membrane. 
1.3.2.1 ESCRT and MVB formation 
During the down regulation of membrane proteins from the plasma membrane, these 
proteins usually acquire ubiquitin as the sorting signal and are internalised by endocytosis, 
and subsequently delivered to the complex endosomal system by fusion of endocytic 
vesicles with early endosomes.  The endosomes further undergo a maturation process 
leading to the incorporated membrane proteins being internalised into vesicles that form 
within the lumen of the endosome. These so called intra-luminal vesicles (ILVs) are 
completely segregated from the cytoplasm. The vesicle containing endosomes ultimately 
fuse with lysosomes and their contents are degraded by the lysosomal enzymes. This 
cellular journey for membrane protein degradation is called MVB pathway (Barelli & 
Antonny, 2009; Nickerson et al., 2007). 
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The first observation of MVBs goes back over fifty years when large vesicles containing 
small internal vesicles were observed by electron microscopy [reviewed in (Henne et al., 
2011; Piper & Katzmann, 2007)]. The name MVBs was given to those large cellular 
vesicles at the time before any knowledge about their functions. Pioneering work on the 
regulation of epidermal growth factor receptor (EGFR) in human cancer cells led to the 
observation that EGFR is sorted into ILVs of endosomes (Haigler et al., 1979). Subsequent 
work indentified a crucial role for ubiquitination in the targeting of EGFR into ILVs, a 
process we now know is directly associated with the ESCRT machinery.  Lysosomes 
(equivalent to the vacuole in yeast) are the major cellular sites for the degradation of 
ubiquitin labelled membrane proteins, and the formation of ILVs within the MVB pathway 
via ESCRT function is crucial for delivering cargos for degradation in the yeast vacuole 
and the mammalian lysosome.  
1.3.2.2 ESCRT and retroviruses 
All viruses are intracellular parasites and they require host cell factors and machineries to 
complete their life cycle. This section explains the discovered relationship between human 
immunodeficiency virus (HIV) and the ESCRT machinery. 
After initial viral infection and viral gene expression, it is the Gag protein of HIV that 
drives the virus assembly and subsequent release. Gag associates closely with the inner side 
of the plasma membrane and the oligomerisation of the Gag protein is able to deform the 
lipid bilayer to form spherical protein shells. It was reported twenty years ago that the 
disruption of the p6 region of Gag in HIV-1 resulted in defects in virus budding. Further 
investigations revealed a PTAP amino acid motif within p6 and mutation of this motif also 
caused defects in HIV-1 budding (Gottlinger et al., 1991; Martin-Serrano et al., 2001; 
2003b). This early research offered a hint to initiate the idea that viruses might hijack a 
common cellular machinery to assist their budding. Subsequently, the YPXnL motif was 
also found in HIV Gag, which has a similar function to the PTAP motif (Morita & 
Sundquist, 2004; Strack et al., 2003). As disruption of these motifs results in defects during 
the late stage of virus assembly/budding, they were named late (L) domain motifs. 
Consequently it has been discovered that Gag protein interacts with the ESCRT-I 
component TSG101 and the ESCRT associate protein ALIX through the L domain motifs 
PTAP and YPXnL respectively. The late-acting components of this machinery, ESCRT-III 
proteins, are recruited through these interactions to the sites of HIV budding. The release 
of HIV-1 particles from the plasma membrane through pinching off from the cell surface 
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relies on the oligomerisation of ESCRT-III proteins (CHMPs) at the cytoplasmic side of 
the membrane (Weiss & Gottlinger, 2011).  
1.3.2.3 ESCRT and cell division 
More recently, research work reported from different laboratories have provided evidence 
for a crucial role of the ESCRT machinery in the final stages of cytokinesis.  
The first evidence came from experiments performed in Arabidopsis, as cells containing 
multiple nuclei were observed among various cell types when the TSG101 homologue 
gene elch was mutated. The reported results implied that cell division was impaired by this 
mutation (Spitzer et al., 2006). Soon after, it was reported that the human ESCRT 
component TSG101 is involved in the abscission stage of cytokinesis during HeLa cell 
division when Carlton and colleagues demonstrated interactions between TSG101 and 
CEP55, a centrosome and midbody protein essential for abscission. In addition, not only 
the ESCRT-I component TSG101 but also the ESCRT associated protein ALIX interacts 
with CEP55 (Carlton & Martin-Serrano, 2007). Furthermore, studies from the same 
research group reported that the human increased sodium tolerance (hIST) binds to VPS4 
and ESCRT-III components and it is required for cytokinesis in mammalian cells 
(Agromayor et al., 2009). Subsequently, through high-resolution structured illumination 
microscopy and time-lapse imaging, Elia and colleagues found TSG101, the ESCRT-III 
component CHMP4B and VPS4 proteins are sequentially localised to the narrow 
constriction sites during abscission between two daughter cells (Elia et al., 2011). 
Furthermore several other ESCRT-III subunits have been found to be involved in the 
abscission stage during cytokinesis [reviewed in (Caballe & Martin-Serrano, 2011)].  
For all the processes involving the ESCRT machinery described above, the late stage is the 
recruitment of the ESCRT-III complex to complete physical separation of membranes. 
The recruitment of ESCRT-III can be accomplished through different routes, either via 
ubiquitination and ESCRT-0 and/or ESCRT-I interactions or direct interaction with 
ESCRT-I and/or ALIX with retroviral Gag or cellular CEP55. It is conceivable that other 
processes that require ESCRT mediated membrane scission could achieve this by any 
mechanism that allows the appropriate recruitment and activation of ESCRT-III. 
1.3.2.4 ESCRT and HSV-1 
The secondary envelopment of HSV-1 shares topological similarities with MVB formation 
and it also requires membrane deformation and scission to form mature HSV-1 virus 
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particles. It has been reported that transient expression of dominant-negative VPS4 
inhibits HSV-1 replication during secondary assembly stage and the expression of 
dominant-negative ESCRT-III proteins also reduces HSV-1 infectious virus production. 
Interestingly, different from HIV, the recruitment of ESCRT by HSV-1 is independent of 
TSG101 and/or ALIX (Crump et al., 2007; Pawliczek & Crump, 2009). However, very 
little is known about how HSV-1 interacts with the ESCRT machinery. 
1.4 Hypotheses  
For large complex viruses, such as HSV-1, the assembly of virus particles involves the 
functions of many viral and host cellular proteins. The complex networks between viral 
and cellular proteins are still far from understood. As a large complex virus which 
assembles in the cytoplasm, HSV-1 assembly requires many viral proteins to be present at 
intracellular assembly sites. Especially, the cellular localisation of essential proteins is 
important for virus survival. Glycoproteins that arrive at the cell surface through the 
secretory pathway need to be internalised in order to be incorporated into the virions. It 
has been previously reported that gM causes the relocalisation of gD and gH/L from the 
plasma membrane to TGN in transfection assays (Crump et al., 2004), suggesting a role of 
gM in targeting viral glycoproteins to the viral assembly sites for incorporation. It was 
therefore hypothesized that gM is able to relocalise certain HSV-1 glycoproteins to the 
viral assembly sites in infected cells for efficient virion incorporation. 
In addition, many host proteins are also required for the viral assembly. The secondary 
envelopment shares topological similarities with the MVB formation, which involves the 
function of the ESCRT machinery. It has been previously shown that the ESCRT 
machinery is important for HSV-1 replication (Crump et al., 2007). However, no direct 
interactions between HSV-1 viral proteins and ESCRT have been reported. It was 
therefore hypothesized that the tegument proteins, which are located between the capsid 
and envelope, could mediate direct interactions with ESCRT/ESCRT associated proteins 
leading to the recruitment of the ESCRT machinery. 
1.5 Aims of this thesis 
As one of the few glycoproteins found throughout the Herpesviridae family, gM has been 
conserved for millions of years. Although such conservation of a gene usually indicates 
important function(s) for the organism, gM has previously been shown to be non-essential 
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for HSV-1 in tissue culture. Hitherto, many research studies have been carried out and 
phenotypic results have been reported where the gM gene in several herpesviruses has 
been disrupted. However, it is still unclear what role(s) gM plays during HSV-1 infection. 
According to the previous published data from the laboratory (Crump et al., 2004), it has 
been demonstrated in transfection assays that gM has the ability to cause relocalisation of 
other viral proteins, particularly gD and gH/L, in host cells. The first part of this thesis is 
therefore aimed at investigating the role(s) of gM in the cytoplasmic assembly stage during 
HSV-1 life cycle, particularly to examine the function of gM in relocalisation of other viral 
glycoproteins during infection.  
In addition to gM, there are many other viral and cellular factors involved in the 
cytoplasmic assembly of HSV-1 to form such large and complex infectious virus particles. 
In a parallel project to that investigating gM, the roles of certain cellular proteins were also 
studied. In 2007, the laboratory published the first evidence that HSV- 1 cytoplasmic 
assembly requires the function of VPS4 (Crump et al., 2007), suggesting a crucial role of 
the ESCRT machinery in the HSV-1 life cycle. Subsequently, further data from the 
laboratory were published demonstrating that the ESCRT-III components are important 
for HSV-1 replication, while different from HIV-1, TSG101 and/or ALIX are dispensable. 
Aiming at understand further details about the role ESCRT-III components in HSV-1 
replication, the direct role of CHMP4A/B/C proteins of ESCRT-III was investigated in 
this thesis. In addition, as there were no reported interactions between HSV-1 and ESCRT 
proteins, Y2H screening was performed for HSV-1 tegument proteins with a panel of 
human ESCRT and ESCRT associated proteins in order to identify interactions between 
the virus and cellular ESCRT machinery. These studies were aimed at understanding the 
complex interplay between HSV-1 and the human ESCRT machinery. 
The studies carried out for this thesis have been aimed at exploring the functions of both 
viral and host cellular proteins in HSV-1 secondary assembly. On one hand, the role of 
viral glycoproteins during cytoplasmic assembly was examined with a primary focus on gM. 
On the other hand, the function of the cellular ESCRT machinery during this stage and 
virus-host interactions that could recruit this machinery were investigated.  
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2     The role of glycoprotein M in HSV-1 
cytoplasmic assembly 
2.1 Introduction 
Being structurally complex viruses, a large number of different proteins need to be 
coordinated to successfully assemble new infectious herpesvirus particles. At least fifteen 
different viral transmembrane proteins have been identified in HSV-1 particles, all of 
which must be correctly localised to the appropriate cellular membrane sites to be 
incorporated into virions (Adams et al., 1998; Foster et al., 2001a; Foster et al., 2001b; 
Ghiasi et al., 1998; Loret et al., 2008).  
The envelope proteins, gB, gH, gL, gM and gN/pUL49.5, are conserved in all 
herpesviruses, which implies important functions of these proteins. The essential function 
of gB and the gH/L complex in herpesvirus entry is now well established and crystal 
structures of HSV-1 gB and HSV-2 gH/L have been recently solved (Chowdary et al., 
2010b; Heldwein et al., 2006). However, the role of gM and gN/pUL49.5 in the 
herpesvirus life cycle remains unclear. HSV-1 gM is a type III viral membrane protein 
encoded by gene UL10. It is predicted to have eight transmembrane domains and has been 
demonstrated to form a disulphate linked complex with gN/pUL49.5 in many herpes 
viruses (Crump et al., 2004). In several herpes viruses, gM has been shown to inhibit 
membrane fusion assays. For example, PRV gM has been reported to inhibit glycoprotein-
mediated fusion (Klupp et al., 2000). HSV-1 gM has also been shown to inhibit the fusion 
induced by HSV-1 gB, gD, gH and gL in a similar manner although with higher efficiency 
when co-expressed with HSV-1 pUL49.5 (Crump et al., 2004). Previous studies in the 
laboratories have shown that gM may have functional roles in localising other viral 
envelope proteins to sub-cellular compartments. Both PRV gM and HSV-1 gM are 
localised to the TGN when expressed in cells by transfection. In addition, these proteins 
can cause both gD and gH/L to be relocalised from the plasma membrane to a 
juxtanuclear compartment. These data suggest the mechanism of fusion inhibition is likely 
to be the removal of fusion proteins from the cell surface by gM. Furthermore, it also 
suggests a possible role of gM in targeting gD and/or gH/L to viral assembly sites (Crump 
et al., 2004).  
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Similar as gM, pUL43 is also a type III membrane protein and it is among the least 
characterised herpesvirus membrane proteins. It has been reported that the PRV pUL43 
was able to inhibit fusion induced by PRV glycoproteins in a transient expression-fusion 
assay to a similar extent as gM. pUL43 has been predicted to contain 9 transmembrane 
domains with a hydrophilic loop in the middle region and an N-terminal hydrophilic 
extension (Klupp et al., 2005). Due to the structure similarity and a similar ability to inhibit 
cell fusion, pUL43 and gM may have redundant function(s). 
The previous investigations of gM and pUL43 were carried out in cell models where the 
proteins were transiently expressed by transfection. The behaviours of these proteins could 
be different with the context of viral infection. In addition, the possible role of pUL43 in 
HSV-1 replication has not been reported. In this study, a gM deletion virus (∆gM) and its 
revertant (gMR), as well as a gM and pUL43 double deletion virus (∆gM/∆UL43) and gM 
revertant were created (gMR/∆UL43). These recombinant viruses were used to investigate 
the function of HSV-1 type III membrane proteins, with a primary focus on gM. 
2.2 Result 
2.2.1 Virus construction 
2.2.1.1 Glycoprotein M deletion virus 
HSV-1 strain SC16 isolated from a human recurrent lesion (Hill et al., 1975) was used in 
this study. The design and construction of ∆gM and gMR were carried out by Dr C. 
Crump and S. Bell. Briefly, ∆gM was constructed by replacing codons 134 to 466 of UL10 
with a β-galactosidase (β-gal) reporter gene using homologous recombination. The 
revertant virus was generated as a control by replacing the lacZ reporter gene with the wild 
type UL10 fragment (Figure 2.1).  
2.2.1.2 Glycoprotein M and pUL43 double deletion virus 
The design and construction of ∆gM/∆UL43 and gMR/∆UL43 were carried out by Dr C. 
Crump and S. Bell. Briefly, HSV-1 ∆gM/∆UL43 was constructed by replacing the entire 
UL43 ORF (genomic sequence 94733-96061) in ∆gM virus with the EGFP expression 
cassette through homologous recombination. Therefore, UL43 is deleted from the virus 
genome in addition to the deletion of the majority of UL10 as detailed above. Therefore, 
∆gM/∆UL43 carries both GFP and β-galactosidase reporter gene products for isolation. 
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Figure 2.1: Construction of ∆gM virus. A schematic of the HSV-1 genome with relevant restriction sites 
and ORFs highlighted. The region of UL10 between the indicated MscI and BsrGI restriction enzyme 
recognition sites in HSV-1 strain SC16 was replaced with a lacZ reporter gene, leaving 399bp of UL10 
remaining at the 5’-end and 22bp at the 3’-end. 
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Figure 2.2: Construction of ∆gM/∆UL43 virus. A schematic of the HSV-1 genome with relevant 
restriction sites and ORFs highlighted. The region of the indicated AseI and MluI restriction enzyme 
recognition sites in HSV-1 strain SC16 was replaced with a EGFP expression cassette, resulting the deletion 
of the entire UL43 gene. 
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The revertant virus (gMR/∆UL43) was generated as a control by replacing the EGFP 
expression cassette with the wild type UL43 fragment (Figure 2.2). 
2.2.2 Analysis of viral replication in vitro 
2.2.2.1 Single time point growth analysis in various cell lines 
Thirteen different mammalian cell lines (HT29, HFF, A549, CaCo2, HRT18, 293T, 
MDCK, COS-7, BHK, Vero, HaCaT, HeLa and SK-NSH) were used to compare the 
relative single cycle virus replication of the wild type SC16, ∆gM and ∆gM/∆UL43 viruses. 
The cells were seeded into six-well plates and the following day infected at 5 PFU/cell at 
37 °C for 1 h. The input viruses were removed and the cells were acid washed to inactivate 
any remaining input viruses. The infected cells were harvested at 26 hpi and infectious 
titres were determined by plaque assays. The result showed various differences in virus 
titres among these cell lines. All three viruses replicated poorly in the human 
neuroblastoma SK-NSH cells and the titres were about 4 logs lower than the other cell 
lines (Figure 2.3). This level of virus titre could be residual viruses which were not 
efficiently inactivated by the acid wash and so the results with SK-NSH cells were 
discounted. All three viruses replicated efficiently in all other cell types with relatively small 
difference between the viruses. A consistent reduction in titre in the absence of gM and 
pUL43 expression was observed for HT29 (human colon adenocarcinoma) cells and 
HaCaT (human keratinocyte) cells where SC16 > ∆gM > ∆gM/∆UL43. Unexpectedly, the 
opposite phenotype was observed in CaCo2 (human colorectal adenocarcinoma) and 
slightly in HeLa (human cervix carcinoma) cells with the titre of SC16 < ∆gM < 
∆gM/∆UL43 (Figure 2.3). For all the other cell lines there was no difference (HFF, A549 
and Vero) or there was no obvious trend for the effect of the viral gene mutation(s) on 
viral growth. However, one potential problem with this approach is that samples were 
collected at a late time point (26 hpi) but for many cells HSV-1 replication reaches the 
plateau phase around 14 hpi. 
2.2.2.2 Single-step growth analysis of HSV-1 mutant viruses 
Based on the single time point growth analysis result, six cell lines were chosen for further 
analysis. HT29 and HaCaT cells as they demonstrated a consistent reduction in titre in the 
absence of gM, HFF which showed little difference between the viruses but the cells are 
human primary diploid cells (foreskin fibroblasts), CaCo2 as they demonstrated a 
consistent increase in titre in the absence of gM. Furthermore Vero cells were chosen as 
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Figure 2.3: Single time point high MOI growth analysis of SC16, ∆gM and ∆gM/∆UL43 viruses in 
thirteen cell lines. Cells were seeded into six-well plates at 2.5 x 105 cells per well one day prior to being 
infected at 5 PFU/cell at 37 °C for one hour. The inocula were removed and the cells were acid washed to 
inactivate remaining input virus. The cells were frozen at -70 °C at 26 hpi and were sonicated after thawing 
to release progeny viruses. The titres were determined by plaque assay on Vero cell monolayers. The mean 
titres and standard errors of duplicated samples are shown. 
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Figure 2.4: Single-step virus growth analysis in Vero, HFF, RK13, HT29, HaCaT and CaCo2 cell 
lines. The cells were infected at 5 PFU/cell at 37 °C for one hour. The inocula were removed and acid 
washed to inactivate remaining input virus. Samples were collected at indicated time points by freeze-thaw at 
-70 °C and sonicated to release progeny virus. The titres were determined by plaque assay on Vero cell 
monolayers. The mean titres and standard errors of duplicated samples are shown. 
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they are wildly used in herpesvirus research and another cell line RK13 (rabbit kidney cell) 
was also chosen as a previous report demonstrated that gM deletion resulted in a 
significant growth defect in these cells (Leege et al., 2009). 
The cells were seeded into six-well plates and the following day infected at 5 PFU/cell at 
37 °C for one hour. The virus inocula were removed and acid washed to inactivate residual 
input viruses. Samples were harvested at various time points and progeny viruses were 
released by sonication for titration by plaque assay on Vero cell monolayers. As the results 
shown in Figure 2.4, there was almost no defect in virus growth in Vero or HFF cells as 
the titres of all the three viruses were almost identical from 10 hpi onwards. Although a 
relatively large growth defect of HSV-1 gM deletion virus constructed in a strain KOS 
background was reported in RK13 cells (Leege et al., 2009), the two SC16-based gM 
deletion viruses used here showed a much smaller defect in replication in RK13 at early 
time points and the titres reached a similar level as wild type by 26 hpi (Figure 2.4). This 
may due to the different virus strain used in the study or difference in experimental 
approach. In the two human cell lines HT29 and HaCaT, the mutant viruses demonstrated 
a greater defect in replication. Both mutant viruses had lower titres than the wild type 
during the whole time course. There were no difference between the growth of ∆gM and 
∆gM/∆UL43 in HT29 cells, however, the double deletion virus showed a stronger defect 
in HaCaT cells. Interestingly, in CaCo2 cells the absence of gM again resulted in increased 
virus titres than the wild type SC16 at late stages of the growth curve although 
∆gM/∆UL43 only demonstrated this at the final 2 time points (Figure 2.4). However, the 
reason for this phenotype is currently unknown.  
2.2.2.3 Multi-step growth analysis of HSV-1 mutant viruses 
The single-step growth kinetics suggests gM and pUL43 may have cell type dependant 
functions and the deletion of gM alone or together with pUL43 has small effects on 
infectious virus assembly in certain in vitro cell culture models including two human cell 
lines: HT29 and HaCaT. In order to further investigate the growth defects caused by the 
deletion of gM and/or pUL43 from the virus, multi-step growth ananlysis of ∆gM and 
∆gM/∆UL43 as well as their gM revertant viruses (gMR, gMR/∆UL43) were performed in 
HT29, HaCaT and Vero cells. The gMR/∆UL43 virus is equivalent to a single ∆UL43 
deletion virus. 
In HT29 cells, the deletion of pUL43 had very small defects (~ 2-fold) in growth (compare 
gMR to gMR/∆UL43, and ∆gM to ∆gM/∆UL43) (Figure 2.5 A). The single deletion of  
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Figure 2.5: Multi-step virus growth analysis. HT29 (A), HaCaT (B) and Vero (C) cells were infected with 
the indicated viruses at 0.001 PFU/cell at 37 °C for one hour. Samples were collected at the indicated time 
points and titrated by plaque assay on Vero cell monolayers. The mean titres and standard errors of 
duplicated samples are shown. 
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gM showed a defect in viral growth in these cells with 20-30 fold decrease in titre at 72 hpi 
(comparing ∆gM to gMR, and ∆gM/∆UL43 compared to gMR/∆UL43) (Figure 2.5 A). 
Furthermore, the growth of the virus with gM and pUL43 double deletion had the slowest 
growth rate with 54-fold lower titre at 72 hpi (comparing ∆gM/∆UL43 to gMR) (Figure 
2.5 A). These results suggest that pUL43 deletion has little or no effect on HSV-1 growth 
while gM deletion has a relatively greater defect in HSV-1 multi-step replication. In HaCaT 
cells, the deletion of pUL43 did cause defects in replication as shown comparing the gMR 
to gMR/∆UL43, or ∆gM to ∆gM/∆UL43. The deletion of gM caused larger defects in 
growth at early stage but the mutant viruses reached a similar level as the revertants at 72 
hpi (comparing ∆gM to gMR and ∆gM/∆UL43 to gMR/∆UL43) (Figure 2.5 B). Similar to 
HT29 cells, in Vero cells the single deletion of pUL43 had virtually no effect on virus 
growth (compare gMR to gMR/∆UL43, and ∆gM to ∆gM/∆UL43), while the deletion of 
gM caused 14-22 fold decrease in titre at the final time point (comparing ∆gM to gMR, and 
∆gM/∆UL43 compared to gMR/∆UL43) (Figure 2.5 C).  
Surprisingly, in these experiments the parental virus strain (SC16) demonstrated a 
significantly lower replication rate in all cell types than the gMR virus (Figure 2.5 A-C), 
which should be an equivalent “wild type” virus, while the reasons for this are unclear. The 
parental SC16 strain is a low passage isolate that is known to have a certain level of 
heterogeneity in plaque size. As the ∆gM virus is a clone isolate, the revertant gMR virus 
that was generated from ∆gM is likely to be more isogenic and thus a better control than 
the parental SC16. 
2.2.2.4 SC16 wild type control 
As mentioned above HSV-1 strain SC16 is a low passaged isolate that displays 
heterogeneity in the population as reflected by the various sized plaques (Figure 2.6 A). 
The parental virus has been passaged during the generation of the mutant and revertant 
viruses and so that original SC16 parental strain stocks may not be a fair comparison. In 
order to test the effect of passage on the parental SC16 virus plaque population, Vero cells 
were infected with SC16 at 0.1 PFU/cell for two passages. As would be expected, the 
proportion of large plaques increased with each passage (Figure 2.6 A-C). These results 
suggest that the SC16 population does change during serial passage and it would be more 
reasonable to use a wild type SC16 that has been subjected to the same procedures as the 
mutant viruses for a control. Thus the high molecular weight DNA harvested from SC16 
infected cells was transfected into Vero cells to generate a virus stock P0 (Figure 2.6 D). 
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Figure 2.6: Virus plaque sizes on Vero cell monolayer. Vero cells were seeded at 5 x 105 cell per well into 
six-well plate and incubated to form monolayer. The cells were infected with appropriate diluted virus stocks 
in 0.5 ml per well volume at 37 °C for one hour. Semisolid medium was added for incubation and the cells 
were fixed and stained three days post infection. (A-C) SC16 virus stocks were passaged twice and the 
plaques of different passaged virus stocks are shown. (D) High molecular weight DNA was prepared from 
SC16 infected cells and transfected into BHK cells to generate virus stock used for the plaque assay. (E) The 
virus stock harvest from D was passaged once and the plaques of the passaged virus stock are shown. (F) 
∆gM plaques. (G) gMR plaques. 
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This virus stock was passaged with infection at 0.1 PFU/cell to generate the virus stock P1 
for SC16 control (Figure 2.6 E). This new SC16 “wild type” control demonstrated a much 
more homogenous plaque size that was virtually the same as gMR (Figure 2.6 E, G), with 
both showing larger plaques than ∆gM (Figure 2.6 F). 
2.2.3 Glycoprotein M in HSV-1 cytoplasmic assembly 
2.2.3.1 The effect of gM deletion on virus replication 
From the virus growth analysis in vitro, there was little effect observed when pUL43 was 
deleted in HSV-1. Furthermore while investigating many cell lines does give a broad range 
of information, it is difficult to draw a conclusion by comparing the results from different 
cell models. Therefore, further experiments were focused on the function of gM using the 
HT29 cell line as the one showing the strongest phenotype and the Vero cell line as a 
control cell line as it has been used widely in published work. 
To investigate the effect of gM deletion on viral replication, the ∆gM, gMR and the 
equivalently treated wild type SC16 viruses were analysed in single- and multi-step growth 
assays in both cell lines. SC16 and gMR had virtually identical growth properties in both 
cell lines (Figure 2.7). ∆gM demonstrated a small growth deficit in HT29 cells at high 
multiplicity of infection (MOI) and showed ~10 fold reduction in titre at 10-14 hours post 
infection (hpi) compared to the other two viruses, although the difference became smaller 
(~3-fold) by 24 hpi (Figure 2.7 A). Much greater defects in the growth of ∆gM were 
observed in HT29 cells at low MOI with up to 37-fold reduction in infectious titre at 36-
48 hpi (Figure 2.7 C). At 72 hpi the reduction was about 24-fold, which indicates that the 
total production of ∆gM virus was about 4% of the two control viruses. In Vero cells there 
was virtually no difference in the growth properties of ∆gM compared to the control 
viruses in the single-step growth curve (Figure 2.7 B), comparable to previously published 
data on the growth properties of an independently generated SC16-based gM deletion 
virus in Vero cells (Browne et al., 2004). In the case of low MOI infection, ∆gM showed a 
modest delay in replication kinetics in Vero cells, with 4-8 fold lower titres at 36-48 hpi 
(Figure 2.7 D). However, different from HT29, the titres of the three viruses were similar 
at 72 hpi. These data suggest that while the absence of gM has small effect on the assembly 
of infectious virions in the human cell line HT29, gM expression is necessary for efficient 
cell-to-cell spread in these cells. Furthermore, gM expression also appears to aid efficient 
spread in Vero cells. 
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Figure 2.7: Virus growth analysis. Single-step (A, B) and multi-step (C, D) growth analysis at MOI of 10 
and 0.01 respectively were performed on HT29 and Vero cells. The mean titres of ∆gM, gMR and wild type 
SC16 and standard errors are shown (n=3). 
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Figure 2.8: Plaque size quantification. The plaques of ∆gM, gMR and wild type SC16 on HT29 and Vero 
cell monolayer are shown in the upper panel. The relative plaque sizes of ∆gM and gMR were calculated as 
the percentage of SC16 (set as 100%). The mean relative diameters and standard errors (n=50) are shown. 
***: p < 0.001 (two-tailed Student’s t-test). 
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2.2.3.2 Plaque size and quantification 
Defects in cell-to-cell spread can also be determined by analysis of plaque formation under 
semi-solid media. The size of plaques formed by wild type SC16 and gMR were virtually 
identical in size in both cell types. However, the ∆gM plaques were significantly smaller on 
both HT29 and Vero monolayers (Figure 2.8). Quantification data revealed that the ∆gM 
plaque diameter was reduced by ~60% in both cell types. Taken together with single and 
multi-step growth analysis, these data suggest defects in cell-to-cell spread in the absence 
of gM in both cell types. 
Given that plaque size and growth kinetics were virtually identical between wild type SC16 
and gMR, further experiments were performed on ∆gM and gMR only. 
2.2.4 The expression of viral proteins 
The expression of a panel of viral proteins in HT29 and Vero cells infected by ∆gM or 
gMR was analysed by western blot. As expected there was no detectable gM expression in 
either cell line infected by ∆gM (Figure 2.9). However, a slight reduction in the expression 
of pUL11 was observed in cells infected with ∆gM, which may be due to the proximity of 
the UL11 gene to the engineered deletion within the gM gene (UL10). Importantly, the 
major capsid protein VP5, the major tegument proteins VP16 and VP22, as well as the 
envelope proteins gB, gC, gD and gH were all expressed at similar levels in cells infected 
with ∆gM or gMR (Figure 2.9). This result suggests that the loss of gM did not have 
significant effect on viral gene expression. However, a greater population of the mature 
forms of gB, gC and gD were observed in Vero cells infected by ∆gM although the reason 
for this is unclear (Figure 2.9 B). Immunofluorescence analysis also confirmed the loss of 
gM expression in ∆gM and the regain of gM expression in gMR (Figure 2.10). 
2.2.5 gH/L and gD localisation 
It has previously been shown that when gD or gH/L is expressed alone by transfection, 
they localise at the cell surface, while when co-expressed with gM, both gD and gH/L 
localises mainly at the TGN (Crump et al., 2004). Here the localisation of these 
glycoproteins in infected cells was examined by immunofluorescence microscopy. In both 
∆gM and gMR infected cells, gH/L showed some co-localisation with the Golgi markers 
GM130 and TGN46 (Figure 2.11). In addition, the amount of gH/L present on the cell 
surface was greater in ∆gM infected cells compared to gMR (Figure 2.11). Thus it appears 
that the localisation of gH/L in infected cells at least partially relies on the expression of  
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Figure 2.9: Analysis of viral protein expression levels in infected cells. HT29 cells (A) or Vero cells (B) 
were infected with ∆gM or gMR at an MOI of 10 and harvested at 24 hpi. Two-fold dilutions of cell lysates 
(indicated by the gray triangles) were loaded and samples were probed with antibodies against HSV-1 
proteins. The tubulin signals were used as loading controls. 
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Figure 2.10: Immunofluorescence staining of gM. HeLa cells were seeded on cover slips and infected by 
HSV-1 wild type SC16, ∆gM or gMR at MOI of 2. The samples were fixed at 14 hpi followed by staining 
with primary antibodies anti-HSV and anti-gM (CB18). Donkey-anti-rabbit 568 (red) and donkey-anti-mouse 
488 (green) (Molecular probes/Invitrogen) were used as secondary antibodies. Pictures were taken with a 
fluorescent microscope (Olympus IX70) and processed in ImageJ software.  
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Figure 2.11: gH/L and gD localisation in infected cells. The localisation of gH/L and gD in Vero cells 
infected with ∆gM or gMR were determined by immunofluorescence microscope. The cells were fixed and 
stained at 6 hpi. Images were compiled and pseudocoloured with green representing gH/L or gD, red 
represents Golgi markers TGN46 or GM130 and blue indicating nuclei (DAPI staining). 
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gM. In contrast, there were no obvious differences in the distribution of gD between ∆gM 
or gMR infected cells, suggesting gM-independent mechanisms for controlling the sub-
cellular localisation of gD during infection (Figure 2.11). 
2.2.6 Analysis of the levels of gD and gH/L on the cell surface 
of infected cells 
To further investigate the levels of gH/L present on the cell surface in the presence or 
absence of gM, infected cells were analysed by flow cytometry. Vero cells were infected 
with ∆gM or gMR at three different MOI (0.8, 2.0 and 5.0 PFU/cell) and labelled with 
primary antibody anti-gH/L (LP11) followed by fluorescent secondary antibody labelling 
at 6 hpi. Signals from 10000 cells were collected for analysis. The mean value of cell 
surface gH/L and standard error bars are shown (Figure 2.12 A). As expected, for both 
viruses the cell surface gH/L levels increased with the increase of MOI. Interestingly, the 
∆gM infected cells demonstrated higher surface gH/L levels than the gMR infected cells at 
all three MOI conditions (Figure 2.12 A). 
In the above experiment conditions, the increased gH/L on the surface of ∆gM infected 
cells could be due to greater numbers of virions attached to the cell surface rather than 
free glycoprotein expressed upon infection. In order to test this, the cell surface gD level 
was labelled in parallel with gH/L. No significant difference was observed in surface levels 
of gD in cells infected with either virus. However, an increase in the level of gH/L was 
observed on the surface of cells infected with ∆gM compared to gMR (Figure 2.12 B). 
These data suggest that gM plays an important role in controlling the sub-cellular 
localisation of gH/L and in the absence of gM, gH/L internalisation is inhibited and/or 
gH/L transport to the cell surface is increased. 
2.2.7 Analysis of the internalisation of gD and gH/L in 
infected cells 
To test whether the increased level of gH/L on the plasma membrane was due to the 
impaired internalisation in the absence of gM, infected cells were incubated with antibodies 
specific to the extracellular domains of gH/L complex or gD at 37 ºC for one hour prior 
to fixation. The gH specific antibody LP11 recognises gH in gL dependant manner, while 
antibody 52S recognise gH in a gL independent manner. It was observed that both of the 
antibodies were efficiently internalised to cytoplasmic organelles in gMR-infected cells. 
However, in cells infected with ∆gM, these antibodies remained on the plasma membrane  
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Figure 2.12: Analysis of cell surface gH/L and gD in infected cells by FACS. (A) Vero cells were 
infected with ∆gM or gMR at 0.8, 2.0 and 5.0 PFU/cell. At 6 hpi, the live cells were incubated with gH/L 
specific antibody on ice followed by fluorescent secondary antibody labelling. The cell surface fluorescent 
signals were analysed by FACS. Uninfected cells and infected cells incubated with secondary antibody only 
were used as the negative controls. (B) Vero cells infected with ∆gM or gMR were separated into two parallel 
samples at 6 hpi for labelling with gH/L or gD specific antibodies and analysis by FACS. Histograms show 
the gH/L (upper panel) or gD (lower panel) present on the cell surface of uninfected controls (grey filled), 
∆gM infected cells (solid line) and gMR infected cells (dashed line). 
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Figure 2.13: Analysis of gD and gH/L internalisation. Vero cells were infected by ∆gM or gMR at 3 
PFU/cell. At 6 hpi, cells were incubated with gH/L, gH or gD specific antibodies at 37 ºC for one hour and 
then fixed and labelled with fluorescent secondary antibodies. Pictures were taken with a fluorescent 
microscope (Olympus IX70) and processed in ImageJ software. 
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(Figure 2.13). No obvious differences were observed in the internalisation of a gD specific 
antibody in cells infected by ∆gM or gMR (Figure 2.13). These data suggest that gM has a 
specific role in the internalisation of gH/L from the cell surface during HSV-1 infection. 
2.2.8 Analysis of virion proteins in purified ∆gM and gMR 
viruses 
Previously it has been demonstrated that gM can cause the internalisation of both gD and 
gH/L, which suggests a possible role of gM in transporting these envelope proteins from 
cell surface to the secondary envelopment sites for incorporation to virions (Crump et al., 
2004). As observed from section 2.2.6 and 2.2.7, more gH/L is on cell surface and the 
internalisation of gH/L is impaired in the absence of gM suggesting that the virion 
incorporation of gH/L might be affected. To analyse whether the deletion of gM had any 
effect on the incorporation of gH/L and other viral proteins into virions, ∆gM and gMR 
viruses were purified by Ficoll gradient centrifugation from the media of infected cells. 
The viral protein content in the purified virus preparations was examined by coomassie 
blue staining and western blotting. 
According to the coomassie blue staining of viruses purified from HT29 cell culture 
supernatant, the protein profiles of ∆gM and gMR were similar. There are bands at 
estimate size on the gel showing tegument proteins including VP1/2, VP13/14, VP16 and 
VP22, the major capsids protein VP5 and various bands indicating the glycoproteins 
(Figure 2.14 A). Interestingly, with the same amount of PFU (8 x 106) loading, purified 
∆gM showed stronger viral protein signals than gMR (Figure 2.14 A). This result suggests 
that with the same amount of infectious particles the purified ∆gM virus contains more 
protein content than gMR. Upon analysing a range of PFU it was found that the 
preparations of ∆gM contained approximately twice the amount of the capsid and 
tegument proteins than the equivalent PFU of gMR (Figure 2.14). This suggests that the 
particle-to-PFU ratio is higher for ∆gM and the loss of gM causes virions to be less 
infectious. When comparing similar levels of capsid (VP5) loading (compare 1.6 x 107 PFU 
of gMR with 8 x 106 PFU of ∆gM in Figure 2.14), the two viruses harvested from HT29 
cells had no significant difference in the levels of tegument proteins VP16 and VP22 or 
envelope proteins gB and gD. However, a small decrease in gC and a significant decrease 
in gH were observed in ∆gM virions (Figure 2.14 B). Quantification of signals and 
normalisation of the data to VP5 levels demonstrated that ∆gM virions contained 
approximately 6-fold less gH and 3-fold less gC than gMR virions (Figure 2.14 C). 
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Figure 2.14: Analysis of viral protein incorporation in virions generated by HT29 cells. ∆gM or gMR 
were purified from the culture supernatant of HT29 cells. 8 x 106 PFU purified viruses were separated by 
SDS-PAGE and stained with coomassie blue* (A). Two-fold dilution series of each virus were analysed by 
western blotting with antibodies against HSV-1 proteins (B). The integrated intensity (I.I.) values for viral 
protein signals were normalised to VP5 and the values of log2 (∆gM:gMR) after the normalisation are shown 
(C). * Coomassie blue staining was done by Dr C. Crump. 
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Figure 2.15: Further western blot analysis of viral protein incorporation in virions generated by 
HT29 cells. ∆gM or gMR were purified from the culture supernatant of HT29 as an independent 
preparation. Two-fold dilution series of each virus were separated by SDS-PAGE gels and analysed by 
western blotting with the indicated antibodies. Two gH specific antibodies were used: mouse monoclonal 
antibody BBH1, α-gH (M), and rabbit polyclonal antibody Shabba, α-gH (P). 
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Figure 2.16: Analysis of viral protein incorporation in virions generated by Vero cells. ∆gM or gMR 
were purified from the culture supernatant of Vero cells. 8 x 106 PFU purified viruses were separated by 
SDS-PAGE and stained with coomassie blue (A). Two-fold dilution series of each virus were analysed by 
western blotting with antibodies against HSV-1 proteins (B). The integrated intensity (I.I.) values for viral 
protein signals were normalised to VP5 and the values of log2 (∆gM:gMR) after the normalisation are shown 
(C). The virus samples were also analysed by anti-gL antibody (D). * Coomassie blue staining was done by Dr 
C. Crump. 
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Figure 2.17: Analysis of viral protein incorporation in virions generated by HaCaT cells. (A) Two-fold 
dilution series of purified ∆gM and gMR were loaded into SDS-PAGE gel as indicated by the PFU amount 
per lane and analysed by western blotting. (B) The integrated intensity (I.I.) values for all the viral protein 
signals were normalised to VP5 and the values of log2 (∆gM:gMR) after the normalisation are shown. 
 
   
2 The role of glycoprotein M in HSV-1 cytoplasmic assembly 
64 
 
Western blotting of independent purified virus preparations from HT29 culture 
supernatant was performed in order to confirm the observation. Both of the anti-gH 
monoclonal and polyclonal antibodies showed with similar capsid protein VP5 loading, 
there was lower gH in ∆gM virus (Figure 2.15). Furthermore, the gL content from the 
purified viruses were also tested and, as expected, the purified ∆gM virus contains less gL. 
Unfortunately, the anti-gL antibody always gave weak and fuzzy band, thus gL was omitted 
from the protein band quantification to avoid potential errors (Figure 2.15). 
Similarly, ∆gM and gMR viruses produced by Vero cells also had same protein profile 
according to the coomassie blue staining but ∆gM contains higher protein content (Figure 
2.16 A). According to the western blotting, the Vero generated ∆gM and gMR had no 
significant difference in the incorporation of the tegument proteins VP16 and VP22 
between the two viruses, but approximately 3-fold less gH was found in ∆gM than gMR 
virions (Figure 2.16 B, C). However, unlike virions prepared from HT29 cells, when 
viruses were prepared from Vero cells there was little difference in the incorporation of gC, 
and surprisingly ∆gM virions contained 2-3 times more gB and gD than gMR virions 
(Figure 2.16 B, C). The gL content from the purified viruses were also tested and, as 
expected, the purified ∆gM virus contains less gL (Figure 2.16 D). 
These observations were consistent between independent preparations of purified viruses 
from both cell types and the gH reductions in ∆gM virions agree with the gL levels 
observed by western blot (Figure 2.15, 2.16 D). In addition, viruses purified from HaCaT 
culture supernatant were also investigated by western blotting. It was found that similarly 
as viruses generated by HT29 and Vero cells, the particle-to-PFU ratio is consistently 
higher in ∆gM virions and there were similar level of VP16 and VP22 in ∆gM and gMR 
virions. However, the ∆gM virions contains about 4-fold less gH than gMR (Figure 2.17).  
Overall these data suggest gM plays an important role in the efficient incorporation of 
gH/L into HSV-1 particles, but to a greater extent in HT29 cells than in Vero and HaCaT 
cells. 
2.2.9 Entry kinetics of HSV-1 in the absence of gM 
It is widely known that gB, gD and the gH/L complex are essential for HSV-1 entry 
(Heldwein & Krummenacher, 2008). The decrease of gH/L levels in ∆gM virions 
observed in section 2.2.8 could alter the entry kinetics of HSV-1. Therefore virus 
penetration assays were performed to examine the entry rate of HSV-1 with or without gM.  
2 The role of glycoprotein M in HSV-1 cytoplasmic assembly 
65 
 
 
Figure 2.18: Entry assay on three cell lines using ∆gM and gMR working stocks. Appropriate diluted 
∆gM and gMR working stocks were incubated on HT29 (A), Vero (B) or HaCaT (C) cell monolayers at 4 °C 
and then shifted to 37 °C for various times as indicated. Acid wash was applied at each time points and the 
cells were incubated at semi solid medium for plaque formation. The plaques were counted and the relative 
penetrations of the viruses were determined by calculating the percentage of plaques formed of the input. 
The means and standard errors from triplicate experiments are shown.  
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Standard working stocks of ∆gM and gMR viruses grown in Vero cells were tested for 
entry kinetics on HT29, Vero and HaCaT cell monolayers (Figure 2.18, A-C). The cells 
were seeded into six-well plates to form monolayers and incubated with 240 PFU/well of 
either ∆gM or gMR virus at 4 ºC for 1 hour. The cells were shifted to 37 ºC for virus 
penetration and acid wash was performed at the various time points to inactivate viruses 
that had not penetrated into the cells. The percentage of the PFU at each time point of the 
total input PFU was calculated to determine penetration rates. In HT29 cells, ∆gM 
demonstrated a significantly delayed penetration rate compared to gMR. For instance, at 
20 min time point, the penetration rate of gMR was nearly 80% while it was only ~30% 
for ∆gM; gMR reach the plateau phase within one hour while it took two hours for the 
penetration rate of ∆gM to reach the same level (Figure 2.18 A). In Vero cells, ∆gM 
demonstrated a delayed penetration rate than gMR but the difference between these two 
viruses was much smaller than in HT29 cells. ∆gM had slower penetration rate than gMR 
during the initial 30 min but both of these viruses reached the plateau phase within one 
hour (Figure 2.18 B). In HaCaT cells, both of the viruses had faster penetration rate than 
on HT29 and Vero cells with steeper slopes for the penetration rate curves. Consistent 
with the other two cell lines ∆gM also demonstrated a delayed penetration rate. gMR 
reached a plateau phase within 20 min while ∆gM took 30-60 min in HaCaT cells (Figure 
2.18 C). Therefore, for all the three tested cell lines, the deletion of gM caused defects in 
host cell penetration. 
The viruses used in the above experiments were standard working stocks prepared from 
whole lysate of infected cells and they contain not only viruses but also cell debris, which 
could cause unexpected effects during the penetration assays. The gradient purified virus 
stocks contain low level of cellular contamination and the virus content can be determined 
by both titration and western blotting. Thus penetration assays using purified virus stocks 
can offer more detailed information. Furthermore, the working stocks used above were 
prepared from infected Vero cells and as demonstrated in Figure 2.14-2.16, the deletion of 
gM showed a greater reduction of gH/L in virions generated from HT29 cells compared 
to Vero cells. Therefore, the ∆gM and gMR viruses purified from Vero and HT29 cells 
were analysed in penetration assays. On comparison of ∆gM and gMR viruses purified 
from Vero (Figure 2.19 A) and HT29 (Figure 2.19 B) cells, there was a significant delay in 
the initial rate of ∆gM entry. It took approximately twice as long for ∆gM to reach 50% 
entry as it did for gMR (Figure 2.19 A, B). The two viruses harvested from Vero cells 
obtained an equivalent level of entry by 70 min (Figure 2.19 A). However, for the viruses  
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Figure 2.19: Entry assay on Vero cell monolayers using ∆gM and gMR purified viruses. The purified 
viruses were incubated on Vero monolayers and the entry assays were performed as described in Figure 2.18. 
The plaques were counted and the relative penetrations of ∆gM and gMR purified from Vero (A) and HT29 
(B) culture supernatant were determined. The means and standard errors from triplicate experiments are 
shown. 
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Figure 2.20: Entry assay on HT29 cell monolayers using ∆gM and gMR purified viruses. The entry 
assay was performed as described in Figure 2.18. The relative penetration rates of ∆gM and gMR purified 
from HT29 culture supernatant were determined. The means and standard errors from triplicate experiments 
are shown. 
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purified from HT29 cells, ∆gM showed a more severely attenuated entry with just ~9% of 
the virus penetrated into the host cells by 20 min compared to the 38% of gMR and they 
did not reach an equivalent level until 2 h (Figure 2.19 B). In addition, both of the viruses 
purified from Vero cells penetrated Vero cells fast than the corresponding virus harvested 
from HT29 cells. These may be directly related to the different profiles of the viral protein 
content of the purified viruses from these two cell types (Figure 2.14-2.16). Furthermore, 
the penetration assay was also performed on HT29 cell monolayers for ∆gM and gMR 
viruses purified from HT29 cells. Consistent with the other penetration assay results, ∆gM 
had a delayed penetration rate compared to gMR (Figure 2.20). However, it took both of 
the viruses three hours to reaching the plateau phase (Figure 2.20), suggesting a generally 
slower entry of HSV-1 into HT29 cells in these assay conditions.  
Taken together, gM deletion causes delayed penetration rate for HSV-1 and this delay in 
viral entry correlates with the observed reduction of gH/L in ∆gM virions, with more 
significant delay in entry for ∆gM viruses prepared from HT29 cells, which had the lowest 
level of gH/L in purified virions. 
2.3 Discussion and conclusion 
The work described in this chapter is primarily an investigation into the role of gM in 
HSV-1 assembly. Particular focus was given to the possible role of gM  in the targeting of 
other HSV-1 glycoproteins to virus assembly sites, as previous data from the laboratory 
had shown gM mediated internalisation and targeting of gD and gH/L in transfection 
studies. To investigate the function of gM in HSV-1, the gM encoding gene UL10 was 
deleted from the low passage strain SC16 and the effects of this deletion in infected cells 
was analysed. As another type III membrane protein, pUL43 may have similar functions as 
gM, in the initial studies, a gM and pUL43 double deletion virus was also included.  
The product of the UL43 gene in HSV-1 was firstly reported and characterised as a protein 
about 32 kDa in size (Carter et al., 1996). In addition, pUL43 has been predicted to contain 
multi-transmembrane domains (Klupp et al., 2005) as a type III membrane protein. There 
were potential implications for regulation of gene expression by antisense transcription of 
UL43.5, although, pUL43 is one of the least characterised proteins in alphaherpesviruses. 
Both UL43 and UL43.5 are dispensable for viral replication in HSV-1 in tissue culture 
(MacLean et al., 1991; Powers et al., 1994). Subsequently it was also shown that the PRV 
pUL43 is present in the virions but the deletion of UL43 from the viral genome did not 
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show a significant effect on virus replication (Klupp et al., 2005). However, the expression 
of PRV UL43 protein in cells inhibited membrane fusion induced by the viral fusion 
proteins to a similar extent as gM (Klupp et al., 2000), suggesting possibly related 
functional roles of gM and pUL43 in controlling glycoprotein localisation. Previous data 
has also shown that the deletion of HSV-1 UL43 protein has no effect in a mouse model 
(MacLean et al., 1991) and so it is unclear what roles pUL43 may have in vivo. In the viral 
growth assays performed for these studies, no robust phenotype was found. Furthermore, 
no antibodies were available to investigate pUL43 proteins in infected cells, and so 
additional studies were not performed on UL43 and its deletion viruses. However, the data 
collected in a relatively wide range of in vitro cell models for these studies will be 
informative for future analysis of HSV-1 UL43. 
The combined data from the single- and multi-step growth analysis together with the 
observed plaque sizes suggest that gM is relatively dispensable for the viral assembly but 
that gM is important for efficient cell-to-cell spread. Analysis of purified virus particles 
demonstrated a significant reduction in the incorporation of gH/L into ∆gM virions, and a 
concomitant inhibition of the internalisation of gH/L from the plasma membrane was 
observed in ∆gM-infected cells. These data are best explained by a functional role of gM in 
the retrieval of gH/L from the cell surface, and subsequent targeting to sites of secondary 
envelopment for efficient virion incorporation. However, although internalisation of gH/L 
appears to be significantly inhibited in the absence of gM, gH/L could still be observed in 
Golgi/TGN compartments in ∆gM infected cells when the sub-cellular localisation of total 
gH/L was probed. As all glycoproteins pass through the Golgi on their way from the 
endoplasmic reticulum (ER) to the plasma membrane, this Golgi/TGN localised gH/L 
may be newly synthesised protein within the secretory pathway. Furthermore, as infectious 
particles can still be produced in the absence of gM, this suggests that the pool of gH/L 
within the secretory pathway must pass through the viral assembly compartment and be 
present at sufficient concentrations to be incorporated into virions, albeit at a lower level, 
when gM is deleted. These data suggest that while gM is not essential for newly synthesised 
gH/L to reach sites of secondary envelopment, gM is necessary for maintaining an 
appropriate concentration of gH/L within the secondary envelopment compartment for 
assembling fully infectious particles, by retrieving gH/L molecules that have escaped 
further down the secretory pathway. 
Previously it has been shown that gM and/or the gM/N complex can cause the 
relocalisation of both gD and gH/L from the plasma membrane to the TGN in 
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transfection assays. It was therefore surprising that no decrease in the incorporation of gD 
into ∆gM virions was observed neither the internalisation of cell surface gD in infected 
cells was affected in the absence of gM. Whilst gM has the capacity to relocalise gD to 
intracellular compartments in transfected cells, in the context of HSV-1 infection other 
viral proteins must also be able to control gD localisation. It is currently unclear what 
performs this function in infected cells, although possible candidates are the gK/pUL20 
complex or pUL43. 
One of the surprising observations we made during these studies was that more gB and 
gD were incorporated into ∆gM produced in Vero cells. Upon analysis of the expression 
of viral proteins there was a greater proportion of higher molecular weight gB, gD and gC 
species in ∆gM infected compared to gMR infected Vero cells, suggesting more rapid 
maturation of these glycoproteins in the absence of gM (Figure 2.9). Interestingly, gM has 
been shown to localise to the ER in infected cells (Baines et al., 2007b; Zhang et al., 2009a). 
It is therefore conceivable that ER localised gM could retard the exit of glycoproteins from 
the ER, thereby delaying their processing in the Golgi. This could increase levels of mature 
glycoproteins in post-Golgi membranes in the absence of gM, leading to enhanced 
incorporation into virions. However, this appears to be a phenotype specific to Vero cells; 
there was no observable difference in viral glycoprotein expression patterns between ∆gM 
and gMR in HT29 cells (Figure 2.9). 
Whether gM can control the localisation of other HSV-1 envelope proteins is currently an 
open question. It is interesting that in HT29 cells less gC is incorporated into virions in the 
absence of gM. The cytoplasmic domain of HSV-1 gC is only 11 amino acids with no 
consensus trafficking motifs present. Therefore gC is likely to be localised to the plasma 
membrane in the absence of other viral proteins. In addition, one of the currently on-going 
projects in the laboratory where the plasma membrane fraction of ∆gM or gMR infected 
cells was extracted and subjected to mass spectrometer for analysing the change of plasma 
membrane proteins under ∆gM or gMR infection. Data has shown that ∆gM infected cells 
demonstrate higher gC level on cell surface than gMR infected cells (S. Y. K. Lau et al. 
unpublished data). These data suggest gM is indeed important in the efficient 
internalisation and targeting of gC to viral assembly compartments. 
Recently, it has been reported that the absence of gM in the HSV-1 KOS causes an 
inhibition of virion morphogenesis in the cytoplasm of infected cells (Leege et al., 2009). It 
is plausible that reduced levels of envelope glycoproteins such as gH/L to assembly 
compartments could lead to defects in secondary envelopment. Indeed the cytoplasmic 
2 The role of glycoprotein M in HSV-1 cytoplasmic assembly 
72 
 
domain of gH has been shown to interact with the major tegument protein VP16 (Gross et 
al., 2003). Given that gM can also interact with the major tegument protein VP22 
(Stylianou et al., 2009) at least two routes of tegument-envelope interaction would be 
inhibited for ∆gM viruses. However, we observe much smaller effects on the single cycle 
replication kinetics of HSV-1 lacking gM expression with strain SC16 than was observed 
for strain KOS (Leege et al., 2009). This may imply that there are mechanisms in SC16 that 
can compensate for the loss of gM function that are absent from the highly passaged KOS 
strain. It would also be interesting to determine whether reductions in titre that have been 
previously observed for gM deletion viruses are due to fewer virus particles being 
produced or whether similar numbers of virions are made but they are less infectious due 
to defective envelope protein incorporation.  
Overall, data in this chapter demonstrate an important role for HSV-1 gM in gH/L 
internalisation from the plasma membrane of infected cells and incorporation into mature 
virions. Although still many questions remain about the mechanisms of the role of this 
conserved herpesvirus protein gM, this work is the first demonstration of a functional role 
of gM in viral glycoprotein trafficking in infected cells. 
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3     Searching for interactions between HSV-
1 tegument and human ESCRT proteins 
3.1 Introduction 
The ESCRT machinery is involved in the pathway for the down regulation of cell surface 
receptors by controlling their transport and incorporation into the intraluminal vesicles of 
MVBs, which subsequently fuse with lysosomes to degrade their content (Wollert & 
Hurley, 2010). The ESCRT proteins were first identified in yeast and this pathway is 
conserved from yeast to human. There are four ESCRT complexes (ESCRT-0, -I, -II and -
III), the VPS4 ATPase complex and many associated proteins. Many studies have shown 
that ESCRTs are also responsible for the membrane remodelling during retrovirus 
budding on the cell surface (Morita & Sundquist, 2004) and the cleavage of the membrane 
neck between daughter cells during cytokinesis (Carlton & Martin-Serrano, 2007; Morita et 
al., 2007b).  
While the use of ESCRTs by retroviruses [reviewed in (Morita & Sundquist, 2004)] and 
several other families of RNA viruses (Ariumi et al., 2011) has been well established, less is 
known about the role of ESCRTs in the replication of large complex DNA viruses such as 
the herpesviruses. Previous studies have shown that the replication of HSV-1 is inhibited 
by the over expression of dominant-negative VPS4 (Calistri et al., 2007; Crump et al., 2007). 
It has also been shown that over expressing dominant-negative ESCRT-III proteins 
inhibits infectious HSV-1 production, which suggests ESCRT-III proteins are important 
for HSV-1 replication. However, the mechanism by which HSV-1 recruits the ESCRT 
machinery is unknown, and no direct interaction between HSV-1 proteins and the ESCRT 
machinery has been reported. ESCRT recruitment by HSV-1 does appear to be different 
from human immunodeficiency virus (HIV) which interacts with TSG101 and ALIX 
through late domain motifs to recruit ESCRTs because the disruption of TSG101 and/or 
ALIX function does not impair HSV-1 replication (Pawliczek & Crump, 2009).  
When the tegumented HSV-1 capsids bud into host membrane structures in the cytoplasm, 
the tegument layer located in between the viral capsid and membrane would seem the 
most likely to be involved in ESCRT recruitment (by analogy to RNA virus that primarily 
interact with ESCRT protein via their matrix). In order to identify direct interactions 
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between HSV-1 viral proteins and ESCRTs, HSV-1 tegument genes were cloned and 
tested against a panel of ESCRT and ESCRT-associated proteins in yeast two-hybrid (Y2H) 
assays. Positive hits from interaction screens were analysed using GST pull-down, co-
immunoprecipitation and protein co-localisation assays for validation. In addition, 
experiments were performed to identify short motifs/domains within tegument proteins 
and ESCRT candidates that are important for their interactions. 
3.2 Result 
3.2.1 HSV-1 tegument gene cloning and ESCRT plasmids 
A panel of ESCRT and ESCRT associated protein in yeast expressing plasmids were 
provided by J. Martin-Serrano at King’s College London. The CC2D1B clone that was 
included in this library is a variant of the full length protein lacking the C-terminal domain. 
The CC2D1B full length (CC2D1BFL) clone was obtained by PCR using a human cDNA 
library as the template. The primers were designed according to the full length CC2D1B 
gene (Gene ID: 200014) (Table 6.8) and the plasmid was sequenced for confirmation. HD-
PTP protein was reported to be functionally related to ALIX and has been shown to be 
involved in endosomal cargo sorting and multivesicular body morphogenesis. HD-PTP 
plasmids were not included in the original set of Y2H plasmids and so the appropriate 
yeast expression plasmids were generated by sub-cloning from pcDNA3-HA-HD-PTP 
from P.Woodman at University of Manchester (Doyotte et al., 2008). 
The yeast strain Y190 used in the screen contains the lacZ reporter gene under the control 
of a Gal4 promoter. The paired plasmids pHB18 and pGBKT7 express the prey and 
tagged bait respectively. Plasmids derived from pHB18 express the prey fused to the VP16 
activation domain (AD) and plasmids derived from pGBKT7 express the bait fused to the 
Gal4 DNA binding domain (BD). Yeast cells were co-transformed with the pGBKT7- and 
pHB18- derived plasmids, grown in selective agar plates to form colonies and the report 
gene product β-gal activity was measured as described later in Chapter 6. 
There are 23 HSV-1 tegument proteins that were identified to be component of 
extracellular virions by mass spectrometry (Loret et al., 2008). Although UL4 was not 
found in HSV-1 extracellular virions in this study, it was detected in HSV-2 virions 
(Yamada et al., 1998), and thus it was included in the tegument library construction for 
Y2H assays. In order to clone the HSV-1 tegument genes into the pHB18 and pGBKT7 
plasmids, primers were designed based on the HSV-1 strain 17 genomic sequence (Refseq: 
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NC_001806) with appropriate restriction enzyme sites to enable insertions of the full 
length ORFs into plasmid multi-cloning sites. Plasmids containing HSV-1 KOS EcoR I 
genomic fragments (Goldin et al., 1981) were used as templates during PCR (Table 6.5). As 
UL48 (VP16) of HSV-1 is a strong transactivator, when fused to the Gal4 DNA binding 
domain it is likely to cause high levels of auto-activation of reporter genes in the yeast two-
hybrid assays. Therefore, a C-terminal activation domain truncated construct (UL48∆AD) 
was made to attempt to prevent this auto-activation. 
Table 3.1 Sequencing result of HSV-1 tegument gene clones for Y2H. 
Tegument 
gene 
Strain 17 
size (bp) 
Protein sequence differences compared to strain 17 
UL4 600 A189T. 
UL7 891 Y201H. 
UL11 291 A8T. 
UL13 1557 R25Q; V35I; A56G; V198A; P422L; C433R. 
UL14 660 G131E; G163S; P177H; S194A. 
UL16 1122 No amino acid mutation. 
UL21 1608 No amino acid mutation. 
UL23 1131 N23S; K36E; R89Q; A265T. 
UL37 3372 D82A; D153E; M205L; P446A; S1054A; M1071T; A1088V; G1092E. 
UL41 1470 R19Q. 
UL46 2157 V180A; R304C; N411S; S443R; Ins482P; N502D; T513A. 
UL47 2082 T82S; A162D; A532T. 
UL48 1473 N13D; T124A. 
UL49 906 G29C; S49A; Q51P; G95A; L252I. 
UL50 1115 A85S; E162A; A172D; T177P. 
UL51 735 A40V; F92L; I177L. 
UL55 561 No amino acid mutation. 
US2 876 R57Q; T85I; L124Y; D231S; L232H; Y239S; K253I; T254L. 
US3 1446 S62G; E63D; C136R; D162Q. 
US10 903 ∆LPGSPGLPGSPG; A117D. 
US11 450 ∆PRSPREPRSPRE. 
RL2 (ICP0) 2328 
Sub cloned from plasmid pT7-111-ICP0cDNA containing strain 17 
ICP0 cDNA. 
UL36∆PQ 9420 
From Dr Crump. PQ repeat was replaced with in frame AflII site. 
L243M, V279G, ∆PPSAD352, T480M, A527T, N595S, W599R, V1219G, 
T1315I, H1580D, V1670L, S1700N, L2015I, Q2093H, A2168V, A2171T, 
V2242A, V2515A, A2520T, P2708L, A2723F, A2831T, A2850T, S2881N, 
A3030T, G3048R. 
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All of the clones were verified by sequencing (Table 3.1). In cases of significant protein 
sequence alterations, at least two independent clones were sequenced for confirmation. 
Comparison of the sequencing results of these KOS genes to HSV-1 strain 17 
demonstrated that only three genes UL16, UL21 and UL55 had no amino acid differences. 
The other KOS gene sequences are highly similar to strain 17 except for a few single 
amino acid alterations, short deletions (12 amino acids) in the repeat sequences of US10 
and US11, and one amino acid insertion in UL46 (Table 3.1). The nucleotide sequences are 
shown in the appendix. 
Attempts were made to clone ICP4, ICP34.5 and ICP0 from the KOS strain plasmids by 
PCR using various conditions, however, no optimised condition was found to generate 
sufficient PCR products. These genes are highly GC rich (>75%) and the PCR reactions 
produced many non-specific product bands. There was no available plasmid contaning 
ICP4 and ICP34.5 that could be used for sub-cloning in the lab. Thus these tegument 
proteins were not included in the screen. Plasmid pT7-111 containing the ICP0 cDNA 
from strain 17 (from R. Everett) was used to sub-clone ICP0 cDNA into yeast expression 
plasmids for Y2H assays. 
3.2.2 Yeast two-hybrid screen 
In order to search for potential interactions between HSV-1 tegument and cellular ESCRT 
proteins, yeast cells were transformed with all combinations of prey and bait plasmids and 
tested for β-gal reporter gene activity. Liquid β-gal activity assays were performed using 
chlorophenol red-β-D-galactopyranoside (CPRG) as substrate and absorbance was 
measured at 550 nm (OD550 nm) in a microplate spectrophotometer (Martin-Serrano et al., 
2001). 
For any new bait protein fused with a DNA binding domain there is the potential for false 
positive due to non-specific activation (auto-activation) of the reporter genes. Therefore 
pGBKT7 tegument constructs were initially tested for auto-activation by co-transfection 
with empty pHB18. Those constructs with OD550 nm > 0.20 were counted as auto-
activated and were eliminated from the screen. Among all the constructs tested, pGBKT7-
UL7, UL11, UL16, UL21, UL48 and UL48∆AD constructs showed auto-activation with 
OD550 nm readings greater than 0.20  (Figure 3.1). Thus these six constructs in pGBKT7 
were eliminated from the screen. This auto-activation was expected for pGBKT7-UL48 
because it is known that the UL48 gene product VP16 is a strong transactivator. However, 
surprisingly, the pGBKT7-UL48∆AD construct, which expresses Gal4 DNA binding 
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domain fused with VP16 without its activation domain, also showed strong auto-activation 
level (Figure 3.1). This was despite previous reports using UL48∆AD as bait in Y2H assays 
(Vittone et al., 2005). However the difference in the system used here is the prey plasmid 
(pHB18) expresses the VP16 activation domain. These observations suggest that the VP16 
activation domain may be able to interact with the VP16 core domain thereby causing 
expression of the reporter gene. In addition, the constructs pGBKT7- UL4, UL13, UL14 
and UL37 showed a low level of auto-activation with OD550 nm between 0.05 and 0.20 
(Figure 3.1). They were included in the screen although they may have relatively higher risk 
of generating false positive results. 
Resulting colonies from leucine/tryptophan dual selection plates were screened for β-gal 
activity. The interaction between TSG101 and VPS28 has been reported in Y2H assays; 
therefore the combination of pGBKT7-TSG101 and pHB18-VPS28 was used as a positive 
control (Martin-Serrano et al., 2003a). The bait plasmid (pGBKT7 derived) and empty 
pHB18 or the prey plasmid (pHB18 derived) and empty pGBKT7 combination were used 
as negative controls. The combined results from all these initial Y2H screens are shown 
when the tegument constructs were used as prey (Figure 3.2 A) and bait (Figure 3.2 B). 
The potential interactions are illustrated by colour boxes based on the values of OD550 nm. 
The OD550 nm values of the negative controls are mostly less than 0.20, so OD550 nm 
values larger than 1.00 give at least 5 fold higher level of the reporter gene expression, 
which indicates a high stringency for positive interactions. The protein pairs with OD550 
nm values greater than 1.00 (orange and red colour boxes) were counted as positive hits. 
Thus orange and red coloured boxes were chosen as the primary candidates for further 
analysis. A part of these Y2H screen was performed by S. Rauch at King’s College London 
as indicated in the figure. 
CHMP4B and Nedd4 both showed positive interactions with many tegument proteins 
(Figure 3.2 A). While among these positive hits, there may be interesting candidates for 
further analysis; these data suggest CHMP4B and Nedd4 are generally “sticky” in this Y2H 
assay system. Therefore the tegument candidates that showed positive interactions with 
these two ESCRT proteins would need to be further analysed with more stringent 
methods. Similarly, the tegument protein pUL47 (VP13/14) also showed many positive 
hits (Figure 3.2 B), which also indicates that pUL47 may be prone to have non-specific 
interactions when expressed in yeast.  
In addition, as shown in Figure 3.2, most of the identified interactions only occurred in 
one combination of the prey and bait plasmid pair but not the other way around (e.g.,  
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UL47 and ALIX). In theory, interaction between two proteins should be reflected in both 
combinations. However, similar to the published Y2H assays (Vittone et al., 2005), many 
interactions were usually only demonstrated in one combination but not the other, and 
unfortunately the reasons for this are unclear. Among all of the positive hits, CC2D1A 
showed interaction with pUL47 in both combinations (Figure 3.2 A, B), suggesting this 
interaction is less likely to be an artefact. 
All candidates that gave OD550 nm > 1.0 in the initial screen (except pGBKT7-CHM4B 
and pGBKT7-Nedd4 combinations) were re-tested by Y2H assays in triplicate. Consistent 
with the initial screen result, CIN85 showed reproducible interactions with pUL46 and 
pUL49 (Figure 3.3 A). pUL47 showed strong interactions with CHMP6, ALIX, CIN85, 
Vps37A and Vps37C (Figure 3.3 B). However, other potential interactions identified in the 
initial screen were not reproducible during the repeat assays including the combinations of 
VPS28 and UL4, EAP45 and UL4, and EAP30 and UL46. Furthermore the interactions 
between UL36-3’ and TSG101 as well as CIN85 and US11 were relatively weak. Although 
these potential weak interactions might also contribute to the recruitment of ESCRTs by 
HSV-1, further studies were focused on the candidates that gave the strongest interactions. 
Current understanding of ESCRT function in the literature suggests that the CHMP4 
proteins of the ESCRT-III complex play the key role in the scission event that separates 
membrane and so the recruitment of CHMP4A, B and/or C are likely to be crucial for 
envelopment. Interestingly, several proteins that interact directly or indirectly with 
CHMP4A/B/C proteins were identified in this study. CHMP6 and ALIX both directly 
interact with CHMP4A/B/C. CIN85 interacts with ALIX, thus it is potentially linked to 
the function of CHMP4A/B/C via ALIX. Therefore, CHMP6, ALIX and CIN85 were 
chosen as ESCRT candidates for further analysis. In addition, among the part of this Y2H 
screen performed at King’s College London, one interesting ESCRT candidate, CC2D1A, 
showed reproducible interactions with six tegument proteins (pUL11, pUL16, pUL21, 
pUL46, pUL47 and pUL49) (Figure 3.2 A). It has been reported that CC2D1A directly 
interacts with CHMP4A/B/C (Tsang et al., 2006), and so CC2D1A was also chosen as a 
good candidate for further analysis. 
Taken together, the Y2H screen identified the following interactions as reproducible and 
potentially interesting: CHMP6 with pUL47, ALIX with pUL47, CIN85 with pUL46, 
pUL47 and pUL49, and CC2D1A with pUL11, UL16, UL21, pUL46, pUL47 and pUL49. 
These interaction candidates were taken forward for further characterisation. The analysis 
for interacting domain(s) in tegument proteins pUL46, pUL47 and pUL49 as well as  
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Figure 3.3: Repeat Y2H test of potential interactions with OD550 nm > 1.00 from the initial screen. 
Yeast cells were co-transformed with the indicated combinations of pGBKT7 and pHB18 constructs. The 
yeast two-hybrid assays were carried out as described in Figure 3.2. The empty pGBKT7 and pHB18 
combinations were used as the negative control and the pGBKT7-TSG101 and pHB18-VPS28 combination 
was used as the positive control. (A) Repeat test of potential interactions (except pUL47) revealed from the 
initial screen. (B) The repeat assays to confirm potential interactions between the ESCRT candidates and 
pUL47. The mean OD550 nm values and standard errors are shown (n=3). 
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CIN85 has been performed in this study. The further characterisations of UL11, UL16 and 
UL21, as well as the search of interaction domain(s) of CC2D1A have been carried out by 
S. Rauch at King’s College London.  
3.2.3 Identification of interacting domains 
As a first step to characterise the candidates identified from the Y2H screen, the domain(s) 
or short motif(s) of the tegument proteins that could mediate these interactions were 
investigated. A series of UL46, UL47 and UL49 domain constructs were generated by PCR 
using the full length gene as template and cloned into pGBKT7 or pHB18. All of the 
clones from PCR products were confirmed by sequencing. 
3.2.3.1 Interaction domains of pUL47 
Primers for twelve constructs were designed initially to generate a series of UL47 domains 
with about 100 aa truncation by each time from either N- or C-terminus (Figure 3.4 A). In 
order to reduce the scale of Y2H assays, the twelve pUL47 constructs in pGBKT7 were 
tested in Y2H assays firstly with one ESCRT candidate pHB18-CHMP6. Other than the 
full length pUL47, only the construct containing aa 83 to 693 UL47(83-693) demonstrated 
a strong interaction (Figure 3.4 B). To confirm these data, further Y2H assays were 
performed to test the interactions of ALIX and CHMP6 with UL47 constructs 1-82, 1-592, 
83-693 and 182-693 (Figure 3.5). The construct UL47(1-82) contains the N-terminal 
region 1-82 missing from the construct UL47(83-693), and thus serves as a control for 
construct UL47(83-693). The constructs UL47(1-592) and UL47(182-693) were included 
to confirm that further truncations of about 100 aa from either N-terminus or C-terminus 
of UL47(83-693) will inhibit the interactions. The results clearly show that only pUL47(83-
693) and full length pUL47 interacts with CHMP6 and ALIX, but all other truncated 
constructs failed to maintain the interactions.  
It has previously been shown in the literature that pUL47 (VP13/14) is primarily targeted 
to the nucleus in transfected (Donnelly & Elliott, 2001) and infected cells (Verhagen et al., 
2006b). Furthermore pUL47 exhibits the properties of a protein that shuttles between the 
nucleus and cytoplasm, mediated by a nuclear localisation signal (NLS) and a nuclear 
export signal (NES) located in the N- and C-terminal domains of pUL47 respectively 
(Donnelly & Elliott, 2001; Verhagen et al., 2006a). The truncation analysis conducted so far 
indicated that the structure of pUL47 is likely to be important for interactions with 
ESCRT proteins and that the nuclear localisation signal at the N-terminal of the protein is 
not important for the interaction. 
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Figure 3.4: UL47 domain constructs and Y2H analysis. (A) Diagram illustrating the twelve UL47 
constructs and the aa positions are indicated by the numbers. The top line represents the full length UL47 
gene with its nuclear localisation signal at aa position 63-76 and nuclear export signal at aa position 658-667 
as indicated. (B) UL47 constructs in pGBKT7 were tested for interactions with pHB18-CHMP6 in Y2H. 
The Y2H assays were performed as described in Figure 3.2. The pHB18-VPS28 and pGBKT7-TSG101 
combination was used as the positive control. 
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Figure 3.5: Y2H assay of UL47 domain constructs with CHMP6 and ALIX. Competent yeast cells 
were co-transformed with the indicated UL47 pGBKT7 derived constructs and pHB18-CHMP6 or ALIX. 
The Y2H assays were performed as described in Figure 3.2. The pHB18-VPS28 and pGBKT7-TSG101 
combination was used as the positive control. The mean OD550 nm and standard error bars are shown (n=3). 
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Figure 3.6: Y2H assay of UL47 domain constructs. (A) This diagram illustrates five further domain 
constructs of UL47. The top line shows the full length UL47 gene as described in Figure 3.4. The aa position 
of the various truncated constructs are shown. The constructs retaining the interactions with ESCRT 
proteins are highlighted in red. (B) The pGBKT7-UL47(83-693), UL47(128-693) and UL47(1-667) 
constructs were tested with the indicated four ESCRT proteins in pHB18 derived plasmids. The Y2H assays 
were performed as described in Figure 3.2. The mean OD550 nm and standard error bars are shown (n=3). (C) 
Three UL47 constructs UL47(83-693), UL47(128-693) and UL47(1-667) were test against pGBKT7- or 
pHB18-CC2D1A. The pHB18-VPS28 and pGBKT7-TSG101 combination was used as the positive control.  
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Figure 3.7: Y2H assay of UL47 domain constructs. (A) This diagram illustrates three further domain 
constructs of UL47. The top line shows the full length UL47 gene as described in Figure 3.4. The aa position 
of the various truncated constructs are shown at left hand side. The Y2H assays were performed as described 
in Figure 3.2. (B) The values of OD550 nm are shown. The pHB18-VPS28 and pGBKT7-TSG101 
combination was used as the positive control. 
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In order to further narrow down the domain of pUL47 that is important for the 
interaction and address any role of the NES, five additional UL47 constructs were created 
(Figure 3.6 A). The constructs were made to truncate further at the N-terminus of 
UL47(83-693) or C-terminus of the full length UL47. According to the Y2H assays, the 
construct UL47(1-667) and UL47(128-693) retained interactions with CHMP6, ALIX, 
CIN85, and CC2D1A (Figure 3.6 B). However, the construct UL47(1-657) lacking the 
NES (658-667) did not interact with any tested ESCRT proteins. Therefore, UL47(658-667) 
was constructed (contains only the NES) along with two additional constructs with further 
truncations UL47(147-693) and UL47(165-693) (Figure 3.7 A). These three constructs 
were tested against CHMP6 and CC2D1A together with full length UL47 and UL47(83-
693) constructs. As the result shown, the further truncation of UL47 from aa 128 to 147 
abolished the interactions. Furthermore, the NES fragment construct UL47(658-667) did 
not show interactions in yeast two-hybrid assays (Figure 3.7 B). 
Overall these data suggest a core domain of pUL47 encompassing aa 128-667 appears 
crucial for all the interactions identified. Although the loss of NES abolished the 
interaction with CHMP6, ALIX, CIN85 and CC2D1A, the NES alone was not sufficient 
for any interaction. According to these results, the NLS is not important for the 
interactions. This suggests a large folded domain or the structure of pUL47 is required for 
these interactions, and unfortunately no short motif could be identified. 
3.2.3.2 Interaction domains of pUL46 
In order to search for potential domains that are responsible for the interactions between 
pUL46 and the ESCRT candidates, similarly to pUL47, a series of truncation constructs of 
pUL46 were generated by PCR and cloned into pGBKT7 and pHB18. All of the clones 
from PCR products were confirmed by sequencing. Six domain constructs were cloned of 
approximately 200 aa in length (Figure 3.8 A).  
The pGBKT7-CC2D1A showed positive interaction with full length UL46 construct 
pHB18-UL46 in the initial Y2H screen (Figure 3.2 A). In this same bait and prey plasmid 
combination, among the six UL46 constructs, CC2D1A showed positive interaction with 
the domain construct UL46(357-718) with OD550 nm > 1.0 (Figure 3.8 B). Therefore, this 
domain of UL46 contains a potential CC2D1A interacting site. Interestingly, the construct 
UL46(1-193) also showed an interaction that almost reached OD550 nm threshold (1.0) for 
positive interactions, suggesting there could be two interacting sites. However, these 
results need to be treated with caution. Additionally, the OD550 nm values of the domain  
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Figure 3.8: Domain constructs of UL46 and Y2H assays. (A) This diagram illustrates the six domain 
constructs of UL46. The top line represents the full length UL46 with the numbers indicating the amino acid 
positions. (B) Y2H assay of the six UL46 domain constructs in pHB18 and pGBKT7-CC2D1A and –
CC2D1B. (C) Y2H assay of the six UL46 domain constructs in pGBKT7 and pHB18-CC2D1A and –
CC2D1B. (D) Y2H assay of the six UL46 domain constructs in pGBKT7 and pHB18-CIN85. The Y2H 
assays were performed as described in Figure 3.2. The pHB18-VPS28 and pGBKT7-TSG101 combination 
was used as the positive control. 
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constructs are only half the values of the full length UL46, which suggests the fully folded 
pUL46 protein is required for optimal CC2D1A interaction. In agreement with the initial 
screen results, CC2D1B did not show any interactions with either the full length pUL46 or 
any truncated protein (Figure 3.8 B). 
Interestingly, positive interactions were detected by Y2H assays for the UL46 construct 
pGBKT7-UL46(540-718) with both pHB18-CC2D1A and pHB18-CC2D1B. However, in 
this prey-bait combination, neither of pHB18-CC2D1A or pHB18-CC2D1B showed 
positive interactions with the full length UL46 protein (Figure 3.8 C). In addition, the 
pHB18-CIN85 protein also showed interaction with pGBKT7-UL46(540-718) (Figure 3.8 
D), suggesting the pGBKT7-UL46(540-718) construct may be general “sticky” in Y2H 
assays. 
Apart from the UL46(540-718) construct described above, the pHB18-CIN85 also showed 
positive interactions with constructs pGBKT7-UL46(357-718) and pGBKT7-UL46(1-539) 
(Figure 3.8 D). This result suggests the interaction domain for CIN85 may reside in the aa 
357-539 region although further characterisation will be necessary. 
3.2.3.3 Interaction domains of pUL49 
Two domain constructs of pUL49 were made to contain the N or C-terminal region of full 
length pUL49 (Figure 3.9 A). The ESCRT associated proteins CC2D1A and CIN85 
showed positive interactions with full length pUL49 in the original screen (Figure 3.2). 
Thus the pGBKT7-CC2D1A and pHB18-CIN85 were tested against the domain 
constructs of pHB18-UL49 and pGBKT7-UL49 in yeast two-hybrid assays respectively. 
The interactions between full length pUL49 and these two proteins were reproducible, 
although no positive interactions could be detected for the truncated pUL49 constructs 
(Figure 3.9 B, C). This result suggests that the structure of pUL49 could be important for 
interactions with both CC2D1A and CIN85, although it is possible that the interacting 
domain may be located in the middle region of the full length protein and neither of the 
constructs retains an intact functional interacting domain. 
3.2.4 Validation of the HSV-1 tegument-ESCRT interactions 
Yeast two-hybrid assays are an efficient screening strategy to search potential interactions 
between two proteins. The prey and bait proteins are cloned into plasmids that fuse the 
proteins of interest to a DNA binding domain and a transactivation domain respectively. 
During the assay, the fusion proteins are overexpressed in yeast cells and the products of  
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Figure 3.9: Domain constructs of UL49 and Y2H assays. (A) This diagram illustrates the two domain 
constructs of UL49. The top line represents the full length UL49 with the numbers indicating amino acid 
positions. (B) Y2H assay of the two UL49 domain constructs in pHB18 and pGBKT7-CC2D1A. (C) Y2H 
assay of the two UL49 domain constructs in pHB18 and pGBKT7-CIN85. 
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downstream reporter genes are used as an indirect indicator for positive interactions. The 
major disadvantage of yeast two-hybrid assays is the relatively high frequency of false 
positive/false negative results. The proportion of the protein interactions identified by 
Y2H that agree with other methods may be as low as 30% (Deane et al., 2002).  Therefore, 
it is important to use alternative and independent assays to validate the candidate 
interactions that arise from yeast two-hybrid assays. 
3.2.4.1 Interactions of HSV-1 pUL47 with CHMP6 and ALIX 
According to the Y2H results, both CHMP6 and ALIX showed reproducible interactions 
with pUL47, both full length protein as well as the N-terminal truncated pUL47 lacking 
the first 81 to 127 aa. To investigate whether the interactions occur in mammalian cells, 
GST pull-down assays were performed. The UL47 gene was sub-cloned into pEGFP-C2 
to express N-terminal GFP tagged pUL47 in mammalian cells. Due to the presence of a 
nuclear localisation signal (NLS) at the N-terminus of pUL47 (aa 63-76) (Donnelly & 
Elliott, 2001), pUL47 was found to mainly localise to the cell nucleus in transfected cells 
(Figure 3.10 A, B). This is likely to result in a significant loss of the GFP-pUL47 protein 
during the cell lysate preparation when the cell nuclei are removed by centrifugation. 
Therefore the N-terminally truncated pUL47 (aa 83-693), which lacks the NLS was also 
sub-cloned into pEGFPC2. GFP-pUL47(83-693) demonstrated much stronger signals in 
the cytoplasm of transfected cells (Figure 3.10 B). 
For the GST pull-down assays, 293T cells were transfected with plasmid expressing GST 
tagged ALIX or CHMP6 together with plasmid expressing GFP tagged pUL47 or 
pUL47(83-693). In the control samples, the GST tagged constructs were co-transfected 
with plasmid expressing GFP only, and the GFP tagged constructs were co-transfected 
with plasmid expressing GST only. Cell lysates were prepared at 48 h post transfection and 
small portions of the lysates were retained to test protein expression levels. The rest of the 
lysates were incubated with glutathione Sepharose beads for GST binding. The beads were 
harvested by centrifugation and washed. The GFP signals in the bead fractions were tested 
by western blotting using a GFP specific antibody.  
According to the analysis of the beads fraction samples, there were no background signals 
detected in the control samples. The GST tagged ALIX or CHMP6 did not show 
interactions with GFP only, neither did the GFP tagged pUL47 or pUL47(83-693) show 
interactions with GST only (Figure 3.10 C). GFP tagged pUL47(83-693) was successfully 
pulled down by GST tagged ALIX and CHMP6 (Figure 3.10 C). This result suggests  
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Figure 3.10: GST pull-down assay of pUL47 and pUL47(83-693) with ALIX and CHMP6. (A) 
Illustration of full length UL47 and UL47(83-693) with the numbers indicating amino acid positions. (B) 
GFP tagged full length UL47 and the truncated UL47(83-693) plasmids were transfected into HeLa cells. 
The samples were fixed at 24 h post transfection, and were embedded in ProLong Gold+Dapi. The samples 
were imaged on an Olympus IX70 microscope with a 60x oil immersion lens and a Retiga 2000R ccd camera. 
Images were acquired with the Q capture Pro software and processed with ImageJ. (C) GST pull-down assay 
of GFP tagged pUL47 or pUL47 (83-693) with GST tagged ALIX or CHMP6. The indicated plasmids were 
co-transfected into 293T cells. The plasmids contain GFP or GST were used as the negative controls. After 
48 h post transfection, cells were harvested and cell lysates were prepared. Glutathione-sepharose beads were 
added into the lysate for GST binding at 4 ºC for 3 h. The beads were spun down, washed three times and 
samples were analysed by western blotting. The GFP signals detected from the pull-down and lysate samples 
are shown. 
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pUL47(83-693) does indeed interact with both ALIX and CHMP6 in mammalian cells. 
However, there were no detectable signals of GFP-pUL47 from the GST-ALIX or GST-
CHMP6 pull-down samples. This could be due to the lower level of full length GFP-
pUL47 protein present in the lysates. 
All of the GFP tagged proteins and GFP only control samples showed the protein bands 
at expected sizes (Figure 3.10 C, lysate). The levels of GFP tagged pUL47 full length 
protein presenting in the lysates were significantly lower than the GFP tagged pUL47(83-
693) (Figure 3.10 C, lysate). This agrees with the cellular localisation of the two proteins 
(Figure 3.10 B) and that a higher proportion of the cell nucleus localised pUL47 may be 
lost during the removal of cell nuclei during lysate preparation. 
3.2.4.2 Interactions of tegument protein with CIN85 
3.2.4.2.1 GST pull-down 
CIN85, Cbl-interacting protein of 85 kDa, was firstly identified as a novel adaptor protein 
which is likely to be involved in the EGF receptor-mediated signalling cascade (Take et al., 
2000). CIN85 contains three SH3 domains within the N-terminal region, a proline-rich 
domain in the middle and a C-terminal coiled-coil domain (Figure 3.11 A).  CIN85 has 
been subsequently reported to interact with ALIX (Schmidt et al., 2004). In the GST pull-
down assay, when GST tagged ALIX and GFP tagged CIN85 were co-expressed in 
mammalian cells, GFP-CIN85 could be efficiently pulled down by GST-ALIX (Figure 
3.11 B). This result agrees with the reported interaction between ALIX and CIN85.  
In order to confirm the interactions between CIN85 and pUL46, pUL47, pUL49 and 
US11 observed in yeast two-hybrid assays (Figure 3.2 B), CIN85 was sub-cloned from 
pHB18-CIN85 into pCAG-GST to express GST tagged full length CIN85. In order to 
investigate the domains of CIN85 that may mediate interactions, primers (Chapter 6) were 
designed for PCR to generate five truncated constructs: N-terminal three SH3 domains 
(SH3), middle proline-rich domain (PR), C-terminal coiled-coil domain (CC), CIN85 
lacking the coiled-coil domain (∆CC) and  one lacking the three SH3 domains (PRC) 
(Figure 3.11 A). All the PCR products were confirmed by sequencing. 
The indicated five GST tagged CIN85 domain constructs and the full length construct 
were co-expressed with GFP tagged pUL46 or pUL49 in 293T cells. Cell lysates were 
prepared at round 48 h post transfection and incubated with glutathione Sepharose beads. 
The cell lysates were tested for protein expression levels and the beads fraction were tested 
for GFP signals. As the result shows, the constructs without the SH3 domains (PR, CC  
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Figure 3.11: CIN85 domain constructs and GST pull-down assays. (A) Diagram of CIN85 domains. 
Five truncated constructs containing different domain(s) were created and named as SH3, PR, CC, ∆CC and 
PRC. (B) GST pull-down assay of GST-ALIX and GFP-CIN85. The GST-ALIX + GFP and GST + GFP-
CIN85 combinations were used as negative controls. The GFP signals detected from the pull-down and 
lysate samples are shown. (to be continued) 
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Continued:  
(C) GST pull-down of GFP-pUL46 by CIN85 constructs. 293T cells were co-transfected with GFP-UL46 
and the indicated GST tagged CIN85 constructs. GST pull-down was performed using glutathione-
sepharose beads and the GFP and GST signals detected from the pull-down samples are shown. (D) GST 
pull-down of GFP-pUL49 by CIN85 constructs. The assay was performed as described above and the GFP 
and GST signals detected from the pull-down samples are shown. (to be continued)  
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Continued:  
(E) GST pull-down of GFP-pUL47 by CIN85. The assay was performed as described above and the GFP 
signals detected from the pull-down and lysate samples are shown. (F) GST pull-down of GFP-CIN85 by 
GST-pUS11. The assay was performed as described above and the GFP signals detected from the pull-down 
and lysate samples are shown.  
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and PRC) did not interact with the tegument proteins, while GST-CIN85 full length as 
well as the SH3 domain containing constructs (SH3 and ∆CC) were able to pull down both 
GFP tagged pUL46 (Figure 3.11 C) and pUL49 (Figure 3.11 D). However, the pull-down 
signals of pUL46 and pUL49 from the full length CIN85 were weaker than the domain 
constructs (Figure 3.11 C, D). This may be due to the lower expression level of GST-
CIN85 than the domain constructs (Figure 3.11 C, D). In contrast, there was no detectable 
signal of GFP-UL47 observed from the GST pull-down samples (Figure 3.11 E). Further, 
there may be relatively weak interaction between CIN85 and pUS11; however, GFP-tagged 
CIN85 was not pulled down by the GST tagged pUS11 protein (Figure 3.11 F).  
Taken together, these results suggest that overexpressed CIN85 interacts with pUL46 and 
pUL49 in mammalian cells. In addition, the N-terminal SH3 domains are important for the 
interactions between CIN85 and these two tegument proteins. However, the interactions 
of pUL47 and pUS11 with CIN85 may be false positive hits from the Y2H assays. 
3.2.4.2.2 Protein co-localisation assay 
A convenient method to determine whether two proteins interact with each other is to 
examine their co-localisation in transfected cells by fluorescence microscopy, where the 
proteins are tagged with different fluorescent proteins and co-expressed in mammalian 
cells. If different proteins have specific localisations within cells, then interaction between 
the proteins can be evaluated by examining their co-localisation upon co-expression. One 
disadvantage to this approach is that interactions cannot be determined if both proteins 
have the same localisation independent of each other, e.g. soluble cytoplasmic localisation. 
Based on the result from GST pull-down assays, the SH3 and PRC domains of CIN85 
were cloned into pEGFPC2 plasmid, and pUL46, pUL47 and pUL49 were tagged with 
mCherry in mammalian expressing plasmids. The GFP tagged CIN85 constructs were co-
transfected with the mCherry tagged tegument constructs into HeLa cells, and ~24 h post 
transfection, the samples were fixed and examined by fluorescence microscopy. GFP 
tagged CIN85-SH3 domain demonstrated good co-localisation signals with Cherry-pUL46 
and Cherry-pUL49, whereas GFP-PRC or GFP alone did not show any co-localisation 
with either pUL46 or pUL49 (Figure 3.12 A, B). However, no co-localisation of Cherry-
pUL47 could be observed with the CIN85 domain constructs (Figure 3.12 C). The GFP 
tagged CIN85 SH3 and PRC domain constructs were co-expressed with Cherry only for 
further control conditions. As expected, there were no co-localisation signals in these 
control samples (Figure 3.12 D).  
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Figure 3.12: Protein co-localisation assay of CIN85 domain constructs and tegument proteins. The 
Cherry tagged tegument protein pUL46 (A), pUL49 (B) and pUL47 (C) were co-expressed in HeLa cells with 
GFP tagged CIN85 SH3 or PRC domain. The mCherry and GFP only plasmids were used as the negative 
controls. The cells were fixed at 27 h post transfection and examined by fluorescence microscopy. The 
images were obtained and processed in ImageJ software and pseudo-coloured in green, red and blue for the 
GFP, mCherry and DAPI channels respectively. 
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These results agree with the data from GST pull-down assays, and further confirmed that 
the interactions of CIN85 with pUL46 and pUL49 are likely to be genuine and the SH3 
domains of CIN85 are required for these interactions. However, these data further 
confirmed that the interaction of CIN85 and pUL47 is likely to be a false positive result 
from the Y2H assays. 
3.2.4.2.3 Co-immunoprecipitation 
The above results suggest direct interactions occur between CIN85 and pUL46 as well as 
CIN85 and pUL49. However, so far all assays have been performed with individual 
proteins and not in the context of viral infection. In order to further examine the 
interactions between CIN85 and tegument proteins in infected cells, co-
immunoprecipitation (co-IP) analyses were performed in HSV-1 infected cells. HeLa cells 
were infected at 5 PFU/cell and harvested at 24 hpi for lysate preparation. Mock infected 
cells were used as controls. The lysates were incubated with anti-CIN85 antibody for ~5 h 
followed by incubation of protein A-Sepharose beads. The beads were harvested by 
centrifugation, washed three times and the samples were analysed by western blotting. 
pUL49 (VP22) was clearly observed in the anti-CIN85 precipitated sample but not in the 
control (Figure 3.13 A), indicating that CIN85 binds to pUL49 in infected cells. However, 
it should be noted that additional controls using an irrelevant antibody in the co-IP and 
blotting for pUL49 would be required to confirm this result. As a control, the anti-CIN85 
antibody precipitated sample was also blotted by anti-VP16 (pUL48) specific antibody. 
Interestingly, VP16 was also pulled down by anti-CIN85 antibody (Figure 3.13 B), 
although there was no interaction observed between CIN85 and pUL48 from the initial 
Y2H screen (Figure 3.2 A). The immunoprecipitates were also blotted with anti-VP13/14 
(pUL47) and there were no detectable signal of pUL47 further confirming CIN85 and 
pUL47 do not interact (Figure 3.13 C). The viral proteins VP22, VP16 and VP13/14 were 
detected from the infected cell lysate but not from the uninfected control as expected 
(Figure 3.13 A-C). Unfortunately, no pUL46 specific antibody was available in the lab and 
so it could not be tested whether pUL46 interacts with CIN85 in infected cells. 
One of the interesting results described above is the potential interaction between CIN85 
and VP16 revealed by co-IP (Figure 3.13 B). VP16 (pUL48) is a major tegument protein 
and perhaps it has interactions with host cellular proteins that are important for HSV-1 
assembly. However, due to the strong auto-activation in yeast two-hybrid assays, pUL48 
could not be tested in the assay as a bait protein in pGBKT7. Therefore some potential 
interactions between VP16 and ESCRT proteins could be missed in the screen. Previous  
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Figure 3.13: Co-immunoprecipitation of CIN85 and tegument proteins. HeLa cells were seeded into 
T75 flask and infected at 5 PFU/cell one day later. At 24 hpi, cells were harvested for co-
immunoprecipitation. Cell lysates were prepared and incubated with anti-CIN85 antibody followed by 
protein A-Sepharose. The beads fractions were resolved by SDS-PAGE and examined by western blotting 
with anti-pUL49 (VP22) (A) or anti-pUL48 (VP16) (B) or anti-pUL47 (VP13/14) (C) antibodies. Uninfected 
cell lysates were used as the negative control. The viral proteins in the lysate samples were detected by 
western blotting and shown in corresponding panels.  
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Figure 3.14: GST pull-down of CIN85 with pUL48 (VP16). The assay was performed as described above 
and the GFP signals detected from the pull-down and lysate samples are shown. 
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reported data have shown that tegument protein VP16 interacts with pUL49 (VP22) 
(Hafezi et al., 2005) and pUL46 (Vittone et al., 2005). Thus the VP16 signal observed from 
the anti-CIN85 immunoprecipitates could be indirect via interaction(s) of pUL48 with 
pUL49 and/or pUL46, or through other unknown viral proteins that bind to CIN85. 
Hence, to further analyse whether there is a direct interaction between CIN85 and VP16, 
GST pull-down assay were performed. 293T cells were co-transfected with GST tagged 
VP16 and GFP tagged CIN85 plasmid, or GST and GFP only as negative controls. The 
GFP tagged CIN85 protein was clearly detected in the GST-VP16 pull-down sample and 
there was no binding of GST-VP16 to GFP only or GFP-CIN85 to GST only in the 
control samples (Figure 3.14). This result suggests that CIN85 can indeed directly interact 
with VP16. 
3.2.4.3 Interactions of tegument proteins with CC2D1A and CC2D1B 
3.2.4.3.1 GST pull-down 
From the yeast two-hybrid screen assays performed by S. Rauch at King’s College London, 
CC2D1A showed specific interactions with six HSV-1 tegument proteins (Figure 3.2). 
CC2D1A has been previously reported to interact with ESCRT-III protein CHMP4A, 
CHMP4B and CHMP4C according to Y2H assays (Tsang et al., 2006), thus CC2D1A is 
potentially a pathway for HSV-1 to recruit CHMP4A/B/C proteins. CC2D1A has a 
homologous protein CC2D1B that may have similar functions as CC2D1A. Therefore, 
CC2D1B was also included for further analysis.  
GST pull-down assays were performed to test whether CC2D1A and CC2D1B directly 
interact with CHMP4 proteins. All of three YFP tagged CHMP4 isoforms were pulled 
down by both GST tagged CC2D1A and CC2D1B (Figure 3.15). Among the three YFP 
tagged CHMP4 proteins, CC2D1A and CC2D1B showed the strongest binding to YFP-
CHMP4C and weakest binding to YFP-CHMP4A. Protein bands at estimated sizes were 
detected from the cell lysates suggesting YFP control and YFP tagged CHMP4 proteins 
were all expressed. However, the YFP tagged CHMP4A/B/C showed cleavage products 
suggesting a level of instability. Taken together, these results are in agreement with the 
previously reported interactions between CC2D1A and CHMP4A, CHMP4B and 
CHMP4C identified by Y2H assays (Tsang et al., 2006) and further confirm the direct 
interactions of CC2D1B with all three human CHMP4 proteins in mammalian cells. 
In the initial Y2H screen with HSV-1 tegument proteins, CC2D1A showed interactions 
with six HSV-1 tegument proteins: pUL11, pUL16, pUL21, pUL46, pUL47 and pUL49 
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Figure 3.15: GST pull-down of YFP-CHMP4 proteins by CC2D1A and CC2D1B. 293T cells were 
seeded into six-well plates at density of 6 x 105 cells per well one day before transfection. The GST tagged 
CC2D1A or CC2D1B plasmids were co-transfected with the indicated YFP tagged CHMP4A, CHMP4B or 
CHMP4C plasmids. The GST or GFP only plasmids were used as negative controls. 48 h post transfection, 
the cells were harvested to prepare lysates and subjected to GST pull-down assay. The GFP signals of the 
pull-down and lysate samples are shown.  
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Figure 3.16: GST pull-down of YFP/GFP tagged tegument proteins by GST-CC2D1A and CC2D1B. 
293T cells were seeded into six-well plates at density of 6 X 105 cells per well one day before transfection. 
The GST tagged CC2D1A (1A) or CC2D1B (1B) plasmids were co-transfected with the indicated GFP/YFP 
tagged tegument plasmids. The GST or GFP only plasmids were used as negative controls. 48 h post 
transfection, the cells were harvested to prepare lysates and subjected to GST pull-down assay. The GFP 
signals of the pull-down and lysates are shown. The positive interactions above non-specific binding are 
indicated by the green stars. 
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(Figure 3.2). While the homologous protein of CC2D1A, CC2D1B failed to show any 
interactions with HSV-1 tegument proteins in the initial Y2H screen. It was noticed that 
the CC2D1B clone used in the assays was shorter than expected. This CC2D1B clone is 
missing 309 aa from the N-terminus and has a different sequence at the C-terminus. The 
full length CC2D1B (CC2D1B-FL) clone was obtained by PCR using total cDNA from 
human cells as template (the sequence is shown in the appendix). Surprisingly, the 
CC2D1B-FL also showed no positive interactions with tegument proteins in Y2H assays. 
However, due to the possibility for homologous protein to have overlapping functions, 
and relatively high level of false negative result from yeast two-hybrid assays, it was 
considered worthwhile to further analyse the interactions of both CC2D1A and full length 
CC2D1B with HSV-1 tegument proteins. To do so, GST pull-down assays were 
performed from lysate of cells expressing YFP/GFP tagged pUL11, 16, 21, 46, 47 and 49 
with GST tagged CC2D1A or CC2D1B. 
GST tagged CC2D1A demonstrated interactions with GFP/YFP tagged pUL16 (Figure 
3.16 A), pUL46, pUL47 and pUL49 (Figure 3.16 B), and GST tagged CC2D1B interacted 
with GFP/YFP tagged pUL16 (Figure 3.16 A) and pUL47 (Figure 3.16 C), within all these 
samples demonstrating either no background signals for GST only control or the sample 
signals were clearly higher than the background.  In addition, GST tagged CC2D1A and 
CC2D1B both interacts with GFP tagged pUL47(83-693) (Figure 3.16 B, C) in agreement 
with the Y2H data (Figure 3.6 B, C). However, the GFP tagged pUL11 and pUL21 appear 
to bind to GST under the conditions used, thus these interactions could not be confirmed 
here (Figure 3.16 A). Furthermore, GST tagged CC2D1B did not show any interaction 
with GFP tagged pUL46 and pUL49 above background binding to GST controls (Figure 
3.16 C). In agreement with these results, GST pull-down assays performed by S. Rauch at 
King’s College London have demonstrated that CC2D1A interacted with HA-tagged 
pUL16, 21, 46, 47 and 49 and CC2D1B interacted with HA tagged pUL47 (S. Rauch, 
unpublished data). 
3.2.4.3.2 Co-immunoprecipitation 
Co-immunoprecipitation assays were performed to investigate whether CC2D1A and 
CC2D1B interact with the identified tegument candidate proteins in infected cells. 
Procedures were followed as described in section 3.2.4.2.3 using anti-CC2D1A and anti-
CC2D1B antibodies. The protein A-Sepharose beads fractions were subjected to western 
blotting and tested by anti-pUL49 (VP22), anti-pUL48 (VP16), and pUL47 (VP13/14) and 
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Figure 3.17: Co-immunoprecipitation of CC2D1A/1B and tegument proteins. HSV-1 infected HeLa 
cells lysates were prepared as described in Figure 3.13 and were incubated with anti-CC2D1A or anti-
CC2D1B antibody followed by protein A-Sepharose. The beads fractions were resolved by SDS-PAGE and 
examined by western blotting with anti-pUL49 (VP22) (A), anti-pUL48 (VP16) (B), anti-pUL47 (VP13/14) 
(C) or anti-pUL11 (D) antibody. Uninfected cell lysates were used as the negative control. Except the pUL11 
signals in infected cell lysate (D), the viral proteins in the lysate samples are shown in Figure 3.13. The beads 
fractions were also examined with anti-CC2D1A or anti-CC2D1B antibodies (E).  
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anti-pUL11 antibodies. As the results shown in Figure 3.17 A-D, there was no detectable 
signal from any of the immunoprecipitate samples. The expression levels of VP22, VP16 
and VP13/14 in infected cell lysates are shown in Figure 3.13 (experiments performed 
with same lysate samples) and pUL11 band was detected from the lysate at ~17 kDa 
(Figure 3.17 D). The endogenous CC2D1A and CC2D1B precipitated were tested using 
anti-CC2D1A and anti-CC2D1B respectively (Figure 3.17 E). Surprisingly, the antibody 
precipitation efficiency was lower in infected cells than the mock control. This, presumably, 
could be due to the inhibition of protein expression by viral host-cell shutoff, or protein 
degradation upon infection. These data suggest there were no detectable interactions 
between CC2D1A/1B and the viral tegument proteins that could be observed with this 
approach. This, however, could be due to the low levels of CC2D1A/1B precipitated by 
the antibodies, or the interactions between CC2D1A/1B and tegument proteins are of a 
relatively low efficiency and are disrupted during the washing of the IP samples. 
Optimisation of these experiments would be required to further analyse the interactions of 
these HSV-1 tegument proteins and endogenous CC2D1A or CC2D1B, although time 
constraint prevented this from being pursued further. 
Unfortunately, there were no anti-pUL16, anti-pUL21 or anti-pUL46 antibodies available 
for this analysis. It would be interesting to test the immunoprecipitates to examine whether 
these tegument candidates were precipitated by the CC2D1A and/or CC2D1B antibodies. 
3.2.4.3.3 CC2D1A and CC2D1B stable cell lines and virion incorporation 
Although the co-IP assays did not support direct interactions between endogenous 
CC2D1A/1B and tegument proteins under the conditions tested, the Y2H and GST pull-
down data in the previous sections, as well as additional data from our collaborator at 
King’s College London, suggest that these proteins do directly interact. Close contacting 
between cellular proteins and viral proteins could lead to the cellular proteins being 
incorporated into the virions. ESCRT components have been previously observed in 
purified HSV-1 preparation (Pawliczek & Crump, 2009). In the following studies, the 
virion incorporation of tagged CC2D1A and CC2D1B proteins has been examined in 
human keratinocyte HaCaT cells.  
The HaCaT cell lines stably expressing YFP tagged CC2D1A and CC2D1B were generated 
by retroviral transduction, using a VSV-G pseudotyped murine leukemia virus (MLV) 
system. Stable cell populations were selected and maintained in puromycine. The CC2D1B 
plasmid used was the C-terminal truncated variant of the full length protein. The YFP 
3 Searching for interactions between HSV-1 tegument and human ESCRT proteins 
112 
 
 
 
Figure 3.18: HaCaT stable cell line expressing CC2D1A-YFP or CC2D1B-YFP. (A) Fluorescence and 
phase-contrast images of stable cell populations. (B) HaCaT cell lysates were prepared and tested by western 
blotting using anti-GFP antibody to further confirm the over expressed CC2D1A-YFP (~ 130 kDa) and 
CC2D1B-YFP (~ 89 kDa) signals. 
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signals in HaCaT cells could be detected by both fluorescence microscopy (Figure 3.18 A) 
and GFP antibody in western blotting (Figure 3.18 B). The over expression levels of the 
two tagged protein were similar. 
As a first step to examine whether the YFP tagged CC2D1A and/or CC2D1B are 
incorporated into HSV-1 virions, the cells were infected by HSV-1 strain KOS and virions 
in the culture supernatant were partially purified by centrifugation through a 33.3% sucrose 
cushion. The virion samples were subjected to western blotting and GFP antibody was 
used to detect the YFP-CC2D1A and YFP-CC2D1B signals. YFP-CC2D1A signals were 
detected in the virus samples harvested from the cells stably expressing YFP-CC2D1A and 
the protein band was at the same size as the YFP-CC2D1A band detected from the lysate 
sample.  However, no YFP signals were observed in the viruses produced by YFP-
CC2D1B over expressing cells (Figure 3.19 A top panel). In addition, it has been 
previously shown that CHMP2B is incorporated into HSV-1 virions (Pawliczek & Crump, 
2009). Consistently with the reported data, CHMP2B was detected in the viruses purified 
from the two cell lines and the levels detected from the two viruses were similar (Figure 
3.19 middle panel). A potential caveat to this approach is the viral cytopathic effect (CPE) 
can cause lysis of cells, which might lead to contamination of virus samples with cellular 
factors. To monitor this, tubulin was used as an indicator for potential cellular protein 
contamination. As the result shows tubulin was only detected from the cell lysate (Figure 
3.19 A bottom panel), which implies little or no cellular component contamination of the 
virus preparation.  The viral capsid signals in the sucrose purified viruses from the two 
stable cell lines were also shown by western blotting and the two virus preparations had 
similar levels of VP5 (Figure 3.19 B). 
Thus these data suggest that YFP-CC2D1A is incorporated into HSV-1 KOS virions, but 
not YFP-CC2D1B. However, CC2D1B-YFP might also be incorporated into the virions, 
but of a much lower level. To test this, viruses could be harvested from a greater number 
of cells, or other methods, such as density gradient purification, could be performed to 
generated more concentrated virus stocks for further testing. Additionally, virus sucrose 
cushion “purification” is not as stringent as gradient purification. Although there was no 
tubulin signal in the virion samples, there might be some other cellular contaminations. 
Thus Ficoll gradient purification was performed to obtain higher purity virus stocks for 
western blotting analysis. 
HaCaT cells over expressing YFP-CC2D1A or YFP-CC2D1B were infected with HSV-1 
strain KOS at 0.01 PFU per cell. After three days o
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Figure 3.19: YFP-CC2D1A and YFP-CC2D1B in sucrose cushion purified HSV-1. (A) HaCaT cells 
stably over expressing YFP-CC2D1A or YFP-CC2D1B were seeded into T75 flasks at 4 x 106 cells per flask 
one day before infection. The cells were infected with HSV-1 strain KOS at 10 PFU per cell in 2 ml DMEM 
culture medium at 37 ºC for one hour. The inocula were removed and 10 ml medium per flask was added 
after the cells were washed in PBS. The culture supernatant was collected at 24 hpi and the cell debris was 
removed by centrifugation at 1800 rpm at 4 ºC for 10 min. The supernatant was overlaid onto 33.3% sucrose 
cushion and the viruses were harvested by centrifugation at 35000 rpm at 4 ºC for 90 min. The supernatant 
from uninfected HaCaT cells were used as control. YFP, CHMP2B and tubulin signals were tested for all the 
samples. (B) The viral capsid protein (VP5) signals were tested for the sucrose cushion purified KOS from 
the two HaCaT stable cell lines. 
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supernatant was harvested and cell debris was removed by low speed centrifuge. The 
viruses were harvested by ultracentrifugation and overlaid onto 5-15% Ficoll gradient for 
purification. The visible virus band located near the middle of the gradient was harvested, 
virion pelleted by ultracentrifugation and then resuspended in a small volumn of PBS and 
stored at -70 °C. The infectious titres were determined by plaque assays on Vero cell 
monolayers. The purified viruses were loaded at 4 x 108 PFU per lane in SDS-PAGE gel 
for western blotting. There was strong YFP-CC2D1A signal detected from the viruses 
harvested from the HaCaT cells stably express YFP-CC2D1A. The detected band is at the 
same position as the YFP-CC2D1A signal from the cell lysate sample. However, there was 
no YFP-CC2D1B signal detected from the viruses generated by YFP-CC2D1B expressing 
HaCaT cells (Figure 3.20 A, upper panel). 
In addition, it has been previously shown that VPS4A is incorporated into HSV-1 virions 
(Pawliczek & Crump, 2009). As expected, VPS4A was detected from the two purified 
viruses and the levels in the two purified viruses were similar (Figure 3.20 A, lower panel). 
However, there was no VPS4A signal detected from the cell lysate samples, which may due 
to the protein concentration of the cell lysates being too low.  
The purified virus samples were also tested with an anti-CC2D1B antibody.  Surprisingly, 
the anti-CC2D1B detected the presence of YFP-CC2D1B in the virion preparation 
purified from cells expressing YFP-CC2D1B (Figure 3.20 B), despite the fact that the GFP 
antibody did not detect any signal in this sample (Figure 3.20 A, upper panel). This might 
be due to the anti-CC2D1B antibody being more efficient than anti-GFP in detecting 
YFP-CC2D1B. No band at the size of YFP-CC2D1B could be detected in virions purified 
from YFP-CC2D1A expressing cells. However, faint bands at ~100 kDa were detected in 
both purified viruses by the anti-CC2D1B, which could represent full length endogenous 
CC2D1B (predicted size ~94 kDa). Analysis of VP5 showed that the loading of the two 
viruses were similar (Figure 3.20, C). Overall, these data suggest that both YFP-CC2D1A 
and YFP-CC2D1B are incorporated into HSV-1 virions, while YFP-CC2D1B was only 
incorporated at a low level. As a further step, it will be interesting to test whether the 
endogenous CC2D1A and CC2D1B proteins are incorporated into the virions during viral 
replication.  
3.2.4.3.4 Virion incorporation of endogenous CC2D1A and CC2D1B 
In order to investigate whether the endogenous CC2D1A and CC2D1B are incorporated 
into HSV-1 virions, anti-CC2D1A and anti-CC2D1B antibodies were used to detect  
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Figure 3.20: Virion incorporation of YFP-CC2D1A and YFP-CC2D1B in HSV-1. HaCaT cells stably 
expressing YFP tagged CC2D1A or CC2D1B proteins were infected with HSV-1 strain KOS at 0.01 PFU 
per cell. After incubation at 37 ºC for three days, the culture supernatant was collected and the cell debris 
was removed by centrifugation at 1200 rpm at 4 ºC for 20 min. The viruses from the supernatant were 
harvested by ultracentrifugation at 16000 rpm at 4 ºC for 2 h. The virus pellets were resuspended in 1% 
BSA/PBS solution, carefully overlaid onto 5-15% Ficoll gradient and centrifuged at 12000 rpm at 4 ºC for 
1.5 h. The virus band was harvested, virion pelleted by centrifuged at 20000 rpm at 4 ºC for 2 h and the virus 
pellets were resuspended in PBS. The titres were determined by plaque assays on Vero cell monolayer. 4 x 
108 PFU of the viruses were loaded per lane of SDS-PAGE gels for western blotting. Lysates of HaCaT 
stable cell lines were included for reference. Anti-GFP and anti-VPS4A antibodies were used to detect 
CC2D1A-YFP/CC2D1B-YFP and VPS4A singles respectively (A). Anti-CC2D1B was used to detect 
CC2D1B-YFP (B) and the viral capsid protein VP5 was detected by anti-VP5 antibody (C). 
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signals from purified virus stocks. Using the anti-CC2D1A antibody, both the YFP-tagged 
CC2D1A and the endogenous CC2D1A protein can be detected from the YFP-CC2D1A 
stable expressing HaCaT cell line, as well as from the purified KOS virions generated by 
this cell line. Further, another HSV-1 strain SC16 generated by two human cell lines 
(HaCaT and HT29) also showed endogenous CC2D1A signals (Figure 3.21 A). These data 
suggest that endogenous CC2D1A is indeed incorporated in HSV-1 virions. 
Similarly, CC2D1B specific antibody was also used to test whether the endogenous 
CC2D1B is incorporated into HSV-1 virions. HSV-1 strain KOS and SC16 were harvested 
from different human cell lines (HT29 and HaCaT) and purified through 5-15% Ficoll 
gradient as described above. As the results show, there is weak signal from 1.4 x 109 PFU 
of SC16 while the signal was barely detectable from 1 x 108 PFU of KOS sample (Figure 
3.21 B). This result implies that the endogenous CC2D1B is incorporated into HSV-1 
virions, and while it is difficult to compare signals from two different antibodies, these data 
together with the observation using YFP-CC2D1B expressing cells suggest less CC2D1B 
is presented in virions than CC2D1A. 
3.3 Discussion and conclusion 
In order to identify direct interactions between the viral and cellular ESCRT proteins, a 
Y2H screen was performed. Twenty-two tegument genes were cloned from HSV-1 strain 
KOS and the sequence results showed certain amino acid changes compare to strain 17. 
These changes including amino acid point mutations, short deletions in the repeat region 
of the viral genome and one amino acid insertion. In all, the differences between the 
different strains were minor.  
From the Y2H screen results, the tegument proteins US3 and US10 showed toxicity to 
yeasts. The amount of yeast colonies generated was generally much lower than the other 
samples. In these instances, some of the Y2H results were not obtained as there were not 
enough yeast cells for accurate measurement and these proteins are shown in Figure 3.2 as 
grey-coloured boxes. ICP0 has not been tested in the screen part performed at King’s 
College London and they are also shown by the grey-coloured boxes. In the initial screen 
result, some proteins such as CHMP4B and Nedd4 appear to be ‘sticky’ in this system, as 
they had many positive interactions with tegument proteins, suggesting generally non-
specific interactions. 
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Figure 3.21: Endogenous CC2D1A and CC2D1B in HSV-1 purified virions. (A) HSV-1 strain KOS 
purified from HaCaT cells stably express YFP-CC2D1A, and strain SC16 purified from normal HaCaT and 
HT29 cells were loaded to SDS-PAGE at 4 x 108 PFU per lane for western blotting using anti-CC2D1A 
antibody. The expected positions of YFP tagged CC2D1A and endogenous CC2D1A protein bands are 
indicated. (B) 1.4 x 109 PFU of SC16 purified from HT29 cells and 1 x 108 PFU of KOS purified from 
HaCaT cells were loaded to SDS-PAGE for western blotting using anti-CC2D1B antibody. The expected 
position of endogenous CC2D1B is indicated. 
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Although ESCRT-0, I, II and III complexes are important for the MVB pathway in the 
cells, they are not all essential for HSV-1 assembly. During the forming of intraluminal 
vesicles in MVB pathway, membrane deformation requires the functions of ESCRT-0, I 
and II to recruit the ubiquitin labelled cargos and initiate the bud forming, while the viral 
structure proteins are likely to drive the initial membrane deformation thus becoming 
independent of the function of ESCRT-0, I and II complexes. In addition, previous 
reported data has demonstrated that the disruption of ESCRT-I complex did not affect 
HSV-1 production (Pawliczek & Crump, 2009). Thus among the positive hits, the 
interactions between HSV-1 tegument and ESCRT-III related proteins were the primary 
focus and these candidates were investigated by other methods. The interactions between 
pUL47 and CHMP6, ALIX and CC2D1A were reproducible in GST pull-down assays. 
The interactions of CC2D1A with other tegument proteins pUL16, pUL46, and pUL49 
were also confirmed in GST pull-down assays. CC2D1B is a homologous protein of 
CC2D1A and these two proteins are proposed to have similar functions in cells. 
Surprisingly, there were no positive interactions found between CC2D1B and tegument 
proteins in Y2H assays. This may be due to poor expression of CC2D1B in yeast cells, or 
the overexpressed protein is either somehow not stable or misfolded. However, direct 
interactions between pUL47 and pUL16 with CC2D1B were observed in GST pull-down 
assays using mammalian cells. These data suggest that similar as CC2D1A, CC2D1B 
maybe directly interact with HSV-1 tegument proteins. 
After identifying new interactions between the virus and ESCRT/ESCRT associated 
proteins, attempts were made to search domains that are important for the interactions. 
For pUL47 it was found that the N-terminal 127 aa, including the NLS, were dispensable 
for interactions with CHMP6, ALIX, CIN85 and CC2D1A. Furthermore, the NES region 
near the C-terminus of pUL47 is required for these interactions because while the C-
terminal 26 aa of pUL47 downstream of the NES were dispensable, the truncation of 
pUL47 region beyond the NES resulted in the loss of interactions in Y2H assays (Figure 
3.4 - 3.7). In addition, some evidence was obtained for possible interacting domains in 
pUL46 for CIN85 and CC2D1A/1B (Figure 3.8), while for pUL49, neither of the domain 
constructs tested showed interactions with CC2D1A or CIN85 (Figure 3.9). Different 
from short late domain motifs (usually contain 4 amino acid) identified in retroviruses that 
interact with ESCRT proteins, so far no such short motifs could be found from HSV-1 
tegument proteins and large folded domains appear to be necessary. There is no 
information available about the structures of the HSV-1 tegument proteins in question. 
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Hence, protein structure prediction based on aa sequencing may offer helpful information 
for further analysis and domain constructs design in the future.  
The investigation of interacting domains in CIN85 revealed that the N-terminal SH3 
domains were important for interactions with pUL46 and pUL49. Both pUL46 and pUL49 
are relatively proline rich (9.9% and 12.6% respectively) and contain multiple potential 
SH3 binding motifs (PxxP). It would be interesting to perform further experiment to study 
which SH3 domain (or short motif) is responsible for the interactions between CIN85 and 
these proteins.  
Furthermore, the interaction between CIN85 and pUL49 (VP22) was confirmed by co-IP 
in infected cells. The result suggests that a direct interaction between pUL49 and CIN85 
does occur in infected cells. In addition, despite not showing positive hits in the Y2H 
assays, VP16 demonstrated an interaction with CIN85 in both GST pull-down and co-IP 
assays. This result adds further information to the complex interactions between tegument 
proteins and ESCRTs, some of which may not be revealed by the Y2H screen. However, 
the control samples for the co-IP experiments presented in this thesis could have been 
improved by using a control antibody in addition to the controls using uninfected cell 
lysates (Figure 3.13 and 3.17). 
The involvement of cellular ESCRT proteins in HSV-1 assembly might lead to their virion 
incorporation as previously reported from the laboratory for some ESCRT-III and VPS4 
proteins (Pawliczek & Crump, 2009). The data presented in this thesis now show virion 
incorporation of the ESCRT associated CC2D1A and CC2D1B proteins quite clearly for 
both YFP tagged and endogenous CC2D1A (Figure 3.19 - 3.21), while the incorporation 
of both forms of CC2D1B appears to be much lower. These data offer further evidence 
for close contact/interactions between CC2D1A/1B and HSV-1. In addition, there were 
no CIN85 signals detected in purified HSV-1 samples, which could be due to low 
incorporation level, or the CIN85 antibody is not efficient enough. Moreover, the virus 
might interact with CIN85 in order to establish the link to ALIX to recruit ESCRT, 
therefore the interaction with CIN85 occurs at a relatively early stage during secondary 
assembly, which could possibly result in low level of (or no) incorporation. Future 
construction of stable cells overexpressing GFP-CIN85 and examine HSV-1 virions 
generated by these cells may address this question. 
Over all in this chapter, ESCRT and tegument candidates were chosen according to the 
Y2H screen result. Some interactions observed from Y2H were confirmed by other 
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methods such as GST pull-down, protein co-localisation and co-IP assays. The ESCRT 
associated protein CC2D1A and CC2D1B were found to be incorporated into the HSV-1 
extracellular virions. These results demonstrate that there are direct interactions between 
the tegument and ESCRT/ESCRT associated proteins. The interactions may play 
important roles in recruiting ESCRT machinery. Further experiments to examine the effect 
of depleting ESCRT/ESCRT associated proteins on viral replication are detailed in the 
following chapter. 
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4     The effect of depleting ESCRT and 
ESCRT associated proteins on HSV-1 
replication 
4.1 Introduction 
During the HSV-1 life cycle, mature virus particles are formed by the budding of 
tegumented capsids into membrane compartments in the cytoplasm of the host cell. This 
event results in a double-membrane structure, where the inner membrane is the viral 
envelope, and the mature enveloped virus particle is contained in a transport vesicle 
formed by the outer membrane. During the formation of virus containing vesicles, the 
separation of the inner and outer membranes requires membrane scission.  
The ESCRT machinery has been identified as being involved in several events which 
require membrane scission. This machinery has four major complexes (ESCRT-0, I, II and 
III) and VPS4 ATPase. The ESCRT-III proteins polymerise into ring filaments and are 
thought to directly mediate the membrane scission event at sites of membrane 
deformation (Wollert et al., 2009). VPS4 ATPase is the only energy providing complex and 
is responsible for recycling ESCRT-III proteins after the separation of membrane is 
completed (Babst et al., 1998). It has been previously reported that HSV-1 replication 
requires the function of VPS4 ATPase (Crump et al., 2007). Additionally, previous data 
have shown that HSV-1 replication requires the function of the ESCRT III complex as 
overexpression of dominant negative ESCRT III proteins inhibited the production of 
infectious HSV-1 (Pawliczek & Crump, 2009). Among the eleven CHMP proteins 
(CHMP1A/B, 2A/B, 3, 4A/B/C, 5, 6 and 7) of the human ESCRT-III complex, there is 
evidence that the CHMP4 isoforms drive the actual membrane scission event. For example, 
CHMP4A and CHMP4B proteins can form circular arrays and cause plasma membrane 
deformation (Hanson et al., 2008) and the S. cerevisiae ESCRT III protein Snf-7 (the yeast 
homologue protein of human CHMP4A/B/C) has been shown to be essential for 
membrane scission in vitro (Wollert & Hurley, 2010). These reported data suggest that the 
key step in the separation of membranes during inducing vesicle/virus particle formation is 
the recruitment and activation of CHMP4 proteins.  
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Previous data from the laboratory has shown that overexpression of dominant negative 
CHMP4A/B/C proteins inhibited HSV-1 production (Pawliczek & Crump, 2009). 
However, the expression of dominant negative ESCRT III protein is thought to affect the 
entire protein complex and may not give information on the specific role of individual 
CHMP proteins, and the role of endogenous CHMP4 proteins in HSV-1 replication had 
not been described. In this chapter, HSV-1 replication was investigated in cells depleted of 
all three isoforms of CHMP4. Further investigations were carried out to study the role of 
the proteins identified in Chapter 3 that interact with HSV-1 tegument proteins and may 
mediate the recruitment of CHMP4A/B/C. These ESCRT and ESCRT associated 
proteins are ALIX, CHMP6, CIN85 and CC2D1A/1B that were identified to interact with 
HSV-1 tegument proteins by yeast two-hybrid screening and validated by several methods 
(see Chapter 3). ALIX, CHMP6 and CC2D1A/B have all been shown to directly interact 
with CHMP4 proteins (McCullough et al., 2008; Teis et al., 2008; Tsang et al., 2006) and are 
thus potential pathways for the virus to recruit the membrane scission activity of the 
ESCRT machinery. CIN85 has been shown to interact with ALIX, and so it is another 
potential route for CHMP4A/B/C recruitment, albeit via ALIX. 
It was hypothesised that HSV-1 may recruit the ESCRT machinery via these direct 
interactions, and therefore if these cellular factors are removed or depleted from the host 
cells, viral replication would be affected. However, it has been previously shown that the 
depletion of ALIX or CHMP6 did not significantly affect HSV-1 production [T. Pawliczek 
PhD thesis 2010 and (Pawliczek & Crump, 2009)]. Therefore, there is likely to be 
functional redundancy between these pathways. The effect of depleting CIN85 and 
CC2D1A/1B on HSV-1 production was investigated initially, and then further 
experiments were conducted to determine the effect of several combined depletions of 
these proteins. 
Additionally, in the Y2H screen demonstrated in Chapter 3, the HSV-1 tegument protein 
pUL47 was found to interact with many ESCRT and ESCRT associated proteins. While 
several of these interactions may be false positives, it is possible to inhibit all these 
potential interactions between pUL47 and ESCRTs by removing the UL47 gene from the 
virus genome. This strategy would result in HSV-1 having fewer possible pathways 
available to recruit the ESCRT machinery and thus could make the virus more sensitive to 
the depletion of other ESCRT proteins. Hence, a UL47 deletion virus (∆UL47) was 
created and the replication of ∆UL47 was analysed in cells with depletion of certain 
ESCRT and ESCRT associated proteins using siRNA. 
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Finally an alternative pathway beyond the candidates identified from the yeast two-hybrid 
screen in Chapter 3 was explored. ALIX has been shown to interact with CHMP4 
isoforms via its Bro1 domain (Meckes & Wills, 2007). Related Bro1 domains are also 
present in other mammalian proteins, and they could serve as alternative routes for the 
recruitment of ESCRT III. One of these Bro1 domain containing proteins, HD-PTP, 
although it did not show interactions with tegument proteins in the yeast two-hybrid 
screen, has been reported to be required in endosomal cargo sorting and multivesicular 
body morphogenesis (Doyotte et al., 2008). Therefore the effect of depleting HD-PTP on 
HSV-1 replication was investigated. 
4.2 Results 
4.2.1 HSV-1 replication in CHMP4A/B/C depleted cells 
Among the eleven CHMP proteins in the ESCRT III complex, CHMP4A/B/C proteins 
are the most important components for membrane scission events. In this section, the 
requirement for endogenous CHMP4A/B/C in HSV-1 replication has been investigated 
by siRNA depletion and the ultrastructures of the infected cells were examined by 
transmission electron microscopy (TEM).  
Previous studies in the laboratory have demonstrated that siRNA depletion of all three 
CHMP4 isoforms is highly toxic for HeLa cells, resulting in cell death before assays of 
viral replication could be performed. However, more recently it was observed that 293T 
cells are less sensitive to the loss of ESCRT function and remain viable for long enough to 
assay viral replication. 293T cells were transfected twice consecutively with 
CHMP4A/B/C siRNA oligonucleotides to knockdown endogenous protein expression. 
48 h after the second transfection, cells were infected with HSV-1 strain KOS at 10 
PFU/cell and the production of infectious viruses from a single round of viral replication 
was determined by plaque assay. In cells with simultaneous CHMP4A/B/C depletion, 
HSV-1 production is inhibited by more than 100 fold compared to the controls (Figure 4.1 
A). The expression levels of CHMP4A, CHMP4B and CHMP4C were tested in western 
blotting using anti-CHMP4A, anti-CHMP4B and anti-CHMP4C antibodies. The 
endogenous expression of the three CHMP4 proteins was reduced in CHMP4A/B/C 
siRNA treated cells, while the expression levels were not affected by the control siRNA 
ConX (Figure 4.1 B). The tubulin signals were at a similar level indicating there were 
similar amount of cells in different samples at the time of infection. 
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Figure 4.1: HSV-1 replication is inhibited by the depletion of CHMP4A/B/C. 293T cells were seeded 
into six-well plates at density of 4 x 105 cells per well. The first transfection was performed 2 h post seeding. 
Around 48 h after the first transfection, the cells were split into new plates and 2 h later the second 
transfection was performed. The cells were infected with HSV-1 strain KOS at 10 PFU/cell at 48 h post the 
second transfection. The infected cell samples were collected at 24 hpi by freezing at -70℃. The parallel 
uninfected cell samples were harvested for cell lysate preparation for western blotting. Tubulin signals in the 
samples were used as the loading control. (A) The progeny viruses produced in the cells were released by 
sonication. The infectious virus titres were determined by plaque assays on Vero cell monolayers. The mean 
titres and standard error bars from triplicate samples are shown. (B) The expression levels of endogenous 
CHMP4A, CHMP4B and CHMP4C in CHMP4A/B/C triple depleted cells and the control samples.  
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Figure 4.2: Ultrastructure of ConX siRNA treated cells infected with HSV-1. 293T cells were treated 
with two rounds of siRNA as described in the legend of Figure 4.1. The cells were infected with HSV-1 
strain KOS at 5 PFU/cell at 48 h post the second siRNA transfection. The infected cells were fixed at 16 hpi 
in 2% glutaraldehyde in 0.1M HEPES buffer (pH 7.4) on ice and subjected to preparation for TEM by Dr J. 
Skepper (Multi Imaging Unit of Physiology Development and Neuroscience, University of Cambridge). The 
images were obtained using a FEI Philips CM100 TEM with a digital camera. An image of the ConX treated 
cells showing the major events in viral life cycle highlighted by the dot line boxes in the cell. More details of 
the structures are shown by the enlarged pictures (A-E). N: nucleus. NM: nuclear membrane. NC: nuclear 
capsid. Cyt: cytoplasm. PM: plasma membrane. CC: cytoplasmic capsid. ECV: extracellular virion. PE: 
primary envelopment. SE:  secondary envelopment. 
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Figure 4.3: Ultrastructure of CHMP4A/B/C triple depleted cells infected with HSV-1. The samples 
were prepared as described in Figure 4.2. N: nucleus. NM: nuclear membrane. NC: nuclear capsid. Cyt: 
cytoplasm. PM: plasma membrane. CC: cytoplasmic capsid. ECV: extracellular virion. PE: primary 
envelopment. SE:  secondary envelopment. 
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The infected cell samples were also examined by TEM. Figure 4.2 shows a representative 
image obtained from the ConX treated control sample demonstrating the nucleus (N), 
nuclear membrane (NM), cytoplasm (Cyt) and plasma membrane (PM). All stages of the 
viral replication cycles were observed in ConX siRNA treated cells including nuclear 
capsids (NC), primary envelopment (PE), secondary envelopment (SE) and extracellular 
virions (ECV) (Figure 4.2 A-E). The PE stages show the capsids in the cell nucleus 
enveloped by the inner nuclear membrane (Figure 4.2 A, D, E). The secondary 
envelopment stage is shown when the viral capsid has budded into a membrane 
compartment in the cytoplasm to form mature virus particles (Figure 4.2 C). 
In the CHMP4A/B/C depleted cells, nuclear capsids and primary envelopment events 
could be readily observed, with examples of all three types of A, B and C capsids in the 
nucleoplasm (Figure 4.3 A, B, E). However, there was virtually no extracellular virus 
particles observed and no secondary envelopment events could be detected in the 
cytoplasm of infected cells. Furthermore, higher levels of free cytoplasmic capsids (CC) 
were observed in the CHMP4A/B/C depleted cells (Figure 4.3 C-H). These results suggest 
that the secondary envelopment of HSV-1 is inhibited in the absence of CHMP4A/B/C 
proteins while the early stages of the viral life cycle such as genome replication, capsid 
assembly and nuclear egress remain largely unaffected. Additionally, these data 
demonstrated that siRNA mediated depletion of endogenous CHMP4 function leads to a 
strong inhibition of HSV-1 replication, suggesting that depletion of cellular pathways 
utilised by HSV-1 to recruit CHMP4A/B/C using siRNA may demonstrate a similar 
phenotype.  
4.2.2 The effect of CIN85 knockdown on HSV-1 replication 
CIN85 is a Cbl-interacting protein which has previously been shown to interact with ALIX 
(Usami et al., 2007). Thus CIN85 could indirectly link to the function of CHMP4A/B/C 
via ALIX. As described in Chapter 3, CIN85 showed interactions with pUL46, pUL47 and 
pUL49 in the yeast two-hybrid screen and the interactions with pUL46 and pUL49 were 
further validated in GST pull-down and protein co-localisation assays. In addition, the 
CIN85 specific antibody could co-immunoprecipitate tegument protein pUL49 (VP22) 
and pUL48 (VP16) in infected cell lysate. These data imply that there are direct 
interactions between CIN85 and HSV-1 tegument proteins in host cells during infection 
and HSV-1 could recruit CHMP4A/B/C by CIN85 via its interaction with ALIX.  
4 The effect of depleting ESCRT and ESCRT associated proteins on HSV-1 replication 
132 
 
 
 
Figure 4.4: Effect of depletion of CIN85 by siRNA on HSV-1 replication. 293T cells were transfected 
with four independent siRNA oligonucleotides against the human CIN85 gene. The non-targeting siRNA 
ConX treated cells and mock transfected cells were used as controls. (A) Uninfected cell samples were 
harvested at 74 h post siRNA transfection and analysed by western blotting. Anti-CIN85 antibody was used 
to detect the CIN85 expression levels in the different treated samples. Tubulin signals were used for loading 
control. (B) Cells were infected by HSV-1 strain KOS at 10 PFU per cell at 72 h post siRNA transfection. 
Infected cells were harvested at 23 h post infection, sonicated and frozen-thawed once to release infectious 
progeny viruses. The infectious virus titres were determined by plaque assay on Vero cell monolayers. The 
mean titres and error bars of triplicate samples are shown. 
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Figure 4.5: Effect of depletion of CIN85 by combined siRNA oligonucleotides on HSV-1 replication. 
293T cells were transfected with a mixture of four siRNA oligonucleotides targeting CIN85. The non-
targeting siRNA ConX treated cells and mock transfected cells were used as controls. (A) The endogenous 
CIN85 expression levels in different samples are tested by western blotting. The tubulin levels were used as 
the loading control. The signals were from the same blot but the irrelevant lanes were cut out. A and B 
indicate the duplicates of CIN85 siRNA treated samples. (B) Cells were infected by HSV-1 strain KOS and 
collected as described above. The average titres and error bars of triplicate samples are shown. 
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To further investigate the function of CIN85 in HSV-1 viral replication. siRNA was used 
to knockdown CIN85 expression in cells and infectious virus production was tested by 
plaque assay. Endogenous CIN85 expression was significantly depleted in 293T cells using 
any of the four individual oligonucleotides tested (Figure 4.4 A), while the expression 
levels of CIN85 in ConX and mock treated cells were comparable. The depletion of 
CIN85 caused little cytotoxicity as the tubulin levels in the samples were all similar (Figure 
4.4 A). However, in CIN85 depleted cells the viral replication was at comparable levels to 
the control samples (Figure 4.4 B). Thus CIN85 depletion did not have a significant effect 
on HSV-1 replication.  
According to the western blotting result shown in Figure 4.4 A, the expression of 
endogenous CIN85 is significantly inhibited in cells treated with single CIN85 siRNA 
oligonucleotide. However, it is conceivable that low levels of CIN85 protein remain in the 
cells which are not detectable by western blotting, and that these levels of CIN85 might be 
sufficient for the virus to recruit the ESCRT machinery efficiently. Single siRNA 
oligonucleotides only targets one region of a gene while the silencing efficiency could be 
improved by combining multiple siRNA oligonucleotides to target several regions of a 
specific gene. Thus the cells were treated with a mixture of the four individual CIN85 
siRNA oligonucleotides and the virus production from these cells was tested. Similarly as 
single siRNA oligonucleotide treated samples, the expression level of CIN85 was 
efficiently depleted by the mixture of four siRNA oligonucleotides in two independent 
samples. The cells were viable and the tubulin levels in the different samples were 
equivalent (Figure 4.5 A). However, in the CIN85 siRNA mixture treated cells, the virus 
replicated as well as in the control cells (Figure 4.5 B). Thus transient silencing of CIN85 
expression by single or multiple siRNA oligonucleotide(s) did not have a significant effect 
on HSV-1 replication. 
4.2.3 HSV-1 replication in CC2D1A or CC2D1B depleted cells 
In Chapter 3, CC2D1A showed interactions with HSV-1 tegument proteins pUL11, 
pUL16, pUL21, pUL46, pUL47 and pUL49. The interactions between CC2D1A and 
pUL16, pUL46, pUL47 and pUL49 have been validated by GST pull-down assays. 
CC2D1A has a homologous protein called CC2D1B, which shares ~50% amino acid 
identity with CC2D1A (Hadjighassem et al., 2011). According to GST pull-down data, 
CC2D1B interacts with pUL16 and pUL47, although these interactions were not identified 
in the original Y2H assays. It has been reported that CC2D1A interacts with the CHMP4  
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Figure 4.6: HSV-1 replication in HeLa cells with CC2D1A or CC2D1B depleted by siRNA. HeLa cells 
were seeded into six-well plates at 1 x 105 cells per well one day before siRNA transfection. The cells were 
transfected with siRNA oligonucleotides against CC2D1A (1A02 and 1A04), oligonucleotides against 
CC2D1B (1B01 and 1B03), the control siRNA ConX or mock treated. (A) The cells were infected with 
HSV-1 strain KOS at 10 PFU per cell at 66 h post transfection. At 24 hpi the infected cell samples were 
harvested and the progeny viruses were released by sonication. The infectious virus titres were determined by 
plaque assay on Vero cell monolayers. The mean titre and standard error bars from triplicate samples are 
shown. (B) Uninfected cell samples were harvested at 70 h post transfection for cell lysate preparation for 
western blotting. The endogenous expression levels of CC2D1A and CC2D1B are shown. The tubulin 
signals were used as a loading control and an indication for cell viability. 
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Figure 4.7: HSV-1 replication in 293T cells with CC2D1A or CC2D1B depleted by siRNA. 293T cells 
were seeded into six-well plates at 2 x 105 cells per well one day before siRNA transfection. The samples 
were treated and processed as described in Figure 4.6. 
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proteins of the ESCRT III complex (Tsang et al., 2006), which implies that the virus may 
be able to recruit ESCRT III via the direct interaction with CC2D1A and/or CC2D1B. 
Therefore, the ability of HSV-1 to replicate in cells depleted of these proteins was 
investigated. 
HeLa cells were transfected with two independent siRNA oligonucleotides against 
CC2D1A and CC2D1B respectively. The cell samples were infected with HSV-1 strain 
KOS at 10 PFU/cell at 66 h post transfection and harvested at 24 hpi. The infectious titres 
were determined by plaque assays on Vero cell monolayers. Cells treated with the 
CC2D1A siRNA 1A02 generated approximately 6-fold lower infectious virus particles 
compare to the ConX control, whereas the 1A04 treated cells produced a 16-fold lower 
viral titre. However, the depletion of CC2D1B from the host cells did not have a 
significant effect on virus replication compared to ConX treated cells (Figure 4.6 A). The 
efficiency of siRNA mediated protein depletion was analysed by western blotting. Both 
endogenous CC2D1A and CC2D1B were depleted in HeLa cells, although there were low 
levels of both proteins detected in the siRNA treated samples. The depletion level of 
CC2D1A appeared better than CC2D1B although the 1A04 oligonucleotide showed some 
level of cytotoxicity in HeLa cells as the tubulin signal was lower than the control samples 
(Figure 4.6 B).  
Different cell lines may respond differently to siRNA in both protein depletion level and 
cytotoxicity. Therefore, similar experiments were also performed in 293T cells. The 
CC2D1A siRNA 1A02 treated cells generated about 5 fold lower infectious virus particles 
compared to the ConX control. However, the 1A04 treated cells demonstrated almost the 
same titre as the control (Figure 4.7 A, B). Similarly as in HeLa cells, the CC2D1B 
depletion did not have a significant effect on HSV-1 replication in 293T cells (Figure 4.7 
A). According to the western blotting data, the depletion of CC2D1A by 1A02 oligo was 
as efficient as observed in HeLa cells, while the 1A04 oligonucleotide appeared to be less 
efficient in 293T cells than in HeLa cells (Figure 4.7 B). The depletion level of CC2D1B 
was not very efficient as there were still relatively high levels of signals detected from both 
1B01 and 1B03 siRNA treated cells, although the levels were lower than the control 
samples (Figure 4.7 B). Different from HeLa cells, there was no significant cytotoxicity 
observed in 293T cells as the tubulin levels from all samples were similar to the controls 
(Figure 4.7 B). Due to the lower cytotoxicity and other siRNA experiments conducted with 
this cell line, 293T cells were chosen as the model for further siRNA analysis. 
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Figure 4.8: HSV-1 replication in 293T cells with CC2D1A or CC2D1B depleted using combined 
siRNA oligonucleotides. 293T cells were seeded into six-well plates at 2 x 105 cells per well one day before 
siRNA transfection of the stated combinations. Cells were infected with HSV-1 strain KOS at 10 PFU at 69 
h post transfection. (A) The infected cell samples were harvested at 26 hpi and titrated on Vero monolayers. 
The mean titres and standard error bars of triplicate samples are shown. (B) Uninfected cell samples were 
harvested at 72 h post transfection for cell lysate preparation for western blotting. The endogenous CC2D1A 
and CC2D1B expression levels in the cell samples are shown, and tubulin was used as the loading control. 
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HSV-1 replication was also examined in cells with CC2D1A and CC2D1B depleted by a 
mixture of two siRNA oligonucleotides. Compared to the ConX treated control, the virus 
titres of CC2D1A single siRNA treated samples were about 2 fold lower (Figure 4.8 A, 
sample 1A02, 1A04), while the titres of the mixed CC2D1A siRNA treated samples were 
about 3-4 fold lower (Figure 4.8 A, samples 1A02+04-A/-B). However, there was little 
effect on viral replication when CC2D1B was depleted from the host cells (Figure 4.8 A). 
The depletion levels of CC2D1A and CC2D1B by single or mixed siRNA oligonucleotides 
were both efficient and similar according to the western blotting data (Figure 4.8 B). There 
was little difference in the levels of tubulin for any sample, indicating little or no 
cytotoxicity from any siRNA treatment (Figure 4.8 B). 
The data described above suggested only minor effects on HSV-1 replication when 
depleting CC2D1A and virtually no effect when depleting CC2D1B. However, these 
experiments were performed with only a single round of siRNA transfection. In all the 
above cases, a certain level of CC2D1A or CC2D1B could be detected in the siRNA 
treated samples and it is conceivable that these low levels of endogenous protein could be 
sufficient for HSV-1 replication. Therefore similar experiments were performed in cells 
with prolonged depletion of CC2D1A and CC2D1B using two rounds of transfection with 
single (Figure 4.9 A, B) or combined (Figure 4.9 C, D) siRNA oligonucleotides. The cells 
with prolonged depletion of CC2D1A showed a three to five fold reduction in infectious 
virus production in cells treated with two rounds of siRNA 1A02 (Figure 4.9 A, sample 
1A0202), or one round of 1A02 followed by a second round with 1A04 (Figure 4.9 A, 
sample 1A0204). However cells treated with two rounds of 1A04 (Figure 4.9 A, sample 
1A0404), one round of 1A04 followed by 1A02 (Figure 4.9 A, sample 1A0402) or two 
rounds of the combined 1A02 and 1A04 (Figure 4.9 C, sample 1A02+04-A, B) showed 
very minor effects on HSV-1 titre, despite all CC2D1A siRNA treatment showing efficient 
depletions of the endogenous protein by western blotting (Figure 4.9 B, D). 
Prolonged depletion of CC2D1B did not appear to significantly affect HSV-1 replication 
in any combination of siRNA treatment (Figure 4.9 A, C). However, while CC2D1B levels 
were efficiently reduced, the depletion of CC2D1B was not as robust as CC2D1A. Taken 
together, this data suggest that the prolonged depletion of CC2D1A or CC2D1B 
individually from host cells does not cause a significant inhibition of HSV-1 replication. 
Small effects on infectious viral production were observed when CC2D1A was depleted 
from the host cells. However, these observations were not always reproducible, although it 
is possible that there was a more efficient depletion of CC2D1A in the samples showing a  
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Figure 4.9: HSV-1 replication in 293T cells with prolonged depletion of CC2D1A or CC2D1B. 293T 
cells were seeded into six-well plates at 2 x 105 cells per well one day before siRNA transfection. The second 
siRNA transfection was performed 48 h post the first transfection. The cells were infected with HSV-1 strain 
KOS 48 h post the second transfection and the infected cell samples were harvested at 25 hpi for titration. 
The mean titres and standard error bars are all from triplicate samples. (A) Virus titres from cells treated with 
single siRNA oligonucleotide. The two rounds of siRNA transfections are indicated by the labels. For 
example, 1A0204 indicates the cells were transfected with siRNA oligonucleotide 1A02 for the first time and 
1A04 for the second time. (B) The depletion levels of CC2D1A and CC2D1B were determined by western 
blotting. (C) Virus titres of cells treated with combined siRNA oligonucleotides as indicated by the labels. 
For example, 1A02+04-A and 1A02+04-B are duplicated samples of the same condition where cells were 
transfected with 1A02 and 1A04 siRNA oligonucleotide mixture twice. (D) The depletion levels of CC2D1A 
and CC2D1B by western blotting. The results are from the same blot with irrelevant lanes removed. 
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greater inhibition of HSV-1 replication, but this was not detectable due to insufficient 
sensitivity of the western blotting.  
4.2.4 HSV-1 replication in cells depleted of multiple ESCRT 
associated proteins 
The data presented in sections 4.2.2 and 4.2.3 has demonstrated that the single depletion 
of CIN85, CC2D1A or CC2D1B does not have a significant effect on HSV-1 replication. 
However, a direct interaction of the HSV-1 tegument protein with ALIX could serve as an 
alternative route for the recruitment of ESCRT III. The retrovirus HIV-1 has previously 
been shown to recruit the ESCRT machinery via an interaction of Gag with ALIX in a 
manner that was dependant on the ability of ALIX to bind to CHMP4 proteins.  Despite 
the fact that depletion of ALIX has previously been shown to have no effect on HSV-1 
replication (Pawliczek & Crump, 2009), it is conceivable that HSV-1 can make use of 
multiple redundant pathways to recruit the ESCRT III membrane scission machinery. 
Therefore it may be necessary to simultaneous deplete multiple ESCRT candidates in 
order to block the recruitment of ESCRT III by HSV-1, particularly the pathways capable 
of directly recruiting CHMP4A/B/C proteins. 
Triple depletions of ALIX together with CC2D1A and CC2D1B, and CIN85 together 
with CC2D1A and CC2D1B, were performed to test whether inhibiting the CIN85/ALIX 
and CC2D1A/1B pathways in parallel could block HSV-1 replication. Surprisingly, virus 
titres produced by cells with either triple depletion were not reduced compared to the 
control cells (Figure 4.10 A). Western blotting was used to test the depletion levels of the 
proteins. The expression of the targeted proteins was significantly reduced although there 
was some detectable protein expression remaining in siRNA treated cells. This suggests the 
depletion was not efficient when three independent siRNA oligonucleotides were mixed, 
which results in a 3-fold lower concentration of each individual siRNA oligonucleotide 
(Figure 4.10 B). The tubulin signals from the control samples were lower than the triple 
depletion cells, which could have masked some effect of the triple depletion (Figure 4.10 
B). Quantification data show there was 2-3 fold difference in tubulin between the samples 
and the controls (Appendix). Therefore, as the tubulin signals were relatively comparable, 
there is unlikely to be a significant difference due to this sample loading variation. Thus 
neither of the two triple depletion combinations appeared to block the ability of HSV-1 to 
recruit ESCRT III function. This suggests there may be some additional pathways for the 
virus to hijack the ESCRT machinery through other interactions. 
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Figure 4.10: HSV-1 replication in cells with combined depletion of ALIX or CIN85 together with 
CC2D1A and CC2D1B. 293T cells were seeded into six-well plates at 2 x 105 cells per well medium one day 
before the first siRNA transfection. 24 h later, the cells were split into new plates and the second siRNA 
transfection performed 48 h post the first transfection. At 48 h post the second transfection, the cells were 
infected with HSV-1 strain KOS at 10 PFU/cell. Parallel uninfected cell samples were harvested for western 
blotting to test the depletion levels. (A) Mean virus infectious titres and standard error bars from triplicate 
samples are shown. (B) The endogenous protein expression levels in the cell samples. ALIX, CC2D1A and 
CC2D1B triple depleted cells were blotted with anti-ALIX, anti-CC2D1A and anti-CC2D1B antibodies. 
CIN85, CC2D1A and CC2D1B triple depleted cells were blotted with anti-CIN85, anti-CC2D1A and anti-
CC2D1B antibodies. The tubulin signals were used as the sample loading control. 
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4.2.5 Construction of HSV-1 ∆UL47 and its replication in 
ESCRT depleted cells 
4.2.5.1 HSV-1 ∆UL47 construction 
HSV-1 tegument protein pUL47 (VP13/14) showed interactions with many ESCRT and 
ESCRT associate proteins in the initial Y2H screen presented in Chapter 3. Although 
some of the interactions appeared to be false positive (such as the interaction between 
pUL47 and CIN85), some interactions were confirmed by other methods (such as the 
interaction between pUL47 and ALIX). Although it has been previously reported that 
pUL47 is not essential for HSV-1 in tissue culture (Barker & Roizman, 1990; Zhang & 
McKnight, 1993), these results imply that pUL47 might be involved in multiple pathways 
for the recruitment of the ESCRT machinery by HSV-1. As demonstrated by the data in 
the previous sections of this chapter, viral replication was not significantly affected by 
single, double or triple depletion of certain ESCRT proteins, and so there are likely to be 
more redundant pathways for the virus to recruit the ESCRT machinery. All the potential 
interactions of pUL47 and ESCRT proteins would be inhibited by removing the UL47 
gene from the viral genome. This should restrict the number of pathways available to 
HSV-1 to recruit the ESCRT machinery, and possibly make the virus more sensitive to the 
depletion of ESCRT proteins. Following this hypothesis, HSV-1 ∆UL47 virus was created 
by two-step red-mediated recombination to replace the UL47 gene with the tdTomato 
gene (Tischer et al., 2010; Tischer et al., 2006). Western blotting demonstrated that ∆UL47 
infected cells, lack pUL47 expression while the viral capsid protein VP5 expression was at 
a similar level as in the WT virus infected cells (Figure 4.11 A). Viral plaques showed 
fluorescent signals of tdTomato in cells infected with ∆UL47 (Figure 4.11 B). In single-
step viral growth curve analysis, the viral replication kinetics is similar and both the ∆UL47 
and parental wild type viruses reached the plateau phase at around 14 hpi. However, 
∆UL47 showed a small defect with an approximately 3-5 fold lower titres than the wild 
type virus at all time points (Figure 4.11 C). 
4.2.5.2 Viral replication of ∆UL47 in ESCRT depleted cells 
Double depletion of CC2D1A and CC2D1B 
CC2D1A and CC2D1B are homologous proteins and they may share overlapping cellular 
functions. Therefore these proteins could have a certain level of redundancy between them 
and depletion of either CC2D1A or CC2D1B alone might not be sufficient to block the  
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Figure 4.11: HSV-1 UL47 deletion virus. The UL47 gene was replaced by a similar sized reporter gene 
tdTomato in KOS BAC using two-step red-mediated recombination. (A) Vero cells were infected with either 
∆UL47 or wild type KOS (WT) virus. At 33 hpi the cells were harvested and the pUL47 expression levels in 
host cell lysates were tested by western blotting. VP13/14 (pUL47) specific antibody was used and the lysate 
from 293T cells overexpressing GFP tagged pUL47 was used as a control. The HSV-1 major capsid protein 
VP5 signal was used as a loading control between the WT and ∆UL47 viruses. (B) A fluorescent virus plaque 
of ∆UL47 showing tdTomato expression in infected cells. (C) Single-step virus growth curve. Vero cells were 
infected with either ∆UL47 or WT virus at 10 PFU/cell at 37 ℃ for one hour. Unabsorbed viruses were 
inactivated by acid wash and the cells were incubated 37 ℃. At the time points shown cells were freeze-
thawed and sonicated. The virus titres were determined by plaque assay on Vero cell monolayers. The mean 
virus titres and standard error bars are shown (n=3). 
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Figure 4.12: ∆UL47 replication in cells with combined depletion of CC2D1A and CC2D1B. 293T cells 
were seeded into six-well plates at 2 x 105 cells per well one day before the siRNA transfection. The siRNA 
oligonucleotides used for the 1A+1B sample were an equal mixture of 1A02, 1A04, 1B01 and 1B03. At 72 h 
post transfection, the cells were infected with HSV-1 virus at 10 PFU/cell. Parallel uninfected cell samples 
were harvested for western blotting to test the depletion levels of CC2D1A and CC2D1B. The infected cell 
samples were collected at 23 hpi and titrated on Vero cell monolayer. (A) Mean virus titres and standard 
error bars from triplicate samples are shown. (B) The depletion levels of CC2D1A and CC2D1B and the 
tubulin in the samples were determined by western blotting. 
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activity. Additionally, compared to wild type HSV-1, the mutant virus lacking pUL47 has 
less available pathways to recruit the ESCRT machinery. Therefore, the replication of 
∆UL47 is more likely to be inhibited by the depletion of CC2D1A and CC2D1B. Thus 
simultaneous depletions of CC2D1A and CC2D1B from 293T cells were performed and 
the replication of ∆UL47 was investigated in these cells. The cells were treated with single 
or combined siRNA oligonucleotide(s) as indicated. The production of ∆UL47 from 1A02 
treated cells was about 5-fold lower than the ConX siRNA treated control. 1A04 
oligonucleotide treated cells and CC2D1B single depleted cells had similar virus 
productions compared to the controls. Virus titres from cells treated with combinations of 
CC2D1A and CC2D1B siRNA oligonucleotides were 3-9 fold lower than the ConX 
siRNA treated control. However the treatment of cells with 1A02 or double depletions 
showed varying levels of cytotoxicity according to the tubulin signals and so these data 
must be treated with caution (Figure 4.12 A). Nevertheless there was a consistent 
inhibition of HSV-1 ∆UL47 replication by silencing CC2D1A and CC2D1B together.  
Western blotting demonstrated efficient reductions in expression levels of these two 
proteins in siRNA treated cells compared to control cells (Figure 4.12 B). Overall these 
data suggest CC2D1A single depletion may have small effects on ∆UL47 replication, while 
the CC2D1A and CC2D1B double depletion has a synergistic effect on ∆UL47 replication. 
However, the inhibition of interactions related to pUL47 together with CC2D1A/1B did 
not entirely block the pathways for the virus to recruit the ESCRT machinery. 
Triple depletion of CC2D1A/1B and CIN85 
The removal of gene UL47 from the virus genome results in inhibiting of all the potential 
interactions between pUL47 and cellular proteins. However, ESCRT candidates such as 
CC2D1A/1B and CIN85 are still able to interact with HSV-1 via other tegument proteins. 
Thus in order to inhibit as many pathways as possible to block the viral recruitment of 
ESCRT by the tegument, combined siRNA depletion were performed to silence CIN85 
together with CC2D1A/1B in cells and the replication of the ∆UL47 virus was analysed. 
Unfortunately, the triple depletion of CIN85 and CC2D1A/1B did not have a significant 
effect on HSV-1 replication. The production of both the wild type and ∆UL47 viruses 
from a single round of infection in the triple depletion cells was only approximately 2 fold 
lower than the controls (Figure 4.13 A). When compared to the wild type virus, ∆UL47 
virus had lower virus yields (5-7 fold lower) from cells with or without siRNA depletion 
(Figure 4.13 A). Western blotting shows that CIN85, CC2D1A and CC2D1B were all 
depleted efficiently. The depletion of CIN85 was very efficient and there were no  
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Figure 4.13: HSV-1 wild type and ∆UL47 viral replication in cells with CIN85 single depletion, 
CC2D1A/1B double depletion and CIN85, CC2D1A/1B triple depletion. 293T cells were transfected 
with two rounds of individual or combined siRNA as described before. The cells were infected with either 
wild type HSV-1 strain KOS, or the ∆UL47 virus at 10 PFU/cell. The infected cell samples were collected at 
20 hpi and the titres were determined by plaque assays on Vero cell monolayers. (A) The virus titres of KOS 
or ∆UL47 infected samples. The mean virus titres and standard error bars are shown (n=3). (B) The protein 
depletion levels of CIN85, CC2D1A and CC2D1B. The tubulin signals were used as the sample loading 
control. 
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detectable signals of CIN85 from either the CIN85 single or triple depletion samples 
(Figure 4.13 B left panel). CC2D1A was also efficiently depleted in cells treated with 
siRNA targeting CC2D1A + CC2D1B, or CC2D1A + CC2D1B + CIN85, although a 
faint band was detectable in the triple depletion sample. However, the protein depletion 
levels of CC2D1B were not as efficient as the other two proteins, especially in the triple 
depletion cells, where there were relatively high levels of CC2D1B detected in the cell 
lysate, although they were lower than the control samples (Figure 4.13 B right panel). Thus 
the combination of removing pUL47 from the virus and the triple depletion of CIN85 and 
CC2D1A/1B from the host cell did not completely block the viral recruitment of the 
ESCRT machinery. However, it cannot be ruled out that the remaining protein expression 
in the triple depletion cells was sufficient to allow ESCRT III recruitment by HSV-1. 
Depletion of CHMP6 and HD-PTP 
Some other ESCRT recruiting pathways which may be hijacked by HSV-1 were also 
explored. CHMP6 belongs to the ESCRT III complex and can be the initiating event for 
the formation of CHMP4A/B/C filaments on membranes (Wollert et al., 2009). Thus 
interaction between a HSV-1 viral protein and CHMP6 could play role in recruiting 
CHMP4A/B/C proteins. From the Y2H data, CHMP6 interacts with pUL47 and this 
interaction was confirmed by GST pull-down assay. Additionally, the ESCRT interacting 
protein HD-PTP shares structural similarities with ALIX and contains a Bro1 domain that 
can interact with CHMP4 isoforms. Therefore HD-PTP could be an alternative pathway 
for the virus to recruit CHMP4A/B/C although no interactions between HSV-1 tegument 
protein and HD-PTP were observed in Y2H assays. In order to study these alternative 
pathways for recruiting CHMP4A/B/C, replication of wild type and ∆UL47 HSV-1 were 
analysed in cells depleted of HD-PTP and HD-PTP together with CHMP6. In HD-PTP 
single depleted cells, both of the wild type and the ∆UL47 virus replicated to a similar level 
as in control cells (Figure 4.14 A). Thus HD-PTP single depletion did not affect HSV-1 
replication. The virus yields from cells with double depletion of HD-PTP and CHMP6 
were approximately 7 fold lower than the control cells. The reduction in virus production 
caused by HD-PTP and CHMP6 depletion for both the wild type and the ∆UL47 virus 
were similar. However, a certain level of cytotoxicity was observed when double depletion 
of CHMP6 and HD-PTP was performed. The tubulin level of this sample was lower than 
the controls (Figure 4.14 B), suggesting that the effect of double depletion of CHMP6 and 
HD-PTP on HSV-1 replication may be due to general cytotoxicity.  Western blotting  
 
4 The effect of depleting ESCRT and ESCRT associated proteins on HSV-1 replication 
149 
 
 
 
 
Figure 4.14: HSV-1 wild type and ∆UL47 viral replication in cells depleted of HD-PTP and CHMP6. 
293T cells were transfected with one round of individual or combined siRNA as described before. The cells 
were infected with either wild type HSV-1 strain KOS, or the ∆UL47 virus at 10 PFU/cell. The infected cell 
samples were collected at 23 hpi and the titres were determined by plaque assays on Vero cell monolayers. (A) 
The virus titres of KOS or ∆UL47 infected samples. The mean virus titres and standard error bars are shown 
(n=3).  (B) The protein depletion levels of HD-PTP and CHMP6 and tubulin levels were determined by 
western blotting. 
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demonstrated both CHMP6 and HD-PTP were depleted in siRNA treated cells, although 
the HD-PTP antibody gave poor signal levels (Figure 4.14 B).  
Overall, there data suggest the removal of pUL47 from HSV-1 does not make the virus 
significantly more sensitive to the depletion of ESCRT and ESCRT associated proteins. 
However, ∆UL47 replication is somewhat attenuated compared to the wild type virus in 
tissue culture, which suggests that the loss of pUL47 causes defects in viral assembly. 
These defects may be due to the removal of the interactions between pUL47 and ESCRT 
and/or ESCRT associated proteins.  
4.3 Discussion and conclusion 
Depletion of all three isoforms of CHMP4 caused a dramatic reduction of HSV-1 
infectious virus production by over 100 fold (Figure 4.1). These data further confirm the 
requirement of the ESCRT machinery in HSV-1 replication and indicate a specific 
function of CHMP4A/B/C. According to the ultrastructure observed by TEM, the 
formation of viral capsids in the nucleus was indistinguishable between CHMP4A/B/C 
depleted and control cells. This suggests that the initial stages of viral infection were not 
affected by the depletion of CHMP4A/B/C proteins, including the attachment to the cell 
surface, viral entry, capsid delivery and viral genome import to the nucleus, viral gene 
expression and capsid assembly. In addition, there were many primary envelopment events 
observed in the CHMP4A/B/C depleted cells, suggesting that nuclear egress of capsids 
was not affected by the removal of CHMP4A/B/C functions. The relatively high level of 
free capsid observed in the cytoplasm of CHMP4A/B/C depleted cells implies a defect in 
the secondary envelopment stage, which blocked the viral life cycle and inhibited the 
formation of mature virus particles. These data together with previous published work 
suggest that HSV-1 secondary envelopment requires the membrane scission activity of 
CHMP4A/B/C. Surprisingly no partially wrapped capsid structures were observed in the 
cytoplasm of CHMP4A/B/C depleted cells despite the fact that membrane associated 
capsids were observed in dominant negative VPS4 expressing cells previously (Crump et al., 
2007). However, it should be noted that dominant negative VPS4 expression inhibits the 
ESCRT machinery at a later stage than the removal of CHMP4 proteins, possibly 
explaining this discrepancy. Furthermore, capsids extensively associated with membranes 
were relatively rare in the cytoplasm of VPS4 dominant negative cells and may have been 
identified in CHMP4A/B/C depleted samples upon analysis of a greater number of cells. 
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Further experiment could be performed to examine the viral early and late gene expression 
in the CHMP4A/B/C depleted cells to further confirm the inhibition of the virus 
replication is not due to abnormal gene expression. In addition to comparing the tubulin 
levels, the cell viability under siRNA treat could be monitored by other methods, such as 
FACS.  
The recruitment of CHMP4A/B/C to sites of viral assembly could be achieved via direct 
interactions between viral proteins and CHMP4A/B/C, or by interaction with other 
cellular proteins that bind CHMP4A/B/C. Several CHMP4A/B/C interacting proteins 
have been identified in mammalian cells and many have been shown to interact with HSV-
1 tegument in this thesis. Therefore there are many potential pathways for HSV-1 to 
recruit this essential membrane scission machinery. Of these, CHMP6, ALIX, and 
CC2D1A/1B all directly interact with CHMP4A/B/C, while CIN85 may be able to recruit 
CHMP4A/B/C via the interaction with ALIX. The roles of each of these CHMP4 
associated protein in HSV-1 replication was analysed by depleting the endogenous cellular 
protein by siRNA. The depletion of CIN85 did not have a significant effect on HSV-1 
production, in agreement with previous reported data showing that the depletion of ALIX 
did not affect HSV-1 production (Pawliczek & Crump, 2009). Therefore the CIN85-
ALIX-CHMP4A/B/C pathway is not essential for the viral replication in isolation. 
However, it may be one of multiple parallel pathways available to HSV-1 for the 
recruitment of CHMP4A/B/C. 
Investigation of the homologous proteins CC2D1A and CC2D1B gave somewhat varying 
data. As shown in Chapter 3, the virion incorporation of CC2D1A is higher than that of 
CC2D1B, which indicates that more CC2D1A is associated with structural proteins of the 
virus than CC2D1B. Accordingly the result in this chapter suggest a greater role of  
CC2D1A than CC2D1B in HSV-1 replication with virus titres always being lower in 
CC2D1A depleted cells than CC2D1B depleted cells (Figure 4.6-4.9). However, the effects 
of CC2D1A depletions were always mild, and furthermore despite similar, CC2D1A in 
cells treated with two independent siRNA oligonucleotides (1A02 and 1A04) the viral 
replication was only reduced in one condition (1A02) (Figure 4.9, 4.12). This could suggest 
possible off-target effects of this siRNA oligonucleotide, although it cannot be ruled out 
that a more efficient depletion of CC2D1A was achieved with the siRNA 1A02 
oligonucleotide treatment, but the enhanced depletion by this oligonucleotide could not be 
observed due to a lack of sensitivity of the western blotting assay. Despite the observed 
virion incorporation of CC2D1B, albeit of a low level, detected from the purified HSV-1 
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in Chapter 3, the depletion of CC2D1B did not show significant effect on HSV-1 
production. This would suggest any role of CC2D1B in the viral replication as being 
dispensable or redundant.  
Depleting multiple proteins simultaneously by combined siRNA treatment makes it 
possible to block several cellular pathways at the same time. However, the simultaneous 
depletion of ALIX or CIN85 together with CC2D1A and CC2D1B did not have an effect 
on HSV-1 production. However, in the simultaneous depletion assays, in order to keep the 
same total amount of siRNA, each individual siRNA oligonucleotide amount was reduced. 
Thus in the combined siRNA treated samples, the depletion of individual protein was 
usually not as efficient as in the single siRNA treated cells. Therefore, the lack of effect on 
HSV-1 could have been due to the residual level of the targeted proteins remaining in the 
cells. 
In addition to ALIX, CC2D1A/1B and CHMP6, other cellular proteins containing Bro1 
domains, such as HD-PTP, are known to interact with CHMP4 proteins, and so HD-PTP 
was also investigated. The simultaneous depletion of CHMP6 and HD-PTP had a small 
effect on HSV-1 replication, suggesting these are also possibly pathways for the 
recruitment of CHMP4 by HSV-1. It would be interesting to test whether the 
simultaneous depletion of ALIX, CHMP6 and HD-PTP affects the HSV-1 replication. 
However, when inhibiting these three pathways, there are still CC2D1A and CC2D1B to 
be considered, which may be sufficient to enable the virus to recruit CHMP4A/B/C 
proteins. Therefore, depletion of all five cellular proteins may be necessary to inhibit HSV-
1 replication. However, it is virtually impossible to achieve with current technology. 
Among the siRNA combinations tested, only the triple depletion of the ESCRT-III 
CHMP4A, CHMP4B and CHMP4C proteins strongly inhibited HSV-1 replication, while 
other siRNA single or combined depletions only demonstrated mild or insignificant effects 
on HSV-1 replication. These data suggest that HSV-1 virus employs many parallel 
pathways to hijack the ESCRT machinery and specifically the CHMP4A/B/C components. 
However, among the combined double or triple depletion siRNA experiments, the 
efficiency of depletion of each individual protein is lower. It is not known what amount of 
each cellular protein is required for activity in HSV-1 infected cells. Hence in the cases of 
mild or insignificant effect, it is difficult to fully assess the inhibition of functions of those 
proteins.  
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In order to inhibit as many potential parallel pathways as possible, mutant virus lacking 
certain viral proteins could be another strategy in addition to the siRNA depletion. From 
the data presented in Chapter 3, the tegument protein pUL47 showed many potential 
interactions in the yeast two-hybrid screen, thus a ∆UL47 virus was created to inhibit those 
potential pUL47 related interactions. However, as shown in Figure 4.13 and 4.14, this 
mutant virus was no more sensitive than the wild type virus to the depletions of ESCRT 
protein(s) that have been tested. This result suggests that, apart from the interactions of 
pUL47 and the depleted cellular proteins, there are likely to be even more pathways for the 
virus to recruit the ESCRT machinery.  
Further work could be carried out to try to remove more non-essential tegument proteins, 
such as pUL11, pUL16, pUL21, pUL46 or pUL49, from the virus to inhibit further 
pathways for the viral recruitment of ESCRT. This strategy could be combined with 
depletion of ESCRT associated proteins to attempt to block the viral replication. However, 
it is possible that there are yet further redundant pathways to recruit ESCRTs by essential 
tegument proteins, such as VP16 and VP1/2. These essential proteins cannot be removed 
from the virus without complementing cell lines in order to grow virus stocks increasing 
the difficulty of studying the effect of any cellular proteins that may interact with these 
tegument proteins on the viral replication. During the initial Y2H screening, the major 
tegument protein pUL36 (VP1/2) showed potential interaction with TSG101, which could 
be another additional pathway for HSV-1 to recruit the ESCRT machinery, although viral 
replication has been reported to be insensitive to TSG101 depletion (Pawliczek & Crump, 
2009). Furthermore, HSV-1 VP1/2 contains two PTAP (PSAP390, PTAP2828), one YPXL 
(YPYL221) and one PPXY (PPTY2867) type late motifs, and another essential tegument 
protein VP16 also contains a PPXY (PPLY38) motif. These motifs could potentially 
interact with ESCRT proteins in a similar way to retroviral Gag protein for recruiting the 
ESCRT-III membrane scission machinery. In addition, siRNA transient knockdown of 
cellular proteins may have short-comings for studying the function of the proteins 
involved, as any residual protein might be sufficient for the function, especially when 
multiple proteins need to be targeted simultaneously. Furthermore, it is often technically 
not possible to simultaneously knockdown many cellular proteins at the same time without 
affecting cell viability.  
Although informative, it must be taken into account that the data presented in this chapter 
is analysis of HSV-1 replication in cell culture. It is clear from many studies that highly 
conserved viral proteins are often dispensable for replication in cell culture, but they are 
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essential in vivo. Therefore it would be intriguing to analyse HSV-1 replication in transgenic 
mice lacking certain ESCRT or ESCRT associated protein to investigate the relative 
importance of these multiple pathways of ESCRT recruitment HSV-1 appears to have 
evolved using the in vivo model systems. 
In this chapter, several possible pathways for the virus to hijack ESCRTs were explored. 
According to the data presented, we hypothesised that HSV-1 has evolved multiple parallel 
pathways to hijack the ESCRT machinery. All of these pathways presumably converge on 
the recruitment and activation of the CHMP4A/B/C proteins because the simultaneous 
depletion of CHMP4A/B/C from host cells significantly inhibited HSV-1 replication 
(Figure 4.15). 
 
Figure 4.15: Diagram of HSV-1 secondary envelopment and the potential recruitment of ESCRT 
machinery. 
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5     Discussion and Future Work 
5.1 Glycoprotein M 
5.1.1 Phenotypes of previous published alphaherpesviruses 
with gM deletion 
In PRV, deletion of gM resulted in replication to approximately 50-fold lower titres, 
smaller plaques and reduced penetration kinetics (Brack et al., 1999; Dijkstra et al., 1996; 
Kopp et al., 2004). Simultaneous deletion of gM together with the gE/gI complex or UL11 
caused severe defects in viral replication with large accumulations of unenveloped capsids 
in the cytoplasm suggesting a partially redundant or synergistic role for gM in secondary 
envelopment (Kopp et al., 2004; Leege et al., 2009). Similarly to PRV, simultaneous deletion 
of gM and UL11 in HSV-1 strain KOS showed much more pronounced defects in viral 
growth, plaque size and cytoplasmic assembly, suggesting a synergistic role of gM and 
UL11 in HSV-1 cytoplasmic assembly (Leege et al., 2009). Deletion of gM in EHV-1 
caused an approximately 100-fold reduction in viral titres, smaller plaques, reduced 
penetration kinetics and defects in secondary envelopment (Osterrieder et al., 1996; 
Seyboldt et al., 2000). Deletion of gM in EHV-4 also caused large reductions in virus 
replication and plaque size, although only a marginal delay in penetration and no obvious 
defects in cytoplasmic envelopment were observed (Ziegler et al., 2005). In BHV-1, 
deletion of gM caused delayed penetration of virions into cells, impaired release of 
infectious virus and smaller plaques (Konig et al., 2002). In VZV, deletion of gM was also 
shown to cause reductions in plaque size and cell to cell spread (Yamagishi et al., 2008). 
Taken together, all these gM deletion studies suggest a role for gM in penetration/cell-cell 
spread and the efficient production of infectious virus particles, as well as with a possible 
redundant role in the cytoplasmic envelopment process. Data presented in this thesis are in 
agreement with the reported data of replication kinetics, plaque size and penetration rate. 
Furthermore, the observation of the impaired incorporation of gH/L into mature virions 
provides an explanation for defects in penetration. 
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5.1.2 HSV-1 glycoprotein incorporation during secondary 
envelopment 
As a large and complex virus, the assembly of a mature virion involves more than fifty viral 
proteins of which sixteen are transmembrane proteins. All of these proteins need to be 
localised at the correct site for virion incorporation and cellular mis-localisation of these 
membrane proteins could result in defects in incorporation, and virus particles that have 
obtained immature envelope proteins during secondary assembly may be defective. It is 
currently unknown that whether the viral glycoproteins need to be transported to the 
plasma membrane and then internalised for virion incorporation, or they can be 
incorporated during the secretion when newly synthesised, or a combination of both. The 
virus has an advantage to have secondary assembly at early endosomal related membrane 
structures, as the membrane proteins are expressed at different time and modified at 
different rates and an endosomal compartment could be a better site to accumulate 
different mature proteins as they may rapidly exit the TGN. Furthermore, the recycling 
endosomes may be more likely than early endosomes to be involved in the secondary 
envelopment. In addition, there are perhaps some virus induced hybrid endosomes-like 
compartments which could be potential sites for secondary envelopment.  
Data presented in Chapter 2 have demonstrated that in the absence of gM, the 
incorporation of gH/L into HSV-1 virions was impaired. However, certain low levels of 
gH/L are still incorporated and the production of infectious particles were only mildly 
affected according to the single-step grow curves (Figure 2.4 and 2.7). Since the 
internalisation of gH/L is considerably inhibited due to the loss of gM function, this result 
suggests that gH/L may be incorporated into the virion during the secretory pathway 
before arrival at the plasma membrane, although at a reduced level.  
5.1.3 Viral proteins with potential redundancy with gM 
Both gD and gH/L complex are essential envelope proteins and yet do not contain known 
cellular targeting motifs. Presumably, the efficient targeting of these envelopes relies on the 
function of other viral proteins. Previously reported data from the laboratory have 
demonstrated that gM is able to relocalise both gD and gH/L from the plasma membrane 
to interacellular TGN-like compartments in transfection assays (Crump et al., 2004). Data 
presented in this thesis has shown that in the absence of gM the internalisation of gH/L 
from host cell surface was inhibited and the gH/L in purified virions decreased. However, 
in the absence of gM, the cellular localisation and virion incorporation of gD were not 
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affected. One possible explanation for this phenotype of gD is that there may be gM 
independent mechanisms in controlling the localisation of gD. Other viral type III 
membrane proteins including gK/UL20 and pUL43 may possibly play a similar role as gM. 
These are the only other type III membrane proteins expressed by HSV-1 and, similarly to 
gM, they have been shown to inhibit cell-cell fusion induced by the viral entry proteins of 
HSV-1 or PRV (Avitabile et al., 2004; Klupp et al., 2005). These data suggest that 
gK/pUL20 and pUL43 may also be able to remove viral glycoproteins from the cell 
surface and could potentially localise them to virus assembly sites. Another possible reason 
could be that in HSV-1 lytic infection the internalisation mediated by other viral proteins 
targeting gD to the viral assembly site is dispensable due to the large quantities of gD 
being synthesised, which could saturate all the compartments of the secretory/endocytic 
pathways.  
5.1.4 Early involvement of gM in the nuclear membrane 
It has been previously shown that when expressed in transfection assays, gM is mainly 
localised at TGN (Crump et al., 2004). Interestingly, HSV-1 gM has been shown to localise 
to the nuclear membrane, particularly to large invaginations in the nuclear membrane at 
early times post infection, and also to be present in primary enveloped particles (Baines et 
al., 2007a; Zhang et al., 2009a). These data suggest a possible role for gM in primary 
envelopment, although details of what function gM may have during this stage of HSV-1 
assembly are currently unknown. Given recent data showing a role of gH/L or gB, in the 
fusion of primary enveloped particles with the outer nuclear membrane, this raises the 
intriguing possibility of gM-mediated targeting of glycoproteins (especially gH/L) to the 
nuclear membrane (Farnsworth et al., 2007).  
5.1.5 gM and pUL49.5 
It has been demonstrated in this thesis that the efficient incorporation of HSV-1 gH/L 
into virions is gM dependent. Without the function of gM, the internalisation of gH/L 
from the cell surface is impaired and more gH/L is localised on the cell surface, suggesting 
gM is able to alter the cellular trafficking and localisation of gH/L. Like many other HSV-1 
proteins, gM may interact with certain viral and cellular proteins to perform its function. 
One example is the gM-interacting viral protein, pUL49.5, which is a type I 
transmembrane protein consisting of 99 aa (in some herpesviruses pUL49.5 is termed gN 
as it is glycosylated).  In several herpesviruses, gM has been shown to form a disulphide 
bond linked complex with gN/pUL49.5, which is also conserved throughout the 
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Herpesviridae (Barnett et al., 1992). These include pseudorabies virus (PRV) (Jons et al., 
1998), HHV-8 (Koyano et al., 2003),  EBV (Lake et al., 1998), bovine herpesvirus type 1 
(BHV-1) (Lipinska et al., 2006; Wu et al., 1998), human cytomegalovirus (HCMV) (Mach et 
al., 2000), and equine herpesvirus 1 (EHV-1) (Rudolph et al., 2002).  
In spite of the high conservation, the function(s) of gM, gN/pUL49.5 or the complex 
formed by these two proteins are not entirely clear. It has been reported that the 
incorporation of PRV gM into virions is independent of gN, but not vice versa, suggesting 
gM can function in the absence of gN in this virus (Jons et al., 1998). Furthermore, the 
deletion of pUL49.5 in HSV-1 demonstrates a milder phenotype than deletion of gM, 
implying possible functions of HSV-1 gM that are independent of pUL49.5 (Adams et al., 
1998; MacLean et al., 1993). There is evidence that gN/pUL49.5 has functions 
independent of gM, as it has been shown that pUL49.5  is able to inhibit the transporter 
associated with antigen processing (TAP) transport for MHC class-I peptide loading 
(Verweij et al., 2011). 
Therefore, it will be interesting to investigate the effect of pUL49.5 deletion on gM 
expression and gH/L incorporation into HSV-1 virions. 
5.1.6 gM function and immune evasion 
Upon viral infection, the host immune system could recognise the infected cells and 
induce a series of immune responses to counteract the infection and the subsequent viral 
spreading. The retrieval of viral protein(s) from host cell surface by gM could reduce the 
exposure of these viral proteins on cell surface to antibodies. This function of gM 
represents a potentially interesting strategy for immune evasion.  
5.1.7 gM function and host cellular proteins 
There may also be a function of gM in host cellular proteins relocalisation. In the reported 
transfection assays, gM appears to be able to target a broad range of membrane proteins, 
including a cellular protein, to intracellular compartments (Crump et al., 2004). 
Furthermore, it has been observed that gM is able to relocalised tetherin (BST-2) in a 
similar fashion (H. Zenner unpublished data). Tetherin has been reported to counteract 
HIV by the tethering of the virion on the cell surface (Neil et al., 2008). In addition, it has 
been shown that the herpesvirus, KSHV, down-regulates tetherin through viral protein 
mediated ubiquitination. This raises the interesting question of whether gM is able to cause 
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relocalisation of proteins such as tetherin and result in a viral counteraction against this 
host “anti-viral” factor.  
5.1.8 Future studies 
5.1.8.1 Interactions between the cytoplasmic tails of gM and gH/L 
In Chapter 2, it has been shown that without the function of gM, the incorporation of 
gH/L into HSV-1 virions is impaired. This result implies a potential interaction between 
these two glycoproteins. Unfortunately, as gM is a hydrophobic protein with multi-
transmembrane domains, it has been difficult to investigate direct interactions between gM 
and gH/L. However, an alternative approach will be to examine whether certain domains 
of gM and gH/L interact with each other. This could be accomplished by cloning the 
cytoplasmic tails/loops into yeast two-hybrid plasmids to examine potential interactions. 
However, the hypothesised interaction between gM and gH/L could also be indirect and 
mediated by other viral/cellular proteins. Therefore, to test whether gM could be 
immunoprecipitated by anti-gH/L antibody, or vise versa, and to make use of chemical 
cross-linkers could be sensible approaches for testing the interaction between gM and 
gH/L.  
5.1.8.2 gH incorporation in individual virion 
The lower amount of gH/L present in the purified virion samples was shown by western 
blotting (Figure 2.14-2.16), and this approach reveals the total gH/L level in the whole 
purified virion population. However this approach provides no conclusive evidence about 
the gH/L incorporation in each individual virion. The total gH/L decrease in virions could 
be the results of two situations. One is each individual virions has a lower level of gH/L 
incorporation, the other is there are more defective particles with no gH/L while there is a 
small population of virions that have a normal gH/L incorporation level. To test this, high 
resolution microscopy techniques to examine fluorescence labelled individual virion could 
possibly reveal the answer.  
5.1.8.3 Further investigation about gC and gD sub-cellular localisation 
It has been shown that gC plays a role in the initial host entry by binding to heparin 
sulphate. The decreased level of gC observed in ∆gM purified from HT29 cells (Figure 
2.14) implies that the efficient incorporation of gC may also be related to the function of 
gM, although the effect on gC is at a lower level than gH/L. To address this hypothesis, 
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similar experiments could be performed to examine cell surface gC level by FACS and the 
internalisation of gC specific antibodies in the presence and absence of gM.  
In addition, it would be interesting to examine the effect on gC and gD sub-cellular with 
deletion/mutation in gK, pUL20 or pUL43, or the combinations of gM deletion and these 
deletions/mutations. 
5.2 ESCRT and HSV-1 
5.2.1 The interactions identified between HSV-1 and host cells 
The Y2H screen result presented in this chapter contains many potentially interesting 
candidates for future work. The cellular protein candidates that were identified are not only 
associated with the ESCRT machinery but also involved in many other functions. For 
example, the ESCRT associated protein CIN85 interacts with E3 ligase Cbl and acts as an 
adaptor protein in the regulation of endocytosis and lysosomal degradation of ligand-
induced receptor, including epidermal growth factor receptor (EGFR) (Soubeyran et al., 
2002). CIN85 is also likely to play a role in actin dynamics as it directly interacts with F-
actin and induces bundling of actin filaments (Gaidos et al., 2007). Further it has been 
shown that CIN85 binds to AMAP1 and the interaction is important for the invasive 
activities of breast cancer cells (Nam et al., 2007). Thus the interactions identified in this 
study are important not only in analysing ESCRT machinery recruitment, but may also 
shed light on other facets regarding viral-host cell interactions. 
5.2.2 Mammalian ESCRTs – not all needed 
It has been known that ESCRT-0, I, II complexes are involved in the ubiquitinated cargo 
recognition and the membrane bud initiation during ILV formation. ESCRT-III complex 
polymerises into ring filaments and carries out the membrane scission, while the VPS4 
ATPase provides energy to recycle the ESCRT-III proteins [reviewed in (Raiborg & 
Stenmark, 2009)]. However, there is evidence that different cargos show different 
requirement of the ESCRT complexes in mammalian cells. For example, the sorting of 
ubiquitinated ferroportin via the MVB pathway requires ESCRT-I, II and III as shown by 
the inhibition of down-regulation of ferroportin by depletion of TSG101, EAP20 and 
CHMP6 (De Domenico et al., 2007). Surprisingly, however, the depletion of ESCRT-II did 
not affect the down-regulation of ubiquitinated major histocompatibility complex (MHC) 
class I or the degradation of epidermal growth factor (Bowers et al., 2006). This “cargo” 
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specific function of ESCRT complex subsets in mammalian cells is also reflected by the 
different requirement of ESCRTs during the membrane scission events in different viruses. 
For instance, the budding of HIV-1 requires ESCRT-I and III complexes, while it is 
independent of ESCRT-II. Whilst, the budding of avian sarcoma virus does require 
ESCRT-II (Pincetic et al., 2008). Additionally, it has been shown that ESCRT-III 
components CHMP4s and CHMP2s are required but not CHMP3 or CHMP6 (Langelier et 
al., 2006; Martin-Serrano & Neil, 2011; Martin-Serrano et al., 2003a; Morita et al., 2011). All 
of the reported virus budding/assembly events which involve membrane separation 
require the function of ESCRT-III and VPS4 ATPase, while the upstream recruiting 
pathways appear to vary greatly among different viruses. The yeast two-hybrid screen 
results and the validation experiments shown in Chapter 3 suggest that HSV-1 is able to 
interact with multiple proteins to recruit the ESCRT (especially ESCRT-III) machinery. 
Electron microscopy and siRNA results presented in this thesis have shown that HSV-1 
requires CHMP4 proteins to accomplish the membrane separation process, and has 
revealed possible several routes for viral recruitment of CHMP4s.  
Taken together, these different requirements of ESCRT component implies that the 
membrane deformation and scission reactions that occur during the life cycle of various 
viruses are different from the topologically related MVB pathway, and the abscission event 
at the end of cytokinesis. While the result, the ESCRT-III based membrane scission, is the 
same, many options appear to be available for the viruses to achieve this goal. 
5.2.3 Functional redundancy in recruiting ESCRT by HSV-1  
Although the depletion of some ESCRT components, such as ALIX and CHMP6, did not 
show significant effect on HSV-1 replication, it cannot be ruled out that HSV-1 does 
interact with these proteins in infected cells, as the virus could utilise these interactions 
among the many parallel pathways with a redundant fashion. This strategy potentially 
makes the virus able to cope with many different host cellular conditions (e.g., the 
replication in cells that do not express certain ESCRT components, or mutations occuring 
in certain viral protein involved in ESCRT recruitment). In addition, data presented in this 
thesis have shown at least four pathways, ALIX, CHMP6, CIN85 (via ALIX) and 
CC2D1A/1B, that could be available to HSV-1 for the recruitment of CHMP4 proteins 
for membrane scission during secondary envelopment. As several other candidates were 
revealed from the yeast two-hybrid screen, the interactions between HSV-1 tegument and 
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ESCRT/ESCRT associated proteins may be even more complex than the four presented 
pathways.  
Furthermore, the viral glycoprotein tails presented at the cytoplasmic side of the assembly 
membrane compartment may also play roles in recruiting ESCRT proteins for mature 
virion formation. It has been shown that tegument proteins are able to self-assemble in a 
process independent of capsid to form L-particles, which consist of tegument and 
envelope, but no capsid (Fuchs et al., 2002). As the formation of these L-particles also 
requires the same membrane deformation and scission events, this is a strong evidence for 
the involvement of tegument and/or envelope proteins in ESCRT recruitment, but not 
capsid proteins.  
In addition, it has been shown that human T cell leukemia virus type I (HTLV-I) Gag 
interacts with Nedd4 ubiquitin ligase family members and hijacks the ESCRT machinery, 
presumably through the ubiquitin interacting domain of the ESCRT-I complex (Martin-
Serrano & Neil, 2011). Potentially, HSV-1 could also hijack the ESCRT machinery via 
these upstream ubiquitin ligases. Unfortunately, the Nedd4 protein tested in yeast two-
hybrid screen showed many positive interactions, which are likely due to its non-specific 
binding when expressed in yeast cells. It is possible that HSV-1 may have direct 
interactions with Nedd4, although it is not revealed by the study in this thesis. This could 
add even more complexity to the recruitment of ESCRT machinery by HSV-1. 
5.2.4 Avoiding lysosomes after ESCRT recruitment 
The ESCRT machinery involvement is located on the plasma membrane during both HIV 
budding and cytokinesis. However, HSV-1 secondary envelopment, where virus particle 
containing vesicles are formed, and the formation of MVBs that are ILVs containing 
vesicles, both occur in the cytoplasm and share many topological similarities. The final 
stage of the cellular MVB pathway is the fusion of MVBs with lysosomes for protein 
degradation. In addition, there is evidence for ESCRT machinery being involved in 
autophagy (Lee et al., 2007; Rusten et al., 2007), which also leads to the degradation of 
cellular components by fusion with lysosomes. It has been previously reported that the 
depletion of TSG101 (an ESCRT-I component) inhibits the down-regulation of epidermal 
growth factor receptor (EGFR) while it causes sustained downstream activation by EGF, 
suggesting the initial sorting of EGFR from the cell surface is inhibited due to the loss of 
TSG101 function (Hewitt et al., 2002). However, the depletion of CHMP3 (an ESCRT-III 
component) did not affect the endocytosis but caused the accumulation of EGFR in 
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significantly smaller MVBs. This suggests the possible functional involvement of CHMP3 
in the fusion of MVBs with lysosomes (Bache et al., 2006). Therefore, it is plausible to 
hypothesise that there is a close link between ESCRT and lysosome. This raises the 
interesting question how the virions containing vesicles escape the potential fusion with 
lysosomes and complete the transport to the cell surface for release. Presumably, HSV-1 
encodes activities to prevent the fusion of virus containing vesicles with lysosomes. 
However, what viral protein(s) may be involved is currently unknown. 
5.2.5 Possible involvement for ESCRT at primary envelopment 
Another intriguing question is whether the ESCRT machinery could be involved in the 
primary envelopment stage, which also requires membrane separation. However, no 
research work on ESCRT function at the nuclear membrane has been reported. ESCRT 
components are soluble proteins presenting in cytoplasm and presumably these proteins 
could also be recruited to nuclear membrane for membrane deformation and scission. In 
addition, some of the tegument proteins are presented in the cell nucleus and there is 
evidence that certain tegument proteins (such as VP16) are presented in the primary 
enveloped virions (Naldinho-Souto et al., 2006). These tegument proteins could potentially 
play a role in assisting primary envelopment through the interactions with ESCRTs if they 
are presented at the nuclear membrane. However, a role of ESCRTs in nuclear egress may 
be unlikely because no defects in perinuclear particle envelopment were observed in VPS4 
dominant-negative expressing cells (Crump et al., 2007). 
On the other hand, some viruses use different strategies to complete the membrane 
scission. Since VPS4 is the only energy providing complex of ESCRT machinery required 
for membrane scission, the ESCRT-dependence of virus budding is usually characterised 
by whether the viruses have the ability to complete the budding process in cells with 
overexpression of dominant-negative VPS4. Interestingly, Influenza virus budding has 
been shown to be VPS4 independent (Bruce et al., 2009). The fact that there are viruses 
independent of VPS4 activity/ESCRT machinery suggesting either the presence of 
alternative pathways, or virus budding process independent of cellular assistance. For 
example, it has been shown that Influenza virus encodes a viral protein called M2, that 
appears to mediate the membrane scission during budding (Rossman et al., 2010). By 
analogy to Influenza virus, HSV-1 could also encode viral protein(s) to mediate membrane 
scission during the primary envelopment stage without the assistance of ESCRT 
machinery. Which HSV-1 proteins could accomplish such membrane scission is unknown. 
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Candidates could be pUL31, pUL34 and pUS3, proteins known to be involved in nuclear 
egress of HSV-1. 
5.2.6 Future studies 
5.2.6.1 Triple deletion virus 
As a complex virus, HSV-1 often has significant functional redundancy. The siRNA 
experiments performed to deplete certain combinations of CIN85, CC2D1A/1B, ALIX 
and HD-PTP did not show significant inhibition of virus replication. Presumably, there is 
a highly complex level of functional redundancy involved in the ESCRT machinery 
recruitment. From the yeast two-hybrid screen, tegument proteins pUL46, pUL47 and 
pUL49 showed interactions with several ESCRT proteins (Figure 3.2). The attempt was 
made to delete pUL47 aiming at making the virus more sensitive to siRNA depletion of 
certain ESCRT protein(s). While the ∆UL47 virus did show a small defect in replication, it 
appeared no more sensitive to the siRNA depletions than wild type HSV-1. Therefore, 
further approaches could be explored to simultaneously delete multiple tegument proteins 
and examine the virus replication in cells with ESCRT depletion(s). This kind of approach 
might be able to avoid the complex functional redundancy and reveal more confident 
information about the requirement of certain ESCRT/ESCRT associated proteins by 
HSV-1. 
5.2.6.2 Searching for potential HSV-1 L domain motif(s) 
It has been shown that HSV-1 viral proteins contain many potential L-domain motifs of 
the known type: PTAP, PPXY and YPXnL (Pawliczek & Crump, 2009). Intriguingly, it has 
been previously reported that different L-domain motifs can be exchanged between 
different viruses. For example, the L-domain motif of Rous sarcoma virus (RSV, a 
retrovirus that causes sarcoma in chicken) could be replaced with the HIV L-domain motif 
in the Gag protein (Parent et al., 1995). Therefore, it will be very interesting to continue the 
searching for potential novel L-domain motifs from HSV-1 tegument proteins, such as 
pUL46, and examine the function of these motifs when they are presenting in other 
viruses, such as HIV-1.  
5.2.6.3 Immunoelectron microscopy 
It has been shown in this thesis that the ESCRT associate proteins CC2D1A and CC2D1B 
directly interacts with HSV-1 tegument proteins and they are present in purified virions. 
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As a further step to the studies performed, immunoelectron microscopy could be 
employed to examine whether the identified ESCRT/ESCRT associated proteins co-
localise with the secondary envelopment and its closely related events.  
This thesis presents the new observations of gM-dependant gH/L sub-cellular localisation 
in host cells and the direct interactions between HSV-1 tegument and ESCRT/ESCRT 
associated proteins. These observations are related to HSV-1 secondary envelopment and 
opens up many interesting questions for further studies in order to develop the current 
understanding of HSV-1 secondary assembly further. In summary, the results presented in 
this thesis show that the efficient incorporation of gH/L relies on the function of gM and 
that HSV-1 has evolved multiple parallel pathways to hijack the membrane scission event 
mediated by CHMP4 proteins to facilitate the viral replication. 
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6     Materials and Methods 
6.1 Materials 
6.1.1 Mammalian cell lines 
The cells were grown in Dulbecco’s modified Eagle’s medium (DMEM), Glasgow 
Minimum Essential Medium (GMEM) or RPMI supplemented with 10% fetal calf serum 
(FCS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin. Cell lines 
used in this thesis are listed in Table 6.1. 
Table 6.1 Cell lines. 
Name Description 
293T Highly transfectable human cell line derived from the 293 human embryonic kidney 
(HEK) cell line by insertion of the temperature sensitive gene for SV40 T antigen 
(American Type Culture Collection (ATCC)). 
A549 Human alveolar epithelial cell line derived from lung carcinomatous tissue from a 
58-year-old Caucasian male (Giard et al., 1973). 
BHK Syrian hamster fibroblast cell line obtained from an unusually rapidly growing 
primary culture of new-born hamster kidney tissue (Nature 203: 1355-1357, 1964). 
Caco-2 Human colorectal adenocarcinoma. The cells can be polarized under certain 
conditions (Hidalgo et al., 1989). 
COS-7 African green monkey fibroblast-like cell line containing SV40 viral DNA and 
expressing the SV40 T antigen (ATCC). 
HaCaT Spontaneously immortalised human keratinocyte cell line (Boukamp et al., 1988). 
HeLa Immortal human cell line isolated from an aggressive glandular cervical cancer of a 
patient called Henrietta Lacks in 1951 as the first in vitro continuous human cell line 
(Masters, 2002). 
HFF Human foreskin fibroblasts. They are adherent primary cells at relatively early 
passages. 
HRT-18 Human ileocecal colorectal adenocarcinoma. The HRT-18 line is identical to the 
HCT-8 cell line (ATCC). 
HT29 Human colon adenocarcinoma adherent cells purchased from the European 
Collection of Cell Cultures (ECACC). It was isolated from a primary tumour in a 44-
year-old Caucasian female. 
MDCK Dog kidney cell line derived from a kidney of an apparently normal adult female 
cocker spaniel (ATCC). 
RK13 Rabbit kidney cell line (ATCC). 
SK-N-SH Human neuroblastoma cell line (ATCC). 
Vero African green monkey cell line isolated from the kidney of a healthy animal (ATCC). 
6.1.2 Yeast 
Saccharomyces cerevisiae strain Y190 used for yeast two-hybrid assay was from Dr J. Martin-
Serrano at King’s College London. 
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6.1.3 Escherichia coli 
Escherichia coli strain DH5α was used for transformation during cloning. 
Escherichia coli strain GS1783 use for two-step markerless red recombination was from G. 
Smith at Northwestern University (Tischer et al., 2010). 
6.1.4 HSV-1 viruses 
HSV-1 wild type and mutant viruses used in this thesis are listed in Table 6.2. 
Table 6.2 HSV-1 viruses. 
Name Description 
SC16 
A clinical isolate from a recurrent lesion with a low passage history in 
laboratory (Hill et al., 1975). 
KOS 
A clinical isolate of HSV-1 with a high passage history from human oral 
lesions (Smith, 1964). 
K∆UL36 
HSV-1 mutant derived from strain KOS with a partial deletion of the UL36 
ORF that expresses only a small N-terminal region of pUL36. This virus does 
not replicate in cells without expressing pUL36 (Desai, 2000). 
∆gM* 
Created in this study. HSV-1 mutant derived from strain SC16 with the gM 
gene UL10 replaced by lacZ reporter gene. 
gMR* 
Created in this study. The lacZ reporter gene in ∆gM was replaced with the 
wild type UL10 fragment. 
∆gM/∆UL43* 
Created in this study. HSV-1 double mutant derived from ∆gM with the gM 
gene UL10 replaced by lacZ reporter gene and UL43 gene replaced by EGFP 
expression cassette. 
gMR/∆UL43* 
Created in this study. The lacZ reporter gene in ∆gM/∆UL43 was replaced 
with the wild type UL10. 
∆UL47 
Created in this study. HSV-1 mutant derived from strain KOS with the UL47 
gene replaced by tdTomato reporter gene, using the two-step Red-mediated 
recombination method (Tischer et al., 2010; Tischer et al., 2006). 
* viruses created by C. Crump and S. Bell. 
6.1.5 Antibodies 
Primary antibodies used for Western blot (WB), immunofluorescence microscopy (IF), 
Fluorescence Activated Cell Sorting (FACS) and Co-immunoprecipitate (Co-IP) are shown 
in Table 6.3 and 6.4 for cellular proteins and viral proteins respectively. Primary antibodies 
were either purchased from the indicated companies, developed in the laboratory or kindly 
provided by Gillian Elliott (Imperial College London), J. Martin-Serrano (King’s College 
London), Wesley I. Sundquist (University of Utah), J. Paul Luzio (Cambridge Institute for 
Medical Research), Gary Cohen (University of Pennsylvania), Tony Minson and Helena 
Browne (University of Cambridge). Secondary antibodies used: Alexa Fluor® 680 goat 
anti-rat (Invitrogen, A21096, 1:20000), LI-COR IRDye 680 goat anti-rabbit, 800CW 
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donkey anti-rabbit, 800CW goat anti-mouse (LI-COR Biosciences, 926-32221, 926-32213, 
926-32210, 1:20000). 
Table 6.3 Primary antibodies against cellular proteins. 
Antigen Name Source Species Application 
Actin AC-40 Sigma Mouse WB, 1:2000 
ALIX UT325 W. I. Sundquist Rabbit WB, 1:1000 
CC2D1A ab70375 Abcam Rabbit WB, 1:1000 
CC2D1B sc-134634 Santa Cruz Biotechnology Rabbit WB, 1:200 
CHMP2B ab33174 Abcam Rabbit WB, 1:200 
CHMP4A sc-67229 Santa Cruz Biotechnology Rabbit WB, 1:250 
CHMP4B sc-82556 Santa Cruz Biotechnology Rabbit WB, 1:100 
CHMP4C - J. Martin-Serrano Mouse WB, 1:20 
CHMP6 - J. Paul Luzio Rabbit WB, 1:1000 
CIN85 AB8225 Millipore Rabbit WB, 1:5000; IP, 1:100 
dsRed 632496 Clontech Rabbit WB, 1:1000 
HD-PTP sc-55205 Santa Cruz Biotechnology Goat WB, 1:200 
GFP/YFP JL-8 Clontech Mouse WB, 1:5000 
GM130 - BD Biosciences Mouse IF, 1:100 
GST sc-459 Santa Cruz Biotechnology Rabbit WB, 1:1000 
Tubulin α MCA77G AbD Serotec Rat WB, 1:2000 
TGN46 - AbD Serotec Sheep IF, 1:200 
VPS4A UT289 W. I. Sundquist Rabbit WB, 1:500 
 
Table 6.4 Primary antibodies against viral proteins. 
Antigen Name Source Species Application 
gB R69 G. Cohen and R. Eisenberg Rabbit WB, 1:6000 
gC ab6509 Abcam Mouse WB, 1:1000 
gD 
LP2 T. Minson Mouse IF, 1:3; FACS, 1:2 
LP14 T. Minson Mouse WB, 1:10 
gH 
BBH1 H. Browne Mouse WB, 1:10 
Shabba H. Browne (Desai et al., 1988) Rabbit WB, 1:200 
LP11 T. Minson Mouse IF, 1:3; FACS, 1:2 
52S (Showalter et al., 1981) Mouse IF, 1:3 
gL CHL28 G. Cohen (Cairns et al., 2006) Mouse WB, 1:500 
gM 
anti-gM-B H. Browne Rabbit WB, 1:1000 
CB18 C. Crump and S. Bell Mouse IF, 1:3 
HSV-1 B0114 DAKO Rabbit IF, 1:1000 
pUL11 - T. Mettenleiter Rabbit WB, 1:50000 
VP1/2 CB2 C. Crump and S. Bell Mouse WB, 1:2 
VP5 ab6508 Abcam Mouse WB, 1:1000 
VP13/14 - G. Elliott Rabbit WB, 1:3000 
VP16 LP1 T. Minson Mouse WB, 1:50 
VP22 AGV30 G. Elliott Rabbit WB, 1:2000 
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6.1.6 Bacterial artificial chromosome 
The bacterial artificial chromosome (BAC) containing HSV-1 strain KOS genome used in 
the two-step markerless red recombination was from David A. Leib (Gierasch et al., 2006).  
6.1.7 Plasmids 
The plasmids used in this thesis are listed in Table 6.5.  
Table 6.5 Plasmids. 
Name 
Selection 
marker 
Application and description 
pHB18 Ampicillin 
Yeast two-hybrid assay. Expresses a protein of interest 
(pray) and VP16 activation domain fusion protein in yeasts. 
pGBKT7 Kanamycin 
Yeast two-hybrid assay. Expresses a protein of interest (bait) 
and Gal4 DNA binding domain fusion protein in yeasts. 
pCAG-GST Ampicillin 
GST pull-down assay. Expresses N-terminal tagged GST 
fusion proteins in mammalian cells. 
pEGFP-N1 Kanamycin 
Expresses C-terminal tagged GFP fusion proteins in 
mammalian cells. 
pEGFP-C2 Kanamycin 
Espresses N-terminal tagged GFP fusion proteins in 
mammalian cells. 
pSG124 (A) Ampicillin Template used for UL37 and UL41 in PCR for cloning. 
pSG10 (D) Ampicillin 
Template used for UL7, UL11, UL13 and UL14 in PCR for 
cloning. 
pSG28 (EK) Ampicillin 
Template used for UL55 and ICP4 (RS1) in PCR for 
cloning. 
pSG 16 (G) Ampicillin Template used for UL16 and UL21 in PCR for cloning. 
pSG 25 (H) Ampicillin 
Template used for US2, US3, US10 and US11 in PCR for 
cloning. 
pSG 22 (I) Ampicillin 
Template used for UL46, UL47, UL48, UL49, UL50 and 
UL51 in PCR for cloning. 
pSG 1 (JK) Ampicillin Template used for ICP34.5 (RL1) in PCR for cloning. 
pSG 87 (N) Ampicillin Template used for UL23 in PCR for cloning. 
pT7-111-
ICP0cDNA 
Ampicillin 
For ICP0 subcloning. Template used for ICP0 in PCR for 
cloning. 
pHIT VSV-G Ampicillin 
Retroviral transduction system used for establishing stable 
cell lines. Plasmids Encoding vesicular stomatitis virus G 
protein (VSV-G) envelope, MLV Gag-pol and YFP tagged 
CC2D1A and CC2D1B (Carlton et al., 2008).  
pHIT60 Gag-pol Ampicillin 
pCMS28-YFP-
CC2D1A 
Ampicillin 
pCMS28-YFP-
CC2D1B 
Ampicillin 
pEP-tdTomato-in Kanamycin 
Template used for recombination sites flanked kanamycin 
gene in PCR for creating HSV-1 ∆UL47 virus by replacing 
UL47 codons 1-479by tdTomato reporter gene. 
pGS403 Ampicillin 
Used to remove bacterial backbone from BAC during the 
Two-step Red-mediated recombination for markerless 
mutant virus construction. Contains a gene encoding Cre 
recombinase under HCMV promoter. This enzyme is a type 
I topoisomerase that catalyses site-specific recombination of 
DNA between LoxP sites. 
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6.1.8 Primers 
Table 6.6 Primers for tegument cloning. 
 
Name 
Sequence 
(with restriction enzyme sites underlined) 
Restriction 
enzyme 
UL4 
5’-CTGAGAATTCGCCACCATGTCCAATCCACAGACGAC-3’ EcoRI 
5’-CTGACTCGAGTCA GGACCCCAAAAGTTTGTCTG-3’ XhoI 
UL7 
5’-CTGAGAATTCGCCACC ATGGCCGCCGCGACGGC-3’ EcoRI 
5’-CTGACTCGAGTCA ACAAAACTGATAAAACAGCG-3’ XhoI 
UL11 
5’-CTGAGAATTCGCCACC ATGGGCCTCTCGTTCTCCG-3’ EcoRI 
5’-CTGACTCGAGTCA TTCGCTATCGGACATGGGG-3’ XhoI 
UL13 
5’-CTGAGAATTCGCCACC ATGGATGAGTCCCGCAGAC-3’ EcoRI 
5’-CTGAGGATCCTCA CGACAGCGCGTGCCG -3’ BamHI 
UL14 
5’-CTGAGAATTCGCCACC ATGGACCGAGATGCCGCC-3’ EcoRI 
5’-CTGAGGATCCTCA TTCGCCATCGGGATAGT-3’ BamHI 
UL16 
5’-CTGAGAATTCGCCACC ATGGCGCAGCTGGGACCC-3’ EcoRI 
5’-CTGACTCGAGTCA TTCGGGATCGCTTGAGGAG-3’ XhoI 
UL21 
5’-CTGAGAATTCGCCACCATGGAGCTTAGCTACGCCAC-3’ EcoRI 
5’-CTGAGGATCCTCA CACAGACTGTCCGTGTTGG-3’ BamHI 
UL23 
5’-CTGAGAATTCGCCACC ATGGCTTCGTACCCCTGCC-3’ EcoRI 
5’-CTGACTCGAGTCA GTTAGCCTCCCCCATC-3’ XhoI 
UL37 
5’-CTGAGAATTCGCCACC ATGGCAGACCGCGGTCTC-3’ EcoRI 
5’- GTATGGATCCGCTTATTGGTAACTAGTTAACGGC-3’ BamHI 
UL41 
5’-CTGAGAATTCGCCACCATGGGTTTGTTCGGGATGATG-3’ EcoRI 
5’-CTGACTCGAGTCA CTCGTCCCAGAATTTGGCC-3’ XhoI 
UL46 
5’-CTGAGAATTCGCCACC ATGCAGCGCCGGACGCG-3’ EcoRI 
5’-CTGACTCGAGTCA CCGGCTCCGGCGTC-3’ XhoI 
UL47 
5’-CTGAGAATTCGCCACC ATGTCGGCTCGCGAACCC-3’ EcoRI 
5’-CTGACTCGAGTCA TGGGCGTGGCGGGCCTC-3’ XhoI 
UL48 
5’-CTGAGAATTCGCCACC ATGGACCTCTTGGTCGACG-3’ EcoRI 
5’-CTGACTCGAGTCA CCCACCGTACTCGTCAATTC-3’ XhoI 
UL48
∆AD  
5’-CTGAGAATTCGCCACC ATGGACCTCTTGGTCGACG-3’ EcoRI 
5’-CTGACTCGAGTCA CGACAGTCTGCGCGTGTG-3’ XhoI 
UL49 
5’-CTGAGAATTCGCCACC ATGACCTCTCGCCGCTCC-3’ EcoRI 
5’-CTGAGGATCCTCA CTCGACGGGCCGTCT-3’ BamHI 
UL50 
5’-CTGAGAATTCGCCACC ATGAGTCAGTGGGGATCCG-3’ EcoRI 
5’-CTGAGCGGCCGCTCA ATACCGGTAGAACCAAAACC-3’ NotI 
UL51 
5’-CTGAGAATTCGCCACC ATGGCTTCTCTTCTCGGGG-3’ EcoRI 
5’-CTGAGGATCCTCA TTGACCCAAAACACACGGAG-3’ BamHI 
UL55 
5’-CTGAGAATTCGCCACC ATGACAGCGACCCCCCTC-3’ EcoRI 
5’-CTGACTCGAGTCA CGCCTTAATTTTAATCTTGA-3’ XhoI 
US2 
5’-CTGAGAATTCGCCACC ATGGGCGTTGTTGTCGTCAA-3’ EcoRI 
5’-CTGACTCGAGTCA AAGGGTGGTAACCGGATAG-3’ XhoI 
US3 
5’-CTGAGAATTCGCCACC ATGGCCTGTCGTAAGTTTTGT-3’ EcoRI 
5’-CTGAGCGGCCGCTCA TTTCTGTTGAAACAGCGG-3’ NotI 
US10 
5’-CTGAGAATTCGCCACC ATGATCAAGCGGCGGGGC-3’ EcoRI 
5’-CTGACTCGAGTCA GCACAGGGGTGGGGTTAG-3’ XhoI 
US11 
5’-CTGAGAATTCGCCACC ATGAGCCAGACCCAACCCC-3’ EcoRI 
5’-CTGAGCGGCCGCTCA TACAGACCCGCGAGCCGT-3’ NotI 
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Table 6.7 Primers for generation of mutant viruses. 
 
Table 6.8 Primers for ESCRT protein gene (domain) constructs cloning. 
 
6.1.9 siRNA 
Table 6.9 Sequences of siRNA oligonucleotides. 
Name Sequence 
CHMP4A CCCUGGAGUUUCAGCGUGATT 
CHMP4B CGAUAAAGUUGAUGAGUUATT 
CHMP4C CACUCAGAUUGAUGGCACATT 
siCIN85-1 CAAGGUCAAUUGAAGUAGA 
siCIN85-2 GGAGUGGACGCGUCAAAGA 
siCIN85-3 CUAUCCAAGUCAAGUUUAA 
siCIN85-4 ACGAGAGAUUAAACAGUUA 
ALIX GAAGGAUGCUUUCGAUAAAUU 
CHMP6 SMARTpool 
UCACCCAGAUCGAAAUGAAUU 
GGACAAGGCCAUCCUGCAAUU 
CGCAAUCACUCAGGAACAAUU 
GAGUACCAGCGGCAAAUAGUU 
CC2D1A (1A02) CCAAGGGACUGGAGCCUAU 
CC2D1A (1A04) GGACGGAUGAGGACGACUU 
CC2D1B (1B01) GAUCAACUCUUCAAACUAA 
CC2D1B (1B03) GAGCAAAGGCAUCAAGUUU 
HD-PTP A gift from P. Luzio. 
 
Name Sequence Purpose 
SB003 5’-GCGGCCATTAATACAGGGAAAGGAAATACACG-3’ 
∆gM/∆UL43 
SB004 5’-GCGGCCATTAATAGCCTTCTGGACTCGCTTC-3’ 
SB005 5’-GCGGCCACGCGTCAATAAAAGGCATTAGTCCCG-3’ 
SB009 5’-CAGGGGCACGTAGTGGGGCTGGAGGGTCAGAG-3’ 
COL398 
5’-TTCTTTTTTGGGGGGTAGCGGACATCCGATAACCCGC 
GTCTATCGCCACCATGGTGAGCAAGGGCGAGGAG-3’ 
∆UL47 
COL399 
5’-GCGTTGAGCCCGCTGTTGGCGAGCAGCCGGCGCGCT 
GCGGTGTCGCCCAGTCACTATTACTTGTACAGCTCGTCCA
TGCC-3’ 
Name Sequence 
Restriction 
enzyme 
CIN85-
SH3(1-331) 
5’-CTGAGAATTCGCCACCATGGTGGAGGCCATAGTGGA-3’ EcoRI 
5’-CTGACTCGAGTCATTCAAAGTCCGGTGGAAGTA-3’ XhoI 
CIN85-PR 
(332-600) 
5’-CTGAGAATTCGCCACCAAGGAAGGGAATAGACCCAA-3’ EcoRI 
5’-CTGACTCGAGTCACTCCATCTTTGGTTTTCCTT-3’ XhoI 
CIN85-CC 
(594-665) 
5’-CTGAGAATTCGCCACCGAAGGAAAACCAAAGATGGA-3’ EcoRI 
5’-CTGACTCGAG TCA TCATTTTGATTGTAGAGCTT-3’ XhoI 
CC2D1B 
5’-CTGAGAATTCGCCACCATGATGCCAGGGCCAAGACC-3’ EcoRI 
5’-CTGACTCGAG TCA TCACAAGCCCCTGGGCTCCAG-3’ XhoI 
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siRNA related reagents were purchased from Qiagen and Dharmacon, Thermo Fisher 
Scientific. The siRNA oligonucleotides are dissolved in 1 × siRNA buffer with final 
concentration of 100 µM and aliquots are stored at -20 °C. 
6.1.10 Buffers and media solutions 
Table 6.10 Electrophoresis buffers and gels. 
Name Composition 
TAE (1X) 40 mM Tris acetate, 1 mM EDTA pH7.8. 
TBE (1X) 89 mM Tris base, 89 mM borate, 2.6 mM EDTA pH8.0. 
DNA loading (10X) 
50% glycerol, 100 mM EDTA (pH 8.0), 1% SDS, 0.25% 
bromophenol blue. 
SDS-PAGE running buffer (1X) 25 mM Tris base, 200 mM glycine, 0.1% SDS. 
SDS-PAGE transfer buffer (1X) 25 mM Tris base, 200 mM glycine, 10% methanol. 
SDS-PAGE loading buffer (5X) 
250 mM Tris-HCl pH6.8, 10% SDS, 50% glycerol, 0.05% 
bromophenol blue, 1.39% b-mercaptoethanol. 
Acrylamide stock 
30% (w/v) acrylamide/methylene bisacrylamide solution 
(ProtoGel). 
5% stacking gel 
0.67 ml stock acrylamide solution, 0.5 ml 1.0 M Tris-HCl 
(pH6.8), 40 µl 10% SDS, 40 µl 10% APS, 4 µl TEMED. 
8/10/12% resolving gel 
2.7/3.3/4.0 ml stock acrylamide solution, 2.5 ml 1.5 M Tris-
HCl (pH8.8), 100 µl 10% SDS, 100 µl 10% ammonium 
persulfate (APS), up to 10 ml with dH2O, 4 µl TEMED 
(N,N,N’,N’-tetramethylethylenediamine). 
 
Table 6.11 IF, FACS and TEM buffers. 
Name Composition 
IF fix 3% formaldehyde in PBS. 
IF perm/quench solution 50 mM NH4CL, 0.2% saponin in PBS. 
IF blocking PGAS 0.2% gelatin, 0.02% saponin, 0.02% NaN3 in PBS. 
IF gE/gI Fc receptor blocking 0.1 mg/ml human IgG (Sigma) in PGAS. 
FACS blocking 3% BSA in PBS. 
TEM saline 0.9% sodium chloride. 
TEM wash 0.1 M HEPES. 
TEM fix 2% glutaraldehyde, 0.1 M HEPES, pH7.4. 
 
Table 6.12 Yeast two-hybrid solutions. 
Name Composition 
LiAc working solution 0.1 M LiAc, pH7.5, in TE. 
TE (10X) 100 mM Tris base, 10 mM EDTA, pH7.5. 
PEG working solution 40% PEG 3350, 0.1 M LiAc, pH7.5, in TE. 
Z buffer (5X) 
0.3 M Na2HPO4, 0.14 M NaH2PO4, 0.05 M KCl, 0.01 MgSO4, 
pH7.0. 
Working buffer (10ml) 
2ml of 5X Z buffer, 28 µl β-mercaptoethanol, 8ul 10% SDS 
and 8 ml H2O. 
Adenine hemisulfate (1000X) 100 mg/ml in H2O. 
CPRG solution 14 mg/ml in H2O (store at -20 °C in dark). 
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Table 6.13 Buffers for high molecular weight DNA preparation. 
Name Composition 
Lysis buffer 
1 ml of 1M Tris pH7.5 
10 ml of 0.1M EDTA 
89 ml of H2O 
Lysis mixture 
20 ml of lysis buffer 
1.2ml of 10% SDS 
Add proteinase K with final concentration of 50 µg/ml 
 
Table 6.14 Buffers for GST pull-down and Co-IP. 
Name Composition 
Lysis buffer 
50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5% glycerol, 
1% Triton ×-100. 
Wash buffer 
50 mM Tris-HCl, pH 7.4, 150mM NaCl, 5 mM EDTA, 5% glycerol, 
and 0.1% Triton ×-100. 
 
Table 6.15 Miscellaneous. 
Name Composition 
LB, 2TY, SOC, CMC 
Prepared by technical staff at the Department of Pathology, 
University of Cambridge. 
PEI 1mg/ml, pH 7.0, linear 25 kDa polyethylenimine from Polysciences. 
YPD broth and agar 
Purchased from Clontech and prepared according to the 
instructions. Contains 1x adenine hemisulfate. 
SD agar 
Purchased from Clontech and prepared according to the 
instructions. Yeast synthetic dropout medium supplement without 
Leucine and Tryptophan was added. 
DMEM, GMEM, RPMI 
Purchased from Sigma and supplemented with 100 U/ml penicillin, 
100 mg/ml streptomycin, 2 mM L-glutamine from Gibco BRL, and 
10% (vol/vol) fetal calf serum. 
CCMB 
11.8 g of CaCl2, 4.0 g of MnCl2, 2.0 g of MgCl2, 0.7 g of KCl and 100 
ml of glycerol dissolved in water with final volume of 1 litre. 
mRIPA 
50 mM Tris, pH 7.9, 150 mM NaCl, 1% NP-40, 1% sodium 
deoxycholate. 
Acid wash 40 mM citric acid, 135 mM NaCl, 10 mM KCl, pH3.0. 
 
6.1.11 General biochemical reagents and consumables 
General biochemical reagents were supplied by the following companies: Amersham 
Bioscience, BDH Chemicals, Bethesda Research Laboratories (BRL), Roche, Fisher 
Scientific, Clontech, and Sigma-Aldrich. Materials for cell culture and plasticware were 
obtained from BD Biosciences, Sterilin Ltd, Corning, Gibco, Greiner Bio-One, Sigma 
Chemical, and Techno Plastic Products (TPP). Molecular biology reagents and enzymes 
were obtained from Roche, Clontech, Invitrogen, New England Biolabs, and Promega. 
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For chemiluminescence detection, medical X-ray film was supplied by Fuji Film. 
Immunological reagents were supplied by Abcam, Amersham Biosciences, Santa Cruz 
Biotechnology, Millipore, Abnova, BD Biosciences, AbD Serotec and Invitrogen. 
6.2 Methods 
6.2.1 Virus construction using homologous recombination 
6.2.1.1 ∆gM and gMR 
The gM deletion (∆gM) and revertant (gMR) viruses were created through homologous 
recombination and the cloning details for construction are described as follows (carried 
out by Dr C. Crump and S. Bell). The plasmid pc73.1 contains the BamHI (21653)-BglII 
(25153) region of the HSV-1 genome that covers the UL10 ORF (23204-24625; 
numbering relates to strain 17 sequence available online: Refseq: NC_001806). The 
plasmid pc78.1 is pc73.1 with an SV40 promoter driven lacZ gene inserted into an NruI 
site (24343) near the 3’ end of UL10 (MacLean et al., 1991). Plasmid pc78.1 was digested 
with PpuMI and religated to generate pc78.1∆PpuMI, in which the majority of the UL10 
ORF (from 23765-24592) and the entire lacZ cassette were removed. A CMV promoter 
driven lacZ gene was excised from pMW10 with HindIII, ligated into pEGFP-C3 
(Clontech) and screened for clones containing the lacZ cassette in the reverse orientation 
to the GFP ORF to generate pEGFPC3-LacZrev. The lacZ cassette was excised from 
pEGFPC3-LacZrev with SmaI + BsrGI and ligated into pc78.1∆PpuMI cut with MscI and 
BsrGI to create pc78.1∆MscI-BsrGI-LacZ. This deletes bases 23604-24599 and replaces 
this region of the UL10 ORF (corresponding to amino acids Ala134–Val466 of gM) with 
the selectable marker lacZ. Vero cells were transfected with pc78.1∆MscI-BsrGI-LacZ 
together with high molecular weight DNA prepared from SC16 infected cells by calcium 
phosphate precipitation as previously described (Balan et al., 1994). Resulting plaques were 
analysed for β-galactosidase activity by staining with X-gal (5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside) and limiting dilution was used to isolate single blue plaques. As a 
more isogenic control for comparison, a revertant virus was made by transfecting Vero 
cells with pc73.1 together with high molecular weight DNA prepared from ∆gM infected 
cells. Resulting plaques were analysed for β-galactosidase activity by staining with X-gal 
and single white plaques were isolated.  
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6.2.1.2 ∆gM/∆UL43 and gMR/∆UL43 
The design and construction of ∆gM/∆UL43 and gMR/∆UL43 were carried out by Dr C. 
Crump and S. Bell as follows. For ∆gM/∆UL43, the HSV-1 genomic sequence at the 3’ 
end of UL43 (96062-97138) was amplified by PCR using primers SB005 and SB009 (Table 
6.6) and strain 17 genomic DNA as template. This introduced a 5’ MluI site (encode in 
primer SB005) and included the DraIII site at position 97129. This 3’ flanking region was 
then sub-cloned into the MluI/DraIII sites of pEGFPC2 (at the 3’ end of the EGFP 
expression cassette poly-A signal) to generate pEGFPC2-3’flank. The HSV-1 genomic 
sequence (93269-94732) was amplified by PCR using primers SB003 and SB004 (Table 6.6) 
and strain 17 genomic DNA as template. This introduced 5’ and 3’ AseI sites (encoded in 
the primers). This 5’ flanking region was then sub-cloned into the AseI site of pEGFPC2-3’ 
flank (at the 5’ end of the EGFP expression cassette promoter) and screened for correct 
orientation by restriction digest. The resulting plasmid (pEGFPC2-∆UL43flanks) was 
cotransfected with high molecular weight DNA prepared from HSV-1∆gM infected cells. 
Resulting plaques were screened for GFP fluorescence and single GFP/β-galactosidase 
positive plaques were isolated. gMR/∆UL43 virus was prepared by co-transfecting pc73.1 
with high molecular weight DNA from ∆gM/∆UL43 infected cells. Resulting plaques were 
screened for GFP fluorescence positive (indicating remains ∆UL43) while for β-
galactosidase activity negative (indicating gM revertant). 
6.2.1.3 Wild type SC16 
To generate an equivalently treated wild type SC16 strain, BHK cell were transfected with 
high molecular weight DNA prepared from SC16 infected cells. The progeny viruses 
generated were harvested and stocks prepared in Vero cells. 
6.2.2 Two-step Red-mediated recombination for markerless 
mutant virus construction  
The method used was from B. K. Tischer et al. with modifications (Tischer et al., 2010). 
Briefly, PCR primers (Table 6.7) were designed to contain 50 bp homology sequences to 
HSV-1 genomic DNA for recombination at the desired location followed by sequences 
annealing to pEP-tdTomato-in. The PCR products were harvested and digested by DpnI 
enzyme to remove any potential template plasmid contamination. 100 ng of the PCR 
product was electroporated into E. Coli GS1783 containing KOS BAC. GS1783 contains 
heat shock inducible red recombination enzymes, and arabinose-inducible I-SceI. The 
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bacteria were selected in both kanamycin (Kan) and chloramphenicol (Cam). BAC DNA 
was harvested from liquid culture of the positive colonies and subjected to restriction 
enzyme digestion to confirm recombination.  
Positive colonies were inoculated into LB containing Cam for starter cultures and then a 
final concentration of 1% arabinose was added to induce I-SceI expression. Subsequently 
the Red recombinase was induced at 42 °C for 30 min. The bacteria were plated out onto 
agar plates containing Cam and 1% arabinose and incubated for 1-2 days. Cam resistant 
but Kan sensitive colonies were identified by replica plating and then cultured. BAC DNA 
was harvested and subjected to restriction enzyme digestion to confirm recombination. 
BAC DNA and pGS403 were co-transfected into Vero cells and incubated at 37 °C until 
visible plaques were formed to generate a pre-master virus stock. The virus was harvested 
and used to generate virus stocks.  
6.2.3 Production of virus working stocks 
BHK or Vero cells growing in either 850 cm2 roller bottles or 175 cm2 flasks were infected 
with HSV-1 at 0.05-0.1 PFU/cell. The cells were incubated at 37 °C for two to three days 
until most has rounded up and could be detached by shaking. Cell-associated virus was 
obtained by harvesting the cells at 2000 rpm for 10 min at 4 °C (Beckman GH-3.8). The 
cell pellet was resuspended in a small volume of culture supernatant (1-2 ml per 175 cm2 
flask, 4-6 ml per 850 cm2 roller bottle). Resuspended cell pellets were treated by sonication 
in iced water at 39% amplitude for 20 s using a cup-horn sonicator (Jencons) in order to 
liberate the viruses. 250 µl aliquots were stored at -70°C and the titres were determined by 
plaque assay on Vero cells.  
6.2.4 Production of sucrose cushion purified HSV-1 
Cells growing in 75 cm2 flasks were infected with HSV-1 working stock at 10 PFU/cell. 
Infected cells were incubated in 10 ml DMEM growth medium per 75 cm2 flask for ~24 
hours. The cell culture supernatant was harvested and the cell debris removed by 
centrifugation at 1800 rpm for 15 min at 4 °C (Beckman GH-3.8). 9 ml of cleared culture 
supernatant was carefully overlaid onto a 2 ml cushion consisting of 33% (w/v) sucrose 
dissolved in PBS. Virus particles were harvested by centrifugation at 35000 rpm for 90 min 
at 4 °C (Beckman TLA-100.3) and resuspended in 50 µl SDS-PAGE loading buffer. 
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6.2.5 Gradient purified HSV-1 virions 
Cells growing in 175 cm2 flasks were infected either with HSV-1 at 0.01 PFU/cell. The cell 
culture medium was harvested three days after infection, and cellular debris was removed 
by low-speed centrifugation at 2000 rpm for 20 min at 4 °C (Beckman GH-3.8). Virus 
particles were pelleted at 18000 rpm for 2 hr at 4 °C (Beckman R19 rotor). The 
supernatant virus pellets were resuspended in 2 ml of PBS containing 1% fetal calf serum 
and layered onto a 30 ml 5 to 15% Ficoll 400 (in PBS) continuous gradient. After 
centrifugation at 12000 rpm for 90 min at 4 °C (Beckman SW 32 Ti), the visible band 
approximately in the middle of the gradient was collected carefully. The virus containing 
solutions were diluted in sterile PBS and harvested by centrifugation at 20000 rpm for 2 hr 
at 4 °C (Beckman SW 32 Ti). Virus pellets were resuspended in sterile PBS. The titres were 
determined by plaque assay on Vero cells and 20 µl aliquots were stored at -70 °C. 
6.2.6 HSV-1 plaque assay and plaque size analysis 
Infectious titres of wild-type HSV-1 or mutant viruses were determined by plaque assay on 
Vero cell monolayers in six-well plates. Ten-fold serial dilutions of virus samples were 
prepared with supplemented DMEM media. 0.5 ml of the virus dilutions were added to 
each well and incubated at 37 °C for one hour. Then each well was overlaid with two ml of 
DMEM solution containing 0.6% carboxymethyl cellulose, 2% FCS and antibiotics. After 
incubation for two to three days at 37 °C the monolayers were fixed in 3.7% formaldehyde 
in PBS for 20 min and then stained with 0.1% toluidine blue solution to visualise plaques 
in the cell layer. Plaques were counted using a plate microscope and the infectious virus 
titre was calculated as plaque forming units per ml (PFU/ml). For plaque size analysis, the 
plaques were scanned at 600 dpi and the diameters were determined by Adobe Photoshop 
in pixels. 
6.2.7 Virus growth analysis 
For single-step virus growth curves, cells were infected at 10 PFU/cell at 37 ºC for one 
hour. Unabsorbed viruses were inactivated with acid wash (Table 6.14) for 1 min at room 
temperature. Cells were washed 3 times in PBS and then cultured in complete media. At 
various times post infection, samples were harvested by scraping cells into the medium and 
liberating infectious viruses by sonication and then freezing at -70 ºC followed by thawing 
at 37 ºC. Infectious virus titres were determined by plaque assay on Vero cells. In multi-
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step growth curves, cells were infected at 0.01 PFU/cell and the samples were treated as 
described above. 
6.2.8 Western blot analysis and signal quantification 
Cell lysates or purified virus samples were separated by SDS-PAGE followed by electro-
transfer to nitrocellulose membrane. The presence of various proteins was determined by 
labelling with the primary and secondary antibodies (Table 6.3-6.4). The LI-COR Odyssey 
V3.0 software was used to calculate the integrated intensity for quantification. 
6.2.9 Immunofluorescence microscopy 
Vero cells were seeded on glass cover slips at a density of 2 × 105 cells per well in six-well 
dishes one day before infection. Cells were infected at 3 PFU/cell and washed in PBS. 
Depending on the purpose of the experiment, the infected cells were fixed at different 
times post infection in 3% paraformaldehyde in PBS for 10 min and then permeabilised in 
IF perm/quench solution (Table 6.10). After incubation in fresh IF perm/quench solution 
for 10-15min, the samples were incubated with IF blocking PGAS (Table 6.10) for at least 
5min. Primary antibodies were appropriately diluted in PGAS and incubated for 45-60 min 
and then washed with PGAS for three times before the incubation with secondary 
antibodies (Alexa Fluor 488, 568 or 633-conjugated secondary antibody, 1:2000, Molecular 
Probes) in PGAS in the dark for about 30min. After three washes with PGAS, three 
washes with PBS and twice in water, the excess liquid was removed from the cover slips. 
The cell side of the cover slips were mounted in ProLong Gold antifade reagent with 
DAPI (4, 6-diamidino-2-phenylindole; Invitrogen) on glass slides. The samples were stored 
in drawer overnight before imaging on an Olympus IX70 microscope with a 60x oil 
immersion lens and a Retiga 2000R ccd camera. Images were acquired with the Q capture 
Pro software and processed with ImageJ (available from: http://rsbweb.nih.gov/ij/) and 
Photoshop (Adobe). 
6.2.10 Virus penetration assay 
Monolayers of Vero were chilled at 4 ºC for one hour followed by incubation with 300 
PFU of purified viruses in ice cold HEPES (0.02 mM) buffered medium for one hour. The 
virus containing medium was removed followed by two ice cold PBS washes and the plates 
were incubated at 37 ºC. At various time points unabsorbed virus was inactivated by acid 
wash for one minute at room temperature followed by two PBS washes. For the zero 
minute time point, the acid wash was performed immediately at the end of the 4 ºC virus-
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binding step. Samples that were not acid washed served as controls for input virus levels. 
The cells were overlaid with CMC and incubated at 37 ºC before fixing and staining as 
described above. Plaque numbers were counted for each time point and rate of penetration 
was calculated as the percentage of plaques produced at different time points in relation to 
the controls. 
6.2.11 FACS 
Vero cells were infected at 10 PFU/cell, harvested at 6 hpi and incubated with anti-gH/L 
(LP11, 1:2) or anti-gD (LP2, 1:2) antibodies on ice for one hour. After two ice cold PBS 
washes, the cells were incubated with Alexa Fluor® 488-conjugated goat anti-mouse 
(1:2000) on ice for one hour. Cells were washed and resuspended in cold PBS and analysed 
using a BD FACSort™ Cell Sorter. Data from 10000 cells for each sample were collected 
and the fluorescent signals were analysed using Software Summit 4.3. 
6.2.12 Antibody internalisation assay 
Vero cells grown on glass cover slips were infected at 10 PFU/cell. At 6 hpi the cells were 
incubated with anti-gH/L (LP11, 1:2), anti-gH (52S, 1:2) or anti-gD (LP2, 1:2) for one 
hour at 37 ºC in a humidified chamber. Cells were then washed in PBS, fixed in 3% 
formaldehyde, incubated in perm/quench solution for 10 min and blocked in PGAS 
before labelling with Alexa Fluor® 488-conjugated goat anti-mouse (1:2000). The samples 
were embedded and processed as described in 2.2.9. 
6.2.13 Cloning 
6.2.13.1 General conditions 
Insertion fragments and plasmid backbone preparation 
PCR reactions (Phusion High-Fidelity PCR Kit, NEB), DNA extraction (QIAquick Gel 
Extraction Kit, Qiagen), restriction enzyme digestions (NEB/Roch/Invitrogen), plasmid 
backbone de-phosphorylation (Antarctic Phosphatase, NEB), blunting sticky end (T4 
polymerase, NEB), ligation (T4 ligase, NEB), plasmid miniprep (Wizard Plus SV 
Minipreps DNA Purification System, Promega) and plasmid midiprep (Nucleobond AX 
Xtra Midi, Macherey-Nagel) were all performed according to the manufacturer’s 
instructions. All the clones obtained from PCR were sequenced (DNA Sequencing Facility, 
Department of Biochemistry, University of Cambridge) for confirmation. Some general 
conditions are listed in Table 6.16-6.18.  
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Table 6.16 PCR condition. 
Reagent Volume 
HF/GC Buffer 5 × 10 µl 
dNTP (10 mM) 1 µl 
Forward primer (5 µM) 5 µl 
Reverse primer (5 µM) 5 µl 
Template (plasmid, ~200 ng/µl) 1 µl 
DNA polymerase 0.5 µl 
DMSO (for GC rich amplicons) 1.5 µl 
Betaine (2 M)* 25 µl 
H2O Top up to 50 µl 
*Betaine was only added into the reactions with high non-specific products. 
 
Table 6.17 PCR program. 
Temperature Time  
98 °C 30 s  
98 °C 10 s 
25 cycles 58 °C 30 s 
72 °C 15-30 s per kb 
72 °C 10 min  
4 °C - End 
 
Table 6.18 Ligation condition. 
Reagent Volume Others 
PCR product 7 µl 
The ligation mixture 
was incubated at 10 °C 
for overnight or longer. 
Plasmid backbone 1 µl 
10 × buffer 1 µl 
T4 ligase 1 µl 
 
Competent DH5α preparation 
Single colony of E.coli strain DH5α was inoculated in 3-4 ml of antibiotic free 2YT for a 
starter culture and incubated with shaking at 37 °C overnight. The start culture was 
inoculated into fresh 2YT with 100-fold dilution for an initial culture and incubated with 
shaking at 37 °C for 3 h. The bacteria were harvested by centrifugation at 4000 rpm for 10 
min and the pellet was resuspended in ice cold CCMB (Table 6.15, one fourth of the initial 
culture volume) followed by incubation on ice for 4 h and centrifugation at 4000 rpm for 
10 min at 4 °C. The pellet was resuspended in ice cold CCMB (one twelfths of the initial 
culture volume) and aliquots were stored at -70 °C. To test the competence, 10 pg of 
pUC19 was transformed into 50 µl of the competent DH5α and the colonies formed on 
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selective agar were counted to calculate the competence as colonies per µg of plasmid. A 
good competence is around 107 colonies/ µg. 
Transformation 
Frozen competent DH5α were thawed on ice and 3-5 µl of the ligation mixture was mixed 
with 50 µl competent DH5α. After 30 min incubation on ice, the bacteria were heat 
shocked at 42 °C for 30 sec and chilled on ice. 300 µl of pre-warmed SOC media was 
added and the bacteria were incubated with shake at 37 °C for 1 h. The culture was then 
plated onto selective agar and incubated at 37 °C overnight to form visible colonies. 
6.2.13.2 Tegument gene cloning for Y2H assays 
The plasmids containing KOS EcoRI fragments were used as templates (Table 6.5). 
Primers for tegument gene cloning were designed by Dr C. Crump according to the online 
sequence of HSV-1 strain 17 (NC_001806) with appropriate enzyme sites (Table 6.6). 
Tegument gene fragments were obtained by PCR and DNA gel electrophoresis followed 
by gel extraction. The PCR products were subjected to restriction enzyme digestions, 
ligation with plasmid backbones and transformation into competent DH5α. Colonies 
formed under selective culture conditions were amplified for plasmid mini prep. The new 
constructs were confirmed by restriction enzyme digestions before sending for sequencing 
and the sequencing results are shown in the appendix. 
6.2.13.3 ICP0 cDNA sub-cloning 
The ICP0 constructs for Y2H was sub-cloned from plasmid pT7-111 (containing HSV-1 
strain 17 ICP0 cDNA) into pGBKT7 via NcoI and BamHI sites. In order to sub-clone 
ICP0 cDNA from pGBKT7 into pHB18, pGBKT7-ICP0 was cut by enzyme NcoI before 
creating a blunt end by Klenow fragment for the 5’ end of the ICP0 cDNA fragment 
(Table 6.19). The DNA was quick purified (QIAquick Gel Extraction Kit, Qiagen). As 
there is a SalI site near the 3’ end of ICP0 in addition to a SalI site in the pGBKT7 
multiple cloning site, the NcoI digested and blunted pGBKT7-ICP0 was partially digested 
by SalI (2 µg DNA per unit of enzyme, incubated at 37 °C for 10 min followed by 
inactivation at 65 °C for 20 min). The resulting ICP0 fragment was cut from DNA gel, 
purified and then ligated into pHB18 that had been cut with EcoRI enzyme, blunted the 
EcoRI sticky end and then cut with XhoI. Positive clones were sequenced to confirm the 
presence of an intact ICP0 cDNA (appendix).  
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Table 6.19 Conditions for blunt reaction. 
Reagent Volume Others 
NcoI digestion reaction (5 µg plasmid, NEB buffer 3) 100 µl Incubation at room 
temperature for 25-50 
min. 
dNPT (10 mM) 0.4 µl 
Klenow fragment 10 µl 
 
6.2.13.4 Full length CC2D1B cloning 
For the full length CC2D1B cloning, the primers were designed according to the online 
sequence (Gene ID: 200014) with appropriate enzyme sites (Table 6.8). Human total 
cDNA library (prepared by Dr C. Crump) were used as the template. As the RCP reactions 
often had high non-specific background, betaine (Table 6.16) was added to improve the 
specificity. The PCR products were processed as described above. Positive clones were 
confirmed by sequencing (appendix). 
6.2.13.5 CIN85 domain cloning 
Primers for CIN85 domain constructs were designed with appropriate enzyme sites 
according to the full length CIN85 sequence and the reported aa positions of different 
domains (Zhang et al., 2009b) (Table 6.8). Plasmid containing full length CIN85 gene 
(pHB18-CIN85) was used as the template. The cloning was performed as described above 
and positive clones were confirmed by sequencing. 
6.2.14 Yeast two-hybrid 
6.2.14.1 Preparation of competent yeast cells 
Yeast colonies were inoculated in YPD broth for starter cultures and incubated with shake 
at 30°C overnight. The start culture was inoculated into fresh YPD broth with 8-fold 
dilution and grown at 30 °C for ~3.5 h until OD600 nm (1 cm cuvette) reach between 0.5 
and 0.7. The yeast cells were harvest the by centrifugation at 1800 rpm for 10 min at room 
temperature (Megafuge 1.0R) and washed in water. The yeast pellet was resuspended in 
LiAc working solution (Table 6.12) and incubated at room temperature for 1.5 h. The 
volume of LiAc working solution = 0.5 × OD600 × yeast culture volume (ml). Aliquots of 
competent yeast suspension were stored at -70 °C. 
6.2.14.2 Yeast transformation 
For one reaction, 3 µl of single stranded DNA (ssDNA) from salmon testes (D9156, 
Sigma) was boiled for 8min and chilled on ice for 5min. 30 µl of the competent yeast cell 
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solution was mixed with the denatured ssDNA and 1 µg each of prey and bait plasmids. 
230 µl of PEG working solution was added (Table 6.12) and mixed by vortex. The mixture 
was incubated at 30 °C for 45 min followed by heat shock at 42 °C for 15 min. Yeast cells 
were plated directly on SD agar plates containing yeast synthetic drop-out medium 
supplement without Leucine and Tryptophan and incubate at 42 °C for 3 days to form 
visible colonies. 
6.2.14.3 Measuring β-Gal activity in yeast colonies 
Yeast colonies were scraped off SD agar plates and resuspended in 250 µl Working buffer 
(Table 6.12). 25 µl of chloroform and 25 µl of CPRG solution (Table 6.12) were added and 
mixed by vortex. After incubation at room temperature for 30 min, the solution was 
clarified by centrifugation at 13000 rpm for 30 sec (Bench top centrifuge). 100 µl of each 
supernatant was transferred into 96-well plates and OD550 (or OD540) measured in a 
microplate spectrophotometer. 
6.2.15 Preparation of cell lysates 
Cell samples for protein analysis were harvested by scraping into PBS and centrifugation at 
4000 rpm for 5 min at 4°C in a bench-top centrifuge. Cell pellets were resuspended in 
mRIPA (Table 6.15) supplemented with protease inhibitor cocktail (Roche) and incubated 
on ice for 20 min. Cell debris and nuclei were removed by centrifugation at 13000 rpm for 
15 min at 4°C in a bench-top centrifuge. The supernatants were collected and mixed with 
SDS-PAGE loading buffer (Table 6.10) and denatured in a boiling water bath for 5 min 
before separating by SDS-PAGE. 
6.2.16 GST pull-down assay 
293T cells were seeded into six-well plates at 6 × 105 cells per well and incubated at 37 °C 
overnight. Combinations of GST and GFP plasmids (0.5 µg each) were co-transfected by 
TransIT-LT1 (Mirus) according to the manufacture instructions. Cells were examined 
under a fluorescent microscope at 24-48 h post infection to examine GFP singles and 
harvested at 48 h post transfection by scrapping into PBS followed by centrifugation at 
5000 rpm for 5 min at 4 °C.  Cells from one well were lysed in 1 ml of ice cold lysis buffer 
(Table 6.14) supplemented with protease inhibitor cocktail (complete mini-EDTA free, 
Roche) and incubated on a rotating wheel at 4°C for 20 min. Cell lysates were clarified by 
centrifugation at 13000 rpm for 15 min at 4°C. 50 µl of the supernatant was retained to 
test protein expression levels in Western blotting. The rest of the supernatant was 
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incubated with 25 µl of bead suspension [Glutathione-Sepharose beads (GE Healthcare) 
that had been washed three times in ice cold wash buffer (Table 6.14) and resuspended in 
wash buffer (50% v/v)] on a rotating wheel at 4 °C for 3 h or longer.  Beads fractions were 
harvested by centrifugation and washed three times in ice cold wash buffer. After the final 
wash, proteins in the beads fractions were eluted by resuspending in 50-100 µl of SDS 
sample buffer and incubating in a 98 °C water bath for 5 min. Samples were separated by 
SDS-PAGE gels (10 µl per lane) and examined using anti-GFP and anti-GST antibodies by 
Western blotting. 
6.2.17 Co-immunoprecipitation 
To preparae the protein A-Sepharose for co-immunoprecipitation, 100 mg of protein A-
Sepharose was suspended in 2-3 ml of 25 mM Tris pH7.6 at 4 °C overnight. The 
supernatant was removed and the beads were resuspended in 350 µl of 25 mM Tris pH7.6.  
HeLa cells were seeded in T75 flasks and infected with HSV-1 at 5 PFU/cell in 2 ml of 
media per flask at 37 °C for 1 h. The virus inocula were removed followed by a brief wash 
in PBS. Cells were incubated in complete DMEM at 37 °C and harvested at 24 hpi by 
scrapping. Mock infected cells were used as controls. Cells lysates were prepared as 
described in 6.2.16 and 200 µl of lysate from ~1 × 106 cells were incubated with each 
antibody on rotating wheel at 4 °C for 5 h or longer followed by incubation with protein 
A-Sepharose beads at 4 °C for 3 h or longer. The beads were harvested by centrifugation 
and washed three times in ice cold wash buffer (Table 6.14). After the final wash, proteins 
in the bead fractions were eluted by resuspending in 40 µl of SDS-PAGE loading buffer 
(Table 6.10) and incubating at 98 °C 5 min. Samples were separated by SDS-PAGE gels 
and analysed in Western blotting. 
6.2.18 Protein co-localisation assay 
HeLa cells were seeded in 24-well plates on cover slips at a density of 2 × 104 cells per well 
and incubated overnight at 37 °C with 5% CO2. The cells were co-transfected with 
plasmids expressing GFP and Cherry tagged proteins (0.2 µg each for one well) using 
TransIT-LT1 (Mirus) according to the manufacturer’s instructions. At 24 h post 
transfection, the cells were washed in PBS and fixed in 3% paraformaldehyde for 10 min. 
After three washes with PBS and twice with water, the excess liquid was removed and the 
cover slips were mounted and imaged as described in section 6.2.9. 
6 Materials and methods 
185 
 
6.2.19 Nucleic acid isolation 
DNA and RNA were routinely purified according to the manufacturer’s instructions using 
the following products: 1) Wizard Plus SV Minipreps DNA Purification System (Promega) 
for DNA Mini prep. 2) Nucleobond AX Xtra Midi (Macherey-Nagel) for DNA Midi prep. 
BAC DNA mini/midi preparation was performed by phenol and chloroform extraction. 
Briefly, the bacteria were harvested from 10 ml overnight culture by centrifugation at 3000 
rpm for 10 min (Megafuge 1.0R). The pellet was resuspended in 200 µl of buffer P1 
(supplemented with RNase A), lysed in 300 µl of buffer P2 and neutralised in 300 µl of 
buffer P3 (the P1, P2 and P3 buffers are from Qiagen). Samples were gently inverted for 
mixing and incubated on ice for 10 min before clarified by centrifugation at 13000 rpm for 
10 min at 4 °C (bench-top centrifuge). The supernatant was transferred into tubes 
containing equal volume of phenol and chloroform (300 µl) and inverted gently for mixing. 
After centrifugation at 13000 rpm for 10 min, 700 µl of the top aqueous phase was 
transferred into a new tube, 800 µl of isopropanol for DNA precipitation. After incubation 
on bench for at least 5 min, the DNA was harvested by centrifugation at 13000 rpm for 10 
min and the pellet was washed in 70% ethanol. The DNA was dissolved in 40 µl of EB 
(Qiagen) after drying.  
For high molecular weight DNA preparation, Vero cells were infected in T75 flasks at 1 
PFU/cell. At 26 hpi 5 ml of lysis mixture (Table 6.13) was added to lyse cells and the 
samples were incubated overnight at 37 °C with 5% CO2. The high molecular weight 
DNA was extracted by phenol and chloroform extraction as described above. The DNA 
was precipitated by ethanol (NaCl was added with a final concentration of 0.1 M to 
facilitate the precipitation), spooled out using a glass pipette, dried at room temperature 
and dissolved in EB buffer.  
6.2.20 Generation of stable cell lines 
293T cells were seeded into six-well plates at a density of 1 × 106 cells per well and 
incubated at 37 °C incubator overnight. Cells in each well were transfected with 3 µg of 
plasmids mixture (0.5 µg plasmid expressing VSV G, 1.5 µg plasmid expressing Gag Pol 
and 1 µg plasmid pCMS28-YFP-CC2D1A or pCMS28-YFP-CC2D1B, plasmids are from J. 
Marin-Serrano at KCL, Table 6.5). The mixture of the plasmids, 150 µl of serum free 
DMEM and 12 µl of PEI (Table 6.15) was incubated for 10-15 min before adding to the 
cells. The culture medium was changed 1 day post transfection and 1 ml/well fresh 
medium was added for incubation. HaCaT cells were seeded into six-well plates at 1 × 105 
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cells per well and incubated overnight. The 293T culture supernatant was collected at 48 h 
post transfection, filtered through a sterile filter (0.2 µm) and supplemented with polybrene 
(10 µg/ml) before adding to the polybrene pre-treated (10 µg/ml, ~6 h) HaCaT cells. After 
incubation at 37 °C for one hour, 2 ml/well fresh DMEM was added and the cells were 
incubated for 24 h before the medium was changed. The cells were maintained in 200 
ng/ml puromycin for selecting positive transduced cells. Fluorescent signals are examined 
(signals could be observed in 3 days) and cell lysates were prepared for western blotting to 
confirm the overexpression of YFP tagged CC2D1A or CC2D1B proteins using anti-GFP. 
6.2.21 Chemical fixation of culture cells for TEM 
293T cells were harvested by scrapping off the culture dishes and pelleted by 
centrifugation in a bench-top centrifuge at 4000 rpm for 5 min. The cells were gently 
rinsed in TEM saline (Table 6.11, phosphate and calcium free) and resuspended in TEM 
fix (Table 6.11) for 2-4 h on ice. After fixation, the cells were rinsed five times in ice cold 
TEM wash (Table 6.11) followed by centrifugation in a bench-top centrifuge at 13000 rpm 
for 5 min and stored at 4 °C overnight. The cells were then processed and sectioned by Dr 
J. Skepper at the Multi-Imaging Centre, Department of Physiology Development and 
Neuroscience, University of Cambridge. Briefly, the cells were treated with 1% osmium 
ferricyanide at room temperature for 2 h and then rinsed five times in deionised water and 
treated with 2% uranyl acetate in 0.05M maleate buffer at pH 5.5 for 2 h at room 
temperature. They were again rinsed in deionised water and dehydrated in an ascending 
series of ethanol solutions from 70% to 100%. This was followed by treatment with 2 
changes of dry acetonitrile and infiltration with Quetol epoxy resin.  
6.2.22 siRNA treatment and HSV-1 infection 
293T and HeLa cells were seeded in antibiotic-free DMEM medium at a density of 4 × 105 
and 2 × 105 cells per well of a six-well plate, respectively. Two hours post seeding, or on 
the following day, cells were transfected with a maximum of 100 nM total siRNA in Opti-
MEM I (Gibco) using DharmaFECT 1 (Dharmacon) according to the manufacturer’s 
instructions. If a second siRNA was performed, cells were split at 48 h post the first 
transfection, followed by the second siRNA transfection at 2 h post seeding. At 24 h post 
the second siRNA transfection, the cells were split to 24-wells for infection or 6-wells for 
cell lysate preparation. Cells were infected with HSV-1 at 5-10 PFU/cell at 37 °C for 1 h. 
Acid wash was performed at room temperature for 1 min followed by three PBS washes 
and the cells were incubated in fresh media. The cell samples for lysate preparation were 
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harvested immediately after infection for Western blot analysis. Infected cell samples were 
harvested between 16 and 24 hours post infection, and cell-associated viruses were 
liberated by freeze-thawing and sonication for 20 s at 39% amplitude. Infectious titres 
were determined by plaque assay on Vero cells as described in Section 6.2.6. 
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7     Appendix 
7.1 DNA sequences 
7.1.1 HSV-1 KOS tegument gene sequences 
UL4 
ATGTCCAATCCACAGACGACCATCGCGTATAGCCTATGCCACGCCAGGGCCT
CGCTGACCAGCGCACTGCCCGACGCCGCGCAGGTGGTGCATGTTTTTGAGT
ACGGCACCCGCGCGATCATGGTACGGGGCCGGGAGCGCCAGGACCGCCTG
CCGCGCGGAGGCGTTGTTATCCAGCACACCCCCATTGGGCTGTTGGTGATT
ATCGACTGTCGCGCCGAATTTTGTGCCTACCGCTTTATAGGCCGGGACAGCA
ACCAGAAGCTCGAACGCGGGTGGGACGCCCATATGTACGCGTATCCGTTCG
ACTCCTGGGTCAGCTCCTCGCGCGGCGAAAGCGCCCGGAGCGCCACGGCCG
GCATTTTGACCGTGGTCTGGACCGCGGACACCATTTACATCACTGCAACCAT
TTACGGGTCGCCCCCAGAGGAGACGCCAGGCGCGGCACACGGGGTGGGCG
CCGCGCCTCCACCCCCGACAACCGCCTGCCCCGGGACGGCCGAGTTTCTCCA
GCCCACCGCGGACCTGCTGGTAGAGGTGCTGCGGGAGATTCAACTGAGCCC 
CACCCTGGAATACGCAGACAAACTTTTGGGGTCCTAG 
UL7 
ATGGCCGCCGCGACGGCCGACGATGAGGGGTCGGCCGCCACCATCCTCAAG
CAGGCCATCGCCGGGGACCGCAGCCTGGTCGAGGCGGCCGAGGCGATTAG
CCAGCAGACGCTGCTCCGCCTGGCATGCGAGGTGCGCCAGGTCGGCGACCG
CCAGCCGCGGTTTACCGCCACCAGCATCGCGCGCGTCGACGTCGCGCCTGG
GTGCCGGTTGCGGTTCGTTCTGGACGGGAGTCCCGAGGACGCCTATGTGAC
GTCGGAGGATTACTTTAAGCGCTGCTGCGGCCAGTCCAGTTATCGCGGCTT
CGCGGTGGCGGTCCTGACGGCCAACGAGGACCACGTGCACAGCCTGGCCGT
GCCCCCCCTCGTTCTGCTGCACCGGTTCTCCCTGTTCAACCCCAGGGACCTCC
TGGACTTTGAGCTTGCCTGTCTGCTGATGTACCTGGAGAACTGCCCCCGAAG
CCACGCCACCCCGTCGACCTTTGCCAAGGTTCTGGCGTGGCTCGGGGTCGC
GGGTCGCCGCACGTCCCCATTCGAACGCGTTCGCTGCCTTTTCCTCCGCAGT
TGCCACTGGGTCCTAAACACACTCATGTTCATGGTGCACGTAAAACCGTTCG
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ACGACGAGTTCGTCCTGCCCCACTGGTACATGGCCCGGTACCTGCTGGCCAA
CAACCCGCCCCCCGTTCTCTCGGCCCTGTTCTGTGCCACCCCGACGAGCTCCT
CATTCCGGCTGCCGGGGCCGCCCCCCCGCTCCGACTGCGTGGCCTATAACCC
CGCCGGGATCATGGGGAGCTGCTGGGCGTCGGAGGAGGTGCGCGCGCCTC
TGGTCTATTGGTGGCTTTCGGAGACCCCAAAACGACAGACGTCGTCGCTGTT 
TTATCAGTTTTGTTGA 
UL11 
ATGGGCCTCTCGTTCTCCGGGACCCGGCCCTGCTGCTGCCGAAACAACGTCC
TCATCACCGACGACGGGGAGGTCGTCTCGCTGACCGCCCACGACTTTGACGT
CGTGGATATCGAGTCCGAAGAGGAAGGTAATTTCTACGTGCCCCCGGATAT
GCGCGGGGTTACGCGGGCCCCGGGGAGACAGCGCCTGCGTTCGTCGGATC
CCCCCTCGCGCCACACTCACCGGCGAACCCCCGGAGGCGCCTGCCCCGCCAC 
CCAGTTTCCACCCCCCATGTCCGATAGCGAATAA 
UL13 
ATGGATGAGTCCCGCAGACAGCGACCTGCTGGTCATGTGGCAGCTAACCTC
AGCCCCCAAGGTGCACGCCAACAGTCCTTCAAGGATTGGCTCGCATCCTACA
TACACTCCAACCCACACGGGGCCTCCGGGCGCCCCAGCGGCCCCTCTCTCCA
GGACGCCGCCGGCTCCCGCTCCTCCCACGGGTCCCGCCACCGATCCGGCCTC
CGCGAGCGGCTTCGCGCGGGACTATCCCGATGGCGAATGAGCCGCTCGTCT
CATCGCCGCGCGTCCCCCGAGACGCCCGGTACGGCGGCCAAACTGAACCGC
CCGCCCCTGCGCAGATCCCAGGCGGCGTTAACCGCACCCCCCTCGTCCCCCT
CGCACATCCTTACCCTCACGCGCATCCGCAAGCTATGCAGCCCCGTGTTCGCC
ATCAACCCCGCCCTACACTACACGACCCTCGAGATCCCCGGGGCCCGAAGCT
TCGGGGGGTCTGGGGGATACGGCGACGTCCAACTGATTCGCGAACATAAG
CTTGCCGTTAAGACCATAAAGGAAAAGGAGTGGTTTGCCGTTGAGCTCATC
GCGACCCTGTTGGTCGGGGAGTGCGCTCTACGCGCCGGCCGCACCCACAAC
ATCCGCGGCTTCATCGCGCCCCTCGGGTTCTCGCTGCAACAACGACAGATAG
TGTTCCCCGCGTACGACATGGACCTCGGTAAGTATATCGGCCAACTGGCGTC
CCTGCGCACAACAAACCCCTCGGTCTCGACGGCCCTCCACCAGTGCTTCACG
GAGCTGGCCCGCGCCGTTGTGTTTTTAAACACCACCTGCGGGATCAGCCACC
TGGATATCAAGTGCGCCAACATCCTCGTCATGCTGCGGTCGGACGCCGTCTC
GCTCCGGCGGGCCGTCCTCGCCGACTTTAGCCTCGTCACCCTCAACTCCAACT
CCACGATCGCCCGGGGGCAGTTTTGCCTCCAGGAGCCGGACCTCAAGTCCCC
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CCGGATGTTTGGCATGCCCACCGCCCTAACCACAGCCAACTTTCACACCCTG
GTGGGTCACGGGTATAACCAGCCCCCGGAGCTGTTGGTGAAATACCTTAAC
AACGAACGGGCCGAATTTACCAACCACCGCCTGAAGCACGACGTCGGGTTA
GCGGTTGACCTGTACGCCCTTGGCCAGACGCTGCTGGAGTTGGTGGTTAGC
GTGTACGTCGCCCCGAGCCTGGGCGTACCCGTGACCCGGTTTCCCGGTTACC
AGTATTTCAACAACCAGCTGTCGCTGGACTTCGCCCTGGCCCTGCTCGCCTA
TCGCCGCGTGCTGCACCCAGCCCTGTTTGTCAACTCGGCCGAGACCAACACC
CACGGCCTGGCGTATGACGTCCCAGAGGGCATCCGGCGCCACCTCCGCAAT
CCCAAGATTCGGCGCGCGTTTACGGATCGGTGTATAAATTACCAGCACACAC
ACAAGGCGATACTGTCGTCGGTGGCGCTGCCTCCCGAGCTTAAGCCTCTCCT
GGTGCTGGTGTCCCGCCTGTGTCACACCAACCCGTGCGCGCGGCACGCGCT 
GTCGTGA 
UL14 
ATGGACCGAGATGCCGCCCACGCGGCCCTGCGCCGACGCCTGGCCGAGACG
CACCTCCGAGCCGAGATTTACAAGGACCAGACCCTGCAGCTGCACCGGGAG
GGCGTCAGCACCCAAGATCCTCGGTTTGTTGGCGCCTTTATGGCTGCAAAG
GCGGCCCACTTGGAATTGGAGGCGCGGCTAAAGTCCCGCGCGCGCTTAGAG
ATGATGCGACAGCGCGCGACCTGTGTTAAAATTCGCGTGGAGGAGCAAGCG
GCGCGTCGTGACTTTCTAACCGCACACCGACGGTACCTCGATCCGGCGCTTG
GTGAGCGCCTGGACGCCGTGGACGATCGTCTTGCGGACCAGGAGGAGCAA
CTCGAGGAAGCAGCGACCAACGCTTCTCTGTGGGAAGACGGCGACCTGGCC
GAAGGATGGATGAGTCCCGCAGACAGCGACCTGCTGGTCATGTGGCAGCTA
ACCTCAGCCCCCAAGGTGCACGCCAACAGTCCTTCAAGGATTGGCTCGCATC
CTACATACACTCCAACCCACACGGGGCCTCCGGGCGCCCCAGCGGCCCCTCT
CTCCAGGACGCCGCCGGCTCCCGCTCCTCCCACGGGTCCCGCCACCGATCCG 
GCCTCCGCGAGCGGCTTCGCGCGGGACTATCCCGATGGCGAATGA 
UL16 
ATGGCGCAGCTGGGACCCCGGCGGCCCCTGGCGCCGCCTGGTCCCCCGGG
GACCTTGCCCCGGCCGGATTCCCGGGCCGGAGCTCGCGGCACGCGCGACAG
AGTCGACGACCTGGGGACGGACGTCGACTCTATCGCGCGCATTGTCAACTC
CGTCTTTGTGTGGCGCGTCGTTCGGGCGGACGAGCGGCTCAAGATCTTTCG
GTGTCTAACGGTCCTCACCGAGCCTCTGTGTCAGGTGGCCCTTCCTAACCCA
GACCCCGGGCGCGCCCTCTTCTGCGAGATTTTTCTGTATCTGACGCGCCCCA
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AGGCGCTGCGGTTGCCCCCGAACACCTTCTTTGCCCTCTTTTTCTTTAACCGC
GAGCGCCGCTACTGCGCGATCGTCCACCTCCGGAGCGTGACGCACCCCCTG
ACCCCGCTCCTGTGCACCCTCACGTTCGCCCGCATACGGGCGGCCACCCCCC
CGGAGGAAACCCCCGACCCAACCACCGAACAGCTCGCGGAGGAGCCAGTGG
TCGGCGAGCTGGATGGCGCGTATCTGGTCCCCGCGAAGACCCCCCCGGAGC
CGGGCGCGTGTTGCGCCTTGGGCCCGGGGGCCTGGTGGCACCTCCCCAGC
GGCCAGATCTACTGCTGGGCCATGGACAGCGACCTGGGGTCGCTCTGTCCA
CCGGGAAGCAGGGCCCGCCATCTGGGATGGCTCCTGGCCAGGATCACCAAC
CACCCGGGGGGCTGCGAGTCCTGCGCCCCGCCGCCCCACATCGATTCCGCCA
ACGCACTGTGGCTCTCCTCCGTCGTAACGGAGTCCTGTCCCTGCGTCGCCCC
GTGTCTGTGGGCCAAGATGGCCCAGTGTACCCTGGCGGTCCAGGGGGATG
CTAGCCTGTGTCCGCTTCTCTTTGGCCATCCCGTGGATACGGTCACCCTGCT
GCAGGCCCCCCGCCGTCCTTGCATCACGGACCGTCTGCAAGAGGTCGTCGG
GGGACGGTGCGGCGCGGACAACATCCCCCCGACCAGCGCCGGGTGGCGCC
TGTGTGTCTTCTCTTCGTACATCAGTCGCCTATTTGCTACGAGTTGCCCCACA 
GTTGCCCGGGCCGTTGCCCGGGCCTCCTCAAGCGATCCCGAATAA 
UL21 
ATGGAGCTTAGCTACGCCACCACCATGCACTACCGGGACGTTGTGTTTTACG
TCACAACGGACCGAAACCGGGCCTACTTTGTGTGCGGGGGGTGTGTTTATT
CCGTGGGGCGGCCGTGTGCCTCGCAGCCCGGGGAGATTGCCAAGTTTGGT
CTGGTCGTTCGAGGGACAGGCCCAGACGACCGCGTGGTCGCCAACTATGTA
CGAAGCGAGCTCCGACAACGCGGCCTGCAGGACGTGCGTCCCATTGGGGA
GGACGAGGTGTTTCTGGACAGCGTGTGTCTTCTAAACCCGAACGTGAGCTC
CGAGCTGGATGTGATTAACACGAACGACGTGGAAGTGCTGGACGAATGTCT
GGCCGAGTACTGCACCTCGCTGCGAACCAGCCCGGGTGTGCTAATATCCGG
GCTGCGCGTGCGGGCGCAGGACAGAATCATCGAGTTGTTTGAACACCCAAC
GATAGTCAACGTTTCCTCGCACTTTGTGTATACCCCGTCCCCATACGTGTTCG
CCCTGGCCCAGGCGCACCTCCCCCGGCTCCCGAGCTCGCTGGAGGCCCTGGT
GAGCGGCCTGTTTGACGGCATCCCCGCCCCACGCCAGCCACTTGACGCCCAC
AACCCGCGCACGGATGTGGTTATCACGGGCCGCCGCGCCCCACGACCCATC
GCCGGGTCGGGGGCGGGGTCGGGGGGCGCGGGCGCCAAGCGGGCCACCG
TCAGCGAGTTCGTGCAAGTCAAACACATTGACCGCGTGGGCCCCGCTGGCG
TTTCGCCGGCGCCTCCGCCAAACAACACCGACTCAAGTTCCCTGGTGCCCGG
GGCCCAGGATTCCGCCCCGCCCGGCCCCACGCTAAGGGAGCTGTGGTGGGT
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GTTTTATGCCGCAGACCGGGCGCTGGAGGAGCCCCGCGCCGACTCTGGCCT
CACCCGCGAGGAGGTACGTGCCGTACGTGGGTTCCGGGAGCAGGCGTGGA
AACTGTTTGGCTCCGCGGGGGCCCCGCGGGCGTTTATCGGGGCCGCGTTG
GGCCTGAGCCCCCTCCAAAAGCTAGCCGTTTACTACTATATCATCCACCGAG
AGAGGCGCCTGTCCCCCTTCCCCGCGCTAGTCCGGCTCGTAGGCCGGTACAC
ACAGCGCCACGGCCTGTACGTCCCTCGGCCCGACGACCCAGTCTTGGCCGAT
GCCATCAACGGGCTGTTTCGCGACGCGCTGGCGGCCGGAACCACAGCCGAG
CAGCTCCTCATGTTCGACCTTCTCCCCCCAAAGGACGTGCCGGTGGGAAGCG
ACGTGCAGGCCGACAGCACCGCTCTGCTGCGCTTTATAGAATCGCAACGTCT
CGCCGTCCCCGGGGGGGTGATCTCCCCCGAGCACGTCGCGTACCTTGGTGC
GTTCCTGAGCGTGCTGTACGCTGGCCGCGGGCGCATGTCCGCAGCCACGCA
CACCGCGCGGCTGACAGGGGTGACCTCCCTGGTGCTAGCGGTGGGTGACG
TGGACCGTCTTTCCGCGTTTGACCGCGGAGCGGCGGGCGCGGCCAGCCGCA
CGCGGGCCGCCGGGTACCTGGATGTGCTTCTTACCGTTCGTCTCGCTCGCTC 
CCAACACGGACAGTCTGTGTAA 
UL23 
ATGGCTTCGTACCCCTGCCATCAACACGCGTCTGCGTTCGACCAGGCTGCGC
GTTCTCGCGGCCATAGCAACCGACGTACGGCGTTGCGCCCTCGCCGGCAGC
AAGAAGCCACGGAAGTCCGCCTGGAGCAGAAAATGCCCACGCTACTGCGGG
TTTATATAGACGGTCCTCACGGGATGGGGAAAACCACCACCACGCAACTGCT
GGTGGCCCTGGGTTCGCGCGACGATATCGTCTACGTACCCGAGCCGATGAC
TTACTGGCAGGTGCTGGGGGCTTCCGAGACAATCGCGAACATCTACACCAC
ACAACACCGCCTCGACCAGGGTGAGATATCGGCCGGGGACGCGGCGGTGG
TAATGACAAGCGCCCAGATAACAATGGGCATGCCTTATGCCGTGACCGACGC
CGTTCTGGCTCCTCATATCGGGGGGGAGGCTGGGAGCTCACATGCCCCGCC
CCCGGCCCTCACCCTCATCTTCGACCGCCATCCCATCGCCGCCCTCCTGTGCT
ACCCGGCCGCGCGATACCTTATGGGCAGCATGACCCCCCAGGCCGTGCTGG
CGTTCGTGGCCCTCATCCCGCCGACCTTGCCCGGCACAAACATCGTGTTGGG
GGCCCTTCCGGAGGACAGACACATCGACCGCCTGGCCAAACGCCAGCGCCC
CGGCGAGCGGCTTGACCTGGCTATGTTGGCCGCGATTCGCCGCGTTTACGG
GCTGCTTGCCAATACGGTGCGGTATCTGCAGGGCGGCGGGTCGTGGCGGG
AGGATTGGGGACAGCTTTCGGGGACGGCCGTACCGCCCCAGGGTGCCGAG
CCCCAGAGCAACGCGGGCCCACGACCCCATATCGGGGACACGTTATTTACCC
TGTTTCGGGCCCCCGAGTTGCTGGCCCCCAACGGCGACCTGTATAACGTGTT
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TGCCTGGGCCTTGGACGTCTTGGCCAAACGCCTCCGTCCCATGCACGTCTTT
ATCCTGGATTACGACCAATCGCCCGCCGGCTGCCGGGACGCCCTGCTGCAAC
TTACCTCCGGGATGGTCCAGACCCACGTCACCACCCCAGGCTCCATACCGAC
GATCTGCGACCTGGCGCGCACGTTTGCCCGGGAGATGGGGGAGGCTAACT 
GA 
UL36 
ATGATCGCGGGCACCCCACCGCACTCCACGATGGAACGCGGGGGGGATCGC
GACATCGTGGTCACCGGTGCTCGGAACCAGTTCGCGCCCGACCTGGAGCCG
GGGGGGTCGGTATCGTGCATGCGCTCGTCGCTGTCCTTTCTCAGCCTCATAT
TTGATGTGGGCCCTCGCGACGTTCTGTCCGCGGAGGCCATCGAGGGATGTT
TGGTCGAGGGGGGCGAGTGGACGCGCGCGACTGCGGGCCCTGGGCCGCC
GCGCATGTGTTCGATCGTCGAGCTCCCCAACTTCCTCGAGTACCCAGGGGCG
CGCGGCGGACTGCGCTGTGTCTTCTCGCGCGTATACGGCGAGGTGGGCTTC
TTCGGGGAGCCCGCGGCAGGCCTGCTGGAGACACAATGCCCCGCACACACG
TTCTTCGCCGGCCCGTGGGCCCTGCGCCCCCTGTCGTACACGCTCCTAACCA
TTGGCCCCCTAGGGATGGGGCTGTTCAGGGACGGCGACACCGCATACCTTT
TTGACCCGCATGGCCTTCCGGAGGGCACCCCCGCGTTCATCGCCAAAGTGCG
GGCGGGGGACATGTATCCATACCTGACGTATTACACCCGCGATCGCCCGGA
CGTACGGTGGGCGGGAGCCATGGTGTTTTTCGTGCCGTCGGGCCCGGAACC
CGCGGCTCCTGCGGACTTGACGGCCGCGGCTCTGCATCTTTACGGGGCCAG
CGAGACTTACATGCAGGACGAAgCGTTCAGCGAACGGCGCGTGGCCATCAC
GCACCCCCTGCGGGGCGAGATCGCGGGCCTGGGGGAGCCCTGCGTCGGCG
TGGGCCCCCGGGAGGGGGGAGGGGGGCCGGGGCCACACCCGCCCACAGC
CGCCCAGTCGCCGCCACCGACCCGGGCCCGTCGCGACGACAGGGCCTCCGA
GACATCCCGGGGGACGGCCGGTCCGTCGGCAAAACCAGAGGCCAAGCGCCC
GAATCGGGCGCCCGACGATGTATGGGCGGTGGCCCTAAAGGGTACCCCACC
CACGGATCCCCCCTCCGCCGACCCACCCTCCGCGATCCCACCACCGCCTCCCT
CCGCCCCCAAGACCCCCGCCGCAGAGGCGGCCGAAGAAGATGACGACGACA
TGCGGGTCCTGGAGATGGGCGTCGTCCCGGTTGGTCGGCACCGGGCACGC
TACTCGGCCGGCCTTCCCAAGCGCCGCCGACCCACCTGGACTCCGCCTTCCA
GCGTCGAAGACCTGACTTCGGGGGAGAAAACGAAACGCTCGGCCCCCCCTG
CCAAAACCAAGAAGAAATCCACCCCCAAAGGCAAAACCCCCGTCGGGGCCGC
GGTCCCCGCCTCCGTTCCGGAGCCTGTCCTCGCCTCGGCACCCCCCGACCCG
GCCGGGCCGCCGGTCGCCGAGGCGGGCGAGGACGACGGGCCCATGGTTCC
7 Appendix 
194 
 
GGCGTCCTCACAGGCCCTCGAGGCGCTGAAGACTCGCCGCTCACCCGAGCC
CCCGGGCGCAGACCTCGCCCAGCTGTTCGAGGCCCACCCAAACGTGGCCGC
CACGGCGGTTAAGTTCACCGCGTGCTCCGCCACCCTGGCCCGCGAGGTCGC
CGCGTGTTCGCGGCTCACCATCAGCGCCTTACGGTCGCCGTATCCGGCTTCT
CCGGGGCTGCTGGAGCTCTGTGTTATTTTTTTCTTTGAACGCGTCCTCGCCT
TTCTCATCGAGAACGGGGCCCGGACGCACACCCAGGCCGGGGTGGCCGGCC
CGGCCGCCGCCCTGCTGGAGTTTACCCTGAGCATGCTGCCCCGGAAAACGG
CCGTGGGGGACTTTCTGGCCTCCACGCGCCTGAGCCTGGCCGACGTGGCCG
CCCATCTGCCCCTCGTCCAGCACGTGCTGGACGAAAACTCTCTGATCGGTCG
CCTGGCGCTGGCGAAGCTGATCCTTGTGGCTAGGGATGTCATTCGGGAGAC
GGACGCCTTTTACGGGGAACTCGCGGACCTGGAGCTGCAGCTTCGCGCGGC
CCCGCCGGCCAATCTGTATACACGCCTCGGCGAGTGGCTTCTGGAGCGCTC
GCAGGCCCACCCGGACACCCTTTTTGCCCCCGCCACCCCGACGCACCCAGAA
CCGCTTCTGTATAGAGTCCAGGCTCTGGCCAAATTTGCCCGTGGCGAAGAG
ATTAGGGTGGAGGCGGAGGATCGCCAGATGCGCGAGGCCCTCGACGCCCT
CGCTCGCGGGGTCGACGCGGTCTCACAGCACGCCGGGCCCCTCGGCGTAAT
GCCCGCCCCGGCCGGGGCGGCCCCGCAGGGGGCTCCGCGCCCACCCCCCCT
GGGCCCCGAGGCCGTTCAGGTTCGGCTGGAGGAGGTGCGGACCCAGGCCC
GTCGGGCGATCGAGGGCGCGGTTAAGGAGTACTTTTACCGGGGGGCCGTA
TACAGCGCCAAGGCTCTACAGGCCAGCGACAACAACGACCGCCGGTTTCAC
GTGGCTTCGGCCGCCGTCGTGCCCGTGGTCCAGCTGCTCGAGTCCCTGCCT
GTCTTCGACCAGCACACGCGGGACATCGCGCAGCGCGCCGCCATTCCCGCCC
CGCCCCCGATCGCGACCAGCCCCACGGCCATCCTGTTGCGGGATCTGATCCA
GCGGGGCCAGACGCTGGACGCCCCCGAGGACCTGGCGGCCTGGCTCTCCGT
CCTGACGGACGCCGCCAACCAAGGGCTGATAGAACGCAAGCCGCTGGACGA
GCTGGCGCGCAGCATCCGCGACATTAACGACCAGCAGGCGCGCCGCAGCTC
GGGTCTGGCCGAGCTGCGGCGCTTCGACGCCCTAGATGCGGCCCTGGGCCA
GCAGCTGGACAGCGACGCGGCCTTTGTTCCTGCGCCCGGCGCGTCGCCCTA
CCCCGACGACGGCGGGCTGTCGCCAGAGGCCACGCGCATGGCCGAGGAAG
CGCTGCGGCAGGCGCGGGCCATGGATGCCGCCAAGCTGACGGCAGAGCTC
GCCCCCGATGCGCGTGCCCGTTTGCGGGAGCGCGCGCGCTCCCTGGAGGCA
ATGCTCGAGGGAGCGCGGGAGCGGGCGAAGGTGGCCCGCGACGCCCGGG
AGAAGTTCTTGCACAAACTCCAGGGGGTCCTGCGCCCCCTCCCTGACTTTGT
GGGGCTAAAGGCCTGTCCGGCCGTCCTGGCGACCCTGCGGGCCTCCCTGCC
7 Appendix 
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GGCGGGCTGGTCGGACCTCCCCGAGGCCGTTCGGGGGGCGCCCCCTGAGG
TTACGGCGGCGCTGCGGGCGGACATGTGGGGGCTGCTGGGGCAGTACCGA
GATGCCCTGGAGCACCCGACTCCGGACACGGCGACGGCTCTGTCTGGCTTG
CATCCCAGCTTCGTGGTGGTGCTGAAGAACCTGTTCGCCGACGCCCCAGAG
ACTCCGTTTCTCTTGCAGTTCTTCGCCGATCACGCCCCGATCATAGCCCACGC
CGTCTCGAACGCCATCAACGCCGGCAGCGCCGCCGTCGCGACGGCAGACCC
CGCGTCGACGGTGGATGCGGCCGTGCGGGCGCACCGCGTCCTGGTCGACG
CGGTGACGGCCCTGGGCGCGGCCGCCAGCGACCCGGCCTCCCCCCTGGCCT
TCCTAGCGGCCATGGCCGACAGCGCCGCGGGATACGTCAAGGCGACTCGGT
TGGCCCTGGACGCGCGGGGGGCCATCGCCCAGCTCACGACCTTAGGGTCGG
CGGCAGCCGACCTTGTCGTCCAGGTGCGCCGGGCCGCCAACCAACCGGAGG
GAGAGCATGCCTCCCTGATCCAGGCCGCGACGCGCGCGACCACCGGCGCGC
GGGAAAGCCTCGCGGGCCACGAGGGCAGGTTCGGGGGCCTGTTGCACGCC
GAAGGGACGGCCGGGGACCACTCCCCCAGCGGGCGCGCCCTGCAGGAGCT
GGGAAAGGTCATCGGCGCCACGCGACGCCGCGCCGACGAACTTGAGGCCG
CCATCGCCGACCTGAGAGAGAAGATGGCGGCCCAGCGCGCCCGCAGTAGCC
ATGAGCGCTGGGCCGCCGACGTGGAGGCCGTGCTGGACCGCGTGGAAAGC
GGTGCCGAGTTTGACGTGGTCGAGCTCCGTCGCCTGCAGGCGCTGGCGGG
CACGCACGGCTACAACCCCCGGGACTTCCGAAAGCGGGCCGAACAGGCGCT
GGGAACCAACGCCAAGGCGGTGACCCTTGCCCTGGAGACGGCCCTTGCGTT
TAACCCATACACCCCCGAGAACCAGCGCCACCCCATGCTCCCCCCGCTCGCAG
CCATTCACCGCATCGACTGGAGCGCGGCCTTCGGGGCCGCGGCCGACACGT
ACGCCGACATGTTTCGGGTGGACACCGAGCCCCTGGCGCGGCTTCTGCGGC
TGGCGGGGGGGCTGCTGGAGCGGGCCCAGGCGAACGACGGGTTTATCGAC
TACCACGAGGCCGTCCTACACCTGTCGGAAGACTTGGGGGGCGTGCCGGCC
CTGCGCCAGTACGTGCCGTTTTTTCAAAAGGGCTACGCCGAGTACGTGGAT
ATCCGCGATCGCCTGGACGCCCTCCGGGCCGACGCGCGGCGCGCGATCGGA
AGCGTGGCGCTGGACCTGGCCGCCGCCGCGGAGGAGATATCCGCGGTGCG
CAACGACCCGGCGGCGGCCGCCGAGCTTGTCCGGGCAGGGGTCACCCTGCC
CTGCCCGAGCGAGGACGCGCTGGTGGCGTGCGTGGCGGCGCTGGAGCGCG
TGGACCAGAGCCCCGTGAAGGACACGGCGTACGCCGACTACGTCGCATTCG
TGACCCGACAGGACCTGGCCGATACCAAGGACGCCGTGGTGCGCGCCAAAC
AGCAGCGCGCCGAAGCCACCGAGCGGGTCACGGCGGGGCTGCGGGAGGT
GCTGGCCGCGCGCGAGCGCCGGGCCCAGCTCGAGGCCGAGGGTCTGGCCA
7 Appendix 
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ATCTGAAGACCCTGCTGAAGGTGGTCGCCGTCCCGGCGACCGTGGCCAAGA
CGCTGGACCAGGCGCGCTCGGCGGAGGAGATCGCGGATCAGGTCGAAATT
CTGTTGGACCAGACGGAGAAGGCGCGCGAGCTCGACGTGCAGGCGGTCGC
CTGGTTGGAACATGCCCAGCGTACCTTTGAGACGCACCCGCTAAACGCGGCC
AGCGGCGACGGCCCGGGCCTCCTGACGCGACAGGGCGCGCGCCTGCAGGC
GCTCTTCGACACCCGTCGCCGCGTCGAGGCCCTGCGGAGGTCTCTCGAGGA
GGCCGAGGCGGAGTGGGACGAGGTATGGGGTCGCTTCGGCCGCGTTCGCG
GGGGGGCCTGGAAATCGCCCGAGGGATTTCGCGCGGCATGCGAGCAGCTT
CGCGCCCTGCAGGACACCACCAACACTGTGTCGGGGCTGCGAGCCCAGCGG
GACTACGAGCGCCTTCCCGCCAAGTACCAGGGCGTCCTGGGCGCCAAGAGC
GCCGAGCGGGCCGGGGCCGTGGAGGAGCTCGGGGGGCGCGTGGCCCAAC
ACGCCGACCTGAGCGCCCGGCTGCGGGACGAGGTGGTGCCAAGGGTGGCC
TGGGAGATGAACTTTGACACCCTGGGGGGCCTGTTGGCGGAATTCGACGC
GGTGGCCGGGGACCTGGCCCCATGGGCGGTGGAGGAGTTCCGGGGCGCG
CGGGAGCTCATCCAACGCCGCATGGGCTTATATAGCGCGTACGCCAAGGCC
ACAGGCCAGACGGGCGCGGGCGCGGCGGCCGCGCCCGCGCCCCTGCTCGT
GGATCTTCGCGCCCTAGACGCCCGCGCCCGGGCGTCCGCCCCACCCGGCCAA
GAGGCCGACCCGCAGATGCTGCGCCGCCGGGGCGAGGCGTACCTGCGAGT
GAGCGGAGGCCCGGGGCCCCTGGTGCTGCGCGAGGCCACCAGTACGCTGG
ATCGGCCGTTCGCCCCCAGCTTTTTGGTCCCGGATGGAACGCCACTGCAGTA
CGCGCTCTGCTTCCCGGCCGTGACCGACAAGCTCGGCGCGCTGCTGATGTG
TCCCGAGGCGGCATGCATTCGCCCCCCGCTTCCGACGGACACCCTGGAGTCG
GCCTCGACCGTCACGGCCATGTACGTCATCACCGTCATCAACCGGCTTCAGC
TGGCCCTCAGCGACGCCCAGGCCGCCAACTTTCAGCTCTTCGGACGCTTTGT
GCGCCACCGCCAGGCGAGATGGGGGGCCTCGATGGATGCGGCGGCCGAGC
TCTACGTCGCCCTCGTCGCGACCACTCTCACGCGCGAGTTTGGGTGTCGCTG
GGCCCAGCTGGAATGGGGGGGTGACGCGGCGGCCCCGGGACCGCCGCTCG
GGCCCCACAGCTCCACTAGGCACCGCGTTTCCTTTAACGAGAACGACGTGCT
GGTGGCGCTGGTGGCCAGCTCCCCGGAACACATTTACACCTTTTGGCGCCT
GGATCTGGTCCGCCAACACGAGTACATGCATCTCACCCTCCCCCGTGCGTTT
CAGAACGCAGCAGATTCCATGCTATTCGTGCAGCGCCTGACCCCGCATCCAG
ACGCCCGCATCCGCGTGCTGCCAGTGTTTTCGACCGGAGGCCCTCCGACCCG
GGGCCTCATGTTCGGCACGCGGCTGGCAGACTGGCGCCGCGGCAAGTTGTC
CGAAACCGACCCCCTGGCGCCCTGGCGCTCGGTCCCCGAGCTGGGAACCGA
7 Appendix 
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GCGCGGCGCCGCGCTGGGAAAGCTGAGTCCCGCCCAGGCGCTGGCGGCGG
TGAGCGTCCTCGGGCGCATGTGTCTCCCAAGCACCGCTCTGGCCGCTCTTTG
GACCTGCATGTTTCCGGACGACTACACAGAGTATGACAGTTTCGACGCCCTT
CTGACCGCGCGTCTGGAATCTGGGCAGACGCTGAGCCCCTCGGGGGGGCG
CGAGGCGTCACCCCCCGCTCCCCCCAACGCCCTCTACCGGCCCACGGGCCAG
CACGTCGCCGTGCCGGCCGCCGCCACCCACCGCACCCCCGCGGCGCGCGTTA
CGGCCATGGACCTGGTGCTGGCGGCAGTGCTCCTGGGCGCGCCCGTCGTCG
TGGCGCTCCGCAACACCACGGCCTTTTCCCGCGAGTCGGAGCTGGAGCTGT
GTCTCACGCTGTTTGACTCACGCGCTCGCGGGCCGGACGCCGCCTTGCGCG
ATGCCGTGTCGTCCGACATCGAGACGTGGGCCGTCCGCCTCCTGCACGCCG
ACCTGAACCCGATTGAAAACGCGTGTCTGGCGGCACAGCTCCCGCGCCTGTC
CGCGCTCATCGCCGAGCGGCCCCTCGCCCGGGGCCCGCCGTGTCTGGTGCT
CGTGGACATCTCCATGACCCCGGTCGCGGTGTTGTGGGAAAACCCGGACCC
CCCCGGCCCCCCCGACGTGCGGTTTGTTGGCAGCGAGGCCACCGAGGAGCT
CCCGTTTGTGGCGGGCGGCGAGGACGTCCTCGCCGCCAGCGCCACCGACGA
GGACCCCTTCCTCGCGCGAGCTATCCTCGGGCGGCCGTTCGACGCCTCCCTC
CTGTCGGGGGAGCTATTCCCGGGGCATCCGGTGTACCAGCGCGCCCCCGAC
GACCAGAGCCCCTCGGTCCCGAACCCGACCCCCGGCCCGGCGGACCTTGTTG
GGACGGAGGGCTCGTTGGGGCCCGGAAGCCTGGCCCCCACGCTATTCACCG
ACGCCACCCCCGGCGAGCCCGTCCCCCCTCGCATGTGGGCATGGATTCACGG
CCTGGAGGAGCTCGCGTCTGACGACTCCGGCGGCCCCGCGCCCCTCCTTGCC
CCGGACCCCCTTTCGCCCACCGCCGATCAGTCCGTCCCCACGTCCCAGTGTGC
ACCGCGGCCCCCTGGGCCGGCAGTCACGGCTCGCGAAGCACGACCGGGCGT
CCCGGCCGAAAGCACGCGGCCGGCGCCCGTGGGCCCCCGCGACGACTTCCG
GCGCTTGCCGTCCCCCCAAAGTTCCCCGGCGCCCCCCGATGCCACCGCCCCC
CGCCCCCCCGCCTCCTCCCGCGCTTCTGCCGCTTCTTCGTCCGGGTCGCGCGC
GCGCCGACACCGCCGGGCACGCTCCCTGGCGCGCGCCACCCAGGCTTCCGC
GACCACCCAGGGTTGGCGGCCGCCTGCCCTCCCCGACACGGTCGCCCCGGT
TACCGATTTCGCGCGCCCCCCGGCCCCTCCCAAACCCCCAGAGCCAGCGCTCC
ACGCTTTGGTGTCTGGTGTGCCCCTCCCGCTCGGTCCCCAGTTCGCCGGCCA
GGCTTCTCCCGCTCTCCCTATCGATCCCGTTCCGCCCCCGGTCGCAACCGGCA
CGGTTTTGCCCGGGGGCGAAAACCGCCGCCCCCCGCTAACCTCGGGTCCCG
CGCCAACCCCCCCCAGGGTTCCCGTAGGCGGGCCGCAGCGGCGCCTTACGC
GCCCCGCTGTCGCGTCGCTGTCCGAATCGCGGGAATCCCTCCCTTCACCCTG
7 Appendix 
198 
 
GGACCCCGCCGACCCCACGGCCCCTGTTTTAGGCCGCAACCCGGCCGAGCC
GACCTCATCCTCTCCCGCAGGTCCCTCTCCCCCGCCTCCCGCGGTCCAACCCG
TCACCCCGCCCCCGACGTCAGGCCCGCCCCCCACATACTTGACGCTGGAGGG
CGGTGTTACGCCCGGAGGCCCGGTTTCCCGCCGCCCCACTACACGGCAGCC
GGTGGCCACGCCCACCACATCTGCGCGCCCCCGGGGGCATTTGACCGTCAA
CCGCCTGTCCGCGCCCCAGCCCCAACCCCAGCCCCAACCCCAGCCCCAACCCC
AGCCCCAACCCCAGCCCCAACCCCAGCCCCAACCCCAGCCCCAACCCCAGCCC
CAACCCCAGCCCCAACCCCAGCCCCAACCCCAGCCCCAACCCCAGCCCCAACC
CCAGCCCCAACCCCAACCCCAGCCCCAACCCCAACCCCAGCCCCAACCCCAAC
CCCAGCCCCAACCCCAACCCCAACCCCAACCCCAGCCCCAGCCCCAACCCCAG
CCCCAACCCCAGCCCCAACCCCAGCCCCAACCCCAGCCCCAGCCCCAGCCCCA
GCCCCAACCCCAGCCCCAACCCCAACCCCAGCCCCAGCCCCAGCCCCAACCCC
AGCCCCAGCCCCAGCCCCAGCCCCAACCCCAGCCCCAACCCCAACCCCAGCCC
CAACCCCAACCCCAGCCCCAACCCCAGCCCCAGCCCCAGCCCCAACCCCAACC
CCAGCCCCAACCCCAACCCCAACCCCAGCCCCAGCCCCAACCCCAGCCCCAAC
CCCAGCCCCAGCCCCAACCCCAGCCCCAGCCCCAGCCCCAGCCCCAGCCCCAA
CCCCAGCCCCAAAACGGGCATGTAGCACCCGGGGAGTATCCGGCGGTTCGG
TTCCGGGCACCGCAAAACCGCCCATCCGTCCCGGCTTCCGCGTCGTCCACAA
ATCCACGCACGGGCAGCTCCTTGTCTGGGGTGTCTTCGTGGGCATCCTCCCT
CGCGCTACACATTGACGCTACCCCCCCGCCCGTGTCGCTGCTTCAGACCCTGT
ATGTCTCTGACGACGAAGACTCCGACACCACCTCGTTGTTCCTCTCGGATTCC
GAGGCCGAGGCGCTCGACCCACTCCCTCGGGAACCACACTCCCCCATAACCA
ACGAACCATTCAGTGCGTTATCCGCCGATGACTCCCAAGAGGTGACGCGCTT
ACAATTCGGCCCCCCGCCCGTATCGGCAAACGCAGTTCTGTCGCGACGCTAC
GTGCAACGCACCGGTCGTAGCGCCCTGGCGGTGCTGATCCGCGCCTGTTAC
CGCCTACAACAGCAGTTACAGCGGACCCGCCGGGCGCTGCTTCATCACAGC 
GACGCCGTGCTGACCAGCCTACATCACGTGCGCATGTTACTGGGCTAG 
UL37 
ATGGCAGACCGCGGTCTCCCGTCCGAGGCCCCCGTCGTCACGACCTCACCCG
CCGGTCCGCCCTCGGACGGACCTATGCAGCGCCTATTGGCGAGCCTAGCCG
GCCTTCGCCAACCGCCAACCCCCACGGCCGAGACGGCAAACGGGGCGGACG
ACCCGGCGTTTCTGGCCACGGCCAAGCTGCGCGCCGCCATGGCGGCGTTTC
TGTTGTCGGGAACGGCCATCGCCCCGGCAGACGCGCGGGCATGCTGGCGG
CCGCTGCTGGAACACCTGTGCGCGCTCCACCGGGCCCACGGGCTTCCGGAG
7 Appendix 
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ACGGCGCTCTTGGCCGAGAACCTCCCCGGGTTGCTCGTACACCGCTTGGTG
GTGGCTCTCCCCGAGGCCCCCGACCAGGCCTTCCGGGAGATGGAGGTCATC
AAGGACACCATCCTCGCGGTCACCGGCTCCGACACGTCCCATGCGCTGGAGT
CCGCCGGCCTGCGCACCGCGGCGGCCCTGGGGCCGGTCCGCGTCCGCCAGT
GCGCCGTGGAGTGGATAGACCGCTGGCAAACCGTCACCAAGAGCTGCTTGG
CCATGAGCCCGCGGACCTCCATCGAGGCCCTTGGGGAGACGTCGCTCAAGC
TGGCGCCGGTCCCGTTGGGGCAGCCCAGCGCGAACCTTACCACCCCGGCGT
ACAGCCTGCTCTTCCCCGCCCCGTTCGTGCAAGAGGGCCTCCGGTTCTTGGC
CCTGGTGAGTAATCGGGTGACGCTGTTCTCGGCGCACCTCCAGCGCATAGA
CGACGCGACCCTCACTCCCCTCACACGGGCCCTCTTTACGTTGGCCCTGGTG
GACGAGTACCTGACGACCCCCGAGCGGGGGGCTGTGGTCCCGCCGCCCCTG
TTGGCGCAGTTTCAGCACACCGTGCGGGAGATCGACCCGGCCATAATGATT
CCGCCACTGGAGGCCAACAAGATGGTTCGCAGCCGCGAGGAGGTGCGCGT
GTCGACGGCCCTCAGCCGCGTCAGCCCGCGCTCGGCCTGTGCGCCCCCGGG
GACGCTAATGGCGCGCGTGCGGACGGACGTGGCCGTGTTTGATCCCGACGT
GCCGTTCCTGAGTTCGTCGGCACTGGCAGTCTTCCAGCCTGCCGTCTCCAGC
CTGCTGCAGCTCGGGGAGCAGCCCTCCGCCGGCGCCCAGCAGCGGCTGCTG
GCTCTGCTGCAGCAGACGTGGACGTTGATCCAGAATACCAATTCGCCCTCCG
TGGTGATCAACACCCTGATCGACGCTGGGTTCACGCCCTCGCACTGCACGCA
CTACCTTTCGGCCCTGGAGGGGTTTCTGGCGGCGGGCGTCCCCGCGCGGAC
GCCCGCCGGCCACGGACTCGGCGAAGTCCAGCAGCTCTTTGGGTGCATTGC
CCTCGCGGGGTCGAACGTGTTTGGTCTGGCGCGGGAATACGGGTACTATGC
CAACTACGTAAAAACTTTCAGGCGGGTCCAGGGCGCCAGCGAGCACACGCA
CGGGCGGCTCTGTGAGGCGGTCGGCCTGTCGGGGGGCGTTCTGAGCCAGA
CGCTGGCGCGTATCATGGGGCCGGCCGTGCCGACGGAACATCTGGCGAGC
CTGCGGCGGGCGCTCGTGGGGGAGTTTGAGACGGCCGAGCGCCGCTTTAG
TTCCGGTCAACCCAGCCTTCTCCGCGAGACGGCGCTCATCTGGATCGACGTG
TATGGTCAGACCCACTGGGACATCACCCCCACCACCCCGGCCACGCCGCTGT
CCGCGCTTCTCCCCGTCGGGCAGCCCAGCCATGCCCCCTCTGTCCACCTGGC
CGCGGCGACCCAGATCCGCTTCCCCGCCCTCGAGGGCATTCACCCCAACGTC
CTCGCCGACCCGGGCTTCGTCCCCTACGTTCTGGCCCTGGTGGTTGGGGAC
GCGCTGAGGGCCACGTGTAGCGCGGCCTACCTTCCCCGCCCGGTCGAGTTC
GCCCTGCGTGTGTTGGCCTGGGCCCGGGACTTTGGGCTGGGCTATCTCCCC
ACGGTCGAGGGCCATCGCACCAAACTGGGCGCGCTGATCACTCTCCTCGAAC
7 Appendix 
200 
 
CGGCCGCCCGGGGCGGCCTCGGCCCCACTATGCAGATGGCCGACAACATAG
AGCAGCTGCTCCGGGAGCTGTACGTGATCTCCAGGGGTGCCGTCGAGCAGC
TGCGGCCCCTGGTCCAACTGCAGCCCCCCCCGCCCCCCGAGGTGGGCACCAG
CCTCCTGTTGATTAGCATGTACGCCCTGGCTGCCCGGGGGGTGCTGCAGGA
CCTCGCCGAGCGCGCCGACCCCCTGATTCGCCAACTGGAGGACGCCATCGT
GCTGCTGCGGCTGCACATGCGCACGCTCTCCGCCTTTTTCGAGTGTCGGTTC
GAGAGCGACGGGCGCCGCCTGTATGCGGTGGTCGGGGACACGCCCGACCG
CCTGGGGCCCTGGCCCCCCGAGGCCATGGGGGACGCGGTGAGTCAGTACT
GCAGCATGTATCACGACGCCAAGCGCGCGCTGGTCGCGTCCCTCGCGAGCC
TGCGTTCCGTCATCACCGAAACCACGGCGCACCTGGGGGTGTGCGACGAGC
TGGCGGCCCAGGTGTCGCACGAGGACAACGTGCTGGCCGTGGTCCGGCGC
GAAATTCACGGGTTTCTGTCCGTCGTGTCCGGCATTCACGCCCGGGCGTCGA
AGCTGCTGTCGGGAGACCAGGTCCCCGGGTTTTGTTTCATGGGTCAGTTTCT
AGCGCGCTGGCGGCGTCTGTCGGCCTGCTATCAAGCCGCGCGCGCGGCCGC
GGGACCCGAGCCCGTGGCCGAGTTTGTCCAGGAACTCCACGACACGTGGAA
GGGCCTGCAGACGGAGCGCGCCGTGGTCGTGGCGCCCTTGGTCAGCTCGG
CCGACCAGCGCGCCGCGGCCATCCGAGAGGTAATGGCGCATGCGCCCGAG
GACGCCCCCCCGCAAAGCCCCGCGGCCGACCGCGTCGTGCTTACGAGCCGT
CGCGACCTAGGGGCCTGGGGGGACTACAGCCTCGGCCCCCTGGGCCAGAC
GACCGCGGTTCCGGACTCCGTGGATCTGTCTCGCCAGGGGTTGGCCGTTAC
GCTGAGTATGGATTGGTTACTGATGAACGAGCTCCTGCGGGTCACCGACGG
CGTGTTTCGCGCTTCCGCGTTTCGTCCGTTAGCCGGACCGGAGGCTCCCAGG
GACCTGGAGGTCCGCGACGCCGGAAACAGTCTCCCCGCGCCTACGCCCATG
GACGCACAGAAGCCGGAGGCCTATGGGCACGGCCCACGCCAGGTGGACCG
CGAGGAGGCGCCTCATTCCAACACCCCCGTCGAGGACGACGAGATGATCCC 
GGAGGACACCGTCGCGCCACCCACGGACTTGCCGTTAACTAGTTACCAATAA 
UL41 
ATGGGTTTGTTCGGGATGATGAAGTTTGCCCACACACACCATCTGGTCAAGC
GCCAGGGCCTTGGGGCCCCGGCCGGGTACTTCACCCCCATCGCCGTGGACC
TGTGGAACGTCATGTACACGTTGGTGGTCAAATATCAGCGCCGATACCCCAG
TTACGACCGCGAGGCCATTACGCTACACTGCCTCTGTCGCTTATTAAAGGTG
TTTACCCAAAAGTCCCTTTTCCCCATCTTCGTTACCGATCGCGGGGTCAATTG
TATGGAGCCGGTTGTGTTTGGAGCCAAGGCCATCCTGGCCCGCACGACGGC
CCAATGCCGGACGGACGAGGAGGCCAGTGACGTGGACGCCTCTCCACCGCC
7 Appendix 
201 
 
TTCCCCCATCACCGACTCCAGACCCAGCTCTGCCTTTTCCAACATGCGCCGGC
GCGGCACCTCTCTGGCCTCGGGGACCCGGGGGACGGCCGGGTCCGGAGCC
GCGCTGCCGTCCGCCGCGCCCTCGAAGCCGGCCCTGCGTCTGGCGCATCTG
TTCTGTATTCGCGTTCTCCGGGCCCTGGGGTACGCCTACATTAACTCGGGTC
AGCTGGAGGCGGACGATGCCTGCGCCAACCTCTATCACACCAACACGGTCG
CGTACGTGTACACCACAGACACTGACCTCCTGTTGATGGGCTGTGATATTGT
GTTGGATATTAGCGCCTGCTACATTCCCACGATCAACTGTCGCGATATACTA
AAGTACTTTAAGATGAGCTACCCCCAGTTCCTGGCCCTCTTTGTCCGCTGCCA
CACCGACCTCCATCCCAATAACACCTACGCCTCCGTGGAGGATGTGCTGCGC
GAATGTCACTGGACCCCCCCGAGTCGCTCTCAGACCCGGCGGGCCATCCGCC
GGGAACACACCAGCTCGCGCTCCACGGAAACCAGGCCCCCTTTGCCGCCGG
CCGCCGGCGGCACCGAGATGCGCGTCTCGTGGACCGAAATTCTAACCCAAC
AGATCGCCGGCGGATACGAAGACGACGAGGACCTCCCCCTGGATCCCCGGG
ACGTTACCGGGGGCCACCCCGGCCCCAGGTCGTCCTCCTCGGAGATACTCAC
CCCGCCCGAGCTCGTCCAGGTCCCGAACGCGCAGCTGCTGGAAGAGCACCG
CAGTTATGTGGCCAGCCGGCGACGCCACGTCATCCACGACGCCCCAGAGTCC
CTGGACTGGCTCCCCGATCCCATGACCATCACCGAGCTGGTGGAACACCGCT
ACATTAAGTACGTCATATCGCTTATCGGCCCCAAGGAGCGGGGGCCGTGGA
CTCTTCTGAAACGCCTGCCTATCTACCAGGACATCCGCGACGAAAACCTGGC
GCGATCTATTGTGACCCGGCATATCACGGCCCCTGATATCGCCGACAGGTTT
CTGGAGCAGCTGCGGACCCAGGCCCCCCCACCCGCGTTCTACAAGGACGTCC 
TGGCCAAATTCTGGGACGAGTAG 
UL46 
ATGCAGCGCCGGACGCGCGGCGCGAGCTCCCTGCGGCTGGCGCGGTGCCT
GACGCCTGCCAACCTGATCCGCGGCGACAACGCGGGCGTTCCCGAGCGGCG
CATCTTCGGCGGGTGTCTGCTCCCCACCCCGGAGGGGCTCCTTAGCGCGGC
CGTGGGCGCCTTGCGGCAGCGCTCCGACGACGCGCAGCCGGCGTTTCTGAC
CTGCACCGATCGCAGCGTCCGGTTGGCCGCGCGGCAACACAACACGGTTCC
CGAGAGTTTGATCGTGGACGGGCTCGCCAGCGACCCGCACTACGAGTACAT
CCGGCACTACGCTTCGGCCGCCACCCAGGCGCTGGGCGAGGTGGAGCTGCC
CGGCGGCCAGTTGAGCCGCGCCATCCTCACGCAGTACTGGAAGTACCTGCA
GACGGTGGTGCCCAGCGGCCTGGACGTCCCCGAGGACCCCGTGGGCGACT
GCGACCCCAGCCTTCACGTGCTGCTGCGGCCCACCCTGGCGCCAAAGCTGCT
GGCGCGCACCCCGTTCAAGAGCGGGGCCGCGGCGGCCAAGTACGCCGCCA
7 Appendix 
202 
 
CCGTGGCCGGCCTGCGCGACGCCCTCCATCGGATTCAGCAGTACATGTTCTT
TATGCGCCCGGCGGACCCAAGCCGCCCCAGCACCGACACCGCACTGCGGCTC
AACGAGCTCCTGGCCTACGTCTCCGTGCTGTACCGGTGGGCGTCCTGGATG
CTGTGGACGACGGACAAGCACGTATGTCACCGGCTGAGTCCCTCCAATCGCC
GGTTCCTCCCGCTCGGCGGCAGCCCGGAGGCGCCCGCGGAAACGTTCGCGC
GCCATCTGGACCGGGGTCCCAGCGGCACGACCGGCTCCATGCAGTGCATGG
CGCTCAGGGCGGCGGTCAGCGACGTCCTGGGCCACCTGACGTGCCTAGCCA
ACCTGTGGCAGACCGGCAAGCGGAGCGGCGGTACGTACGGGACCGTGGAT
ACCGTGGTATCCACGGTGGAGGTTCTGTCGATCGTCCATCACCACGCCCAGT
ATATCATCAACGCGACCCTCACCGGGTACGGCGTCTGGGCCACCGACAGCCT
GAACAACGAGTATCTGCGGGCCGCGGTGGACAGCCAGGAGCGTTTCTGTCG
GACCACCGCCCCCCTGTTCCCCACGATGACCGCCCCCAGCTGGGCCCGGATG
GAGTTGAGCATCAAGGCTTGGTTCGGGGCCGCCCTGGCCGCGGATCTGCTC
CGCAGCGGGGCGCCGTCGCTCCACTACGAGTCCATCCTGCGGCTCGTGGCG
TCTCGCCGGACGACGTGGTCCGCGGGGCCTCCCCCGGACGACATGGCCCGC
GGCCCGGGGGGGCATCGCGCGGGGGGTGGGACCTGTCGGGAAAAGATTC
AGCGGGCGCGGCGCGACAACGAGCCCCCGCCCCTCCCCCGACCTCGCCTACA
CTCGACCCCCGCGCCGTCCACCCGGCGGTTCCGGAGGCGCCGTGCGGACGG
CGCGGGGCCCCCGCTTCCGGATGCGGACGACCCGGTCGCCGAGCCCCCCGC
TGCGGCCGCACAGCCGGCCACGTATTACACGCACATGGGGGAGGTGCCCCC
GCGCCTCCCGGCCCGTAACGTCGCGGGACCCGACAGGCGACCGCCGGCGGC
GACGTGCCCCCTTCTTGTCCGGCGCGCGTCTCTGGGGAGCCTCGATCGGCC
ACGGGTGTGGGGACCCGCCCCGGAGGGAGAACCCGACCAGATGGAAGCCA
CGTATCTGACGGCCGACGACGACGACGACGACGCCCGCCGCAAAGCCACCC
ACGCCGCCTCGGCCCGCGAACGGCACGCCCCCTACGAGGACGACGAGTCAA
TATACGAGACCGTGAGCGAGGACGGGGGGCGTGTCTACGAGGAAATACCA
TGGATGCGGGTCTACGAAAACGTCTGCGTGAACACGGCGAATGCAGCGCCG
GCCTCCCCGTACATTGAGGCGGAAAATCCCCTGTACGACTGGGGGGGATCC
GCCCTATTTTCCCCCCCGGGCCGCACCGGACCCCCGCCCCCGCCGTTGAGCC
CCTCGCCCGTCCTCGCCCGCCATCGAGCCAACGCCCTGACCAACGACGGCCC
GACCAACGTCGCCGCCCTGAGCGCCCTCCTGACCAAGCTTAAACGCGAAGGA 
CGCCGGAGCCGGTGA 
UL47 
7 Appendix 
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ATGTCGGCTCGCGAACCCGCGGGGCGCAGGAGGCGCGCATCCACCCGCCCC
CGCGCCTCGCCCGTGGCGGACGAGCCAGCGGGCGATGGGGTGGGGTTCAT
GGGGTACCTGCGTGCGGTGTTCCGCGGGGATGACGACAGCGAGCTAGAGG
CTCTGGAGGAGATGGCGGGCGACGAGCCGCCCGTGCGCCGTCGACGGGAA
GGCCCGCGAGCCCGACGACGGCGCGCGTCGGAAGCCCCGCCCTCATCCCAT
CGCCGAGCGTCCCGGCAGCGCCCCGGGCCCGATGCGGCCCGTAGCCAGTCG
GTGCGCGGTCGCCTGGACGATGATGATGAGGTTCCCCGCGGTCCTCCGCAG
GCCCGGCAGGGGGGATACCTGGGTCCCGTCGACGCGCGGGCTATTTTGGG
GCGGGTCGGCGGTTCGCGGGTGGCGCCGTCGCCGCTGTTCCTAGAGGAAC
TGCAGTACGAGGAGGACGACTACCCGGAAGACGTCGGGCCGGAGGACGGC
GGCGGGGCCCGTTCCCCGCCCAAGGTGGAGGTTCTGGAGGGACGCGTGCC
GGGCCCGGAGCTCCGGGCGGCATTCCCGTTGGATCGACTGGCCCCTCAGGT
TGCCGTGTGGGACGAGTCCGTGCGCTCCGCCCTAGCCCTGGGGCATCCGGC
CGGGTTTTACCCGTGTCCGGATAGCGCGTTCGGGTTATCGCGCGTGGGGGT
CATGCACTTCGCCTCCCCCGACAACCCCGCGGTGTTTTTCCGCCAAACCCTGC
AGCAGGGCGAGGCGTTGGCCTGGTATATCACGGGCGATGGGATTCTTGAC
CTGACGGATCGTCGAACAAAAACCAGCCCCGCCCAGGCGATGAGCTTTTTG
GCGGATGCCGTCGTGCGGCTGGCCATCAACGGGTGGGTGTGCGGGACGCG
CCTTCACGCAGAGGCGCGCGGGTCGGACCTGGACGACAGGGCTGCCGAGC
TGAGGCGGCAGTTCGCGAGCCTCACGGCGTTGCGTCCCGTCGGGGCCGCG
GCCGTGCCGTTACTGAGCGCGGGGGGGTTAGTGTCCCCCCAATCCGGCCCC
GACGCCGCGGTGTTTCGCAGCTCGCTGGGGTCCCTGCTGTACTGGCCCGGG
GTGCGCGCGCTGCTGGACCGCGACTGTCGCGTGGCCGCCCGCTATGCCGGC
CGCATGACGTACCTGGCCACCGGGGCCCTGCTCGCCCGCTTCAATCCCGACG
CCGTCCGGTGCGTTTTGACGCGGGAGGCCGCCTTCCTGGGGCGCGTGCTGG
ATGTGTTGGCGGTGATGGCGGAACAGACGGTCCAGTGGCTCTCGGTGGTC
GTGGGGGCGCGCCTGCACCCGCACGTGCACCACCCCGCCTTTGCGGACGTG
GCGCGGGAGGAGCTGTTTCGCGCCCTGCCCCTGGGAAGCCCCGCGGTCGT
GGGGGCCGAGCACGAGGCGCTGGGCGACACCGCAGCGCGCCGGCTGCTCG
CCAACAGCGGGCTCAACGCCGTGCTGGGCGCTGCGGTGTACGCGCTGCACA
CGGCCCTGGCGACAGTGACCTTAAAGTACGCCCGGGCGTGCGGGGACGCG
CACCGGCGCCGGGACGACGCTGCGACCACGCGCGCCATTCTGGCCGCCGGG
CTCGTCCTGCAGCGGCTGCTGGGCTTTGCCGACACCGTGGTGGCGTGCGTG
ACACTGGCCGCGTTTGACGGGGGATTCACGGCCCCCGAGGTGGGCACGTAC
7 Appendix 
204 
 
ACCCCCCTGCGCTACGCGTGTGTCCTCCGAGCGACCCAGCCCCTGTACGCGC
GCACCACCCCCGCCAAGTTCTGGGCGGACGTCCGCGCGGCCGCGGAGCACG
TGGATCTGCGCCCCGCCTCCTCCGCGCCCCGGGCCCCCGTGTCCGGGACGG
CAGACCCCGCCTTTCTGCTCAAGGACCTGGAGCCCTTCCCCCCCGCCCCCGTA
AGCGGCGGGTCCGTGTTGGGCCCGCGGGTCCGCGTGGTGGACATCATGTC
CCAGTTTAGGAAACTGCTGATGGGAGACGAGGGGGCCGCCGCCCTGCGGG
CGCACGTGTCGGGGAGGCGCGCGACCGGGCTGGGAGGCCCGCCACGCCCA 
TAA 
UL48 
ATGGACCTCTTGGTCGACGAGCTGTTTGCCGACATGGACGCGGACGGCGCT
TCGCCACCACCCCCCCGCCCGGCCGGGGGTCCCAAAAACACCCCGGCGGCCC
CTCCGCTGTACGCAACGGGGCGCCTGAGCCAGGCCCAGCTCATGCCCTCCCC
GCCCATGCCCGTCCCCCCCGCCGCCCTCTTTAACCGTCTCCTCGACGACTTGG
GCTTTAGCGCGGGCCCCGCGCTATGTACCATGCTCGATACCTGGAACGAGG
ATTTGTTTTCGGCGTTACCGACCAACGCCGACCTGTACCGGGAGTGTAAATT
CCTATCAACGCTGCCCAGCGATGTGGTGGAATGGGGGGACGCGTACGTCCC
CGAACGCGCCCAAATCGACATTCGCGCCCACGGCGACGTGGCCTTCCCGACG
CTTCCGGCCACCCGCGACGGCCTCGGGCTCTACTACGAAGCGCTCTCTCGTT
TCTTCCACGCCGAGCTACGGGCGCGGGAGGAGAGCTATCGAACCGTGTTGG
CCAACTTCTGCTCGGCCCTGTACCGGTACCTGCGCGCCAGCGTCCGGCAGCT
GCACCGCCAGGCGCACATGCGCGGACGCGATCGCGACCTGGGAGAAATGCT
GCGCGCCACGATCGCGGACAGGTACTACCGAGAGACCGCTCGTCTGGCGCG
TGTTCTGTTTTTGCATTTGTATCTATTTTTGACCCGCGAGATCCTATGGGCCG
CGTACGCCGAGCAGATGATGCGGCCCGACCTGTTTGACTGCCTCTGTTGCG
ACCTGGAGAGCTGGCGTCAGTTGGCGGGTCTGTTCCAGCCCTTCATGTTCG
TCAACGGAGCGCTCACCGTCCGGGGAGTGCCAATCGAGGCCCGCCGGCTGC
GGGAGCTAAACCACATTCGCGAGCACCTTAACCTCCCGCTGGTGCGCAGCGC
GGCTACGGAGGAGCCAGGGGCGCCGTTGACGACCCCTCCCACCCTGCATGG
CAACCAGGCCCGCGCCTCTGGGTACTTTATGGTGTTGATTCGGGCGAAGTT
GGACTCGTATTCCAGCTTCACGACCTCGCCCTCCGAGGCGGTCATGCGGGAA
CACGCGTACAGCCGCGCGCGTACGAAAAACAATTACGGGTCTACCATCGAG
GGCCTGCTCGATCTCCCGGACGACGACGCCCCCGAAGAGGCGGGGCTGGC
GGCTCCGCGCCTGTCCTTTCTCCCCGCGGGACACACGCGCAGACTGTCGACG
GCCCCCCCGACCGATGTCAGCCTGGGGGACGAGCTCCACTTAGACGGCGAG
7 Appendix 
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GACGTGGCGATGGCGCATGCCGACGCGCTAGACGATTTCGATCTGGACATG
TTGGGGGACGGGGATTCCCCGGGTCCGGGATTTACCCCCCACGACTCCGCC
CCCTACGGCGCTCTGGATATGGCCGACTTCGAGTTTGAGCAGATGTTTACCG 
ATGCCCTTGGAATTGACGAGTACGGTGGGTAG 
UL49 
ATGACCTCTCGCCGCTCCGTGAAGTCGGGTCCGCGGGAGGTTCCGCGCGAT
GAGTACGAGGATCTGTACTACACCCCGTCTTCATGTATGGCGAGTCCCGATA
GTCCGCCTGACACCTCCCGCCGTGGCGCCCTACAGACACGCGCGCGCCCAAG
GGGCGAGGTCCGTTTCGTCCAGTACGACGAGTCGGATTATGCCCTCTACGG
GGGCTCGTCATCCGAAGACGACGAACACCCGGAGGTCCCCCGGACGCGGCG
TCCCGTTTCCGGGGCGGTTTTGTCCGCCCCGGGGCCTGCGCGGGCGCCTCC
GCCGCCCGCTGGGTCCGGAGGGGCCGGACGCACACCCACCACCGCCCCCCG
GGCCCCCCGAACCCAGCGGGTGGCGACTAAGGCCCCCGCGGCCCCGGCGGC
GGAGACCACCCGCGGCAGGAAATCGGCCCAGCCAGAATCCGCCGCACTCCC
AGACGCCCCCGCGTCGACGGCGCCAACCCGATCCAAGACACCCGCGCAGGG
GCTGGCCAGAAAGCTGCACTTTAGCACCGCCCCCCCAAACCCCGACGCGCCA
TGGACCCCCCGGGTGGCCGGCTTTAACAAGCGCGTCTTCTGCGCCGCGGTT
GGGCGCCTGGCGGCCATGCATGCCCGGATGGCGGCGGTCCAGCTCTGGGA
CATGTCGCGTCCGCGCACAGACGAAGACCTCAACGAACTCCTTGGCATCACC
ACCATCCGCGTGACGGTCTGCGAGGGCAAAAACCTGATTCAGCGCGCCAAC
GAGTTGGTGAATCCAGACGTGGTGCAGGACGTCGACGCGGCCACGGCGAC
TCGAGGGCGTTCTGCGGCGTCGCGCCCCACCGAGCGACCTCGAGCCCCAGC 
CCGCTCCGCTTCTCGCCCCAGACGGCCCGTCGAGTGA 
UL50 
ATGAGTCAGTGGGGATCCGGGGCGATCCTTGTCCAGCCGGACAGCTTGGGT
CGGGGGTACGATGGCGACTGGCACACGGCCGTCGCTACTCGCGGGGGCGG
AGTCGTGCAACTGAACCTGGTCAACAGGCGCGCGGTGGCTTTTATGCCGAA
GGTCAGCGGGGACTCCGGATGGGCCGTCGGGCGCGTCTCTCTGGACCTGC
GAATGGCTATGCCGGCTGACTTTTGTGCGATTATTCACGCCCCCGCGCTATC
CAGCCCAGGGCACCACGTAATACTGGGTCTTATCGACTCGGGGTACCGCGG
AACCGTTATGGCCGTGGTCGTAGCGCCTAAAAGGACGCGGGAATTTGCCCC
CGGGACCCTGCGGGTCGACGTGACGTTCCTGGACATCCTGGCGACCCCCCC
GGCCCTCACCGAGCCGATTTCCCTGCGGCAGTTCCCGCAACTGGCGCCCCCC
7 Appendix 
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CCTCCAACCGGGGCCGGGATACGCGCAGATCCTTGGTTGGAGGGGGCGCTC
GGGGACCCAAGCGTGACTCCTGCCCTACCGGCGCGACGCCGAGGGCGGTCC
CTCGTCTATGCCGGCGAGCTGACGCCGGTTCAGACGGAACACGGGGACGGC
GTACGAGAAGCCATCGCCTTCCTTCCAAAACGCGAGGAGGATGCCGGTTTC
GACATTGTCGTCCGTCGCCCGGTCACCGTCCCGGCAAACGGCACCACGGTCG
TGCAGCCATCCCTCCGCATGCTCCACGCGGACGCCGGGCCCGCGGCCTGCTA
TGTGCTGGGGCGGTCGTCGCTCAACGCCCGCGGCCTCCTGGTCGTTCCTAC
GCGCTGGCTCCCCGGGCACGTATGTGCGTTTGTTGTTTACAACCTTACGGG
GGTTCCTGTGACCCTCGAGGCCGGCGCCAAGGTCGCCCAGCTCCTGGTTGC
GGGGGCGGACGCTCTTCCTTGGATCCCCCCGGACAACTTTCACGGGACCAA
AGCGCTTCGAAACTACCCCAGGGGTGTTCCGGACTCAACCGCCGAACCCAG
GAACCCGCCGCTCCTGGTGTTTACGAACGAGTTTGACGCGGAGGCCCCCCC 
GAGCGAGCGCGGGACCGGGGGTTTTGGTTCTACCGGTATTTAG 
UL51 
ATGGCTTCTCTTCTCGGGGCTATATGTGGCTGGGGAGCGCGCCCCGAGGAA
CAATATGAGATGATCCGCGCGGCCGTTCCGCCCTCGGAGGCGGAGCCGCGG
CTGCAGGAGGCCCTGGTGGTCGTTAACGCGCTACTTCCCGCCCCCATCACGC
TCGATGACGCCCTGGGGTCCCTGGACGACACCCGACGCCTCGTGAAGGCCC
GCGCCTTGGCCCGCACGTACCACGCCTGCATGGTGAACCTAGAACGACTGG
CGCGCCACCACCCCGGGCTCGAGGCCCCCACGATCGACGGGGCCGTGGCGG
CCCATCAGGACAAGATGCGGCGCCTGGCGGACACGTGTATGGCCACCATCC
TGCAGATGTACATGTCCGTGGGGGCGGCTGACAAGTCCGCGGATGTGCTCG
TCTCCCAGGCTATTCGGAGCATGGCCGAGAGCGACGTGGTCATGGAGGATG
TGGCCATCGCCGAACGGGCCCTTGGCCTCTCCGCCTTCGGGGTTGCCGGGG
GAACCCGCTCGGGGGGGCTTGGGGTGACCGAGGCGCCCTCCTTGGGGCAC
CCCCACACGCCGCCCCCGGAGGTTACGCTGGCGCCTGCCGCCCGAAACGGC
GACGCCCTCCCGGACCCCAAACCGGAATCGTGTCCCCGCGTGTCCGTTCCCA
GACCTACAGCCTCCCCAACCGCACCTCGCCCTGGCCCATCTCGAGCAGCTCC 
GTGTGTTTTGGGTCAATAA 
UL55 
ATGACAGCGACCCCCCTCACCAACCTGTTCTTACGGGCCCCGGACATAACCC
ACGTGGCCCCCCCTTACTGCCTCAACGCCACCTGGCAGGCCGAAACGGCCAT
GCACACCAGCAAAACGGACTCCGCTTGCGTGGCCGTGCGGAGTTACCTGGT
7 Appendix 
207 
 
CCGCGCCTCCTGTGAGACCAGCGGCACAATCCACTGCTTTTTCTTTGCGGTA
TACAAGGACACCCACCATACCCCTCCGCTGATTACCGAGCTCCGCAACTTTGC
GGACCTGGTTAACCACCCGCCGGTCCTACGCGAACTGGAGGATAAGCGCGG
GGTGCGGCTGCGGTGTGCGCGGCCGTTTAGCGTCGGGACGATTAAGGACG
TCTCTGGGTCCGGCGCGTCCTCGGCGGGAGAGTACACGATAAACGGGATCG
TGTACCACTGCCACTGTCGGTATCCGTTCTCAAAAACATGCTGGATGGGGGC
CTCCGCGGCCCTACAGCACCTGCGCTCCATCAGCTCCAGCGGCATGGCCGCC 
CGCGCGGCAGAGCATCGACGCGTCAAGATTAAAATTAAGGCGTGA 
US2 
ATGGGCGTTGTTGTCGTCAACGTAATGACCCTCCTTGACCAGAACAACGCCC
TGCCCCGGACTTCCGTCGACGCAAGCCCGGCCCTGTGGAGCTTCCTGCTTAG
GCAGTGCCGCATTTTGGCATCAGAACCCCTGGGTACCCCGGTCGTCGTTCGC
CCGGCCAACCTTCAACGGTTGGCCGAGCCGCTGATGGACTTACCCAAACCCA
CCCGCCCGATCGTGCGCACTAGGTCCTGTCGCTGCCCCCCAAACATCACCAC
GGGCCTGTTTGCGGAGGACAGCCCCTTGGAGAGCACCGAGGTCGTGGACG
CCGTGGCGTGCTTCCGACTGTTGCACCGAGACCAACCCAGCCCCCCTCGCCT
CTACCACTTGTGGGTGGTAGGCGCGGCGGATCTGTGTGTGCCGTTTCTCGA
ATACGCCCAAAAAATCCGGCTCGGGGTAAGATTTATCGCCATCAAGACCCCA
GACGCGTGGGTGGGAGAACCGTGGGCCGTGCCGACTCGGTTTTTGCCCGA
GTGGACCGTGGCGTGGACCCCGTTCCCCGCGGCACCCAACCACCCCCTGGA
GACCCTGCTCAGCCGGTACGAATACCAGTACGGCGTGGTCCTGCCCGGGAC
CAACGGACGGGAGCGCGATTGTATGCGCTGGCTGCGGTCCCTGATTGCTCT
GTACAAACCCCACCCAGCTACCTCCCACCCCCTTACGACGTCCCATTCGGTGC
GGCGTCCGTGTTGTGCGTGTATGGGTATGCCCGAGATTTTAGACGAGCAAC
CCACATCACCGGGCCGTGGTCCGCAAGAAACGGACCCTCTGATCGCCGTTCG 
CGGCGAACGGCCCAGACTTCCTCACATCTGCTATCCGGTTACCACCCTTTAG 
US3 
ATGGCCTGTCGTAAGTTTTGTCGCGTTTACGGGGGACAGGGCAGGAGGAA
GGAGGAGGCCGTCCCGCCGGAGACAAAGCCGTCCCGGGTGTTTCCTCATGG
CCCCTTTTATACCCCAGCCGAGGACGCGTGCCTGGACTCCCCGCCCCCGGAG
ACCCCCAAACCTTCCCACACCACACCACCCGGCGATGCCGAGCGCCTGTGTC
ATCTGCAGGAGATCCTGGCCCAGATGTACGGAAACCAGGACTACCCCATAG
AGGACGACCCCAGCGCGGATGCCGCGGACGATGTCGACGAGGACGCCCCG
7 Appendix 
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GACGACGTGGCCTATCCGGAGGAATACGCAGAGGAGCTTTTTCTGCCCGGG
GACGCGACCGGTCCCCTTATCGGGGCCAACGACCACATCCCTCCCCCGCGTG
GCGCATCTCCCCCCGGTATACGACGACGCAGCCGGGATGAGATTGGGGCCA
CGGGATTTACCGCAGAAGAGCTGGACGCCATGGACAGGCAGGCGGCTCGA
GCCATCAGCCGCGGCGGCAAGCCCCCCTCGACCATGGCCAAGCTGGTGACT
GGCATGGGCTTTACGATCCACGGAGCGCTCACCCCAGGATCGGAGGGGTGT
GTCTTTGACAGCAGCCACCCAGATTACCCCCAACGGGTAATCGTGAAGGCG
GGGTGGTACACGAGCACGAGCCACGAGGCGCGACTGCTGAGGCGACTGGA
CCACCCGGCGATCCTGCCCCTCCTGGACCTGCATGTCGTCTCCGGGGTCACG
TGTCTGGTCCTCCCCAAGTACCAGGCCGACCTGTATACCTATCTGAGTAGGC
GCCTGAACCCACTGGGACGCCCGCAGATCGCAGCGGTCTCCCGGCAGCTCC
TAAGCGCCGTTGACTACATTCACCGCCAGGGCATTATCCACCGCGACATTAA
GACCGAAAATATTTTTATTAACACCCCCGAGGACATTTGCCTGGGGGACTTT
GGTGCCGCGTGCTTCGTGCAGGGTTCCCGATCAAGCCCCTTCCCCTACGGAA
TCGCCGGAACCATCGACACCAACGCCCCCGAGGTCCTGGCCGGGGATCCGT
ATACCACGACCGTCGACATTTGGAGCGCCGGTCTGGTGATCTTCGAGACTGC
CGTCCACAACGCGTCCTTGTTCTCGGCCCCCCGCGGCCCCAAAAGGGGCCCG
TGCGACAGTCAGATCACCCGCATCATCCGACAGGCCCAGGTCCACGTTGACG
AGTTTTCCCCGCATCCAGAATCGCGCCTCACCTCGCGCTACCGCTCCCGCGC
GGCCGGGAACAATCGCCCGCCTTACACCCGACCGGCCTGGACCCGCTACTAC
AAGATGGACATAGACGTCGAATATCTGGTTTGCAAAGCCCTCACCTTCGACG
GCGCGCTTCGCCCCAGCGCCGCAGAGCTGCTTTGTTTGCCGCTGTTTCAACA 
GAAATGA 
US10 
ATGATCAAGCGGCGGGGCAATGTGGAGATTCGGGTCTACTACGAGTCGGT
GCGGACACTACGATCTCGAAGCCATCTGAAGCCGTCCGACCGCCAACAATCC
CCAGGACACCGCGTGTTCCCCGGGAGCCCCGGGTTCCGCGACCACCCCGAG
AACCTAGGGAACCCAGAGTACCGCGAGCTCCCAGAGACCCCAGGGTACCGC
GTGACCCCAGGGATCCACGACAACCCCGGTCTCCCAGGGAGCCCCGGACCC
CACGCACCCCCCGCGAACCACGTACGGCTCGCGGGTCTGTATAGCCCGGGC
AAGTATGCCCCCCTGGCGAGCCCAGACCCCTTCTCCCCACAAGATGGAGCAT
ACGCTCGGGCCCGCGTCGGGATCCACACCGCGGTTCGCGTCCCGCCCACCG
GAAGCCCAACCCACACGCACTTGCGGCAAGACCCGGGCGATGAGCCAACCT
CGGATGACTCAGGGCTCTACCCTCTGGACGCCCGGGCGCTTGCGCACCTGG
7 Appendix 
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TGATGTTGCCCGCGGACCACCGGGCCTTCTTTCGAACCGTGGTCGAGGTGT
CTCGCATGTGCGCTGCAAACGTGCGCGATCCCCCGCCCCCGGCTACAGGGG
CCATGTTGGGCCGCCACGCGCGGCTGGTCCACACCCAGTGGCTCCGGGCCA
ACCAAGAGACGTCGCCCCTGTGGCCCTGGCGGACGGCGGCCATTAACTTTA
TCACCACCATGGCCCCCCGCGTCCAAACCCACCGACACATGCACGACCTGTT
GATGGCCTGTGCTTTCTGGTGCTGTCTGACACACGCATCGACGTGTTCGTAC
GCGGGGCTGTACTCGACCCACTGCCTGCATCTGTTTGGTGCGTTTGGGTGT 
GGGGACCCGGCCCTAACCCCACCCCTGTGCTAG 
US11 
ATGAGCCAGACCCAACCCCCGGCCCCAGTTGGGCCGGGCGACCCAGATGTT
TACTTAAAAGGCGTGCCGTCCGCCGGCATGCACCCCAGAGGTGTTCACGCAC
CTCGAGGACACCCGCGCATGATCTCCGGACCCCCGCAACGGGGTGATAATG
ATCAAGCGGCGGGGCAATGTGGAGATTCGGGTCTACTACGAGTCGGTGCG
GACACTACGATCTCGAAGCCATCTGAAGCCGTCCGACCGCCAACAATCCCCA
GGACACCGCGTGTTCCCCGGGAGCCCCGGGTTCCGCGACCACCCCGAGAAC
CTAGGGAACCCAGAGTACCGCGAGCTCCCAGAGACCCCAGGGTACCGCGTG
ACCCCAGGGATCCACGACAACCCCGGTCTCCCAGGGAGCCCCGGACCCCACG 
CACCCCCCGCGAACCACGTACGGCTCGCGGGTCTGTATAG 
Strain 17 ICP0 sequence from pGBKT7-ICP0 with 5’ NcoI site and 3’ BamHI site 
underlined 
CCATGGAGCCCCGCCCCGGAGCGAGTACCCGCCGGCCTGAGGGCCGCCCCC
AGCGCGAGCCCGCCCCGGATGTCTGGGTGTTTCCCTGCGACCGAGACCTGC
CGGACAGCAGCGACTCTGAGGCGGAGACCGAAGTGGGGGGGCGGGGGGA
CGCCGACCACCATGACGACGACTCCGCCTCCGAGGCGGACAGCACGGACAC
GGAACTGTTCGAGACGGGGCTGCTGGGGCCGCAGGGCGTGGATGGGGGG
GCGGTCTCGGGGGGGAGCCCCCCCCGCGAGGAAGACCCCGGCAGTTGCGG
GGGCGCCCCCCCTCGAGAGGACGGGGGGAGCGACGAGGGCGACGTGTGC
GCCGTGTGCACGGATGAGATCGCGCCCCACCTGCGCTGCGACACCTTCCCGT
GCATGCACCGCTTCTGCATCCCGTGCATGAAAACCTGGATGCAATTGCGCAA
CACCTGCCCGCTGTGCAACGCCAAGCTGGTGTACCTGATAGTGGGCGTGAC
GCCCAGCGGGTCGTTCAGCACCATCCCGATCGTGAACGACCCCCAGACCCGC
ATGGAGGCCGAGGAGGCCGTCAGGGCGGGCACGGCCGTGGACTTTATCTG
GACGGGCAATCAGCGGTTCGCCCCGCGGTACCTGACCCTGGGGGGGCACAC
7 Appendix 
210 
 
GGTGAGGGCCCTGTCGCCCACCCACCCGGAGCCCACCACGGACGAGGATGA
CGACGACCTGGACGACGCAGACTACGTACCGCCCGCCCCCCGCCGGACGCC
CCGCGCCCCCCCACGCAGAGGCGCCGCCGCGCCCCCCGTGACGGGCGGGGC
GTCTCACGCAGCCCCCCAGCCGGCCGCGGCTCGGACAGCGCCCCCCTCGGC
GCCCATCGGGCCACACGGCAGCAGTAACACCAACACCACCACCAACAGCAGC
GGCGGCGGCGGCTCCCGCCAGTCGCGAGCCGCGGCGCCGCGGGGGGCGTC
TGGCCCCTCCGGGGGGGTTGGGGTTGGGGTTGGGGTTGTTGAAGCGGAG
GCGGGGCGGCCGAGGGGCCGGACGGGCCCCCTTGTCAACAGACCCGCCCC
CCTTGCAAACAACAGAGACCCCATAGTGATCAGCGACTCCCCCCCGGCCTCT
CCCCACAGGCCCCCCGCGGCGCCCATGCCAGGCTCCGCCCCCCGCCCCGGGC
CCCCCGCGTCCGCGGCCGCGTCGGGACCCGCGCGCCCCCGCGCGGCCGTGG
CCCCGTGCGTGCGAGCGCCGCCTCCGGGGCCCGGCCCCCGCGCCCCGGCCC
CCGGGGCGGAGCCGGCCGCCCGCCCCGCGGACGCGCGCCGTGTGCCCCAG
TCGCACTCGTCCCTGGCTCAGGCCGCGAACCAAGAACAGAGTCTGTGCCGG
GCGCGTGCGACGGTGGCGCGCGGCTCGGGGGGGCCGGGCGTGGAGGGTG
GGCACGGGCCCTCCCGCGGCGCCGCCCCCTCCGGCGCCGCCCCGCTCCCCTC
CGCCGCCTCTGTCGAGCAGGAGGCGGCGGTGCGTCCGAGGAAGAGGCGCG
GGTCGGGCCAGGAAAACCCCTCCCCCCAGTCCACGCGTCCCCCCCTCGCGCC
GGCAGGGGCCAAGAGGGCGGCGACGCACCCCCCCTCCGACTCAGGGCCGG
GGGGGCGCGGCCAGGGTGGGCCCGGGACCCCCCTGACGTCCTCGGCGGCC
TCCGCCTCTTCCTCCTCTGCCTCTTCCTCCTCGGCCCCGACCCCCGCGGGGGC
CGCCTCTTCCGCCGCCGGGGCCGCGTCCTCCTCCGCTTCCGCCTCCTCGGGC
GGGGCCGTCGGTGCCCTGGGAGGGAGACAAGAGGAAACCTCCCTCGGCCC
CCGCGCTGCTTCTGGGCCGCGGGGGCCGAGGAAGTGTGCCCGGAAGACGC
GCCACGCGGAGACTTCCGGGGCCGTCCCCGCGGGCGGCCTCACGCGCTACC
TGCCCATCTCGGGGGTCTCTAGCGTGGTCGCCCTGTCGCCTTACGTGAACAA
GACTATCACGGGGGACTGCCTGCCCATCCTGGACATGGAGACGGGGAACAT
CGGGGCGTACGTGGTCCTGGTGGACCAGACGGGAAACATGGCGACCCGGC
TGCGGGCCGCGGTCCCCGGCTGGAGCCGCCGCACCCTGCTCCCCGAGACCG
CGGGTAACCACGTGATGCCCCCCGAGTACCCGACGGCCCCCGCGTCGGAGT
GGAACAGCCTCTGGATGACCCCCGTGGGGAACATGCTGTTCGACCAGGGCA
CCCTAGTGGGCGCCCTGGACTTCCGCAGCCTGCGGTCTCGGCACCCGTGGT
CCGGGGAGCAGGGGGCGTCGACCCGGGACGAGGGAAAACAATAAGGGAC
GCCCCCCGTGTTTGTGGGGAGGGGGGGGTCGGGCGCTGGGTGGTCTCTGG
7 Appendix 
211 
 
CCGCGCCCACTACACCAGCCAATCCGTGTCGGGGAGGGGAAAAGTGAAAGA
CACGGGCACCACACACCAGCGGGTCTTTTGTGTTGGCCCTAATAAAAAAAAA
CTCAGGGGATTTTTGCTGTCTGTTGGGAAATAAAGGTTTACTTTTGTATCTT
TTCCCTGTCTGTGTTGGATGTATCGCGGGGATGCGTGGGAGTGGGGGTGC
GTGGGAGTGGGGGTGCGTGGGAGTGGGGGTGCGTGGGAGTGGGGGTGC
GTGGGAGTGGGGGTGCGTGGGAGTGGGGGTGCGTGGGAGTGGGGGTGC
GTGGGAGTGGGGGTGCGTGGGAGTGGGGGTGCCATGTTGGGCAGGCTCT 
GGTGTTAGCTTCGGGGGATCC 
7.1.2 CC2D1B sequence 
CC2D1B sequence from pHB18-CC2D1B full length cloned by PCR using human cDNA 
library as library with the missing 18 bp underlined compared to the CC2D1B full length 
ORF (2577bp, Gene ID: 200014). This 18 bp deletion was confirmed by independent 
sequencing of plasmid pcDNA3-CC2D1B-flag (kindly provided by P. Albert at University 
of Ottawa). 
ATGATGCCAGGGCCAAGACCTCGGAAGGGCCCTCAGGCCAGAGGCCAAGG
GGTGGCCGCTGCCAAGCAGATGGGGCTCTTTATGGAGTTTGGCCCTGAGGA
CATGCTGCTGGGCATGGATGAGGCTGAAGATGATGAGGACCTGGAGGCTG
AGCTGCTGGCTCTCACAGGGGAAGCACAAACCACAGGCAAGAAGCCAGCAC
CCAAGGGGCAGGCCCCCCTGCCCATGGCCCACATCGAGAAGTTGGCGGCAG
ACTGTATGCGGGATGTGGAGGAGGAGGAGGAGGAGGAAGGGCTGGAGGA
AGATGCAGAGCTGCTGACGGAGCTGCAGGAGGTCTTAGGTGTGGACGAGG
AGACTGAGCCCCTGGATGGTGATGAGGTAGCTGACCCAGGCGGCTCTGAG
GAGGAGAACGGCCTAGAAGACACTGAACCTCCAGTGCAGACAGCCGTCCTG
ACAGCTTCAGCCCCAGCAGCTCAGGCCGGAGCATCTCAGGGGCTACACGCTT
TGCTGGAGGAACGGATTCACAACTACCGAGAGGCTGCGGCCAGTGCCAAGG
AGGCAGGCGAAGCAGCCAAAGCCAGGCGCTGCGAGCGCGGCCTGAAGACC
TTGGAGTCGCAGCTAGCCTCTGTGAGGAGAGGCAGAAAGATCAATGAGGA
TGAGATCCCACCTCCAGTGGCCTTAGGAAAGCGGCCCCTGGCCCCCCAGGA
ACCAGCCAACAGGAGCCCTGAGACAGACCCTCCAGCTCCCCCTGCCTTGGAG
TCAGACAACCCCTCCCAACCTGAGACCAGCCTCCCTGGCATTTCTGCCCAGCC
CGTTTCAGACTTAGACCCAGACCCGCGGGCCCTGCTGTCATCCCGACAGAGA
GAGTACAAAGTGGCTGCCCTCAGTGCCAAGCGGGCTGGAGAGCTAGACCGT
GCCCGAGAGCTCATGAGGATTGGGAAGAGATTCGGTGCTGTCCTGGAGGC
7 Appendix 
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CCTGGAGAAGGGGCAGCCCGTGGATCTGAGTGCCATGCCCCCGGCACCTGA
GGATCTGAAGCCCCAGCAGGCTTCTCAGGCTCCCACAGCACCCTCAGTCATT
CCCCCAGCCGTGGAGCGAGTGCAGCCAGTGATGGCCCCTGACGTCCCAGCA
ACCCCAGTGGCCCCTACAGAGTCACAGACAGTGCTGGATGCCCTGCAGCAG
AGGCTGAACAAGTACCGCGAGGCGGGCATCCAGGCCCGGAGTGGTGGGGA
CGAGCGCAAGGCTCGGATGCATGAGCGCATTGCCAAGCAATATCAAGATGC
TATTCGAGCACACCGAGCAGGACGGAAAGTCAACTTTGCTGAATTGCCTGTT
CCTCCAGGATTTCCCCCCATCCCTGGCCTGGAGTCCACTATGGGTGTTGAGG
AGGACGCAGTGGCAGCGACATTGGCAGCTGCAGAGAAACTGGCCTCTGCAG
AGGATTCAGCCCCGGCTGATAAAGACGAGGACGAGCCTCCTGGGCACCTGC
AGGGTGAGCCCCCAGCACAGGCCCCAGTGGCCAAGAAACCTGCACGGCCCA
CAGTCCCTTCATCCCAGCGCCTGCCTGAGCCCAGGGCCTCAAGTTCTAAGGA
GTCACCGAGTCCATCTGTGCGGGAGCAGCTGGCACTGCTGGAGGCACGGAA
ACTGCAGTATCAGCGGGCAGCCCTGCAGGCCAAGCGCAGCCAGGACCTGGA
GCAGGCCAAAGCCTATCTGCGGGTAGCCAAATGGCTTGAGGCTCAGATCAT
CCAGGCCCGATCTGGCAGACCTGTTGATCTGTCCAAGGTGCCTTCGCCCTTG
ACGGATGAGGAGGGTGACTTCATCCTCATCCACCATGAGGACCTGCGACTCT
CCCAGAAGGCGGAGGAGGTGTATGCCCAGCTGCAAAAAATGCTTCTGGAGC
AACAAGAGAAGTGCCTGCTGTTCTCCAAGCAGTTCATGCACCAGGGCAACGT
GGCTGAGACCACCCGATTTGAGAAGCTTGCTCAGGACCGCAAGAAACAGCT
GGAGATCCTGCAGCTGGCCCAGGCTCAGGGCCTCGACCCTCCCACCCACCAC
TTTGAGTTGAAGACATTCCAGACTGTGAGGATCTTCTCAGAACTCAACAGCA
CAGAAATGCATCTGATCATTGTCCGGGGAATGAACCTCCCAGCCCCTCCAGG
GGTGACTCCCGATGACCTGGATGCTTTTGTGCGGTTTGAGTTTCACTACCCT
AACTCGGACCAGGCTCAAAAAAGCAAAACAGCTGTGGTGAAGAACACAAAC
TCTCCAGAATTTGATCAACTCTTCAAACTAAACATCAACCGAAACCACCGGGG
CTTCAAGAGGGTGATCCAGAGCAAAGGCATCAAGTTTGAGATCTTCCACAAA
GGGTCCTTCTTCAGAAGCGACAAGCTGGTTGGCACAGCACACCTGAAACTG
GAGCGGCTGGAGAATGAGTGTGAGATCAGAGAAATTGTGGAGGTCCTGGA
TGGAAGGAAGCCCACCGGGGGGAAGCTGGAGGTGAAGGTGAGGCTGCGG
GAGCCTCTGAGTGGCCAGGATGTGCAGATGGTCACTGAGAACTGGCTGGTT 
CTGGAGCCCAGGGGCTTGTGA 
7 Appendix 
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7.2 Tubulin quantification of Figure 4.10 
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